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Bacteriophages have received attention as biological control agents since their 
discovery and recently their value as tools has been further emphasized in many 
different fields of microbiology. Particularly, in drug design and development 
programs, phage and prophage genomics provide the field with new insights. 
Bacteriophages reveals information on the organisms ranging from their biology to 
their applications in agriculture and medicine. Contributors address a variety of topics 
capturing information on advancing technologies in the field. The book starts with 
the biology and classification of bacteriophages with subsequent chapters addressing 
phage infections in industrial processes and their use as therapeutic or biocontrol 
agents. Microbiologists, biotechnologists, agricultural, biomedical and sanitary 
engineers will find Bacteriophages invaluable as a solid resource and reference book.
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in microbial culture collections and their sustainable 
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also worked with bacteriophages since 1986 with particular reference to 
their use as tools in drug discovery.  Since joining the USC in 2001, she has 
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D.I. Kurtböke
Preface 
Therapeutic use of bacteriophages for the prevention and treatment of bacterial 
diseases has been pursued since the discovery of phages in 1917 by d'Herelle. 
Following the advancement of biomedical research, phages have gained further 
importance in biomedicine and examples include the use of polysaccharide-specific 
phages to treat encapsulated pathogenic bacteria forming biofilms on medical devices. 
Genetic engineering of bacteriophages to produce cell death without lysis, hence 
avoiding the release of unwanted endotoxins during control of pathogenic bacteria, 
has also been in progress. Due to increasing antibiotic resistance, phage-derived lytic 
enzymes are also being exploited to control infectious bacteria. In antibiotic resistant 
Gram-positive bacteria, even small quantities of purified recombinant lysin added 
externally have been reported to lead to immediate lysis of the pathogenic cell wall 
making them ideal anti-infectives due to lysin specificity against the pathogens. 
Improved understanding of bacteriophage injectory mechanisms also contributes to 
our knowledge of bacterial secretion mechanisms, particularly the ones in Type VI 
secretion systems (T6SS), which seem to use the same mechanism as bacteriophages to 
inject their DNA into bacterial cell. Moreover, advancements in prophage genomics 
improve the understanding of phage-bacterium interaction at the genetic level 
revealing prophage gene derived-virulence factors and their contribution to fitness 
increase of the pathogenic bacteria.  
Targeting host bacterial functional diversity, in which certain metabolic activities 
might be triggered in a defined ecosystem following phage-mediated gene transfer 
might also offer clues for host biosynthetic activities. As a result, an evaluation of the 
role of host-phage interactions in antibiotic production as well as in rendering 
antibiotics ineffective via lysogenation or prophage exertion will further complement 
therapeutic success. 
Bacteriophages are also utilized as successful biocontrol agents in agriculture as well 
as surrogates and tracers of the fate and transport of pathogens in source water and 
drinking water treatment processes. However, they can also result in significant 
economic losses as contaminants of dairy and natto factories, therefore their detection 
with the aid of effective methods and removal of extreme importance for the industry. 
Bacteriophages is therefore intended to serve as a reference book covering both 
XII Preface
background information as well as current advancements in the field including the use 
of molecular techniques for early detection of bacteriophage contamination in 
industrial operations.  
I thank all contributing Authors who have generously given their time and expertise to 
make Bacteriophages a key collection and their timely meeting of the deadlines has been 
greatly appreciated. I also thank Hans-Wolfgang Ackermann (Canada), Stephen Abedon 
(USA), Nina Chanishvili (Georgia) and Ian Macreadie (Australia) for their invaluable 
contribution to the peer review process. Technical assistance provided by Intech 
Editorial Office during the production of the book is also gratefully acknowledged. 
Ipek Kurtböke 
University of the Sunshine Coast, 
Australia 
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Bacteriophages  
and Their Structural Organisation  
E.V. Orlova  
Institute for Structural and Molecular Biology,  
Department of Biological Sciences, Birkbeck College, 
UK  
1. Introduction 
Viruses are extremely small infectious particles that are not visible in a light microscope, and 
are able to pass through fine porcelain filters. They exist in a huge variety of forms and 
infect practically all living systems: animals, plants, insects and bacteria. All viruses have a 
genome, typically only one type of nucleic acid, but it could be one or several molecules of 
DNA or RNA, which is surrounded by a protective stable coat (capsid) and sometimes by 
additional layers which may be very complex and contain carbohydrates, lipids, and 
additional proteins. The viruses that have only a protein coat are named “naked”, or non-
enveloped viruses. Many viruses have an envelope (enveloped viruses) that wraps around 
the protein capsid. This envelope is formed from a lipid membrane of the host cell during 
the release of a virus out of the cell.  
Viruses interacting with different types of cells in living organisms produce different types 
of disease. Each virus infects a certain type of cell which is usually called “host” cell. The 
major feature of any viral disease is cell lysis, when a cell breaks open and subsequently 
dies. In multicellular organisms, if enough cells die, the entire organism will endure 
problems. Some viruses can cause life-long or chronic infections, where the viruses continue 
to replicate in the body despite the host's defence mechanisms. The other viruses cause 
lifelong infection because the virus remains within its host cell in a dormant (latent) state 
such as the herpes viruses, but the virus can reactivate and produce further attacks of 
disease at any time, if the host’s defence system became weak for some reason (Shors, 2008).  
Viruses have two phases in their life cycle: outside cells and within the cells they infect. 
Viral particles outside cells could survive for a long time in harsh conditions where they are 
inert entities called virions. Outside living cells viruses are not able to reproduce since they 
lack the machinery to replicate their own genome and produce the necessary proteins. 
Viruses can infect host cells, recognising their specific receptors on the cell surface. The viral 
receptors are normal surface host cell molecules involved in routine cellular functions, but 
since a portion of a molecular complex on the viral surface (typically spikes) has a shape 
complementary to the shape of the outer soluble part of the receptor, the virus is able to 
bind the receptor and be attached to the host cell's surface. After receptor-mediated 
attachment to its host the virus must find a way to enter the cell. Both enveloped and non-
enveloped viruses use proteins present on their surfaces to bind to and enter the host cell 
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employing the endocytosis mechanism (Lopez & Arias, 2010). The endocytic vesicles 
transport the viral particles to the perinuclear area of the host cell, where the conditions for 
viral replication are optimal. The other way of infection is to inject only the viral genome 
(sometimes accompanied by additional proteins) directly into the host cytoplasm.  
The viruses are very economical: they carry only the genetic information needed for 
replication of their nucleic acid and synthesis of the proteins necessary for their 
reproduction (Alberts et al., 1989). Interestingly, the survival of viruses is totally dependent 
on the continued existence of their host, since after infection the viral genome switches the 
entire active host metabolism to synthesise the virion components. Without living host cells 
viruses will not be able to produce their progeny. 
With the discovery of the electron microscope it became possible to study the morphology 
of viruses. The first studies immediately revealed that viruses could be distinguished by 
their size and shape, which became the important characteristics of their description. 
Viruses may be of a circular or oval shape, have the appearance of long thick or thin rods, 
which could be flexible or stiff. Some viruses have distinctive heads and a tail. The smallest 
viruses are around 20 nm in diameter and the largest around 500 nm. 
The viruses that infect and use bacteria resources are classified as bacteriophages. Often we 
refer to them as “phages”. The word “bacteriophage” means to eat bacteria, and is so called 
because virulent bacteriophages can cause the compete lysis of a susceptible bacterial 
culture. Bacteriophages, like bacteria, are very common in all natural environments and are 
directly related to the numbers of bacteria present. As a consequence they represent the 
most abundant ‘life’ forms on Earth, with an estimated 1032 bacteriophages on the planet 
(Wommack & Colwell, 2000). Phages can be readily isolated from faeces and sewage, thus 
very common in soil. Sequencing of bacterial genomes has revealed that phage genome 
elements are an important source of sequence diversity and can potentially influence 
pathogenicity and the evolution of bacteria. The number of phages that have been isolated 
and characterised so far corresponds to only a tiny fraction of the total phage population. 
Since bacteriophages and animal cell viruses have many similarities phages are used as 
model systems for animal cell viruses to study steps of the viral life cycle and to understand 
the mechanisms by which bacterial genes can be transferred from one bacterium to another.  
1.1 Discovery of bacteriophages  
Bacteriophages were discovered more than a century ago. In 1896, Ernest Hanbury Hankin, 
a British bacteriologist (1865 –1939), reported that something in the waters of rivers in India 
had unexpected antibacterial properties against cholera and this water could pass through a 
very fine porcelain filter and keep this distinctive feature (Hankin, 1896). However, Hankin 
did not pursue this finding. In 1915, the British bacteriologist Frederick Twort (1877–1950), 
Superintendent of the Brown Institution of London, discovered a small agent that killed 
colonies of bacteria in growing cultures. He published the results but the subsequent work 
was interrupted by the beginning of World War I and shortage of funding. Felix d'Herelle 
(1873-1949) discovered the agent killing bacteria independently at the Pasteur Institute in 
France in 1917. He observed that cultures of the dysentery bacteria disappear with the 
addition of a bacteria-free filtrate obtained from sewage. D'Herelle has published his 
discovery of “an invisible, antagonistic microbe of the dysentery bacillus" (d'Herelle, 1917). 
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In 1923, the Eliava Institute was opened in Tbilisi, Georgia, to study bacteriophages and to 
develop phage therapy. Since then many scientists have been involved in developing 
techniques to study phages and using them for various purposes. In 1969 Max Delbrück, 
Alfred Hershey and Salvador Luria were awarded the prestigious Nobel Prize in Physiology 
and Medicine for their discoveries of the replication of viruses and their genetic structure. 
1.2 Why do we need to study bacteriophages? 
The first serious research of phages was done by d’Herelle which inspired him to do first 
experiments using phages in medicine. D'Herelle has used phages to treat a boy who had 
bad disentheria (d'Herelle, 1917). After administration of phages the boy successfully 
recovered. Later d'Herelle and scientists from Georgia (former USSR) have created an 
Institute to study the properties of bacteriophages and their use in treating bacterial 
infections a decade before the discovery of penicillin. Unfortunately a lack of knowledge on 
basic phage biology and their molecular organisation has led to some clinical failures. At the 
end of 1930s antibiotics were discovered; they were very effective, and nearly wiped out 
studies on the medical use of phages. However, a new problem of bacterial resistance to 
antibiotics has arisen after many years of using them. Bacteria adapted themselves to 
become resistant to the most potent drugs used in modern medicine. The emergence of 
modified pathogens such as Mycobacterium tuberculosis, Enterococcus faecalis, Staphylococcus 
aureus, Acinetobacter baumannii and Pseudomonas aeruginosa, and methicillin-resistant S. 
aureus (MRSA) has created massive problems in treating patients in hospitals (Coelho et al., 
2004, Hanlon, 2007; Burrowes et al., 2011) and the time required to produce new antibiotics 
is much longer than the time of bacterial adaptation. Modern studies on the phage life cycle 
have revealed a way for their penetration through membrane barriers of cells. These results 
are important in the development of methods for using bacteriophages as a therapeutic 
option in the treatment of bacterial infections (Brussow & Kutter, 2005). Phages, like many 
other viruses, infect only a certain range of bacteria that have the appropriate receptors in 
the outer membrane. The antibiotic resistance of the bacteria does not affect the infectious 
activity of a phage. Knowledge of the phage structure, understanding the mechanism of 
phage-cell surface interaction, and revealing the process of switching the cell replication 
machinery for phage propagation would allow the design of phages specific for bacterial 
illnesses.  
2. Classification of bacteriophages 
All known phages can be divided in two groups according to the type of infection. One 
group is characterised by a lytic infection and the other is represented by a lysogenic, or 
temperate, type of infection (Figure 1). In the first form of infection the release of DNA 
induces switching of the protein machinery of the host bacterium for the benefit of 
infectious agents to produce 50-200 new phages. To make so many new phages requires 
nearly all the resources of the cell, which becomes weak and bursts. In other words, lysis 
takes place, causing death of the host bacterial cell. As result new phages are released into 
the extracellular space. The other mode of infection, lysogenic, is characterised by 
integration of the phage DNA into the host cell genome, although it may also exist as a 
plasmid. Incorporated phage DNA will be replicated along with the host bacteria genome 
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through several generations of bacterium without major metabolic consequences for it. 
Eventually the phage genes, at certain conditions impeding the bacterium state, will revert 
to the lytic cycle, leading to release of fully assembled phages (Figure 1). Analysis of phages 
with lysogenic or lytic mode of infection has shown that there is a tremendous variety of 
bacteriophages with variations in properties for each type of infection. Moreover, under 
certain conditions, some species were able to change the mode of infection, especially if the 
number of host cells was falling down. Temperate phages are not suitable for the phage 
therapy. 
 
Fig. 1. Two cycles of bacteriophage reproduction. 1 - Phage attaches the host cell and injects 
DNA; 2 – Phage DNA enters lytic or lysogenic cycle; 3a – New phage DNA and proteins are 
synthesised and virions are assembled; 4a –Cell lyses releasing virions; 3b and 4b – steps of 
lysogenic cycle: integration of the phage genome within the bacterial chromosome (becomes 
prophage) with normal bacterial reproduction; 5- Under certain conditions the prophage 
excises from the bacterial chromosome and initiates the lytic cycle. (Copyright of E.V. Orlova) 
Classification of viruses is based on several factors such as their host preference, viral 
morphology, genome type and auxiliary structures such as tails or envelopes. The most up-
to-date classification of bacteriophages is given by Ackermann (2006). The key classification 
factors are phage morphology and nucleic acid properties. The genome can be represented 
by either DNA or RNA. The vast majority of phages contain double strand DNA (dsDNA), 
while there are small phage groups with ssRNA, dsRNA, or ssDNA (ss stands for single 
strand). There are a few morphological groups of phages: filamentous phages, isosahedral 
phages without tails, phages with tails, and even several phages with a lipid-containing 
envelope or contain lipids in the particle shell. This makes bacteriophages the largest viral 
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Fig. 2. Images of bacteriophages. A – filamentous phage B5 (Inoviridae) infects 
Propionibacterium freudenreichi;  negatively stained with 2% uranyl acetate (UA) (Chopin et al., 
2002, reproduced with permission of M.C. Chopin); B - Sulfolobus neozealandicus droplet-
shaped virus (Guttaviridae) of the crenarchaeotal archaeon Sulfolobus, negatively stained by 2% 
UA (Arnold et al., 2000, reproduced with permission of W. Zillig); C - Acidianus filamentous 
virus 1 (Lipothrixviridae) with tail structures in their native conformation, negatively stained 
with 3% UA (Bettstetter et al., 2003, reproduced with permission of D. Prangishvili); D – 
Bacteriophage T4 (Myoviridae), in vitreous ice (Rossmann et al., 2004, reproduced with 
permission of M.G. Rossman); E – Bacteriophage SPP1 (Siphoviridae), negative stain 2% UA 
(Lurz et al., 2001, reproduced with permission of R. Lurz); F - Bacteriophage P22 (Podoviridae) 
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families that need further characterization. Plasmaviridae (dsDNA) includes phages with 
dsDNA that are covered by a lipoprotein envelope and therefore can be called a nucleoprotein 
granule. Members of the Fusseloviridae family have dsDNA inside a lemon-shaped capsid with 
short spikes at one end; Guttavirus phage group (dsDNA) is represented by droplet-shaped 
virus-like particles (Figure 2B, Arnold et al., 2000). 
There are phages with helical or filamentous organization. The Inoviridae (ssDNA) family 
includes phages that are long, rigid, or flexible filaments of variable length and have been 
classified by particle length, coat structure and DNA content. The Lipothrixviridae (dsDNA) 
phages are characterized by the combination of a lipoprotein envelope and rod-like shape 
(Figure 2C). The Rudiviridae (dsDNA) family represents phages that are straight rigid rods 
without envelopes and closely resemble the tobacco mosaic virus. 
The next group of phages have capsids with an isosahedral shape. Phages from the 
Leviviridae family have ssRNA genome packed in small capsids and resemble enteroviruses. 
The known phages that form Corticoviridae family contain three molecules of dsRNA and, 
which is unusual, RNA polymerase. Phages with icosahedral symmetry for the capsids and 
a DNA genome compose the next three families Microviridae, Cystoviridae and Tectiviridae. 
The first includes small virions with a single circular ssDNA. The second family is currently 
represented only by a maritime phage, PM2, and has a capsid formed by the outer layer of 
proteins with an inner lipid bilayer (Huiskonen et al., 2004). The capsid contains a dsDNA 
genome. The last family, Tectiviridae, is characterised by presence of the lipoprotein vesicle 
that envelops the protein capsid with dsDNA genome. These phages have spikes on the 
apical parts of the envelope.  
 
Fig. 3. Tailed phage families (copyright of E.V. Orlova). 
The tailed phages were classified into the order Caudavirales (dsDNA) (Figure 2D,E,F) 
(Ackermann, 2006). Tailed phages can be found everywhere and represent 96% of known 
phages and are separated into three main phylogenetically related families. Tailed phages 
are divided into three families: A - Myoviridae with contractile tails consisting of a sheath 
and a central tube (25% of tailed phages); B - Siphoviridae , long, noncontractile tails (61%); C 
- Podoviridae , short tails (14 %). Since the tailed phages represent the biggest population of 
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bacteriophages they are easy to find and purify; they are the most studied family both 
biochemically and structurally. For this reason the following part of the review will 
concentrate on results and analysis of the tailed bacteriophages.  
3. Organisation of tailed bacteriophages 
3.1 General architecture of bacteriophages  
The basic structural features of bacteriophages are coats (or capsids) that protect the genome 
hidden inside a capsid and additional structures providing interface with a bacterium 
membrane for the genome release. The Caudovirales order of bacteriophages is characterised 
by dsDNA genomes and by the common overall organisation of the virus particles 
characterized by a capsid and a tail (Figure 3). Different phage species can vary both in size 
from 24-400 nm in length and genome length. Their DNA sequences differ significantly and 
can range in the size from 18 to 400 kb in length.  
Structures obtained by electron microscopy (EM) do not typically provide detailed information 
on the atomic components owing to methods used for visualisation of particles. However, EM 
has allowed visualisation of these minuscule particles and morphological analysis. Each virion 
has a polyhedral, predominantly icosahedral, head (capsid) that covers the genome. The heads 
are composed of many copies of one or several different proteins and have a very stable 
organisation. A bacteriophage tail is attached to the capsid through a connector which serves 
as an adaptor between these two crucial components of the phage. The connector is a hetero-
oligomer composed of several proteins (Lurz et al., 2001; Orlova et al., 2003). Connectors carry 
out several functions during the phage life cycle. They participate in the packaging of dsDNA 
into the capsid, and later they perform the function of a gatekeeper: locking the capsid exit of 
the phage, preventing leakage of DNA which is under high pressure and later, after a signal 
transmitted by the tail indicating that the phage is attached to the bacterium, the connector will 
be open allowing the release of DNA into the bacterium (Plisson et al., 2007).  The tail and its 
related structures are indispensable phage elements securing the entry of the viral nucleic acid 
into the host bacterium during the infectivity process. The tail serves both as a signal 
transmitter and subsequently as a pipeline through which DNA is delivered into the host cell 
during infection. The tails may be short or long, the latter are divided into contractile and non-
contractile tails. The long tails are typically composed of many copies of several proteins 
arranged with helical symmetry. All types of tails have outer appendages attached to the 
distant end of the tail and often include a baseplate with several fibres and a tip, or a needle 
that has specificity to the membrane receptors of the bacterium (Leiman et al., 2010). As soon 
the receptor has been found by the tail needle, which happens during multiple short living 
reversible attachments to the bacterium, the baseplate and tail fibres are involved in the 
binding of the phage to the bacterial outer membrane that makes the attachment irreversible 
(Christensen, 1965; São-José et al., 2006). The docking (irreversible attachment) of the phage 
induces opening of the phage connector and release of the genome through the tail tube into 
the bacterial cell.  
3.2 DNA and its packaging 
The virions of the bactriophage Caudovirales have a genome represented by linear molecules 
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translocated through the central channel of the portal protein located at one vertex of the 
capsid. The portal complex provides a docking point for the viral ATPase complex 
(terminase). The terminase bound to the portal vertex forms the active packaging motor that 
moves the viral dsDNA inside the capsid. Encapsidation is normally initiated by an 
endonucleolytic cleavage at a defined sequence (pac) of the substrate DNA concatemer 
although some phages like T4 do not use a unique site for the initial cleavage. Packaging 
proceeds evenly until a threshold amount of DNA is reached inside the viral capsid. At the 
latter stages of packaging the increasingly dense arrangement of the DNA leads to a steep 
rise in pressure inside the capsid that can reach ~6 MPa (Smith et al., 2001). The headful 
cleavage of DNA is imprecise leading to variations in chromosome size of more than 1 kb 
(Casjens & Hayden, 1988; Tavares et al., 1996). The mechanism of packaging requires a 
sensor that measures the amount of DNA headfilling and a nuclease that will cleave DNA as 
soon the head is full. Termination of the DNA packaging is coordinated with closure of the 
portal system to avoid leakage of the viral genome. In tailed bacteriophages this is most 
frequently achieved through the binding of head completion proteins (or adaptor proteins). 
The complex of the portal dodecamer and these proteins composes the connector (Lurz et 
al., 2001; Orlova et al., 2003). After termination of the first packaging cycle initiated at pac 
(initiation cycle), a second packaging event is initiated at the non-encapsidated DNA end 
created by the headful cleavage and additional cycles of encapsidation follow. Some 
packaging series can yield 12 or more encapsidation events revealing the high processivity 
of the packaging machinery (Adams et al., 1983; Tavares et al., 1996). 
4. Methods for study of bacteriophages 
Microbiology and bacteriology were the first methods used to investigate viruses. Studies 
related to the life cycle of prokaryotic and eukaryotic microorganisms such as bacteria, 
viruses, and bacteriophages are combined into microbiology. This includes gene expression 
and regulation, genetic transfer, the synthesis of macromolecules, sub-cellular organization, 
cell to cell communication, and molecular aspects of pathogenicity and virulence. The earlier 
studies of phages were based on microbiological experiments including immunology. 
Nowadays the research of the biological processes is not limited to biochemical analysis and 
microbiology. To understand processes of virus/cell communication and interaction one 
often needs information on the molecular level and conformational changes of the 
components under different conditions. Gel filtration or Western blotting provides 
information for a protein on the macromolecular level such as size, molecular mass, binding 
to an antibody etc. These experiments will display how the proteins will change their 
characteristics with several chemical modifications and analysing what kind of change 
occurred, one could draw a conclusion for the structure. At the cellular level, optical 
microscopy can reveal the spatial distribution and dynamics of molecules tagged with 
fluorophores. 
4.1 X-ray crystallography and NMR of phages 
The methods of X-ray crystallography and NMR spectroscopy provide detailed information 
on molecular structure and dynamics. However, X-ray crystallography requires the growth 
of protein crystals up to 1 mm in size from a highly purified protein. Crystal growth is an 
experimental technique and there are no rules about the optimal conditions for a protein 
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solution to result in a good protein crystal. It is extremely difficult to predict good 
conditions for nucleation or growth of well-ordered crystals of large molecular complexes. 
In practice, the best conditions are identified by screening multiple probes where a wide 
variety of crystallization solutions are tested. Structural analysis of viral proteins by 
crystallographic methods was very successful when separate proteins were studied. 
Protein crystals contain trillions of accurately packed identical protein molecules. When 
irradiated by X-rays, these crystals scatter X-rays in certain directions producing 
diffraction patterns. Computational analysis of that diffraction produces atomic models of 
the proteins. Viruses are much bigger than single proteins and may comprise thousands 
of components; it is difficult to pack them into crystals, and when successful, crystals have 
large unit cell dimensions (unit cell is an elementary part, from which the crystal is 
composed). Because of that the diffraction from virus crystals is far weaker than that of 
single proteins. It was an extremely challenging task to crystallise viruses for 
crystallographic studies although some icosahedral viruses were crystallised and the 
atomic structures have been obtained (Harrison, 1969; Grimes et al., 1998; Wikoff et al., 
2000). Nowadays X-ray analysis has provided a wealth of information on atomic structures 
of many small protein components of large viruses including bacteriophages (Rossmann et 
al., 2005). 
Nuclear Magnetic Resonance (NMR) is another very powerful method of structural analysis 
allowing studying dynamics of samples in solution. NMR methodology, combined with the 
availability of molecular biology and biochemical methods for preparation and isotope 
labelling of recombinant proteins has dramatically increased its usage for the 
characterization of structure and dynamics of biological molecules in solution. In NMR, a 
strong, high frequency magnetic field stimulates atomic nuclei of the isotopes H1, D2, C13, or 
N15 and measures the frequency of the magnetic field of the atomic nuclei during its 
oscillation period before returning back to the initial state. NMR is able to obtain the same 
high resolution using different properties of the samples. NMR measures the distances 
between atomic nuclei, rather than the electron density in a molecule. Protein folding 
studies can be done by monitoring NMR spectra upon folding or denaturing of a protein in 
real time. However, NMR cannot deal with macromolecules in the mega-Dalton range, the 
upper weight limit for NMR structure determination is ~ 50 kDa. 
4.2 Electron microscopy of tailed bacteriophages 
For microbiological research, light microscopy is a tool of great importance in studies of the 
biology of microorganisms. However, light microscopy is not able to provide a high enough 
magnification to see viruses. The modern development and use of synchrotrons has 
revealed the structures of spherical viruses, nonetheless obtaining virus crystals remained 
problematic, especially for bacteriophages. EM has become a major tool for structural 
biology over the molecular to cellular size range. Bacteriophages do not have exact 
icosahedral symmetry since they have different appendages facilitating interactions and 
infection of the host cells, a fact that makes them very challenging objects for 
crystallography and their size makes them unsuitable for NMR. Members of the Caudovirales 
phage family with dsDNA genome are especially difficult to crystallise because they have 
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The simplest method for examining isolated viral particles is negative staining, in which a 
droplet of the suspension is spread on an EM support film and then embedded in a heavy 
metal salt solution, typically uranyl acetate (Harris, 1997). The method is called negative 
staining because the macromolecular shape is seen by its exclusion of stain rather than by 
binding of stain. During the last two decades other methods became widely used and 
demonstrated their efficiency when samples where fixed in the native, hydrated state by 
rapid freezing of thin layers of aqueous sample solutions at liquid nitrogen temperatures 
(Dubochet et al., 1988). Such rapid cooling traps the biological molecule in its native, 
hydrated state but embedded in glass-like, solid water – vitrified ice. This procedure 
prevents the formation of ice crystals, which would be very damaging to the specimen. EM 
images of particles are used to calculate their three-dimensional structures (Jensen, 2010).  
EM was a major tool used in analysis of phage morphology and initiated a process of 
classification of viruses. The development of cryogenic methods has enabled EM imaging to 
provide snapshots of biological molecules and cells trapped in a close to native, hydrated 
state. High symmetry of the complexes is an advantage, but single particles of molecular 
mass –0.5-100 MDa with or without symmetry (e.g. viruses, ribosomes) can now be studied 
with confidence and can often reveal fine details of the 3D structure. The resulting images 
allow information not only on quaternary structure arrangements of macromolecular 
complexes but the positions of their secondary structural elements like helices and beta- 
sheets (Rossmann et al., 2005).  
4.3 Hybrid methods 
The components of bacteriophages and their interactions have to be identified and analysed. 
This can be done by localisation of known NMR or X-ray structures of individual viral 
proteins and nucleic acids combined with biochemical information to identify them in the 
EM structures. Electron cryo-microscopy and three-dimensional image reconstruction 
provide a powerful means to study the structure, complexity, and dynamics of a wide range 
of macromolecular complexes. One has to use different approaches for several reasons: there 
are limitations of the individual methods; some complexes do not crystallise; phages, being 
multi-protein complexes, have different conformational  organisation at different conditions. 
Therefore all known structural and biochemical methods have to complement each other to 
generate structural information. When atomic models of components or subassemblies are 
accessible, they can be fitted into reconstructed density maps to produce informative 
pseudoatomic models. If atomic structures of the components are not known, it is helpful to 
perform homology modelling so that the generated models could be fitted into the EM 
maps. Fitting atomic structures and models into EM maps allows researchers to test 
different hypotheses, verify variations in structures of viruses and effectively increase the 
EM map resolution creating pseudo-atomic viral models (Lindert et al., 2009).  
5. Examples of bacteriophage structures 
In spite of the great abundance of the tailed phages, details of their organisation have 
emerged only during the last decade. The progress in structural studies of phages as a 
whole entity was slow because of their flexibility and complex organisation. The additional 
hindrance arises from intricate combination of different oligomerisation levels of the phage 
elements. Fully assembled capsids have at least 5-fold symmetry or more often, icosahedral 
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symmetry where multiple structural units form a regular lattice with 2, 3, and 5 rotational 
symmetries. All known portal proteins were found to be dodecameric oligomers; tails have 
overall 6- or 3-fold rotational symmetry, the multiple repeats of major proteins have helical 
arrangement. The proteins related to the receptor sensor system at the far end of the tail 
could be in 6, 3, or only one copy. The information on the relative amount of different 
protein components has been revealed by biochemical and structural methods such as X-ray 
analysis of separate components. Development of hard and software has led to new imaging 
systems of better quality, new programs allowing processing of bigger data sets comprising 
hundreds of thousand images. The modern strategy is based on hybrid methods where 
structure determination at high resolution of isolated phage components is combined in 
three-dimensional maps of lower resolution obtained by electron microscopy. Electron 
microscopy by itself has reached such level of quality that for the complexes with 
icosahedral symmetry it has became nearly routine to obtain structures at 4-5 Å resolution 
(Hryc et al., 2011; Zhou, 2011; Grigorieff & Harrison, 2011) 
5.1 Phage T4 
The T4 phage  of the Myoviridae family infects E. coli bacteria and is one of the largest 
phages; it is approximately 200 nm long and 80-100 nm wide with the capsid in a shape of 
an elongated icosahedron. The phage has a rigid tail composed of two main layers: the inner 
tail tube is surrounded by a contractile sheath which contracts during infection of the 
bacterium. The tail sheath is separated from the head by a neck. Phages of Myoviridae family 
have a massive baseplate at the end of the tail with fibres attached to it. The tail fibres help 
to find receptors of a host cell and provide the initial contact; during infection the tail tube 
penetrates an outer bacterial membrane to secure the pathway for genome to be injected into 
the cell.  
The capsid of the T4 phage is built with three essential proteins: gp23* (48.7 kDa), which 
forms the hexagonal capsid lattice; gp24* (the * designates the cleaved form of the protein 
when the prohead matures to infectious virus) forms pentamers at eleven of the twelve 
vertices, and gp20, which forms the unique dodecameric portal vertex through which DNA 
enters during packaging and exits during infection. 3D-reconstruction has been determined 
at 22 Å resolution by cryo-EM for the wild-type phage T4 capsid forming a prolate 
icosahedron (Figure 4, Fokine et al., 2004). The major capsid protein gp23* forms a 
hexagonal lattice with a separation of ~140 Å between hexamer centres. The atomic 
structure of gp24* has been determined by X-ray crystallography and an atomic model for 
gp23* was built using its similarity to gp24* (Fokine et al., 2005). The capsid also contains 
two non-essential outer capsid proteins, Hoc and Soc, which decorate the capsid surface. 
The structure of Soc has been determined by X-ray crystallography and shows that Soc has 
two capsid binding sites which, through binding to adjacent  gp23* subunits, reinforce the 
capsid structure  (Qin et al., 2010). The failure of gp24* to bind Soc provides a possible 
explanation for the property of osmotic shock resistance of the phage (Leibo et al., 1979). The 
3D maps of the empty capsids with and without Soc (Iwasaki et al., 2000) have been 
determined at 27 and at 15 Å resolution, respectively.  
Single molecule optical tweezers and fluorescence studies showed that the T4 motor 
packages DNA at a rate of up to 2000 bp/sec, the fastest reported to date of any packaging 
motor (Fuller et al., 2007). FRET-FCS studies indicate that the DNA gets compressed during 
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Fig. 4. Structures of T4 (cryo-EM) and HK97 (X-ray analysis) phages (reproduced with 
permission of M.G.  Rossmann and J. E. Johnson).  Ribbon diagrams compare the structure 
of HK97 (gp5) with the structure of the T4 gp24 capsid protein. Phages and sections are on a 
different scale. 
Tails of Myoviridae phages have a long, non-contractible tube surrounded by a contractile 
sheath. Bacteriophage T4 has a tail sheath that is composed of 138 copies of gp18 (Leiman et 
al., 2004). The tail tube inside the sheath is estimated to be assembled from as many gp19 
subunits as there are gp18 subunits in the sheath (Moody & Makowski, 1981). The tail 
sheath has helical symmetry with a pitch of 40.6 Å and a twist of 17.2° (Kostyuchenko et al., 
2005). The tail sheath contraction can be divided into several steps. Previous studies of 
partially contracted sheath showed that conformational changes of the sheath are 
propagated ‘upwards’ starting from the disk of the gp18 subunits closest to the baseplate 
(Moody 1973). The cryo-EM reconstructions showed that during contraction, the tail sheath 
pitch decreases from 40.6 Å to 16.4 Å and its diameter increases from 24 nm to 33 nm 
(Figure 4, Leiman et al., 2004; Kostyuchenko et al., 2005). The combination of X-ray model 
and EM structures show that gp18 monomers remain rigid during contraction and move 
about 50 Å radially outwards while tilting 45° clockwise, viewed from outside the tail. 
During contraction of the tail the interactions between neighbouring subunits within a disk 
are broken so that the subunits from the disk above get inserted into the gaps formed in the 
disk below (Aksyuk et al., 2009). 
The baseplate with the cell-puncturing device of the T4 phage is an ultimate element of the 
phage. This is an extremely complex multiprotein structure on the far end of the tail and 
represents multifunctional machinery that anchor the phage on the bacteria surface and 
provide formation of the DNA entrance into the bacteria. This important part of the phage 
structure is of ~27 nm in height and 52 nm in diameter at its widest part. The baseplate 
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conformation is coupled to that of the sheath: the dome shape conformation is associated 
with the extended sheath, whereas the flat “star” conformation is associated with the 
contracted sheath that occurs in the T4 particle after attachment to the host cell. Short 
treatment of bacteriophage T4 with 3 M urea resulted in the transformation of the baseplate 
to a star-shape and subsequent tail sheath contraction (Kostyuchenko et al., 2003). During 
that switch the baseplate diameter increases to 61 nm and the height decreases to 12 nm 
although the protein composition of the baseplate does not change. It is composed of ~150 
subunits of a dozen different gene products (Leiman et al., 2010). Proteins gp11, gp10, gp7, 
gp8, gp6, gp53, and gp25 form one sector of 6-fold structure. The central hub of the 
baseplate is formed by gp5, gp27, and gp29 and probably includes gp26 and gp28. Assembly 
of the baseplate is completed by attaching gp9 and gp12 to form the short tail fibres, and 
also gp48 and gp54 that are required to initiate polymerization of the tail tube, a channel for 
DNA (Leiman et al., 2010).  
T4 tail has three types of fibrous proteins: the long tail fibres, the short tail fibres, and 
whiskers. Long tail fibres and short tail fibres are attached to the baseplate and whiskers 
extending outwardly in the region of the tail connection to the capsid. The long tail fibres, 
which are ~145 nm long and only ~4 nm in diameter, are primary reversible adsorption 
devices (Figure 4, Kostyuchenko et al., 2003). Each fibre consists of the rigid proximal 
halves, formed by gp34, and the distal ones composed by gp36 and gp37. The distal part of 
the fibre has a rod-like shape about 40 nm long that is connected to the first half of the fibre 
through the globular hinge. Gp35 forms a hinge region and interacts with gp34 and gp36. 
The N-terminal globular domain of gp34 interacts with the baseplate. Short tail fibres are 
attached to the baseplate by the N-terminal thin part, while the globular C-terminus binds to 
the host cell receptors (Boudko et al., 2002). The structure of this domain of the short tail 
fibres was determined by X-ray crystallography (Tao et al., 1997) 
5.2 HK97  
HK97 is a temperate phage from Escherichia coli which was isolated in Hong Kong by 
Dhillon (Dhillon & Dhillon, 1976). It shares a host range with the Lambda phage (Dhillon et 
al., 1976). HK97 has an isometric head and a long, flexible, non-contractile tail representing 
Siphoviridae family (Dhillon et al., 1976). The HK97 phage has multi step pathway of self-
assembly revealing two forms of procapsids of ~470 Å in diameter. Capsid protein gp5 (42 
kDa) forms capsids, with icosahedral symmetry characterised by T = 7 (Hendrix, 2005). A 
part of the gp5 (102 amino acids from the N terminus) plays the role of a scaffold, which is 
cleaved by gp4 (the phage protease) at maturation of the capsid (Conway at al., 1995). The 
first low resolution structures have shown conformation changes reflecting transition of the 
HK97 procapsids into expanded capsids (Conway at al., 1995). The diameter of procapsids 
during transition into the heads increases from 470 Å to 550 Å while the thickness of the 
capsid shell changes from 50 Å to ~ 25 Å.  
The first atomic structure of a capsid for the tailed phage was only published in 2000. Gp5, if 
expressed alone, assembles into a portal-deficient version of prohead I. Co-expressing gp5 
with the gp4 protease, which cleaves gp5 scaffolding domain, produces Prohead II that 
expands into the icosahedral head II (the diameter is ~650 Å) without DNA and portal 
complex; and it was used for the crystallisation. The crystal structure of the dsDNA 
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conformation is coupled to that of the sheath: the dome shape conformation is associated 
with the extended sheath, whereas the flat “star” conformation is associated with the 
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assembly revealing two forms of procapsids of ~470 Å in diameter. Capsid protein gp5 (42 
kDa) forms capsids, with icosahedral symmetry characterised by T = 7 (Hendrix, 2005). A 
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with the gp4 protease, which cleaves gp5 scaffolding domain, produces Prohead II that 
expands into the icosahedral head II (the diameter is ~650 Å) without DNA and portal 
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icosahedral symmetry (Wikoff et al., 2000). The capsid crystal structure shows how an 
isopeptide bond is formed between subunits, arranged in topologically linked, covalent 
circular rings (Figure 4). The structure of the HK97 gp5 coat protein has revealed a new 
category of virus fold: it is mixture alpha-helices and beta-sheets organised into three 
domains that are not sequence contiguous (Figure 4). Domain A is located close to the centre 
of the hexamers and pentamers of the capsid. Domain P (peripheral) provides contacts 
between adjacent molecules within pentamers and hexamers. The third domain, represented 
by the E-loop, is an extension through which each subunit of the HK97 capsid is covalently 
linked to two neighbouring subunits. The bond organization explains why the mature HK97 
particles are extraordinarily stable and cannot be disassembled on an SDS gel without 
protease treatment (Popa et al., 1991; Duda, 1998). 
5.3 SPP1 
SPP1 is a virulent Bacillus subtilis dsDNA phage and belongs to the Siphoviridae family. The 
virion is composed of an icosahedral, isometric capsid (~60 nm diameter) and a long, 
flexible, non-contractile tail. The SPP1 genome length is 45.9 kb. The procapsid (or prohead) 
of SPP1 consists of four proteins: the scaffold protein gp11, the major capsid protein gp13, 
the portal protein gp6, and a minor component gp7. The inside of the capsid is filled with 
gp11 which exits the procapsid during DNA packaging. Gp13 and the decoration protein 
gp12 form the head shell of the mature SPP1 capsid.  
The portal protein is located at a 5-fold vertex of the icosahedral phage head and serves as 
the entrance for DNA during packaging. The structure of gp6 as a 13-subunit assembly was 
determined by EM and X-ray at 10 and 3.4 Å resolution correspondingly (Orlova et al., 2003; 
Lebedev et al., 2007). The 13–mer portal complex has a circular arrangement with an overall 
diameter of ~165 Å and a height of ~110 Å. A central tunnel pierces the assembly through 
the whole height. The portal protein monomer has four main domains: crown, wing, stem, 
and clip. The crown domain consists of three alpha-helices connected by short loops and has 
40 additional C-terminal residues that are disordered in the X-ray structure. Mutations in 
the crown indicate the importance of this area for DNA translocation (Isidro et al., 2004a, 
b).The wing region is formed by alpha-helices flanked on the outer side by a beta-sheet. The 
stem domain connects the wing to the clip domain. It consists of two alpha-helices that are 
conserved in phi29 and SPP1 phages; a similar arrangement of helices was found in the P22 
portal protein (Simpson et al., 2000; Guasch et al., 2002; Lebedev et al., 2007; Olia et al., 
2011). The clip domain forms the base of the portal protein and is expected to be exposed to 
the outside of the capsid during viral particle assembly. The three-dimensional structures of 
the portal proteins of SPP1, phi29, and P22 phages demonstrate a strikingly similar fold. 
Although there is no detectable amino-acid sequence similarity between proteins, they have 
a nearly identical arrangement of two helices forming stem domains and in the clip domain 
which form a tightly packed ring of three stranded beta-sheets each made up of two strands 
from one subunit and one strand from an adjacent subunit. 
After termination of DNA incorporation the portal pore needs to be rapidly closed to 
prevent leakage of the viral chromosome. In SPP1 this role is played by the head completion 
proteins gp15 and gp16 that bind sequentially to the portal vertex forming the connector 
(Lurz et al., 2001). Disruption of the capsids yielded connectors composed of gp6, gp15 and 
gp16. The connector is an active element of the phage that is involved into packaging the 
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viral genome, serves as an interface for attachment of the tail, and controls DNA release 
from the capsid. The connector of Bacillus subtilis bacteriophage SPP1 was found to be a 12-
fold cyclical oligomer (Lurz et al., 2001), though isolated gp6 is a cyclical 13mer. The 
structure of the connector was determined at 10 Å resolution, using cryo-EM (Figure 5, 
Orlova et al., 2003). Both the isolated portal protein and the gp6 oligomer in the connector 
reveal a similar arrangement of four main domains, the major changes take place in the clip 
domain through which gp15 contacts gp6. The connector structure shows that gp15 serves 
as an extension of the portal protein channel where gp16 binds. The central channel is closed 
by gp16 physically blocking the exit from the DNA-filled capsid (Orlova et al., 2003). 
Structures of SPP1 gp15 and gp16 monomers were determined by NMR and together with 
gp6 were docked into the EM map of the connector (Figure 5, Lhuillier at al., 2009). The 
channel of the connector will be opened when the virus infects a host cell. Comparison of 
the structures before and after assembly, provides details on the major structural 
rearrangements (gp15) and folding events (gp15 and gp16) that accompany connector 
formation. 
 
Fig. 5. Surface representation of SPP1phage connector (top left, Orlova et al., 2003), tail tip 
(bottom left, Plisson et al., 2007) and P22 phage tail machine (top right, Lander et al., 2009).  
The fit of the atomic coordinates into each connector is shown as a cut open view adjacent to 
its corresponding surface view. The portal proteins are shown in blue, the adaptor proteins 
in crimson, gp16 of SPP1 and the tail spikes of P22 are shown in green. (Copyright of E.V. 
Orlova) 
The 160-nm-long tail of the SPP1 phage is composed of two major tail proteins (MTPs), gp17.1 
and gp17.1*, in a ratio of about 3:1. They share a common amino-terminus, but the latter 
species is ~10 kDa more than gp17.1. The polypeptide sequence, identical in the two proteins is 
responsible for assembly of the tail tube while the additional module of gp17.1* shields the 
structure exterior exposed to the environment. The carboxyl-terminus domain of MTPs shares 
homology to motifs of cellular proteins (Fraser et al., 2006) or to phage components (Fortier et 
al., 2006) involved in binding to cell surfaces. Structures of the bacteriophage SPP1 tail before 
and after DNA ejection were determined by negative stain electron microscopy. The results 
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viral genome, serves as an interface for attachment of the tail, and controls DNA release 
from the capsid. The connector of Bacillus subtilis bacteriophage SPP1 was found to be a 12-
fold cyclical oligomer (Lurz et al., 2001), though isolated gp6 is a cyclical 13mer. The 
structure of the connector was determined at 10 Å resolution, using cryo-EM (Figure 5, 
Orlova et al., 2003). Both the isolated portal protein and the gp6 oligomer in the connector 
reveal a similar arrangement of four main domains, the major changes take place in the clip 
domain through which gp15 contacts gp6. The connector structure shows that gp15 serves 
as an extension of the portal protein channel where gp16 binds. The central channel is closed 
by gp16 physically blocking the exit from the DNA-filled capsid (Orlova et al., 2003). 
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gp6 were docked into the EM map of the connector (Figure 5, Lhuillier at al., 2009). The 
channel of the connector will be opened when the virus infects a host cell. Comparison of 
the structures before and after assembly, provides details on the major structural 
rearrangements (gp15) and folding events (gp15 and gp16) that accompany connector 
formation. 
 
Fig. 5. Surface representation of SPP1phage connector (top left, Orlova et al., 2003), tail tip 
(bottom left, Plisson et al., 2007) and P22 phage tail machine (top right, Lander et al., 2009).  
The fit of the atomic coordinates into each connector is shown as a cut open view adjacent to 
its corresponding surface view. The portal proteins are shown in blue, the adaptor proteins 
in crimson, gp16 of SPP1 and the tail spikes of P22 are shown in green. (Copyright of E.V. 
Orlova) 
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proposed that the adsorption device–receptor interaction triggers a conformational switch that 
is propagated as a domino-like cascade along the 160 nm -long helical tail structure to reach 
the head-to-tail connector. This leads to opening of the connector, culminating in DNA exit 
from the head into the host cell through the tail tube (Plisson et al., 2007). 
The tail tip is attached to the cap structure that closes the tail tube (Figure 5). The absence of 
a channel for DNA traffic in the tip implies that it must dissociate from the cap for DNA 
passage to the cytoplasm during infection. The structural data show that the tail tip does not 
have a channel for DNA egress and that the signal initiated by interaction of the tip with the 
bacterial receptor causes release of the tip from the tail cap. Reconstructions were performed 
for two states of the tail: before and after DNA ejection. The cap structure was reconstructed 
separately from the tip and the main area of the tail. The reconstructions of the cap together 
with the first four rings of the tail tube demonstrate that the tail external diameter (before 
DNA ejection) tapers from ~110 to ~40Å at the capped extremity and changes symmetry 
from six-fold to three-fold. This arrangement provides a sturdy interface between the tail 
tube and the three-fold symmetric tip. Opening of the dome-shaped cap involves loss of the 
tip and movement of the cap subunits outwards from the tail axis, creating a channel with 
the same diameter as the inner tail tube (Plisson et al., 2007). 
5.4 Phi29 
The Bacillus subtilis bacteriophage phi29 (Podoviridae family) is one of the smallest and 
simplest known dsDNA phages. The bacteriophage phi29 (Figure 6) is a 19-kilobase (19-kb) 
dsDNA virus with a prolate head and complex structure. Proheads consist of the major 
capsid protein gp8, scaffolding protein gp7, head fibre protein gp8.5, head–tail connector 
gp10, and a pRNA oligomer. Mature phi 29 heads are 530Å long and 430Å wide, and the tail 
is 380Å long. The packaging of DNA into the head involves, besides the portal protein, other 
essential components such as an RNA called pRNA and the ATPase p16, required to 
provide energy to the translocation machinery. Once the DNA has been packaged, pRNA 
and p16 are released from the portal protein. In the mature phi29 virion, the narrow end of 
the portal protrudes out of the capsid and attaches to a toroidal collar (gp11). The collar has 
a diameter of about 130Å and is surrounded by 12 appendages that function to absorb the 
virion on host cells (Anderson et al., 1966). A thin, 160Å -long tube, with an outer diameter 
of 60Å, leads away from the centre of the collar (Hagen et al., 1976). The outer end of the tail 
(gp9) has a cylindrical shape and bigger diameter of ~ 80Å.  
The three-dimensional structure of a fibreless variant has been determined to 7.9 Å 
resolution allowing the identification of helices and beta-sheets (Figure 6, Morais et al., 2005, 
Tang et al., 2008). For the prolate capsid phi29 there was not the advantage of using 
icosahedral symmetry for structural analysis, its cryo-EM three-dimensional reconstructions 
have been made of mature and of emptied bacteriophage phi29 particles without making 
symmetry assumptions (Xiang et al., 2006). Possible positions of secondary elements for gp8 
indicate that the folds of the phi29 and bacteriophage HK97 capsid proteins are similar 
except for an additional immunoglobulin-like domain of the phi29 protein: the gp8 residues 
348–429 are 32% identical to the group 2 bacterial immunoglobulin domain (BIG2) 
consensus sequence (Morais et al., 2005; Xiang et al., 2006). The BIG2 domain is found in 
many bacterial and phage surface proteins related to cell adhesion complexes (Luo et al., 
2000; Fraser et al., 2006). The asymmetrical reconstruction of the complete phi29 has 
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revealed new details of the asymmetric interactions and conformational dynamics of the 
phi29 protein and DNA components (Tang et al., 2008). 
The DNA packaging motor is located at a unique portal vertex of the prohead and contains: 
the head-tail connector (a dodecamer of gp10); the portion of the prohead shell that 
surrounds the connector, a ring of 174-base prohead RNAs (pRNA), and a multimer of gp16, 
an ATPase that first binds DNA-gp3 and then assembles onto the connector/pRNA complex 
prior to packaging. The wide end of the portal protein contacts the inside of the head, 
whereas the narrow end protrudes from the capsid where it is encircled by the pentameric 
pRNA. The structure of the isolated phi29 portal complex has been studied by atomic force 
microscopy and electron microscopy (EM) of two-dimensional arrays (Carazo et al., 1985) 
and X-ray crystallography (Simpson et al., 2000; Guasch et al., 2002). X-ray crystallographic 
studies of the phi29 portal showed that it is a cone-shaped dodecamer with a central channel 
(Simpson et al., 2000). The three-dimensional crystal structure of the bacteriophage phi29 
portal has been refined to 2.1Å resolution (Guasch et al., 2002). This 422 kDa oligomeric 
protein is part of the DNA packaging motor and connects the head of the phage to its tail. 
Each monomer of the portal dodecamer has an elongated shape and is composed of a 
central, mainly alpha-helical domain (stem domain) that includes a three-helix bundle, a 
distal a/b domain and a proximal six-stranded SH3-like domain (Simpson et al., 2000). The 
portal dodecamer has a 35 Å wide central channel, the surface of which is mainly 
electronegative. The narrow end of the head–tail portal protein is expanded in the mature 
virus. Gene product 3, bound to the 5’ ends of the genome, appears to be positioned within 
the portal, which may potentiate the release of DNA-packaging machine components, 
creating a binding site for attachment of the tail (Tang et al., 2008). 
The process of DNA packaging is an extremely energy consuming act because electrostatic 
and bending repulsion forces of the DNA must be overpowered to package the DNA to 
near-crystalline density. Force-measuring laser tweezers were used to measure packaging 
activity of a single portal complex in real time where one microsphere has been used to hold 
on to a single DNA molecule as they are packaged, and the other was bound to the phage 
and fixed (Smith et al., 2001). These experiments have demonstrated that the portal complex 
is a force-generating motor which can work against loads of up to 57 pN, making it one of 
the strongest molecular motors reported to date. Notably, the packaging rate decreases as 
the prohead is filled, indicating that an internal force builds up to 50 pN owing to DNA 
confinement. These results suggest that the internal pressure provides the driving force for 
DNA injection into the host cell for the first half of the injection process. 
The structure of the phi29 tail has revealed that 12 appendages protruding from the collar 
like umbrella with 12 ribs that end in ‘tassels’ (Xiang et al., 2006). Two of the 12 appendages 
are extended radially outwards (the ‘up’ position), whereas the other 10 have their tassels 
‘hanging’ roughly parallel to the virus major axis. The adsorption capable ‘appendages’ 
were found to have a structure homologous to the bacteriophage P22 tail spikes. Two of the 
appendages are extended radially outwards away from the long axis of the virus, whereas 
the others are around and parallel to the phage axis. The appendage orientations are 
correlated with the symmetry mismatched positions of the five-fold related head fibres. The 
tail in the mature capsids, that have lost their genome have an empty central channel (Xiang et 
al., 2006). Comparisons of these structures with each other and with the phi29 prohead 
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Fig. 6. Surface representation of EM structures.  The Phi29 capsid is in green, the tassels are 
shown in magenta and blue, the tail is also in blue. The complete phage is shown at 16 Å 
(left) and a mutant phage without spikes at 8 Å (right, Tang et al., 2008) (Image copyright of 
E.V. Orlova). P22 phage is shown at 7 Å resolution (reproduced with permission of J. E. 
Johnson) and Epsilon15 is at 4.5 Å (Tang et al. 2011; Jiang et al., 2008, reproduced with 
permission of W. Chiu) 
5.5 P22 
Bacteriophage P22 infects Salmonella enterica serovar Typhimurium and is a prototypical 
representative of the Podoviridae family. The mature P22 virion presents an icosahedral T = 
7l capsid about 650 Å in diameter. The bacteriophage P22 procapsid comprises hundreds of 
copies of the gp5 coat and gp8 scaffolding proteins, multiple copies of three ejection proteins 
(gp7, gp16, gp20, also known as pilot proteins), and a unique multi-subunit gene 1 (gp1) 
portal (Prevelige, 2006).  
Single-particle cryo-EM has been used to determine the P22 procapsid structure initially at 
low resolution then improved from 9 Å to 3.8 Å resolution (Figure 6, Jiang et al., 2006; Jiang 
et al., 2008; Chen et al., 2011). The procapsids were isolated from cells infected with mutants 
defective in DNA packaging and representing the physiological precursor prior to DNA 
packaging and capsid maturation. Coat protein gp5 is organized as pentamers and skewed 
hexamers as previously reported for the GuHCl treated procapsid (Thuman-Commike et al., 
1999; Parent et al., 2010). The high resolution structure allowed Cα backbone models for 
each of the seven structurally similar but not identical copies of the gp5 protein in the 
asymmetric unit to be built. The analysis has shown that gp5 has fold similar to the HK97 
coat protein (Jiang et al., 2008). 
The first structures of the P22 assembly-naive portal formed from expressed subunits (gp1) 
were obtained at ~ 9 Å resolutions by cryo-EM (Lander et al., 2009). Later two atomic 
structures were obtained for the P22 portal protein: one is for a fragment of the portal, 1–602 
aa (referred to as the ‘portal-protein core’), bound to 12 copies of tail adaptor factor gp4 (Olia 
et al., 2006; Lorenzen et al., 2008). The second was the full-length P22 portal protein (725aa) 
at 7.5 Å resolution. To solve three independent crystal forms of the complex gp1/gp4 to a 
resolution of 9.5 Å, the EM structure of P22 tail at 9.4 Å resolution has been extracted 
computationally from the P22 tail complex and used as molecular replacement model. The 
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high resolution atomic structure of the P22 portal protein has been obtained using a 
combination of multi- and intra crystal non-crystallographic-symmetry averaging, and by 
extension of EM phases to the resolution of the best diffracting crystal form (3.25 Å). The P22 
portal complex is a ~0.96 MDa ring of 12 identical subunits, symmetrically arranged around 
a central channel of variable diameter, with an overall height of ~350 Å (Lander et al., 2009; 
Olia et al., 2011). A lower-resolution structure of the full-length portal protein unveils the 
unique topology of the C-terminal domain, which forms a ~200 Å long alpha-helical barrel. 
This domain inserts deeply into the virion and is highly conserved in the Podoviridae family. 
The quaternary structure of the P22 portal protein can be described as a funnel-shaped core 
~170 Å in diameter, connected to an ~200 Å long, mostly α-helical tube formed by the C-
terminal residues 603–725, which resembles a rifle barrel (Olia et al., 2011). The portal core is 
similar in topology to other portal proteins from phage SPP1 (Lebedev et al., 2007) and 
phi29 (Simpson et al., 2000; Guasch et al., 2002), but presence of the helical barrel is the first 
example of a dodecameric tube in a portal protein. Gp4 binds to the bottom of the portal 
protein, forming a second dodecameric ring ~75 Å in height (Olia et al., 2011).  
In Podoviridae, the mechanisms of bacteria cell penetration and genome delivery are not well 
understood. P22 uses short, non-contractile tails to adsorb to the host cell surface. The tail 
machine comprises the tail spike, gp9; the tail needle, gp26; and the tail factors gp4 and gp10 
(Tang et al., 2005). Protein gp4 serves as an adaptor between portal protein and tail 
elements. The tail has a special fibre known as the “tail needle” that likely functions as a cell 
membrane piercing device to initiate ejection of viral DNA inside the host. The structure of 
the intact tail machine purified from infectious virions has been obtained by cryo-EM at ~ 9 
Å resolution (Figure 5, Lander et al., 2009). The structure demonstrated that the protein 
components are organized with a combination of 6-fold (gp10, trimers of gp9), and 3-fold 
(gp26, gp9) symmetry (Lander et al., 2009). The combined action of an adhesion protein 
(tailspike) and a tail needle (gp26) is responsible for binding and penetration of the phage 
into the host cell membrane (Bhardwaj et al., 2011a). Gp26 probably plays the dual role of 
portal-protein plug and cell wall–penetrating needle, thereby controlling the opening of the 
portal channel and the ejection of the viral genome into the host. In Sf6, a P22-like phage 
that infects Shigella flexneri, the tail needle presents a C-terminal globular knob (Bhardwaj et 
al., 2011b). This knob, absent in phage P22 but shared in other members of the P22-like 
genus, represents the outermost exposed tip of the virion that contacts the host cell surface. 
In analogy to P22 gp26, it was suggested that the tail needle of phage Sf6 was ejected 
through the bacterial cell membrane during infection and its C-terminal knob is threaded 
through peptidoglycan pores formed by glycan strands (Bhardwaj et al., 2011a; 2011b). 
5.6 Epsilon 15 
The Gram-negative Salmonella anatum is the host cell for bacteriophage Epsilon15 (ɛ15, 
Podoviridae family). The ~40kb Epsilon15 dsDNA is packed within the isometric icosahedral 
capsid with a diameter of ~680 Å. The virion capsid contains 11 pentons and 60 hexons 
made from the major capsid protein gp7 and a small decoration protein gp10 (12-kDa). 
Single-particle cryo-EM was used about ten years ago to determine the first structures of 
icosahedral viruses to subnanometre resolutions (Jiang et al., 2006). A 9.5 Å density map 
was generated from EM data using icosahedral symmetry. In the average subunit map, the 
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portal channel and the ejection of the viral genome into the host. In Sf6, a P22-like phage 
that infects Shigella flexneri, the tail needle presents a C-terminal globular knob (Bhardwaj et 
al., 2011b). This knob, absent in phage P22 but shared in other members of the P22-like 
genus, represents the outermost exposed tip of the virion that contacts the host cell surface. 
In analogy to P22 gp26, it was suggested that the tail needle of phage Sf6 was ejected 
through the bacterial cell membrane during infection and its C-terminal knob is threaded 
through peptidoglycan pores formed by glycan strands (Bhardwaj et al., 2011a; 2011b). 
5.6 Epsilon 15 
The Gram-negative Salmonella anatum is the host cell for bacteriophage Epsilon15 (ɛ15, 
Podoviridae family). The ~40kb Epsilon15 dsDNA is packed within the isometric icosahedral 
capsid with a diameter of ~680 Å. The virion capsid contains 11 pentons and 60 hexons 
made from the major capsid protein gp7 and a small decoration protein gp10 (12-kDa). 
Single-particle cryo-EM was used about ten years ago to determine the first structures of 
icosahedral viruses to subnanometre resolutions (Jiang et al., 2006). A 9.5 Å density map 
was generated from EM data using icosahedral symmetry. In the average subunit map, the 





refined to a 4.5 Å resolution (Figure 6, Jiang et al., 2008). The quality of the map allowed 
tracing the backbone chain of gp7. Comparison of the models has shown local discrepancies 
between subunits at the N- terminus and the E-loop in different subunits of gp7 within the 
hexamers of the capsid. Interestingly, a connection between E-loops of neighbouring 
subunits possibly exists, but the resolution was not sufficient to reveal it. Moreover, 
additional density was located between the gp7 monomers. This density has been assigned 
to the gp10 decoration protein that consists mainly of beta-sheets and two short alpha-
helices. A back-to-back dimer of gp10 is positioned at the two-fold axes and makes contact 
with six gp7 subunits through the N-termini and the E-loops. It was suggested that gp10 
‘staples’ the underlying gp7 capsomeres to cement the gp5 cage so that it withstands the 
pressure from packed dsDNA (Jiang et al., 2008). 
The Epsilon15 capsid volume can accommodate up to 90kb dsDNA. Since the Epsilon15 
genome is only ~40kb, there is ample space for a protein core of this size in the capsid 
chamber. The core has a cylindrical shape with a length of ~200 Å and diameter of ~180 Å. 
The protein core may facilitate the topological ordering of the dsDNA genome during 
packaging and/or release as suggested for T7 core. At the virion's tail vertex, six tails pikes 
attach to a central 6-fold-symmetric tail hub of the length ~170 Å. This hub may be 
equivalent to Salmonella typhimurium bacteriophage P22's hub. The hub is connected to the 
portal ring inside the capsid. The Epsilon 15 genome winds around the core, with a short 
segment of terminal DNA passing through the axis of the core and portal (Jiang et al., 2006) 
6. Conclusions 
Bacteriophages represent an example of amazing molecular machines with powerful motors 
energised by ATP hydrolysis and puncturing devices allowing to inject viral genome into 
the host cells. As more and more phage structures been studied a general theme emerges 
pointing to a common bacteriophage ancestor from which they all inherited essentially the 
same capsid protein fold and other elements of their organisation: capsids, tails, portal 
complexes, tail fibres, and other components. The number of phages that were discovered, 
purified, and studied by biochemical, and biophysical methods increased tremendously 
during the last decade. New technologies used for their studies both on the microbiological 
and molecular levels made it possible to analyse their evolutionary relationship and origins 
of the host range specificity. One of the powerful techniques in the structural biology of 
phages is the modern cryo-EM that recently allowed to reach close to atomic resolution level 
of details in the EM reconstructions (Hryc et al., 2011; Zhou, 2011; Grigorieff & Harrison, 
2011). Understanding of the mechanisms which determine the host-range is required to 
solve many practical questions related to infectious human and animal diseases caused by 
bacteria, and quality food and its production (e.g. dairy products). A study conducted in 
Japan has demonstrated the efficiency of phages against bacterial infections of cultured fish 
(Nakai & Park, 2002). The use of bacteriophage as antimicrobial agents is based on the lytic 
phages that kill bacteria via lysis, which destroys the bacterium and makes its adaptation 
nearly impossible. High bacteriophage resistance for external factors is important for the 
stability of phage preparations. However, this stability is disadvantageous for industry 
when maintenance of the active bacterial strains is important. 
Comparative studies demonstrate that bacteriophages have many common features on the 
molecular level and common principle of interaction with a bacterium cell, although 
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components that trigger adsorption of phages to the host cell and the genome release are 
host dependent. Phage infection also depends on the availability of specific receptors on the 
cell surface, and investigation of the structure and biosynthesis of the bacterial cell 
membrane may be undertaken using phage-resistant mutants. Therefore there is a need to 
carry out further studies on phages, identifying receptors of targeted bacteria and 
environmental features that affect phage activity (Jończyk et al., 2011). The growing interest 
of the pharmaceutical and agricultural industries in phages requires more information on 
phage interactions, survivability and methods of their preservation. Structural studies 
revealed many similarities between bacteriophages and animal cell viruses. The chances of 
success in using bacteriophages as model systems for animal cell viruses and eventually as 
medical therapy are much better given our current extensive knowledge of bacteriophage 
biology following the advances in their molecular structural biology.  
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Monophyletic theory of the origin of life postulates that all cellular organisms have evolved 
from a common ancestor. This is based on nucleotide sequence analyses of rRNA genes, 
which all cellular organisms possess (Woese et al., 1975). On this basis and supported by 
other observations, the first common ancestor dates back to ~ 3.7 billion years. However, the 
scenario is not equivalent for the viruses, since they lack these genetic elements. In fact, 
there is such substantial diversity in viral genome structures (dsDNA, dsRNA, ssDNA, 
ssRNA) that it has proven extremely difficult to answer several key evolutionary questions. 
Do they co-evolve with their hosts? How do viruses first infect a new species? When was the 
first virus? Thus, a polyphyletic origin of viruses has been proposed (Bamford, 2003). It has 
been proposed that this could have been even before the appearance of the first cell. 
Although Boyer et al. (2010) have suggested that the eukaryote viruses may have appeared 
just after or simultaneously with the emergence of modern eukaryote lineages. However, 
there are other proposals which state that as new species appeared (of any of these three 
domains: Eukarya, Archaea and Bacteria), and after a certain period of time, their new 
infective viruses emerged. Nevertheless, information about common ancestor(s) related to 
viruses is still an enigma. Similarly, if we ask the same question for bacteriophages, or 
simply, when did the first lambdoid phage emerge? The answer is also unknown. Even with 
the support of bioinformatics and phage genomic knowledge, and quite possibly due to the 
lack of specific strategies and/or design methodologies, and phage genomic complexity the 
problem has not yet been resolved. 
In this chapter, in an attempt to address this issue in grosso modo, we propose the analysis of 
two genomic regions of lambdoid phages, regions that are dissimilar regarding their 
nucleotide variability and stability: (1) The variable and not essential region that confers 
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to repressor; (2) The conserved and essential region for development that is related to the 
gene encoding the "Receptor-Binding Protein" (RBP), and which is involved in the process of 
infection onset. To begin to understand even a fraction of what was the common ancestor of 
lambdoid phages and the changes that had to occur to generate the diversity of lambdoid 
phages could be informative both of lambda biology and virus evolutionary processes in 
general. 
2. Diversity of immunity regions in lambdoid phages 
We reported the isolation and characterization of a collection of 47 lambdoid phages from 
human fecal samples (Kameyama et al., 1999). To determine the immunity group to which 
each phage belonged to; their lysogenic strains (lysogens) were constructed and then 
challenged with each lambdoid phage. The physiological study of growth indicates that 
for two phages belonging to the same immunity group, each lysogen should prevent 
growth of the other phage. For example, as we know each lysogens A and B are resistant 
to their respective phages, and if the lysogen A is resistant to phage B infection, and 
lysogen B to phage A, then both phages (A and B) belong to the same immunity group 
(Fig. 1D).  
 
A) When lysogens are sensitive to the other phages but are resistant to their homologous phages they 
are referred as heteroimmune. B) The lysogen A is resistant to phage B, this indicates that lysogen A 
must have another exclusion system than the repressor. C) Similar example as B, but it is referred to the 
lysogen B. D) If both lysogens (A and B) are resistant to phages A and B infections, this result strongly 
suggests that they belong to the same immunity group. The numbers -2, -4, -6 and -8 represent different 
dilutions of phage lysate that can be tested on the strain. Presence (+) or absence (_) of phage growth can 
be determined by infecting with a series of phage lysate dilutions. 
Fig. 1. Possible combinations between phages (A and B) and their lysogens.  
It is simple to understand when two lysogens A and B are resistant to their respective 
homologous phages, but are sensitive to the phages B an A, respectively, this indicates that 
both phages (A and B) belong to different immunity group (Fig. 1A). A different scenario 
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would be if lysogen A is resistant to phage B, this would indicate that lysogen A must have 
another exclusion system different to the repressor (Fig. 1B). The same case is applied for 
lysogen B (Fig.1C). From this study (Kameyama et al., 1999), it was possible to classify 19 
different immunity groups (Fig. 2), of which 9 out of 19 (~ 50%) had to represent a unique 
individual. 
 
Phages were classified into nineteen immunity groups following the phage-lysogen cross test as 
previously reported by Kameyama et al. (1999). Phage groups were classified according to phage 
number per group. Black bars represent FhuA-receptor dependent phages; striped and white bars are 
phages that were unable to grow in strain MCR106 (∆lamB) and MH760 (ompC-) cells, respectively 
(Taken from Hernandez-Sanchez, et al., 2008). 
Fig. 2. Frequency distribution of nineteen lambdoid phage-infection immunity groups.  
It is noteworthy that the immunity group XVIII (lambda phage belongs to this group) is 
comprised by 6 individuals. To determine whether the lambda specific repressor CI was 
present in all of them, we proceeded to evaluate its physiological function. For this, the 
strain LK1683, derived from the E. coli W3110 with a cryptic lambda prophage and the 
genotypic main feature: N::Kan, cI857 (Kameyama et al., 1999) was used. As expected, 
lambda phage was not developed at 32 °C, since at this temperature the CI857 repressor is 
active, but lambda phage developed normally at 42 °C, as CI857 from lysogenic strain is 
heat-inactivated. If the 5 individuals of the group XVIII all had the same lambda CI 
repressor, one would expect that their behavior were similar to that shown by lambda. 
Indeed, 4/5 phages of this group were unable to develop at 32 °C, while at 42 °C they did. 
One phage did not develop because it is temperature-sensitive, since it did not develop 
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than 5,000-bp of the immunity region of several lambdoid phages and among them the 
mEp234 and mEp332 (belonging to the immunity group XVIII, from our collection). They 
found that the mEp234 and mEp332 sequences coded for repressors almost identical to 
that of lambda CI with equivalent function, although respect to the Rex Region sequences 
they were different. The CI functional assay findings, are supported by genetic and 
sequencing data, therefore the classification of immunity lambdoid phage groups is 
reliable. 
3. The gene coding for the "Receptor-Binding Protein" (RBP), which 
recognizes FhuA is borne by most lambdoid phages 
The structural morphology of lambda and most lambdoid phages is characterized by a non-
contractile and flexible tail, which is necessary for infection. At the onset and in order to 
carry out infection, gpJ lambda protein [equivalent to the Receptor-Binding Protein (RBP) 
for other phages], and located in the distal part of the tail, recognizes an outer membrane 
protein (OM), the trimeric maltoporin LamB (Gurnev et al., 2006). In other lambdoid phages, 
such as 80, HK022, mEp167, they all recognize the ferrichrome-Fe3+ receptor (FhuA) 
(Guihard et al., 1992; Uc-Mass et al., 2004). In an approach to identify the most common 
receptors FhuA, LamB and OmpC used by lambdoid phages from our collection, we used 
three different deficient E. coli mutants fhuA-, lamB- and ompC- for the physiological assay. It 
was found that 37 out of 43 phages (~85%) used FhuA, since they are not able to infect strain 
C600 (fhuA-), but they can whenever this strain is complemented with a plasmid expressing 
FhuA (Hernández-Sánchez et al., 2008). These results clearly indicate that most of the 
lambdoid phages require FhuA to penetrate into bacteria.  
4. The cor gene is present in half of the lambdoid phages population 
cor gene product is involved in phage exclusion, in those that require FhuA receptor for 
infection. Thus, cor excludes lambdoid phages 80, HK022, mEp167, etc., and non lambdoid 
phages T1, T5, etc. (Kozyrev  Rybchin, 1987; Malinin et al., 1993; Matsumoto et al., 1985; 
Uc-Mass et al., 2004), being all of them FhuA dependent. cor gene and the gene encoding 
RBP (gene p21 for phage N15 and gene p23 to HK022), are separated by two ORFs 
(Wietzorrek et al., 2006), and these are located in the cluster of genes that encode tail 
proteins. Because of this tight physical and functional association, we asked how many of 
the lambdoid phages contain cor? The answer was obtained by amplifying a 155 bp 
intragenic region of cor by PCR. We found that 25 out of 43 (~58%) phages bore it. To verify 
that the products corresponded to cor region, 4 PCR fragments were taken randomly and 
sequenced. Alignment analysis confirmed that the amplified region corresponded to cor 
gene (Hernández-Sánchez et al., 2008). 
5. Identification of Nus-dependent non-lambdoid phages group 
During the characterization of the first isolated phages from our collection, a new group of 
phages emerged. As part of the selection strategy, the potential lambdoid phages were 
challenged with 4 isogenic nus mutant strains nusA1, nusB5, nusD026 and nusE71. Pre-
selection of potential lambdoid phages was carried out considering those phages that failed 
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to grow at least in a couple of these mutants (Kameyama et al., 1999). Of these, 97 phages 
were selected. However, in the course of the characterization, a group of them (48 phages) 
did not recombine, nor hybridize with the lambda DNA, nor were recognized by antibodies 
directed against lambda structural proteins, nor their prophages were induced with light 
UV, and most failed to develop at 32 C (Kameyama et al., 2001). However, this group of 
non-lambdoids shares an essential feature with lambdoid phages and that is the 
requirement for Nus factors to grow, suggesting that these phages may have an anti-
termination mechanism homologous to that reported for lambdoid phages. Regarding 
growth cross-test assay, unlike the great diversity found in lambdoid phages, all of them 
had a single immunity! It is amazing how any of these lysogens has the ability to exclude 
any of the 48 phages of this group. 
6. Discussion 
We can infer from phage-lysogen cross test that lambdoid phage immunity groups are 
diverse and rich. If we consider that 9 out of the 19 groups had a unique representative, this 
could indicate that the number of different groups of immunity should be much larger. 
However, taking into account that the sample of the population of phage analyzed is small, 
it is not possible to infer probabilistically the number of possible different immunities in the 
region. A completely different scenario was obtained when testing the requirement of 
different bacterial receptors. It was found that 37 out of 43 require the E. coli FhuA receptor 
for infection. As mentioned above, the gene encoding RBP is essential, therefore nucleotide 
changes in this gene may be deleterious, and then it can be considered highly conserved. On 
the other hand, the bacterium E. coli use the FhuA receptor for iron assimilation through 
the ferrichrome-Fe3+ transport system. Interestingly, although the bacterium E. coli 
contains the genes fhuA, fhuB, fhuC and fhuD in an operon, for the ferrichrome-Fe3+ 
transport, it lacks of the genes for the biosynthesis of ferrichrome. Hence, in nature, the 
ferrichrome is produced by other species such as Ustilago maydis, and is taken in by E. coli 
for growth. This argument suggests that E. coli had to acquire the fhu operon at some 
stage of its evolution. Provided that most of lambdoid phages are FhuA dependent and 
considering that the gene encoding RBP would be highly conserved, as its product 
requires a perfect match with its receptor, it is likely that the first lambdoid phage had to 
require the FhuA receptor to infect its host E. coli. In addition, if we consider the argument 
that the fhu operon was acquired at some stage during E. coli evolution, then, the origin of 
the first lambdoid phage must not be older than that of its host E. coli! This idea though 
highly speculative, if true, it would support the proposal that viruses appeared after new 
cellular species emerged.  
On the other hand, even having a great variety of phage immunity groups, it is still not 
possible to propose a putative origin of the first repressor, because the major constraint is 
present in the sample population. However, the dynamics of changes can be appreciated by 
the wide range of immunities provided.  
Also it is interesting the analysis of cor gene implication. It has been proposed that cor is a 
moron that at some point of phage evolution was obtained (Juhala et al., 2000). Morons are 
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selection of potential lambdoid phages was carried out considering those phages that failed 
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to grow at least in a couple of these mutants (Kameyama et al., 1999). Of these, 97 phages 
were selected. However, in the course of the characterization, a group of them (48 phages) 
did not recombine, nor hybridize with the lambda DNA, nor were recognized by antibodies 
directed against lambda structural proteins, nor their prophages were induced with light 
UV, and most failed to develop at 32 C (Kameyama et al., 2001). However, this group of 
non-lambdoids shares an essential feature with lambdoid phages and that is the 
requirement for Nus factors to grow, suggesting that these phages may have an anti-
termination mechanism homologous to that reported for lambdoid phages. Regarding 
growth cross-test assay, unlike the great diversity found in lambdoid phages, all of them 
had a single immunity! It is amazing how any of these lysogens has the ability to exclude 
any of the 48 phages of this group. 
6. Discussion 
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diverse and rich. If we consider that 9 out of the 19 groups had a unique representative, this 
could indicate that the number of different groups of immunity should be much larger. 
However, taking into account that the sample of the population of phage analyzed is small, 
it is not possible to infer probabilistically the number of possible different immunities in the 
region. A completely different scenario was obtained when testing the requirement of 
different bacterial receptors. It was found that 37 out of 43 require the E. coli FhuA receptor 
for infection. As mentioned above, the gene encoding RBP is essential, therefore nucleotide 
changes in this gene may be deleterious, and then it can be considered highly conserved. On 
the other hand, the bacterium E. coli use the FhuA receptor for iron assimilation through 
the ferrichrome-Fe3+ transport system. Interestingly, although the bacterium E. coli 
contains the genes fhuA, fhuB, fhuC and fhuD in an operon, for the ferrichrome-Fe3+ 
transport, it lacks of the genes for the biosynthesis of ferrichrome. Hence, in nature, the 
ferrichrome is produced by other species such as Ustilago maydis, and is taken in by E. coli 
for growth. This argument suggests that E. coli had to acquire the fhu operon at some 
stage of its evolution. Provided that most of lambdoid phages are FhuA dependent and 
considering that the gene encoding RBP would be highly conserved, as its product 
requires a perfect match with its receptor, it is likely that the first lambdoid phage had to 
require the FhuA receptor to infect its host E. coli. In addition, if we consider the argument 
that the fhu operon was acquired at some stage during E. coli evolution, then, the origin of 
the first lambdoid phage must not be older than that of its host E. coli! This idea though 
highly speculative, if true, it would support the proposal that viruses appeared after new 
cellular species emerged.  
On the other hand, even having a great variety of phage immunity groups, it is still not 
possible to propose a putative origin of the first repressor, because the major constraint is 
present in the sample population. However, the dynamics of changes can be appreciated by 
the wide range of immunities provided.  
Also it is interesting the analysis of cor gene implication. It has been proposed that cor is a 
moron that at some point of phage evolution was obtained (Juhala et al., 2000). Morons are 





acquired by horizontal transfer (Juhala et al., 2000). However, given the proximity to the 
gene encoding RBP and the high percentage that is present in the population (more than 
50%), it would be more likely that cor associated with the RBP gene were acquired together 
in the formation of new phage. Unlike the RBP gene, cor is not essential, making easier to 
explain why cor is missing in a sector of the population. 
It is also interesting to take into account the other group of 48 phages that emerged as a new 
group with a unique immunity, and knowing that this region must be very variable (as well 
as has been indicated for lambdoid phages), this may suggest that this group was recently 
created. However, other explanations are possible. For example the acquisition of the unique 
immunity region as a possible recombination with a different phage, since its repressor must 
be different to that of lambdoid phages, in which this is not inducible by UV light. Based on 
the phage numbers, one can infer that they are successful as lambdoid phages in nature. It is 
also a notable observation that only a single group or family of phages in Brucella abortus has 
been observed (personal communication of Flores, V). This idea complements the proposal 
that viruses appeared after emerging of the species.  
New data will be needed to generate more precise and convincing answers. It should be 
noted that host participation can be critical in certain tasks, and finally given the great 
diversity of the viruses, these studies should be carried out according to each one of the 
family or group of viruses concerned. 
It is clear that this chapter would be subject to polemic, as would any different or relatively 
new idea proposed to explain viral evolution. Indeed, it will serve to enhance, refine, or 
change approaches to shed more precise answers in this topic. 
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1. Introduction 
Advances in biochemistry-based analysis of biotic systems depend on improved procedures 
for the sorting of the non-covalently joined macromolecular assemblies that are obtained by 
the expelling of cellular contents. The development of preparative ultracentrifugation, for 
example, made possible the discovery of both ribosomes and various intracellular organelles 
(reviewed in Alberts et al., 2002). Some biotic systems depend on assembly more than one 
might conclude at first (reviewed in Kurakin, 2007). Improving this biochemistry-based 
analysis is an ongoing process, given that (1) multi-molecular, assembly-derived mechanisms 
are not yet understood, including (especially) the mechanisms of biological motors 
(reviewed in Howard, 2009; Myong & Ha, 2010) and (2) one reasonably projects that 
components of current biotic systems have abiotic ancestors that were also non-covalently 
joined assemblies, the understanding of which is potentially essential for understanding the 
origins of life (Koonin, 2009; Serwer, 2011).  
Separately, advances in analysis of environmental microbial systems depend on improved 
procedures for the propagation and sorting of individual microorganisms following their 
extraction from the environment. Improving microbial propagation/isolation/sorting 
remains an ongoing process (for example, Ferrari et al., 2008; Sait et al., 2002; Serwer et al., 
2009), given that only a small fraction (< 0.01) of environmental microbes have been 
propagated (Ferrari et al., 2008 and included references). I review here some advances in the 
use of agarose and agar gels for both (1) biochemistry-based sorting of macromolecular 
assemblies and (2) detection, propagation and sorting of unusual environmental viruses, 
with focus on bacterial viruses (bacteriophages), abbreviated phages. 
1.1 Basics 
Fractionation-based sorting and characterization of macromolecular assemblies is a strategy 
complementary to biochemical assay-based determining of the activities of single, 
unassembled macromolecules. The unassembled macromolecules include many that 
function when assembled with molecules of other types. The use of these two strategies is 
illustrated by the analysis of mechanisms of DNA replication. The proteins involved 
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thought, the process of DNA replication is so complex that numerous proteins of other types 
are also involved via a multi-molecular complex, usually called a replisome (reviews: 
Hamdan & Richardson, 2008; Langston et al., 2009). However, replisomes are difficult to 
isolate from cells and tend to dissociate during isolation. Thus, investigators usually replace 
sorting-based biochemistry with in vitro replisome assembly, followed by analysis of the 
transitions that occur in vitro. Nonetheless, if appropriate procedures can be developed, in 
theory, one might (1) isolate replisomes from a cell, (2) fractionate the replisomes by the 
extent of DNA replication and then (3) perform a biochemical/biophysical analysis of the 
replisome at each of the various stages of replication. Once this is done, a fluorescence-based 
signature can be developed for each state observed in the sorted replisomes. The signatures 
would provide a way to observe the progression of replisome-associated DNA replication in 
vivo.  
To develop the tools needed for a sorting-based analysis of any biochemical system, we 
have focused on a multi-molecular, biotic system for which sorting has been relatively 
productive, because the multi-molecular complexes involved (1) are relatively stable, (2) are 
relatively uniform in surface characteristics and (3) can be fractionated by the extent of the 
biochemical process being analyzed. This system packages the double-stranded DNA of a 
phage after the phage DNA has been replicated in a phage-infected cell. For all studied 
double-stranded phages, DNA packaging is initiated by a protein capsid (procapsid) pre-
assembled without interaction with DNA. This procapsid is called capsid I in the case of the 
related phages, T3 and T7. Capsid I converts to a larger, more phage-like capsid during 
DNA packaging (capsid II for T3/T7; Figure 1,a-b) and can be made to package DNA in 
vitro, after isolation of capsid I from a lysate of infected cells (reviews: Aksyuk & Rossmann, 
2011; Catalano, 2000; Fujisawa, & Morita, 1997; Serwer, 2010). Subsequent steps in DNA 
packaging begin with capsid II and some are described in Section 1.2.  
Returning to the topic of propagation-/isolation-based analysis of environmental phages, we 
have focused on developing and using procedures to propagate and isolate phages that are not 
isolated by conventional procedures. Our new procedures isolate phages that are 
unconventional in that they have one or more of the following characteristics: (1) propagation-
associated aggregation, (2) unusually large size, (3) inactivation by dilution and (4) absence of 
sufficient propagation in liquid culture to produce cellular lysis in visible amount. The core 
procedure is based on initial isolation by incubation of soil samples in a medium-containing, 
dilute (0.1-0.2%) agarose overlay (Figure 2a; reviewed in Serwer et al., 2009). This procedure 
continues by platinum needle transfer only, as illustrated in Figures 2,b-d. As described in 
Section 5, the pores of the agar gels typically used for a phage plaque-supporting gel are too 
small for propagating some (maybe most) large or aggregating phages.  
After presentation of some details of both DNA packaging and phage isolation in the 
remainder of Section 1, I will describe the studies of the gels and gel electrophoresis used for 
these studies. Understanding of these gels was (and presumably will be) essential to 
improving the use of them.  
1.2 Some details 
Past work on the sorting of infected cell-derived macromolecular assemblies has produced a 
hypothesis for the sequence of T3/T7 DNA packaging events. The solid arrows of Figure 1 
indicate this proposed sequence, as derived from the fractionation-based sorting of particles  
Gels for the Propagation of Bacteriophages  




Fig. 1. Bacteriophage T3/T7 DNA packaging. The solid arrows connect intermediates that 
have been deduced from observed intermediates.  Dashed arrows indicate the observed 
intermediates. 
produced during packaging and found in lysates of infected cells. These latter particles will 
be called intermediates whether or not altered during fractionation. The isolated, 
fractionated intermediates include incompletely packaged DNA (ipDNA)-containing 
capsids (ipDNA-capsids). The ipDNA-capsids were originally sorted by ipDNA length via 
buoyant density-based ultracentrifugal fractionation (Fang et al., 2008). The ipDNA-capsids 
were then identified and the capsid further characterized by agarose gel electrophoresis 
(AGE) of intact particles (Fang et al., 2008), as further described in Section 3. A dashed arrow 
in Figure 1 connects a fractionated and characterized ipDNA-capsid to an intermediate 
proposed to exist during DNA packaging in vivo. The detection of ipDNA-capsid II by AGE 
was simplified by the fact that the AGE-migration of ipDNA-capsid II is independent of the 
length of ipDNA. In general, the migration of any particle during AGE depends only on the 
characteristics of the particle’s surface, not on what is packaged inside. This point is 
discussed in more detail in Section 3.  
The use of advanced procedures of AGE revealed that the protein shell of at least some 
ipDNA-capsid II does eventually undergo changes as ipDNA becomes longer. These 
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2011; Catalano, 2000; Fujisawa, & Morita, 1997; Serwer, 2010). Subsequent steps in DNA 
packaging begin with capsid II and some are described in Section 1.2.  
Returning to the topic of propagation-/isolation-based analysis of environmental phages, we 
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isolated by conventional procedures. Our new procedures isolate phages that are 
unconventional in that they have one or more of the following characteristics: (1) propagation-
associated aggregation, (2) unusually large size, (3) inactivation by dilution and (4) absence of 
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remainder of Section 1, I will describe the studies of the gels and gel electrophoresis used for 
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improving the use of them.  
1.2 Some details 
Past work on the sorting of infected cell-derived macromolecular assemblies has produced a 
hypothesis for the sequence of T3/T7 DNA packaging events. The solid arrows of Figure 1 
indicate this proposed sequence, as derived from the fractionation-based sorting of particles  
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Fig. 1. Bacteriophage T3/T7 DNA packaging. The solid arrows connect intermediates that 
have been deduced from observed intermediates.  Dashed arrows indicate the observed 
intermediates. 
produced during packaging and found in lysates of infected cells. These latter particles will 
be called intermediates whether or not altered during fractionation. The isolated, 
fractionated intermediates include incompletely packaged DNA (ipDNA)-containing 
capsids (ipDNA-capsids). The ipDNA-capsids were originally sorted by ipDNA length via 
buoyant density-based ultracentrifugal fractionation (Fang et al., 2008). The ipDNA-capsids 
were then identified and the capsid further characterized by agarose gel electrophoresis 
(AGE) of intact particles (Fang et al., 2008), as further described in Section 3. A dashed arrow 
in Figure 1 connects a fractionated and characterized ipDNA-capsid to an intermediate 
proposed to exist during DNA packaging in vivo. The detection of ipDNA-capsid II by AGE 
was simplified by the fact that the AGE-migration of ipDNA-capsid II is independent of the 
length of ipDNA. In general, the migration of any particle during AGE depends only on the 
characteristics of the particle’s surface, not on what is packaged inside. This point is 
discussed in more detail in Section 3.  
The use of advanced procedures of AGE revealed that the protein shell of at least some 
ipDNA-capsid II does eventually undergo changes as ipDNA becomes longer. These 





suggest that the T3/T7 DNA packaging motor has two cycles, the second of which changes 
the capsid’s shell and acts as a back-up cycle when the first stalls. The details (Serwer et al., 
2010; Serwer & Wright, 2011) are not reviewed here because they are complex enough to be 
distracting to the main objectives.  
2. Gel-forming polymers 
2.1 Basics 
Gels have spaces through which molecules migrate either by thermal motion or by response 
to an external potential gradient. The potential gradient is typically, but not necessarily, 
electrical. Agar gels, although initially (and still: Rasmussen & Morrissey, 2007) used as a 
supporting matrix for food, were subsequently found to be similarly useful as a supporting 
matrix for bacterial colonies. The bacterial colonies typically grew on the surface, but use of 
dilute (0.4%) agar in the presence of a complex medium was found to permit Salmonella 
typhimurium to swim through the gel. This swimming was used to assay transfer of genes 
needed for motility (Stocker et al., 1953). Thus, the pore size of the medium-containing 0.4% 
agar gel, while not precisely defined by these studies, could be estimated to be at least as 
large as the width of the bacteria, assumed to be ~ 500 nm. Smaller pores would not have 
allowed the bacteria to migrate to the interior of the gel.  
 
Fig. 2. Phage isolation. (a) Post-incubation initial plate with soil (irregular black objects) 
embedded in a dilute agarose overlay and phage-induced zones of clearing (arrows) in a 
host lawn. (b) Needle transfer via stabs (arrow) to the bottom agar of a new Petri plate. (c) 
Pouring of a new overlay. (d) Post-incubation secondary plate with single phage plaques 
one of which is being used for cloning.  Further details are reviewed in Serwer et al. (2009)  
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The cause of the relatively large pores of some polysaccharide gels is the lateral aggregation 
of the polysaccharide polymer to form multi-chain “pillars” that provide gel strength while 
forming a mesh with relatively large pores. The existence of the pillars is qualitatively 
confirmed by simply observing the light scattering of a gel. Agarose gels are typically turbid 
because of the pillars (Rees, 1972). In contrast, polyacrylamide gels of the same total 
concentration and conventional cross-linker concentrations are not turbid (Chen and 
Chrambach, 1979). The turbidity of an agarose gel decreases as (1) the temperature of 
gelation and buffer ionic strength decrease, and (2) the agarose molecular weight increases 
(Griess et al, 1993; Griess et al., 1998; Serwer & Griess, 1999), with an associated decrease in 
the radius of the effective pore (PE). If one adds consideration of the agarose source-, 
purification- and derivatization-dependence of PE (Griess et al., 1989; Griess et al., 1998), one 
can only conclude that PE-dependent results from different studies cannot be compared 
quantitatively unless one is willing to tolerate the likelihood of PE errors of at least 100%. In 
general, quantitative comparisons should be performed with internal standards. 
2.2 Some details 
The gels to be discussed here are cast by cooling solutions of either agar or agarose that had 
been dissolved by boiling. Agar is a -linked alternating co-polymer of two sugars; 
negatively charged groups are attached in variable amount to the sugars. Agar is obtained 
from red seaweed. Agarose is a sub-fraction of agar that has a relatively low density of 
charged groups (reviewed in Rees, 1972). The extent of residual charge is often used to name 
agarose preparations via the field-induced flow of buffer that gel-attached charged groups 
cause (electro-osmosis, abbreviated EEO; Griess et al., 1989). The minimum agarose 
concentration for gel formation varies somewhat with agarose EEO, and agarose chain 
length but can be as low as 0.03% for a high-strength agarose, when the gel is supported at 
its sides by embedding in a more concentrated gel (Serwer et al., 1988).  
If one extrapolates previous determinations of PE to 0.03% agarose, one finds that micron-
sized particles can enter agarose gels. If entry into the gel is to be driven by a potential 
gradient, the entry will become limited by trapping of a micron-sized particle in the pores 
that are relatively small, if the potential gradient is too high in magnitude. The trapping 
occurs because of the relatively low thermal motion of particles this large (Serwer et al., 
1988; Serwer & Griess, 1998). Nonetheless, by use of an electrical potential gradient 
relatively low in magnitude (0.5 V/cm; 2.0 V/cm is too high), intact (alive) cells of the 
bacterium, Escherichia coli, have been subjected to agarose gel electrophoresis and 
fractionated by length (Serwer et al., 1988).  
On the other hand, one lowers PE by raising agarose gel concentration, a process that is 
assisted, if necessary, by lowering the average agarose chain length and, therefore, reducing 
viscosity (Griess et al., 1993). The studies reported below have not been limited by 
difficulties in attaining any PE needed. 
3. Gel electrophoresis 
3.1 Electrophoretic principles and some of their applications 
Fractionation by gel electrophoresis depends on two characteristics of a roughly spherical 
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surface electrical charge that is not counter ion-neutralized (). The force produced by 
application of an electrical potential is proportional to  (Shaw, 1969; Stellwagen et al., 
2003). Therefore, the terminal velocity (v) induced by an electrical potential is also 
proportional to . The magnitudes of  and v typically decrease as the concentration of 
counter ions increases, because of the increase in surface charge neutralization, as described 
by the Debye-Hückel theory (Bull, 1971). The ionic strength of electrophoresis is kept 
relatively low both to increase the magnitude of v and to lower the heat produced during 
electrophoresis. A result is that adding any salt to an electrophoresis buffer reduces the force 
on the particle and, therefore, v.  
This effect causes band spreading when a sample is in a relatively high ionic strength 
solution and electrophoresis is to be conducted at lower ionic strength. The relatively high 
ionic strength of the sample, coupled with diffusion of sample ions into the electrophoresis 
buffer, will cause band spreading because the leading edge of the sample will initially have 
a v higher in magnitude than v of the rest of the sample. Because v is usually (not always) 
proportional to the electrical potential gradient (E), I will sometimes refer to the v/E ratio, 
rather than v. The v/E ratio is also called the electrophoretic mobility ().  
This band spreading becomes important when, to avoid loss of particles during dialysis, one 
wants perform AGE of particles that are in concentrated (2-4 M) solutions of cesium chloride. 
This situation arises after preparative fractionation by ultracentrifugation in a cesium chloride 
density gradient. Band spreading is avoidable, however, if AGE is performed with the gel 
submerged beneath the electrophoresis buffer (submerged gel electrophoresis). Submerged 
gel electrophoresis is a standard procedure with which I assume that the reader is familiar. 
After loading samples for submerged gel AGE, one avoids sample salt-induced band 
spreading by waiting for 1.0-1.5 hours before starting electrophoresis. In this time, salt ions 
dialyze into the electrophoresis buffer. This procedure was based on the previous 
observation that dialysis of 2-4 M cesium chloride from 0.5 inch dialysis tubing is complete 
by 30 minutes, as judged by measuring the refractive index of the cesium chloride solution 
after removing it from the dialysis tubing (unpublished data).  
Although submerged gel AGE of nucleic acids is almost always done without attempting to 
control pH gradients, this absence of control is not a good idea when proteins are the 
samples. Without a counter-measure, a pH gradient is unavoidable because hydrogen gas is 
released at the cathode, thereby raising the pH, and oxygen gas is released at the anode, 
thereby lowering the pH. Proteins titrate much more than nucleic acids in the pH range of 
the pH gradient generated during submerged gel AGE. The result of this protein titration is 
likely to be disastrous. Informally, I have been told of failures of AGE and, in some cases, 
pH gradients would probably have caused failure even if other aspects were in order.  
The most efficient way to prevent a pH gradient with a submerged agarose gel is to circulate 
the electrophoresis buffer from one buffer tank to the other. The buffer flows back to the 
source tank across the surface of the submerged gel. One can also reduce the pH gradient by 
reducing the height of the buffer, but not so much that the cross-sectional area of the buffer 
starts to fluctuate. To avoid buffer circulation-induced washing of the sample out of sample 
wells, the circulation is started after the electrophoresis. The details of timing and circulation 
speed are empirically determined for each system. We circulate at ~ 100 ml/minute, 
beginning at 30 minutes after the start of electrophoresis at 1 V/cm, with a phosphate 
buffer, pH 7.4 and a buffer height of about 0.8 cm.  
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3.2 Other factors that determine procedure 
Any particle can be fractionated by AGE if the particle (1) is electrically charged in the buffer 
used, (2) is small enough to fit into the pores of the gel and is not electrophoretically 
trapped, (3) does not adhere to the gel and (4) is not damaged or dissociated by the process 
of electrophoresis. Particle-gel adherence and particle dissociation are the most likely causes 
of failure if the aspects from the previous section are in order. Particle-gel adherence is 
generally the case when particles either are found either to be broadly distributed near the 
origin or to form a sharp band at the origin edge of the agarose gel.  
Responses to particle-gel adherence include changing the composition of the gel, overloading 
the binding sites by increasing particle concentration (Serwer & Hayes, 1982) and proteolytic 
cleavage of the gel-binding region of the particle (Serwer et al., 1982). Responses to dissociation 
include cross-linking, which is necessary in the case of microtubules, for example. Cross-linked 
microtubules do migrate during AGE, but dissociate if not cross-linked (Serwer et al., 1989).  
3.3 Sieving during AGE 
As solid, spherical particles migrate through a gel, they experience both hydrodynamic and 
steric effects of the presence of fibers that form the gel. If a sphere is almost as large as the 
effective pore of the gel, motion will be restricted to the point that the particle hardly moves. 
As the particle becomes smaller, the “sieving” effect of the fibers decreases and the particle 
undergoes more rapid motion. Eventually, while never zero, the sieving effect becomes so 
small that it changes almost imperceptibly with a percentage change in particle radius that 
caused a large change in sieving for larger spheres. So, to increase the sieving-based 
resolution by radius of a spherical particle, one decreases PE (increases gel concentration), 
but stops before the pores are so small that the particles do not migrate. One pays for the 
increase in sieving-based resolution with an increase in the time of fractionation. A 
quantitative analysis of these effects for spheres is in Griess et al. (1989). 
The effect of particle shape on gel sieving has been investigated for rod-shaped viruses. 
Without discussing the quantitative details, the lessons learned are the following. (1) Sieving 
effects do not discriminate a rod from a sphere when the 0.5xrod length/PE ratio is below ~1 
(Griess et al., 1990). (2) For a rod-shaped particle with length in this range, the effective 
radius that best describes the gel electrophoretic sieving is determined by assuming that the 
rod has a surface area (in contrast to either a length or a volume) equal to that of a sphere 
that exhibits the same sieving (Griess et al., 1990). (3) At smaller PE values, a rod (unlike a 
sphere) has a gel electrophoretic  that increases in magnitude as the magnitude of E 
increases. This effect can be exploited to help identify rod-shaped particles after AGE 
(Serwer et al., 1995).  
3.4 One-dimensional gel electrophoresis 
A frequent application of gel electrophoresis is sodium dodecylsulfate (SDS) polyacrylamide 
gel electrophoresis (SDSPAGE) of proteins (Studier, 2000). This procedure starts with boiling 
of the proteins in the presence of SDS, a negatively charged ionic detergent. The SDS binds 
to the proteins and produces a surface that has a  that is assumed be the same for all 
proteins, based on empirical measurements of SDS binding (Reynolds & Tanford, 1970). 
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possible the interpretation of SDSPAGE patterns via sieving only. That is why SDSPAGE, 
even though one-dimensional, is useful for estimating the molecular weight of a protein. 
Uniformity of  is usually also assumed during the AGE of DNA and RNA. This 
assumption is based on the uniformity of the phosphate backbone and remains accurate 
until end-effects occur as double-stranded DNA fragments are shortened (Stellwagen et al., 
2003). Thus, DNA fractionations are usually interpreted via sieving, without considering 
possible changes in . The sieving effects are complicated by flexibility and, in some cases, 
by either branched or circular conformation (Åkerman, & Cole, 2002; Brewer, & Fangman, 
1991). Conformation-dependent effects on ion binding and, therefore, , also occur for 
unusually bent DNA molecules (Stellwagen et al., 2005). Both circular DNA and DNA 
bound to solid objects undergo elevated E-induced trapping effects. These trapping effects 
are the basis for pulsed field-based separations (Åkerman, & Cole, 2002; Gauthier & Slater, 
2003, for example) that are outside of the area of this review. 
One electrophoretic direction (dimension) is usually used for both SDSPAGE and nucleic acid 
gel electrophoresis (1d-AGE in the case of agarose gels). However, the electrophoretic profile 
does not have a unique interpretation, if both  and particle dimension vary among particles 
subjected to 1d-AGE. To achieve a unique interpretation, based on both  and particle 
dimensions (effective radius for a sphere), a second dimension of electrophoresis is added.  
3.5 Separate analysis of  and effective radius: a second dimension  
To separately measure both the effective radius (RE) and the  of roughly spherical particles 
fractionated by AGE, one must add a second dimension (2d-AGE). Figure 3 illustrates a 2d-
AGE procedure whereby one performs the first dimensional electrophoresis in a relatively 
 
Fig. 3. Illustration of 2d-AGE. A sample is layered in the sample well and subjected to 
electrophoresis (arrow I indicates direction) through a dilute first dimension gel (diagonal 
bars) and, then, at a right angle (arrow II indicates direction) through a more concentrated 
second dimension gel.   
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dilute agarose gel so that  is determined primarily by . The dilute, first dimensional gel is 
stabilized by embedding it in a more concentrated gel used for the second dimension. To 
perform the second dimensional electrophoresis, the field/gel angle is rotated by 90° and 
electrophoresis is repeated with a second dimensional gel that is much more concentrated 
than the first dimensional gel.  
The key to the 2d-AGE-based analysis of RE is that the percentage change in  is 
independent of , when one compares  in the second dimension with  in the first, as first 
empirically confirmed in Serwer et al. (1986). Geometrically, this relationship implies that all 
particles of any given RE are on one line (called a size line) that extends from the effective 
origin of electrophoresis (O in Figure 3) through the center of the band formed by a particle. 
As the angle () between this line and the direction of the first electrophoresis decreases, RE 
increases, as illustrated in Figure 3. The value of  is proportional to the distance migrated 
in the first dimension, as illustrated in Figure 3. With the use of standards of size known by 
small-angle x-ray scattering (Serwer et al., 1986; Serwer et al., 1989), differences in RE as 
small as 0.5% have been resolved by using PE values close to the RE’s of the particles 
analyzed (Casjens et al., 1992). 
An advantage of 2d-AGE is that patterns can be interpreted for particles heterogeneous in 
either  or RE (or both). This aspect was originally demonstrated for vaccine conjugates 
heterogeneous in RE (Serwer & Hayes, 1986) and has been developed in quantitative detail, 
given that these conjugates are of high utility (Tietz, 2007, 2009). More recently, the use of 
2d-AGE with particles heterogeneous in both  and RE has been used to detect ipDNA-
capsids of new type. These new ipDNA-capsids are at positions (d) and (e) in the pathway 
of Figure 1. Details are in Serwer et al. (2010) and Serwer and Wright (2011).  
4. Use of 1d-AGE to determine the kinetics of assembly in vivo 
Major advantages of AGE are (1) the efficiency of fractionation of multiple samples and (2) 
the efficiency and accuracy of the quantification, via either autoradiography or 
fluorography, of the amount of radioisotope in each of several fractionated and detected 
particles. Thus, one can observe the kinetics of the passage of radiolabel through various 
intermediates, for the purpose of both determining the order of intermediate appearance 
and analyzing the mechanism of assembly and associated function. The efficiency makes 
this analysis possible not only for the wild type process, but also for the same process as it 
occurs for a mutant, with the 1d-AGE typically performed in a single agarose slab gel (see 
Serwer & Watson, 1982).  
4.1 An example of information previously obtained  
This strategy was previously used for determining the effects on the assembly of phage T7 
capsid I of removing the protein (called the connector or portal protein; Figure 1) that 
connects the gp10-containing shell with the tail of the mature phage. T7 proteins are labeled 
by gp, followed by gene number, as reviewed in Pajunen et al. (2002); comparable genes in 
T3 and T7 are given the same number. The T3 and T7 connectors are 12-mers of gp8. 
Although gp8 was in a position that suggested a role in nucleating shell assembly (Figure 1), 
genetic removal of gp8 had no detectable effect on the initial kinetics of capsid I assembly. 
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Fig. 3. Illustration of 2d-AGE. A sample is layered in the sample well and subjected to 
electrophoresis (arrow I indicates direction) through a dilute first dimension gel (diagonal 
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terminated prematurely in the absence of gp8 (Serwer & Watson, 1982). In these 
experiments, we analyzed completely unfractionated lysates of T7-infected E. coli by 1d-
AGE.  
Connector-independent shell assembly nucleation was subsequently also observed for 
phage P22, by use of rate zonal centrifugation in a sucrose gradient, rather than 1d-AGE, to 
assay for procapsids (Bazinet & King, 1988). Phages P22 and T7 are basically unrelated, but 
both have icosahedral shells with a triangulation number of 7 (P22: Chang et al., 2006; T7: 
Fang et al., 2008). Thus, the connector apparently has evolved after the shell. I note that the 
nucleus for shell assembly, whatever it is (a proposal is in Serwer, 1987), is likely to have at 
least 6 independent components, which implies a 6th order nucleation reaction, at least. The 
formation of a nucleus will, therefore, have a very high dependence on effective capsid 
protein concentration and, therefore, on excluded volume. Therefore, studies of in vitro shell 
assembly must be performed under conditions that mimic in vivo assembly, if any 
interpretation of what happens in vivo is intended. This in vivo-first priority cannot logically 
be reversed. 
Finally, I note that herpes simplex virus also has a connector and that the herpes simplex 
virus connector (portal) is also not the nucleus for shell assembly, based on experiments 
similar in concept to those performed for phages (Newcomb et al., 2005). The work on 
phages preceded the work on herpes simplex virus by about 20 years largely because of the 
relative simplicity and speed of propagating and performing genetics with phages. 
Combining the simplicity and speed of work on phages with the simplicity and speed of 
AGE is a powerful addition to genetics.  
4.2 Utilizing chromatographical effects during electrophoresis 
Although the basics of 1d-AGE and 2d-AGE are well defined and standardized, the 
transformations of macromolecular assemblies have complex determinants and are 
generally unpredictable. Thus, 1d-AGE and 2d-AGE analysis of macromolecular assemblies 
should be interpreted with as little bias as possible. The data are primary and have 
sometimes been surprising, as illustrated in the previous section. The following, additional 
surprise occurred while we were determining the kinetics of T7 capsid I assembly by 1d-
AGE. We found that some of the assembled, radiolabeled capsid protein appeared only near 
the origin of the agarose gels. This observation appeared, at first, to be a liability in that one 
could not initially characterize this material. However, the apparent liability rapidly became 
an asset when we discovered that these particles were capsid-like, as found by digestion 
with protease. Protease digestion converted these “agarose gel adherent” particles to 
particles that migrated as capsid II. One can only anticipate that non-standardized 
responses, such as this one, will be needed for most, if not all, comparable analyses of the 
biochemistry of multi-molecular complexes. 
Knowing that the T7 agarose-adherent particles were capsid-like, we determined the 
kinetics of their formation in the presence and absence of the gp8 connector. The results 
were the following (Serwer & Watson, 1982). (1) In the presence of the gp8 connector, the 
agarose-adherent particles first increased in amount and then decreased, i.e., the agarose-
adherent particles behaved as though either they or, more likely, related capsid I-like in vivo 
particles (that decayed to agarose adherent particles), were intermediates in the assembly of 
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capsid I. (2) In the absence of the gp8 connector, the agarose-adherent particles increased in 
amount progressively, before and after the assembly of capsid I was terminated, as though 
the agarose-adherent particles had now become an end product of abortive assembly. These 
observations supported the previous conclusion that the gp8 connector did not nucleate 
shell assembly. In addition, the apparent conversion from intermediate to abortive end 
product in the absence of the gp8 connector was interpreted by the assumption that the 
connector was necessary for correction of errors of shell assembly. A role of the connector in 
assembly error correction explains why mis-assembled shells continued to accumulate in the 
absence, but not in the presence, of the connector (Serwer et al., 1982; Serwer & Watson, 
1982). Apparently, analysis of in vivo procapsid assembly has not subsequently advanced 
past this point (recent review: Aksyuk & Rossmann, 2011).  
To give some idea of the uniqueness of the data that can be obtained by AGE, I mention that 
(unpublished) efforts to purify the agarose adherent particles in large amount failed because 
these particles are lost as aggregates when the scale of the lysates was increased. We made 
this observation by mixing radiolabeled particles (from a small lysate) with relatively large 
lysates; the radiolabeled particles had been partially purified by rate zonal sucrose gradient 
centrifugation. That is to say, 1d-AGE (with and without protease digestion) is, thus far, the 
only way to identify these particles.  
5. Propagation of large phages: a use of PE values 
Recent surprises in microbiology include the discovery of “giant” eukaryotic, double-
stranded DNA viruses with genomes larger than 1 million base pairs (reviews: Claverie et 
al., 2009; Colson & Raoult, 2010). These giant viruses, originally thought to be cells, really 
are viruses based on the packaging of the genome in an icosahedral capsid shell assembled 
from subunits that have sequence similarity with the major shell protein of other viruses, 
including Paramecium Bursaria Chlorella Virus 1 (Azza et al., 2009). The first of these viruses, 
Acanthamoebae polyphaga Mimivirus, has shell-associated spikes that extend to an outer 
radius of 373 nm (Klose et al., 2010). This large radius is presumably the reason that no 
plaque assay was initially reported and, to my knowledge, has still not been reported. Based 
on previous determinations of PE, a plaque assay should be possible for these viruses, as 
described in detail in Section 5.1, below.  
The work on gel concentration-dependence of the formation of plaques by relatively large 
viruses began with the largest known phage, called phage G (for giant). Phage G makes only 
very small plaques in the traditional plaque supporting, 0.4-0.7% agar gels. However, the 
dimensions of phage G were roughly the same as the PE of the plaque-supporting agar gels. 
When relatively dilute agarose gels are used to propagate phage G, this phage was found to 
make large plaques that, when confluent, produce an overlay that is an excellent preparative 
source of phage G (Serwer et al., 2009).  
5.1 PE values 
The considerations of Sections 2.1 and 2.2 already suggest that PE values of plaque-
supporting gels can be made high enough to form plaques of Mimivirus and related giant 
viruses. The culmination of a series of sieving-based measurements of PE produced the 
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the LE (low EEO) agarose usually used; gels were formed at ~25 °C in buffer that contained 
0.025 M sodium phosphate, pH 7.4, 0.001 M MgCl2 (Griess et al., 1989). PE = 148A-0.87. This 
relationship predicts that LE agarose gels with A below about 0.34% are dilute enough for 
plaque formation by mimivirus; a concentration ~ 2x lower is appropriate for an initial test. 
This relationship also predicts that a 0.25%LE agarose gel is the most concentrated LE 
agarose gel with a PE value large enough so that mobile Salmonella cells, assumed to have a 
diameter of about 500 nm, migrate through the gel. This A value is lower than the 0.4% used 
by Stocker et al. (1953) for bacterial migration, as discussed in Section 2.1. Higher EEO 
agarose preparations, which should better mimic the agar used in Stocker et al. (1953), form 
gels with an even lower maximal A for migration of bacteria (Griess et al., 1989). Thus, the 
medium present in the 0.4% agar gels of Stocker et al. (1953) appears to have caused an 
increase in PE.  
As discussed in Section 2.2, the value of PE increases as the temperature of gelation 
increases, as judged by both sieving during gel electrophoresis and electron microscopy of 
thin sections. We have applied this principle to the propagation of a phage that is both large 
(shell radius ~ 50 nm; tail length ~ 486 nm) and aggregating and found that, indeed, plaque 
size increases as the temperature of gelation increases for the plaque-supporting gel (Serwer 
et al., 2009). That is to say, (1) the electrophoretic sieving and the apparent sieving during 
plaque formation move, as expected, in the same direction with change in PE and (2) a 
plaque assay should be a possibility for Mimivirus, unless a trapping effect is encountered.  
In the case of Mimivirus, however, the possibility of gravitational field-induced arrest of 
motion exists. If 1g sedimentation causes trapping of Mimivirus in gels, then buoying 
Mimivirus should make plaque formation possible in appropriately dilute agarose, plaque-
supporting gels.  
5.2 Gel-supported propagation of new phages: large and aggregating phages 
Evidence exists that the viruses thus far isolated and propagated are not any more than 1% 
and probably much less of the total in the environment. This evidence includes the 
sequences of environmental viral RNA and DNA obtained without propagating the viruses 
involved (metagenomics: reviewed in Casas & Rohwer, 2007). We have used dilute agarose 
gel propagation to isolate several phages that cannot be propagated in any other way, 
including propagation in traditional agar gels and liquid enrichment culture. Several of 
these phages undergo extensive aggregation during plaque formation (Serwer & Wang, 
2005; Serwer et al., 2009), which suggests that these phages would not be detected by 
metagenomics, because of loss during procedures (filtration, low speed centrifugation, for 
example) that are used to remove bacteria.  
Virus aggregation is a well-known phenomenon, potentially important to new frontiers in 
virology. Historically, virus aggregation was important because of its potential (occasionally 
realized) to inhibit antibody neutralization of several eukaryotic viruses (Wallis, C. & 
Melnick, 1967). The need for revised procedures in the isolation of some, including 
aggregating, phages suggests that revised procedures will also be needed for the isolation of 
some not-yet-isolated eukaryotic viruses. As is usually the case, the advances needed are 
most rapidly explored with phages.  
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Recent work in the author’s laboratory was supported by the Welch Foundation (AQ-764).  
7. In Memoriam 
Dr. Gary A. Griess made large contributions to our current knowledge gel electrophoresis, 
as apparent from the attached manuscript. These contributions were in several areas, 
perhaps most notably in the areas of the structure and sieving of gels. Gary died from 
complications of cancer on April 28, 2008. He had received an undergraduate degree in 
physics from MIT in 1962 and a PhD in biophysical chemistry from the University of 
Massachusetts Amherst (Advisor, John F. Brandts) in 1970. By 1985, Gary and I had 
established a collaboration that began with work on the biophysical characterization of 
phages. We soon developed a focus on the structure and sieving of gels. Gary provided 
essential computational, biophysical and experimental aspects of this work, much of which 
depended on his creativity and ingenuity. He was also very generous with his assistance to 
others in all laboratories of our department. We all miss him. This manuscript is dedicated 
to Gary.  
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phages. We soon developed a focus on the structure and sieving of gels. Gary provided 
essential computational, biophysical and experimental aspects of this work, much of which 
depended on his creativity and ingenuity. He was also very generous with his assistance to 
others in all laboratories of our department. We all miss him. This manuscript is dedicated 
to Gary.  
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1. Introduction 
Less than 1% of the world's fresh water accessible for direct human uses is found in lakes, 
rivers, reservoirs and those underground sources that are shallow enough to be tapped at an 
affordable cost. Only this amount is regularly renewed by rain and snowfall, and is 
therefore available on a sustainable basis (Berger, 2003). 
More than a billion people have limited access to safe drinking water; over 2 million die 
each year from water-related diarrhea, which is one of the leading causes of mortality and 
morbidity in less economically developed countries (UNICEF and WHO, 2009). In more 
economically developed countries, increasing demands on water resources raise concerns 
about sustainable provision of safe drinking water. In 2008, supply and protection of water 
resources was identified as the top strategic priority of North American water professionals 
(Runge and Mann, 2008). This is not surprising given the rapidly expanding competition for 
existing water supplies from industrial, agricultural and municipal development, as well as 
the vital needs to protect human health and ecosystem functions. The challenge of 
sustaining supply is further exacerbated by changes in water quality and availability as a 
direct or indirect result of population growth, urban sprawl, climate change, water 
pollution, increasing occurrence of natural disasters, and terrestrial and aquatic ecosystem 
disturbance. 
Most of the world population depends on groundwater for their supplies. Due to the 
proximity of groundwater to sources of microbial contamination, the increasing occurrence 
of extreme climate events and the lack of adequate disinfection, groundwater is responsible 
for a large percentage of the waterborne outbreaks of disease worldwide (WHO, 2004; 2011). 
For example, between 1999 and 2000, 72% of drinking water outbreaks of disease were 
associated with groundwater. Although the number of groundwater-associated disease 
outbreaks associated in the United States decreased during 2001–02, the proportion of 
outbreaks associated with groundwater increased to 92% from 87% (Tufenkji and Emelko, 
2011). As a result of such outbreaks and the economic implications of waterborne illness, 
stricter water quality regulations to protect public health have been implemented in many 
countries. Significant examples of such regulations include the Surface Water Treatment 
Rules (SWTR -1989a; 2002) and the Ground Water Rule (2006) by the U.S. Environmental 
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Protection Agency (USEPA); the revised Bathing Water Directive (2006/7/EC) and the Water 
Framework Directive (200/60/EC) by the European Union. The pressure generated by such 
regulations has increased the need to quantitatively understand and describe microbial 
pathogen transport and survival in various natural and engineered environments, including 
treatment systems. 
Monitoring the fate and transport of all of the various microorganisms that can cause 
outbreaks of waterborne disease is cost prohibitive; accordingly, representative organisms 
such as “indicators” of pathogenic contamination or “surrogates” for the transport and 
survival of pathogens in various environments are sought. While indicators often originate 
from the same source and act as signals of pathogen presence, surrogates may or may not be 
derived from the same source as pathogens and are often introduced into natural and 
engineered environments to pseudoquantitatively assess pathogen fate and transport. 
Commonly used surrogates for such investigations include several bacteria, aerobic and 
anaerobic bacterial endospores, numerous bacteriophages, microbe-sized microspheres, 
chemically inactivated protozoa, and nonpathogenic, fluorescently labeled bacteria and 
protozoa (Tufenkji and Emelko, 2011). Bacteriophages meet many of the requirements of 
“ideal” surrogates because they have many characteristics that are similar to those of 
mammalian viral pathogens (i.e., size, shape, morphology, surface chemistry, isoelectric 
points, and physiochemistry), are unlikely to replicate in environments such as the 
subsurface due to a lack of viable hosts and other limiting factors, pose little risk to the 
health of humans, plants, and animals, and are easier and less expensive to isolate and 
enumerate relative to enteric viruses (Tufenkji and Emelko, 2011). All of these factors 
contribute to the utility of bacteriophages as surrogates for microbial pathogen transport 
and fate in source waters and in drinking water treatment processes. 
This chapter focuses on the utility of bacteriophages as surrogates for the fate and transport 
of microbial pathogens of health concern in source and drinking waters, with particular 
reference to: (1) indicating the presence of enteric viruses in natural waters, (2) contributing 
to microbial source tracking, (3) evaluating the effectiveness of water treatment processes 
such as disinfection and filtration, and (4) elucidating the mechanisms involved in the fate 
and transport of enteric viruses in natural or engineered filtration media. Present knowledge 
acquired through laboratory and field approaches is reviewed and further research needs 
are identified to respond to current and future challenges in this field. 
1.1 Major waterborne microbial pathogens of concern 
Although water-transmitted microbial pathogens include bacteria, protozoa, helminthes and 
viruses, the groups of major threat to human health in freshwater supplies are pathogenic 
protozoa and enteric viruses (Schijven and Hassanizadeh, 2000) (Table 1). The protozoans 
Cryptosporidium and Giardia are among the major causal agents of diarrhoeal disease in 
humans and animals worldwide, and can even potentially shorten the life span of 
immunocompromised hosts (WHO, 2004). Their resistant forms (cysts or oocysts) are shed 
in large numbers by infected animals or humans and are ubiquitous in surface water. They 
are resistant to harsh environmental conditions and to chemical disinfectants at concentrations 
commonly used in water treatment plants to reduce bacterial contamination (LeChevallier et 
al., 1991; Rose, 1997; Karanis et al. 2002; Aboytes et al., 2004). Their small size (Giardia cysts 8-
13 µm and Cryptosporidium oocysts 4-6 µm) and infectious dose (as low as a single organism - 
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Health Canada, 2004), also contribute to waterborne disease transmission. Several studies 
have revealed little or no correlation between bacterial fecal indicator and protozoan 
(oo)cyst densities in source surface waters (reviewed by Health Canada, 2004). These 
observations highlight the need for: (1) routine monitoring of surface waters for protozoan 
(oo)cysts or for reliable indicators of their presence and infectivity, and (2) implementation 
of improved drinking water technologies to effectively protect public health. 
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coxsackieviruses A and B, echoviruses and four ungrouped viruses numbered 68 to 71) 
(AWWA, 2006). Enteric viruses are widespread in sewage and some have been detected in 
wastewater, surface water and drinking water (Gerba and Rose 1990; Payment and Franco, 
1993; AWWA, 2006). Although they cannot multiply in the environment, they can survive for 
several months in fresh water and for shorter periods in marine water (Health Canada, 2004). 
Enteric viruses are the most likely human pathogens to contaminate groundwater because 
they are shed in enormous quantities in feces of infected individuals (109 to 1010/g) (Melnick 
and Gerba, 1980) and their extremely small size (20 to 100 nm) allows them to infiltrate soils, 
eventually reaching aquifers (Borchardt et al., 2003) (Fig. 1). Depending on physicochemical 
and virus-specific factors (e.g. size and isoelectric point), viruses can move considerable 
distances in the subsurface environment (Vaughn et al., 1983; Bales et al. 1993) and persist 
for several months in soils and groundwater (Keswick et al., 1982; Gerba and Bitton, 1984; 
Yates et al., 1985; Sobsey et al., 1986; Gerba and Rose, 1990; John and Rose, 2005). 
Enteroviruses also have been shown to be more resistant to disinfection than indicator 
bacteria (Melnick and Gerba, 1980; Stetler, 1984; IAWPRC, 1991). 
 
Fig. 1. Migration and survival of viruses and protozoa in the subsurface (adapted from 
Keswick and Gerba 1980 with permission). 
1.2 Source water protection and treatment 
In general the multiple-barrier approach to water treatment including watershed or 
wellhead protection, optimized treatment including disinfection, a well-maintained 
distribution system, monitoring the effectiveness of treatment, and safe water storage, is the 
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best approach for reducing the risk of infection to acceptable or non-detectable levels 
(Health Canada, 2004). Surface and groundwater protection from microbial contamination 
largely depend on adequate land use policies related to: (1) waste and wastewater 
management practices, (2) the interaction of contaminated surface water with 
groundwater supplies (including artificial recharge with treated wastewater) and (3) the 
effective placement and protection of drinking water wells. Pathogenic protozoa and 
enteric viruses are considered priority microbial contaminants in drinking water 
legislation because of the significant role they play in waterborne disease outbreaks and 
the associated risks to public health, their extended survival in the environment, their 
considerable resistance to conventional water disinfection processes compared to bacteria, 
and the often poor or lacking correlation with traditional bacterial water quality indicator 
numbers. 
Commonly used free chlorine concentrations and contact times applied in drinking water 
treatment are effective in inactivating enteric viruses (Thurston-Enriquez et al. 2003; Health 
Canada 2004). Ozone is generally considered more efficient against both protozoa and 
enteric viruses than chlorine or chlorine dioxide (Erickson and Ortega 2006). UV light 
disinfection, although highly effective for inactivation of protozoa, is not as efficient at 
inactivating viruses as more traditional chlorine-based disinfection processes (Health 
Canada, 2004). More recently, the combined performance of UV light and chlorine has been 
suggested as more effective for reclaimed water disinfection than the use of each process 
separately (Montemayor et al., 2008). 
Effective “green” ways to remove existing and emerging pathogens and produce safe 
drinking water at lower cost have received much attention in recent years. These include the 
passage of surface water and/or groundwater through porous media in the subsurface 
during processes such as riverbank filtration, dune recharge, aquifer storage and recovery, 
and deep well injection. The need to develop regulations to protect public health coupled 
with the infeasibility of concentration-based criteria for all known waterborne pathogens 
has resulted in the evolution of regulatory approaches for water quality and treatment that 
rely on performance indicators and surrogates and assume specific levels of pathogen 
reduction through well-operated treatment systems (Tufenkji and Emelko, 2011). 
1.3 Global quest for an effective pathogen indicator 
Because routine monitoring for pathogens is usually costly and often unrealistic, the use 
of surrogate parameters (i.e. microbial indicators) to predict the presence of pathogens in 
water and model their behavior has long been pursued. For decades fecal bacterial 
indicators (e.g. fecal coliforms and E.coli) have been useful to identify fecal contamination 
to indicate the probable presence of microbial pathogens in water (Payment and Locas, 
2011). However, their concentrations rarely correlate well with those of pathogens. Thus, 
bacterial indicators may signal the probable presence of pathogens in water, but they 
cannot predict precisely their level of occurrence (Payment and Locas, 2011). They are also 
not reliable pathogen surrogates because when compared with both virus and protozoa, 
bacterial indicators are less persistent in the aquatic environment and less resistant to 
disinfection and removal by other water treatment processes (IAWPRC 1991; Payment 
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Some enteroviruses have been evaluated for monitoring environmental waters and tracking 
sources of water pollution (Metcalf, 1978; Goyal, 1983; Payment et al., 1985). However, the 
limitations associated with their use soon became apparent: (1) they are not constant 
inhabitants of the intestinal tract and are excreted only by infected individuals and small 
children, (2) laboratory methods for their detection and quantification are time-consuming, 
expensive, require high expertise and are restricted to some enteroviruses subgroups, and 
(3) virion size, surface characteristics and resistance to external agents such as disinfectants 
vary among subgroups. Some studies have suggested using adenoviruses as an index of 
human pollution because they have been shown to be more persistent and present in greater 
numbers than enteroviruses in sewage and fecal contaminated aquatic environments (Pina 
et al. 1998, Thurston-Enriquez et al. 2003). 
When sewage is the source of enteric viruses and protozoa, spores of the anaerobic 
bacterium Clostridium perfringens have been suggested as suitable indicators of the presence 
and behavior of these pathogens in aquatic environments (Payment and Franco, 1993). Both 
Bacillus spp. aerobic endospores and Clostridium perfringens spores have been used as 
models for the removal of protozoa (oo)cysts and enteric viruses by drinking water 
treatment processes (Payment and Franco 1993, Rice et al. 1996). 
Increasing awareness of the shortcomings of fecal bacteria as indicators of the presence of 
pathogenic viruses and protozoa in the environment has attracted attention to the potential 
value of bacteriophages that infect enteric bacteria as indicators and surrogates for 
evaluating the presence and behavior of human pathogenic viruses in aquatic environments 
and during water treatment (Noonan and McNabb, 1979; Stetler, 1984; Gerba, 1987; 
Havelaar, 1987; Havelaar et al., 1993). However, while phage meet many of the 
requirements as surrogates for enteric viruses and are useful in certain situations, they are 
not universal indicators, models or surrogates for enteric viruses in water environments 
because several disadvantages can be associated with their use (further discussed in section 
3). For example, enteric viruses have been detected in treated drinking water supplies that 
yielded negative results for phages, even in presence–absence tests on 500 mL water 
samples (Ashbolt et al., 2001). 
Many years of research gradually elucidated that variations in pathogen input, dilution, 
retention, and die-off in water environments result in conditions in which 
relationships/correlations between any pathogen and any indicator may be random, site-
specific, and/or time-specific (Grabow, 1996; Payment and Locas, 2011). As a consequence, 
the present general scientific consensus is that there is no universal indicator of microbial 
water quality. Each specific situation, set of conditions, and objectives of study require a 
great deal of judgment to select the best group(s) of pathogen indicator(s) and/or 
surrogate(s) to be used most effectively (Table 2). Improved molecular detection techniques 
(e.g. PCR amplification or hybridization) based on host specificity of targeted viral and 
protozoan pathogens and surrogates in environmental samples may soon enable more 
reliable source tracking and improved public health surveillance (Scott et al. 2002; Fong and 
Lipp, 2005). Similarly, in-line microbial and chemical analytical systems installed at critical 
treatment points may replace microbial indicators and may provide continuous monitoring 
and reliable data, facilitating decision making. To further assist in process evaluation, efforts 
also have been made to eliminate ambiguities in the term “microbial indicator”. Several 
subgroups based on function have been recognized and are now commonly used in the 
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literature, such as: process indicators or surrogates (useful for demonstrating the efficiency 
of a process), fecal indicators (that indicate the presence of fecal contamination and imply 
that pathogens may be present), and index or virus models (indicative of pathogen presence 
and behavior respectively) (Ashbolt et al. 2001). 
 
Table 2. Most commonly used pathogen surrogates and their uses (Sources: Havelaar et al. 
1993, Health Canada 2004, Payment and Locas 2011) 
2. Multifunctionality of bacteriophages 
Estimated to be the most widely distributed and diverse entities in the biosphere (McGrath 
and van Sinderen, 2007), bacterial virus, bacteriophages or phage can be found in all 
environments populated by bacterial hosts, such as soil, water and animal guts. Their 
unique characteristics bring several advantages to their use as pathogen surrogates (Table 
3). Phages have been successfully used in a variety of environmental applications as follows: 
 As fecal indicators - the environmental occurrence and persistence of some groups 
relate to health risks associated with fecal pollution and the potential occurrence of 
enteric pathogens in aquatic environments (Havelaar, 1987; IAWPCR, 1991; Leclerc et 
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i. Have no known impact on the environment 
ii. Are non-toxic and non-pathogenic for humans animals or plants 
iii. Have a specific affinity to their bacterial host 
iv. Are reasonably similar to mammalian viral pathogens in size, shape, morphology, 
surface properties, mode of replication and persistence in natural environments  
v. Are colloidal in nature which makes them more adequate virus models then dissolved 
tracers 
vi. Are stable over periods of several months under laboratory conditions, 
vii. Can be detected and enumerated by rapid and inexpensive methods with low 
detection limits (1 to 2 phage per mL) 
viii. Can be prepared in large quantities at high concentrations 
ix. Specific phage groups are similar to specific pathogenic viral groups allowing the use 
of phage cocktails to simultaneously target several groups of concern. 
Disadvantages 
i. Are excreted by a certain humans and animals all the time while pathogenic viruses 
are excreted by infected individuals for a short period of time (depending on the 
epidemiology of viruses, outbreaks of infection, and vaccination). Consequently there 
is no direct correlation between numbers of phages and viruses excreted by humans 
ii. A wide range of different phage can be detected by methods for somatic coliphages 
iii. At least some somatic coliphages may replicate in water environments 
iv. Enteric viruses have been detected in water environments in the absence of coliphages 
v. Pathogenic human enteric viruses are excreted almost exclusively by humans, while 
bacteriophage used in water quality assessment are excreted by humans and animals. 
vi. The microbiota of the gut, diet and physiological state of animals seems to affect the 
numbers of coliphages in their feces 
vii. The composition and numbers of phages excreted by humans is variable (e.g. patients 
under antibiotic treatment excrete lower numbers than healthy or non- medicated 
individuals) 
viii. As water flows through porous media in the subsurface or engineered filtration 
processes phage can attach, detach, and re-attach by physico-chemical filtration 
mechanisms. 
Table 3. Advantages and disadvantages of the use of bacteriophages as viral pathogen 
surrogates and tracers in aquatic environments (Sources: Havelaar et al., 1993; Ashbolt et al., 
2001; Bateman et al., 2006). 
phage infecting enteric bacteria are now accepted as useful indicators in water quality 
control and included in some regulations as required parameters. For example, coliphages 
are used in the US Water Ground Rule (USEPA, 2006), the drinking water quality 
regulation for the Canadian Province of Quebec (Anonymous, 2001) and a few USA states 
regulations regarding required quality for reclaimed water for certain uses (USEPA, 2003).  
 In microbial source tracking (MST) or identification of fecal contamination sources by 
genotypic, phenotypic, and chemical methods, phage have proven useful based on their 
host specificity (Hsu et al. 1995; Hsu et al., 1996; Simpson et al., 2003; Jofre et al., 2011). 
By identifying problem sources (animal and human) and determining the effect of 
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implemented remedial solutions MST is of special interest in waters used for recreation 
(primary and secondary contact), public water supplies, aquifer protection, and 
protection and propagation of fish, shellfish and wildlife (Simpson et al., 2003). 
 As process indicators phage groups are often successfully employed as enterovirus 
surrogates in evaluating the effectiveness of water treatment processes and final 
product quality. This is the case with filtration and disinfection (Stetler et al., 1984; 
Payment et al., 1985; Havelaar et al., 1993; Durán et al., 2003; Davies-Colley et al., 2005; 
Persson et al., 2005; Abbaszadegan et al., 2008). 
 As comprehensive pathogenic virus indices, phages are not very useful. This is because 
their numbers seldom seem to correlate to pathogenic viruses numbers in water 
samples when conventional statistics are applied (Lucena and Jofre, 2010). However, in 
the future the application of advanced mathematical models to new databases may 
reduce uncertainty and provide better information about relationships between phage 
and pathogenic virus numbers (Lucena and Jofre, 2010).  
 As viral models and tracers, bacteriophages are often used at both field and laboratory 
scales as biocolloids to estimate the fate and transport of pathogenic viruses in surface and 
subsurface aquatic environments and through natural and manmade saturated and 
unsaturated porous media. This use of phage as surrogates for pathogen transport applies 
to protection of surface and groundwater supplies from microbial contamination, 
assessment of potential health risk from pathogens in groundwater and design of more 
efficient treatment systems in removing pathogens from drinking water supplies (Sen, 
2011).  
3. Main bacteriophage groups used in environmental studies 
Three bacteriophage groups, somatic coliphages, male-specific F-RNA phages and Bacteroides 
fragilis phages, have been proposed and are frequently used as surrogates for pathogenic 
viruses in environmental studies (IAWPRC, 1991; WHO, 2004; Lucena and Jofre, 2010). 
However, because each group has its pros and cons as a representative of enteric virus 
presence and behavior in aquatic environments and water treatment processes, no agreement 
has been reached on which of the three groups best fulfills the index/indicator function. 
3.1 Somatic coliphages 
Somatic coliphages are the most numerous and most easily detectable phage group in the 
environment. It is a heterogeneous group whose members infect host cells (E.coli and other 
Enterobactereacea) by attaching to receptors located in the bacterial cell wall. Their numbers 
are low in human feces (often <10 g-1), but abundant in untreated domestic sewage (104 to 
105 particles g-1) and in animal feces (Havelaar et al., 1986). 
Somatic coliphages are not usually considered good fecal indicators because some of their 
hosts are unlikely to be of fecal origin (Hsu et al. 1996), and some of these phage are able to 
multiply in waters not subjected to fecal pollution (Gerba, 2006). However, some authors 
argue that the number of somatic phage that replicate in environmental waters is negligible 
(Jofre, 2009). Moreover, they are not predictive indicators of virus presence or absence in 
groundwater (Payment and Locas, 2011), though some somatic phage such as T-4, T-7, 
ΦX174, and PRD-1 have proven useful as viral surrogates of fate and transport in laboratory 
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phage infecting enteric bacteria are now accepted as useful indicators in water quality 
control and included in some regulations as required parameters. For example, coliphages 
are used in the US Water Ground Rule (USEPA, 2006), the drinking water quality 
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regulations regarding required quality for reclaimed water for certain uses (USEPA, 2003).  
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host specificity (Hsu et al. 1995; Hsu et al., 1996; Simpson et al., 2003; Jofre et al., 2011). 
By identifying problem sources (animal and human) and determining the effect of 
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implemented remedial solutions MST is of special interest in waters used for recreation 
(primary and secondary contact), public water supplies, aquifer protection, and 
protection and propagation of fish, shellfish and wildlife (Simpson et al., 2003). 
 As process indicators phage groups are often successfully employed as enterovirus 
surrogates in evaluating the effectiveness of water treatment processes and final 
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Persson et al., 2005; Abbaszadegan et al., 2008). 
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Phage Family name Type Lipid 
(%) 
pHzpc Hosts Phage Size/Shape 
T2, T4, T6 Myoviridae Somatic 
Linear 
ds-DNA 





contractile tail, 95 x 
65 nm (EM) 
T5, λ Siphoviridae Somatic 
Linear 
ds-DNA 





(150 nm), 54-60 nm 
(EM) 
T3, T7 Podoviridae Somatic 
Linear 
ds-DNA 





54-61 nm (EM) 
PM2 Corticoviridae Somatic 
Linear 
ds-DNA 





spikes in vertices, no 
tail, 60 nm (EM) 
PRD-1 * Tectiviridae Somatic 
Circular 
ds-DNA 




(icosahedral), no tail, 
63 nm (EM)  
82 ± 6 nm (DLS) 





E. coli and other 
Enterobateriaceae
Cubic capsid 
(icosahedral), no tail, 
63 nm (EM) 
MS2, Qβ Leviviridae F-specific 
Linear 
ss-RNA 
0 3.9; 5.2 E. coli and 
Salmonella sp. 
Cubic capsid 
(icosahedral), no tail, 
20-30 nm (EM) 
φX174 Microviridae Somatic 
Circular 
ss-DNA 





spikes in vertices, no 






0 — E. coli and 
Salmonella sp. 
Filamentous or rod-







0 — Bacteroides 
fragillis HSP40 
Icosahedral head (60 
nm), flexible non-
contractile tail, 150 x 
8 nm (EM) 
EM - electron microscopy analysis (measures physical diameter of dry particles) 
DLS - dynamic light scattering analysis (measures hydrodynamic size of particles in a fluid) 
pHzpc - zeta potential charge 
Table 4. Characteristics of bacteriophages commonly used as pathogenic virus surrogates in 
environmental studies (adapted from Mesquita et al., 2010). 
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Bacteriophage PRD-1 (Table 4) in particular has emerged as an important viral model for 
studying microbial transport through a variety of subsurface environments. Its popularity is 
due to its similarity to human adenoviruses in size (~62nm) and morphology (icosahedric), 
its relative stability over a range of temperatures and low degree of attachment in aquifer 
sediments (Harvey and Ryan, 2004; Ferguson et al., 2007). 
3.2 F-RNA bacteriophages 
F or male specific RNA bacteriophages are a homogeneous group of phage that attach to 
fertility fimbriae (F-pili or sex-pili) produced by male bacterial cells (possessing an F-
plasmid) in certain stages of their growth cycle. Since the F-plasmid is transferable to a wide 
range of Gram-negative bacteria, F-specific bacteriophages may have several hosts besides 
E.coli (Havelaar 1987). This group ranks second in abundance in water environments 
although its persistence in surface waters, mainly in warm climates is low (Chung and 
Sobsey, 1993; Mocé-Llivina et al., 2005). 
F-RNA bacteriophages have been most extensively studied due to their similarity (in size, 
shape, morphology and physiochemistry) to many pathogenic human enteric viruses, 
namely enteroviruses, caliciviruses, astroviruses and Hepatitis A and E virus (Jofre et al., 
2011) (Table 4). These phages are infrequently detected in human and animal feces (103 g-1) 
or in aquatic environments despite their frequent detection in wastewater (103 to 104 mL-1) 
(Havelaar et al., 1986; Gerba, 2006). Further research is needed to clarify if their consistently 
higher concentrations in sewage relative to feces are the result of direct environmental input 
or multiplication. If the latter is true, F-RNA bacteriophages may not be acceptable fecal 
pollution indicators (Havelaar et al., 1990). Jofre et al. (2011) suggested that the 
environmental multiplication of these phages is unlikely, however, because F-pili 
production only occurs at temperatures above 25oC and replication does not occur in 
nutrient-poor environments and requires a minimum host density of 104 colony forming 
units (cfu) per mL. 
The presence of F-RNA phage in high numbers in wastewater and their resistance to 
chlorination contribute to their usefulness as process indicators, indices of sewage pollution, 
and conservative models of human viruses in water and shellfish (Havelaar et al., 1993; 
Havelaar, 1993; Love and Sobsey, 2007). They are also promising in microbial source 
tracking since they can be subdivided in four antigenically distinct serogroups. Because 
those predominating in humans (groups II and III) differ from those predominating in 
animals (groups I and IV), it is possible to distinguish between human (higher public health 
risk) and animal wastes by serotyping or genotyping F-RNA coliphage isolates (Hsu et al., 
1995; Hsu et al., 1996; Scott et al., 2002). 
F-RNA bacteriophages MS2 and f2 (Table 4) are morphologically similar to enteroviruses 
and are frequently used to study viral resistance to environmental stressors, disinfection and 
other treatment processes (Havelaar, 1986, Havelaar et al., 1993; WHO, 2004). These phage 
have been shown to attach poorly to soil particles and survive relatively well in 
groundwater (Goyal and Gerba, 1979; Yates et al., 1985; Powelson et al., 1990). As a result, 
Havelaar (1993) described F-RNA phage as a “worst case” virus model for virus transport in 
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Together, somatic and F-specific bacteriophages counts in water samples are usually 
designated as “total coliphage count”. Some bacterial strains can be used to enumerate both 
simultaneously (Guzmán et al., 2008). Their enumeration may be a good alternative for 
determination of viral contamination in poorly contaminated waters such as groundwater 
and drinking water or in double disinfection water treatments (Lucena and Jofre, 2010).  
3.3 Bacteriophages of Bacteroides fragilis 
Bacteriophages of Bacteroides fragilis and other Bacteroides species rank third in abundance in 
natural waters. They have been suggested as potential indicators of human viruses in the 
environment by Tartera and Jofre (1987). Their host Bacteroides fragilis is a strict anaerobic 
bacterium abundant in human feces. These bacteriophages attach to the host bacteria cell 
wall and have narrow host range. They occur only in human feces (108 g-1) and in 
environmental samples contaminated with human fecal pollution (Havelaar et al., 1986). 
Consequently they are useful in microbial source tracking, helping to differentiate human 
from animal contamination (Ebdon et al. 2007; Lucena and Jofre, 2010). In contrast with 
other phage they are absent from natural habitats and unable to multiply in the 
environment (Tartera et al., 1989). They also decay in the environment at a rate similar to 
that of enteric viruses. The main drawbacks associated with their use as routine fecal 
indicators, are that: (1) their host is a strict anaerobe requiring complex and tedious 
cultivation methodology, (2) their numbers in water may be low requiring concentration 
from large volumes, and (3) different hosts are needed for different geographic areas. Within 
this group, the most commonly used bacteriophages in environmental and treatment 
resistance studies are B40-8 and B56-3 (Lucena and Jofre, 2010). 
4. Available methodology for bacteriophage detection, enumeration and 
propagation 
Relatively simple and reliable methods for detection, isolation, enumeration and 
characterization of bacteriophages from natural sources are available in the literature. These 
include classic culture-based techniques using liquid or solid bacteriological media, as well 
as more recent physico-chemical, immunological, immunofluorescence, electron 
microscopy, and molecular methods. However, a lack of methodology standardization and 
quality control has for decades limited the use of phage data for comparison studies. This 
situation has improved since the publication of standardized plaque assays and 
presence/absence methods in the USA and Europe. For somatic coliphages (APHA, EWWA, 
and WEF, 2005; EPA, 2001a; 2001b), F-specific RNA phages (ISO, 1995; ISO, 2000; EPA, 
2001a; 2001b) and bacteriophages infecting Bacteroides fragilis (ISO, 2001). 
Sobsey et al. (1990) developed a simple, inexpensive and practical procedure for the 
detection and recovery of F-RNA bacteriophages from low turbidity water using mixed 
cellulose and acetate filters with 47 mm diameter and 0.45 um pore size. A slightly modified 
version of this method has shown excellent performance for recovery of somatic and F-
specific phages, and bacteriophages of Bacteroids fragilis in up to 1L water samples (Mendez 
et al., 2004). Rapid bacteriophage detection methods involving enrichment steps followed by 
latex agglutination or bioluminescence (Love and Sobsey, 2007) and molecular approaches 
have also been developed and recently reviewed by Jofre et al. (2011). 
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Specific methods for the production of the large-volume, high-titer purified bacteriophage 
suspensions that are necessary for many types of environmental fate and transport studies 
were, until very recently, difficult to find in the refereed literature. Given that system 
chemistry and other surface-related characteristics of phage particles, may substantially 
contribute to observations of their environmental fate and transport behavior in many types 
of porous media filtration systems used for water treatment (Pieper et al., 1997; Harvey and 
Ryan, 2004; Cheng et al., 2007), it is critical to consider the impacts of the 
propagation/purification protocol on those factors. In response to this need, a selected 
sequence of rapid, reliable, and cost-effective procedures to propagate and purify high-titer 
bacteriophage suspensions has recently been proposed (Mesquita et al., 2010). This 
methodology emphasizes the most important factors required to ensure maximum 
bacteriophage yields, minimum change on phage particles surface characteristics, and low 
dissolved organic carbon (DOC) concentration in the final suspensions. 
Many of the methods routinely used to quantify microscopic discrete particles such as 
bacteriophages are known to yield highly variable results arising from sampling error and 
variations in analytical recovery (i.e., losses during sample processing and errors in 
counting); thereby leading to considerable uncertainty in particle concentration or log10-
reduction estimates (Emelko et al., 2008; 2010; Schmidt et al., 2010). For example, sampling 
error is substantially greater than analytical error when organisms are present in relatively 
low concentrations; in these cases, improved sampling (i.e., resulting in counts of 
approximately 10 or more organisms in a sample or, in some cases, several replicates) 
substantially contributes to reducing uncertainty. In contrast, when organisms are present in 
higher and homogeneous concentrations, uncertainty in concentration estimates can be 
reduced by decreasing analytical errors (Emelko et al., 2008; 2010). Emelko et al. (2010) 
demonstrated that uncertainty in concentration and removal estimates derived from 
microbial enumeration data can be addressed when these errors are properly considered 
and quantified. The development and use of such quantitative approaches is an essential 
component of strategies (e.g., the monitoring of surrogate parameters/pathogens, 
experimental design, and data analysis) for better evaluating microorganism transport and 
fate in source and treated drinking waters. 
5. Bacteriophages contribution to predicting pathogen transport in filtration 
porous media 
In the last two centuries a large number of field studies have evaluated the transport of 
bacteriophages in the subsurface (especially through the vadose zone) at different field sites 
around the world (Rossi, 1994; Collins et al., 2006; Pieper et al., 1997; Bales et al., 1997; Dowd 
et al., 1998; Rossi et al., 1998; Sinton et al., 1997; Ryan et al., 1999; Auckenthaler et al., 2002; 
McKay et al., 2000; Schijven and Hassanizadeh, 2000; Schijven, 2001; Harvey and Harms, 
2002; Ryan et al., 2002; Harvey and Ryan, 2004; Blanford et al., 2005; Harvey et al., 2007; 
Ferguson et al., 2007). PRD-1, MS-2 and ΦX174 have also been extensively used at controlled 
laboratory conditions to elucidate physicochemical effects on virus transport through a 
variety of porous media (Bales et al., 1991; Bales et al., 1993; Schulze-Makuche et al., 2003; 
Zhuang and Jin, 2003; Han et al., 2006; Sadeghi et al., 2011). 
Based on existing data, major environmental factors affecting enteric viruses and phage 
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(Table 5). Due to the complexity of interactive factors controlling survival and transport 
there is great variability among study outcomes, however. It is, at present, generally 
accepted that the main processes for viral removal in water filtration through porous media  
 
Factors     Findings 
1. Temperature - a major controlling factor for virus inactivation usually with greater 
inactivation at temperatures above 20°C. This may be due to more rapid denaturation 
of viral capsid proteins or potential degradation of extracellular enzymes with 
increased temperature 
2. Native Microbial activity - Inactivation rates have often been reported to be lower in 
the absence of groundwater bacteria possibly because bacterial enzymes and protozoa 
may destroy viral capsid protein. However, other studies have found the opposite to 
be true. 
3. Moisture content - Different viruses and phage (MS2 and PRD-1) have been reported 
to have different inactivation rates in groundwater, saturated, unsaturated and dry 
soils. Migration seems to increase under saturated flow conditions. 
4. Nutrients - addition when native organisms are present seems to determine decreased 
viral inactivation. Possibly because the nutrients offered protection from inactivation 
by enzymatic attack or acted as alternate nutrient sources for the native bacteria 
5. Aerobic and anaerobic condition - Anaerobic conditions have been shown to slow 
down poliovirus and coxsackievirus inactivation. It has been suggested this is 
potentially an interactive factor with the impact of native microorganisms since low 
oxygen will minimize negative microbial activity., 
6. pH - most enteroviruses are stable over a pH range of 3 to 9, survival may be 
prolonged at near neutral; low pH favors virus attachment and high pH detachment 
from soil particles 
7. Salt species and concentration - some viruses are protected from inactivation by 
certain cations: the reverse is also true. Generally increasing the concentration of ionic 
salts and cation valences enhances virus attachment.  
8. Association with soil and other particles – in many cases viral survival is prolonged 
by attachment to soil, although the opposite has also been observed. Usually virus 
transport through the soil is slowed or prevented by association with particles. 
However, attachment to solid surfaces appears to be virus-type-dependent 
9. Soil properties – effects on survival are probably related to the degree of virus 
attachment: greater virus migration is usually observed in coarse-textured soils, while 
there is a high degree of virus retention by the clay fraction of soil. 
10. Virus type – particle-structure may be a deciding factor in attachment/detachment 
and inactivation by physical, chemical and biological factors. 
11. Organic matter (OM) – may protect virus from inactivation or reversibly retard virus 
infectivity. Soluble OM seems to compete with virus particles for attachment sites on 
soil. 
12. Hydraulic conditions – increasing hydraulic loads and flow rates usually increase 
virus transport. 
Table 5. Major factors determining viral survival and transport in the subsurface and in 
groundwater (adapted from: Azadpour-Keeley et al., 2003; John and Rose, 2005). 
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are physio-chemical attachment/detachment and inactivation (Keswick and Gerba, 1980; 
Yates et al., 1987; Bales et al, 1991; 1997; Gitis et al., 2002; Tufenkji and Emelko, 2011). Virus 
attachment and inactivation depend on the type virus, as well as on the physico-chemical 
properties of the water and soil or filtration media grain (Schijven and Hassanizadeh, 2000; 
Tufenkji and Emelko, 2011). Physical and physico-chemical processes such as advection, 
dispersion, diffusion, and physico-chemical filtration all contribute to attenuation of virus 
concentrations (Schijven and Hassanizadeh 2000; Tufenkji and Emelko, 2011). Various 
physico-chemical forces may be involved in the attachment of viruses to soil or filtration 
media particles including, hydrogen bonding, electrostatic attraction and repulsion, Van der 
Waals forces and covalent ionic interaction (Murray and Parks; 1980). Straining (i.e. physical 
blocking of movement) may come into play in some environments as well (Bradford et al., 
2006).  
The unsaturated or vadose zone (i.e. the layer between the land surface and the 
groundwater table) where much of the subsurface contamination originates, passes through, 
or can be eliminated before it contaminates surface and subsurface water resources has 
gained particular attention in recent years. In unsaturated conditions, additional and more 
complex mechanisms are involved in pathogen transport such as: variability in ionic 
strength , pH and water content, particle capture at the water-gas interface, particle capture 
at the solid-water-gas interface, and preferential flow or retention in the immobilization 
zone (Sen, 2011). Biological processes such as growth and decay, active attachment or 
detachment, survival, random mobility and chemotaxis are also believed to strongly affect 
virus transport in saturated and unsaturated porous media (Sen, 2011). Less information is 
available regarding the fate of pathogenic protozoa in the vadose zone (Harvey et al., 1995; 
Harvey et al., 2002; Hancock et al., 1998; Brush et al., 1999; Harter et al., 2000; Darnault et al., 
2004; Davies et al., 2005), however, the physico-chemical processes that affect virus fate and 
transport also apply to protozoan cysts and oocysts during soil transport, albeit to a 
different extent (Schijven and Hassanizadeh, 2000). 
The growing database of information concerning phage attachment, inactivation and 
transport behavior in porous media has led to their use as viral surrogates in mathematical 
models used to describe viral transport within physically or geochemically heterogeneous 
granular media at environmentally-relevant field scales (Rehmann et al., 1999; Schijven and 
Hassanizadeh, 2000; Schijven et al., 2000; Bhatacharjee et al., 2002; Schijven et al., 2010). As 
they continue to improve, such models may become useful tools in decision making related 
to in public health protection because they may ultimately be incorporated into quantitative 
microbial risk assessment to: (1) access groundwater vulnerability, especially of highly 
vulnerable geological settings (i.e. fractured rock aquifers, cross-connecting bore holes, or 
leaking well cases in sandstone and shale aquifers) in combination with significant sources 
of contamination (i.e. wastewater treatment plants, septic tanks and animal manure), (2) 
simulate the transport of viruses from a contamination source at or near the surface to a 
groundwater abstraction well, and (3) evaluate set back distances from abstraction wells 
from potential contamination sources for source protection (Schijven et al. 2010). 
6. Conclusions and recommendations for future research 
Considerable progress has been made in understanding how suitable bacteriophages are as 
surrogates for pathogenic enteric viruses. As a result, they have become invaluable tools in 
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of contamination (i.e. wastewater treatment plants, septic tanks and animal manure), (2) 
simulate the transport of viruses from a contamination source at or near the surface to a 
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Considerable progress has been made in understanding how suitable bacteriophages are as 
surrogates for pathogenic enteric viruses. As a result, they have become invaluable tools in 





 The use of somatic and F-specific coliphages as indices of water contamination by 
sewage and as process indicators in the evaluation of drinking water and the efficacy of 
drinking water treatment processes.  
 The use of F-specific bacteriophages as indices and models of human enteric viruses in 
contaminated water, shellfish and agricultural products and in microbial source 
tracking. 
 The use of particular somatic and F-specific bacteriophages to improve the understanding 
of the multiple physical, chemical and biological processes affecting biocolloid transport 
in saturated and unsaturated subsurface environments. 
 The use of bacteriophages of B. fragilis as indicators of human fecal contamination and 
in microbial source tracking.  
Additional research efforts are needed in the following areas: 
 Use of more sensitive and reliable methodologies (i.e. standardized cultural procedures, 
molecular and other techniques) to minimize the variance between reported and actual 
numbers of bacteriophages in field and laboratory studies and allow the development 
of more complete and reliable databases. 
 Use of more consistent experimental procedures to reduce variability among 
researchers’ findings. Standardized protocols are required for the preparation 
(propagation, concentration and purification) of bacteriophages to be used in laboratory 
and field scale studies, as well the use of phage from well known sources such as the 
American Type Culture Collection (ATCC) or the Canadian Felix d’Herelle Reference 
Center for Bacterial Viruses to avoid differences in the viruses themselves. 
 Evaluation of the complex interactions of native groundwater organisms with 
introduced enteric microbes (including enteric bacteriophage) and the environmental 
factors that influence them. 
 Evaluation of the impact of viral structure and surface properties on attachment/ 
detachment and inactivation of virus particles in various environments. 
 Improved understanding of the transport and survival of both bacteriophages and 
pathogenic enteric viruses in surface water and the subsurface is needed; not only at 
laboratory scale to clarify the generic mechanisms involved, but also at field scale at 
settings with specific environmental conditions (water matrixes, flow regimes, 
hydrogeological and filtration media characteristics, etc.) in an attempt to clarify 
conflicting evidence previously reported on the extent of inactivation and 
immobilization of viruses by some physico-chemical and biological factors. 
 Development of sound databases reflecting the occurrence, persistence and transport of 
viral particles in natural environments and water treatment systems that can be used to 
improve mathematical models of microbial fate and transport. 
 Development of microbial fate and transport models taking into account the many 
factors affecting virus fate and transport under various conditions applicable to: 
improve viral contamination control in specific environments, ensure compliance with 
current water quality regulations, help in the selection and control of treatment 
processes and ultimately improve public health protection. 
 Further investigation of the usefulness of bacteriophages for source tracking purposes. 
Taking advantage of the stringent host specificity of some phage groups and the speed, 
high specificity and sensitivity of molecular detection methods in order to better 
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characterize sources of contamination in aquatic environments so that appropriate and 
cost-effective water quality remediation plans can be developed. 
In the future, the progress of such applications will reveal the true potential of 
bacteriophages as viral pathogen surrogates in water and water treatment. 
7. References 
Abbaszadegan, M; Monteiro, P.; Nwachuku, N.; Alum A. & Ryu H. (2008). Removal of 
adenoviruses, calicivirus, and bacteriophages by conventional drinking water 
treatment. Journal of Environmental Science and Health, 43 (A): 171-177. 
Aboytes R.; DiGiovanni G.D.; Abrams F.A.; Rheinecker C.; McElroy W.; Shaw N. & 
LeChevallier M.W. (2004). Detection of infectious Cryptosporidium in filtered 
drinking water. Journal of the American Water Works Association, 96: 88-98. 
Anonymous (2001). Loi sur la qualité de l’environement : règlement sur la qualité de l’eau 
potable c. Q-2, r.18.1.1. Gazette Officielle du Québec, 24: 3561. 
Anonymous (2005). Draft Guidelines for Drinking Water Quality Management in New 
Zealand, Volume 3 - Micro-organisms and Chemical and Physical Determinands. 
APHA, EWWA & WEF (2005). Section 9224 C- Male-specific coliphage assay using Escherichia 
coli. In American Public Health Association, Standard Methods for the Examination of Water 
and Wastewater, 21th ed. APHA, Washington, DC. pp. 9-77-9-78. 
Ashbolt, N. J., Grabow, W.O.K. & Snozzi, M. (2001). Indicators of microbial water quality. In 
WHO Water Quality Guidelines, Standards and Health. Fewtrell L. and Bartram J. 
(eds.). IWA Publishers, London UK. 
Auckenthaler, A., Raso, G. & Huggenberger, P. (2002). Particle transport in a karst aquifer: 
natural and artificial tracer experiments with bacteria, bacteriophages and 
microspheres. Water Science and Technology, 46 (3): 131–138. 
AWWA (2006). Waterborne Pathogens. AWWA Manual M48. 2nd edition. Published by the 
American Water Works Association. 
Azadpour-Keeley A., Faulkner B.R. & Chen J-S. (2003). Movement and longevity of viruses 
in the subsurface. US-EPA.  
Betancourt W. Q. & Rose J. B, (2004). Drinking water treatment processes for removal of 
Cryptosporidium and Giardia. Veterinary Parasitology 126(1-2): 219-234. 
Bales R.C., Hinkle, S.R., Kroeger, T.W., Stocking K. & Gerba C.P. (1991). Bacteriophage 
adsorption during transport through porous media: chemical perturbations and 
reversibility. Environmental Science and Technology, 25: 2088-2095. 
Bales R.C.; Li S.; Maguire K.M.; Yahya M.T. & Gerba C.P. (1993). MS-2 and poliovirus 
transport in porous media: hydrophobic effects and chemical perturbations. Water 
Resources Research,. 29, 957–963. 
Bales R.C., Li S.M. Yeh T.C.J., Lenczewski M.E. & Gerba C.P. (1997). Bacteriophage and 
microsphere transport in saturated porous media: forced gradient experiment at 
Borden, Ontario. Water Resources Research, 33(4): 639-648. 
Bateman K., Coombs, P. Harrison H., Milodowsky A.E., Noy D., Van C.H. Wagner D. & 
West J.M. (2006). Microbial transport and microbial indicators of mass transport 
through geological media – A literature survey. In A Geological Background and 
Planning for any Area. British Geological Survey. Internal report IR 06/029. 





 The use of somatic and F-specific coliphages as indices of water contamination by 
sewage and as process indicators in the evaluation of drinking water and the efficacy of 
drinking water treatment processes.  
 The use of F-specific bacteriophages as indices and models of human enteric viruses in 
contaminated water, shellfish and agricultural products and in microbial source 
tracking. 
 The use of particular somatic and F-specific bacteriophages to improve the understanding 
of the multiple physical, chemical and biological processes affecting biocolloid transport 
in saturated and unsaturated subsurface environments. 
 The use of bacteriophages of B. fragilis as indicators of human fecal contamination and 
in microbial source tracking.  
Additional research efforts are needed in the following areas: 
 Use of more sensitive and reliable methodologies (i.e. standardized cultural procedures, 
molecular and other techniques) to minimize the variance between reported and actual 
numbers of bacteriophages in field and laboratory studies and allow the development 
of more complete and reliable databases. 
 Use of more consistent experimental procedures to reduce variability among 
researchers’ findings. Standardized protocols are required for the preparation 
(propagation, concentration and purification) of bacteriophages to be used in laboratory 
and field scale studies, as well the use of phage from well known sources such as the 
American Type Culture Collection (ATCC) or the Canadian Felix d’Herelle Reference 
Center for Bacterial Viruses to avoid differences in the viruses themselves. 
 Evaluation of the complex interactions of native groundwater organisms with 
introduced enteric microbes (including enteric bacteriophage) and the environmental 
factors that influence them. 
 Evaluation of the impact of viral structure and surface properties on attachment/ 
detachment and inactivation of virus particles in various environments. 
 Improved understanding of the transport and survival of both bacteriophages and 
pathogenic enteric viruses in surface water and the subsurface is needed; not only at 
laboratory scale to clarify the generic mechanisms involved, but also at field scale at 
settings with specific environmental conditions (water matrixes, flow regimes, 
hydrogeological and filtration media characteristics, etc.) in an attempt to clarify 
conflicting evidence previously reported on the extent of inactivation and 
immobilization of viruses by some physico-chemical and biological factors. 
 Development of sound databases reflecting the occurrence, persistence and transport of 
viral particles in natural environments and water treatment systems that can be used to 
improve mathematical models of microbial fate and transport. 
 Development of microbial fate and transport models taking into account the many 
factors affecting virus fate and transport under various conditions applicable to: 
improve viral contamination control in specific environments, ensure compliance with 
current water quality regulations, help in the selection and control of treatment 
processes and ultimately improve public health protection. 
 Further investigation of the usefulness of bacteriophages for source tracking purposes. 
Taking advantage of the stringent host specificity of some phage groups and the speed, 
high specificity and sensitivity of molecular detection methods in order to better 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
73 
characterize sources of contamination in aquatic environments so that appropriate and 
cost-effective water quality remediation plans can be developed. 
In the future, the progress of such applications will reveal the true potential of 
bacteriophages as viral pathogen surrogates in water and water treatment. 
7. References 
Abbaszadegan, M; Monteiro, P.; Nwachuku, N.; Alum A. & Ryu H. (2008). Removal of 
adenoviruses, calicivirus, and bacteriophages by conventional drinking water 
treatment. Journal of Environmental Science and Health, 43 (A): 171-177. 
Aboytes R.; DiGiovanni G.D.; Abrams F.A.; Rheinecker C.; McElroy W.; Shaw N. & 
LeChevallier M.W. (2004). Detection of infectious Cryptosporidium in filtered 
drinking water. Journal of the American Water Works Association, 96: 88-98. 
Anonymous (2001). Loi sur la qualité de l’environement : règlement sur la qualité de l’eau 
potable c. Q-2, r.18.1.1. Gazette Officielle du Québec, 24: 3561. 
Anonymous (2005). Draft Guidelines for Drinking Water Quality Management in New 
Zealand, Volume 3 - Micro-organisms and Chemical and Physical Determinands. 
APHA, EWWA & WEF (2005). Section 9224 C- Male-specific coliphage assay using Escherichia 
coli. In American Public Health Association, Standard Methods for the Examination of Water 
and Wastewater, 21th ed. APHA, Washington, DC. pp. 9-77-9-78. 
Ashbolt, N. J., Grabow, W.O.K. & Snozzi, M. (2001). Indicators of microbial water quality. In 
WHO Water Quality Guidelines, Standards and Health. Fewtrell L. and Bartram J. 
(eds.). IWA Publishers, London UK. 
Auckenthaler, A., Raso, G. & Huggenberger, P. (2002). Particle transport in a karst aquifer: 
natural and artificial tracer experiments with bacteria, bacteriophages and 
microspheres. Water Science and Technology, 46 (3): 131–138. 
AWWA (2006). Waterborne Pathogens. AWWA Manual M48. 2nd edition. Published by the 
American Water Works Association. 
Azadpour-Keeley A., Faulkner B.R. & Chen J-S. (2003). Movement and longevity of viruses 
in the subsurface. US-EPA.  
Betancourt W. Q. & Rose J. B, (2004). Drinking water treatment processes for removal of 
Cryptosporidium and Giardia. Veterinary Parasitology 126(1-2): 219-234. 
Bales R.C., Hinkle, S.R., Kroeger, T.W., Stocking K. & Gerba C.P. (1991). Bacteriophage 
adsorption during transport through porous media: chemical perturbations and 
reversibility. Environmental Science and Technology, 25: 2088-2095. 
Bales R.C.; Li S.; Maguire K.M.; Yahya M.T. & Gerba C.P. (1993). MS-2 and poliovirus 
transport in porous media: hydrophobic effects and chemical perturbations. Water 
Resources Research,. 29, 957–963. 
Bales R.C., Li S.M. Yeh T.C.J., Lenczewski M.E. & Gerba C.P. (1997). Bacteriophage and 
microsphere transport in saturated porous media: forced gradient experiment at 
Borden, Ontario. Water Resources Research, 33(4): 639-648. 
Bateman K., Coombs, P. Harrison H., Milodowsky A.E., Noy D., Van C.H. Wagner D. & 
West J.M. (2006). Microbial transport and microbial indicators of mass transport 
through geological media – A literature survey. In A Geological Background and 
Planning for any Area. British Geological Survey. Internal report IR 06/029. 





Bhattacharjee S., Ryan J.N., & Elimelech M. (2002). Virus transport in physically and 
geochemically heterogeneous subsurface porous media. Journal of Contaminant 
Hydrology, 57: 161-187.  
Blanford, W.J., Brusseau M.L., Yeh T.C.J., Gerba C.P. & Harvey R. (2005). Influence of water 
chemistry and travel distance on bacteriophage PRD-1 transport in a sandy aquifer. 
Water Research, 39: 2345-2357. 
Borchardt M.A., Bertz P.D., Spencer S., & Battigelli D.A. (2003). Incidence of enteric viruses 
in groundwater from household wells in Wisconsin. Applied Environmental 
Microbiology, 69 (2), 1172-1180. 
Bradford S.A., Tadassa Y.F., & Jin Y. (2006). Transport of coliphage in the presence and 
absence of manure suspension. Journal of Environmental Quality, 35(5):1692-701. 
Brush C. F., Ghiorse W.C., Anuish L.J., Parlange J.-Y. & Grimes H.G.(1998). Transport of 
Cryptosporidium parvum oocysts through saturated columns. Journal of 
Environmental Quality, 28: 809-815. 
CDC (2003). Guideline for Environmental Infection Control in Health-Care Facilities, 
Communicable Disease Control Advisory Committee. USA. 
Cheng L., Chetochine A.S., Pepper I. L. & Brusseau M. L. (2007). Influence of DOC on MS2 
bacteriophage transport in a sandy soil. Water Air and Soil Pollution, 178 (1-4):315-322. 
Collins, K.E., Cronin, A.A., Rueedi, J., Pedley, S., Joyce, E., Humble, P.J. & Tellam, J.H. 
(2006). Fate and transport of bacteriophage in UK aquifers as surrogates for 
pathogenic viruses. Engineering Geology, 85 (1/2), 33-38. 
Chung H. & Sobsey M.D. (1993). Comparative survival of indicator viruses and enteric 
viruses in seawater and sediment. Water Science and Technology, 27, 425-429. 
Darnault, C. J. G., Steenhuis T. S., Garnier P., Kim Y.-J., Jenkins M., Ghiorse W. C., Baveye P. 
C., & Parlange J.-Y. (2004). Preferential flow and transport of Cryptosporidium 
parvum oocysts through the vadose zone: experiments and modeling. Vadose Zone 
Journal, 3: 262-270. 
Davies, C. M., Ferguson C. M., Kaucner C., Altavilla N. & Deere D. A., (2005). Fate and 
transport of surface water pathogens in watersheds. Cooperative Research Centre 
for Water Quality and Treatment (Australia) and AWWA. AWWA Research 
Foundation. Denver, CO, USA, 261pp. 
Davies-Colley, R.J., Craggs, R.J., Park, J., Sukias, J.P.S. Nagels J.W. & Stott, R. (2005). Virus 
removal in a pilot-scale 'advanced' pond system as indicated by somatic and F-
RNA bacteriophages. Water Science and Technology, 51 (12), 107-110 
Dowd S.E., Pillai S.D., Wang S. & Corapcioglu M.Y (1998). Delineating the specific influence 
of virus isoelectric point and size on virus adsorption and transport through sandy 
soils. Applied Environmental Microbiology, 64(2): 405–410. 
Durán A.E., Muniesa M., Mocé-Llivina L., Campos C., Jofre J. & Lucena F. (2003). Usefulness 
of different groups of bacteriophages as model microorganisms for evaluating 
chlorination. Journal of Applied Microbiology, 2003, 95, 29–37 
Ebdon J., Muniesa, M. & Taylor, H. (2007). The application of a recently isolated strain of 
Bacteroides (GB-124) to identify human sources of fecal pollution in a temperate 
river catchment. Water Research, 41: 3683-3690. 
Emelko, M.B., Schmidt, P.J., & Reilly, P.M. (2010). Microbiological Data: Enabling Quantitative 
Rigor and Judicious Interpretation. Environmental Science and Technology, 44:461-472. 
Emelko, M.B., Schmidt, P.J., & Roberson, J.A. (2008). Quantification of Uncertainty in 
Microbial Data: Reporting and Regulatory Implications. Journal of the American 
Water Works Association, 100(3)94-104. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
75 
Erickson M. C. & Ortega Y.R. (2006). Inactivation of protozoan parasites in food, water and 
environmental systems. Journal of Food Protection, 69: 2786-2808. 
EU (2000). Directive (2000/60/EC) of the European of the Parliament and the Council of 23 
de October 2000 establishing a framework for Community action in the field of 
water policy. Journal of the European Union. 
EU (2006). Directive (2006/7/EC) of the European of the Parliament and the Council of 15 
February 2006 concerning the management of bathing water quality and repealing 
Directive 76/160/EEC. Journal of the European Union. 
Ferguson C.M, Davies C.M., Kaucner C., Krogh M., Rodehutskors M.K., Deere D.A. & 
Ashbold N. J. (2007). Field scale quantification of microbial transport from bovine 
faeces under simulated rainfall events. Journal of Water and Health, 5(1): 83-95. 
Fong T-T. & Lipp E.K. (2005). Enteric Viruses of Humans and Animals in Aquatic 
Environments: Health Risks, Detection, and Potential Water Quality Assessment 
Tools. Microbiology and Molecular Biology Reviews, 69(2): 357–371. 
Gerba C.P. (1987). Phage as indicators of fecal pollution, in Goyal S.M., Gerba C.P. and 
Bitton G. (eds.), Phage Ecology. Wiley. New York, USA, pp197-210. 
Gerba C. P. (2006). Bacteriophage as pollution indicators. In Calender R. (ed.) The 
Bacteriophages. Second edition. Oxford University Press. New York, USA. 
Gerba C .P. & Bitton G. (1984). Microbial pollutants: their survival and transport pattern to 
groundwater, p. 65-68 In G . Bitton and Gerba C .P. (eds.). Groundwater pollution 
microbiology, John Wiley & Sons Inc., New York, USA. 
Gerba C .P. & Rose J .B. (1990). Viruses in source and drinking water, p. 380-396. In McFeters 
G.A . (ed.), Drinking water microbiology: progress and recent development, Springer-
Verlag, New York, USA. 
Gitis V., Adin A., Nasser A., Gun J. & Lev O. (2002). Fluorescent dye labeled bacteriophages 
– as new tracer for the investigation of viral transport in porous media : 1. 
Introduction and characterization. Water Research, 36(17): 4227-4234 
Goyal S.M. 1983. Indicators of viruses in Berg, G. (ed), Viral Pollution of the Environment, CRC 
Press Inc., Boca Raton, FL, USA. 
Goyal S.M. & Gerba C.P. (1979). Comparative adsorption of human enteroviruses, simian 
rotavirus and selected bacteriophages to soils. Applied Environmental Microbiology, 
38:241-247. 
Grabow,1996. Waterborne diseases: Update on water quality assessment and control. Water 
S.A., 22: 193-202. 
Guzmán C., Mocé-Levina L., Lucena F. & Jofre J. (2008). Evaluation of Escherichia coli host 
strain (CB390) for simultaneous detection of somatic and F-specific coliphages. 
Applied Environmental Microbiology, 74: 531-534. 
Han, J., Jin Y. & Willson C.W. (2006). Effect of ionic strength and surface hydrophobicity on 
MS-2 and ΦX174 transport through saturated and unsaturated columns. 
Environmental Science and Technology, 40: 1547-1555. 
Hancock, C.M., Rose, J.B. & Callahan, C.M. 1998. Crypto and Giardia in US groundwater. 
Journal of the American Water Works Association, 90 (3): 58-61. 
Harter, T., Wagner, S. & Atwill, E.R. 2000. Colloid transport and filtration of Cryptosporidium 
parvum in sandy soils and aquifer sediments. Enviromental Science and Technology, 
34(1): 62-70. 
Harvey R.W., Kinner N.E., Bunn A., MacDonald D. & Metge D.W. (1995). Transport 
behavior of groundwater protozoa and protozoan-sized microspheres in sandy 





Bhattacharjee S., Ryan J.N., & Elimelech M. (2002). Virus transport in physically and 
geochemically heterogeneous subsurface porous media. Journal of Contaminant 
Hydrology, 57: 161-187.  
Blanford, W.J., Brusseau M.L., Yeh T.C.J., Gerba C.P. & Harvey R. (2005). Influence of water 
chemistry and travel distance on bacteriophage PRD-1 transport in a sandy aquifer. 
Water Research, 39: 2345-2357. 
Borchardt M.A., Bertz P.D., Spencer S., & Battigelli D.A. (2003). Incidence of enteric viruses 
in groundwater from household wells in Wisconsin. Applied Environmental 
Microbiology, 69 (2), 1172-1180. 
Bradford S.A., Tadassa Y.F., & Jin Y. (2006). Transport of coliphage in the presence and 
absence of manure suspension. Journal of Environmental Quality, 35(5):1692-701. 
Brush C. F., Ghiorse W.C., Anuish L.J., Parlange J.-Y. & Grimes H.G.(1998). Transport of 
Cryptosporidium parvum oocysts through saturated columns. Journal of 
Environmental Quality, 28: 809-815. 
CDC (2003). Guideline for Environmental Infection Control in Health-Care Facilities, 
Communicable Disease Control Advisory Committee. USA. 
Cheng L., Chetochine A.S., Pepper I. L. & Brusseau M. L. (2007). Influence of DOC on MS2 
bacteriophage transport in a sandy soil. Water Air and Soil Pollution, 178 (1-4):315-322. 
Collins, K.E., Cronin, A.A., Rueedi, J., Pedley, S., Joyce, E., Humble, P.J. & Tellam, J.H. 
(2006). Fate and transport of bacteriophage in UK aquifers as surrogates for 
pathogenic viruses. Engineering Geology, 85 (1/2), 33-38. 
Chung H. & Sobsey M.D. (1993). Comparative survival of indicator viruses and enteric 
viruses in seawater and sediment. Water Science and Technology, 27, 425-429. 
Darnault, C. J. G., Steenhuis T. S., Garnier P., Kim Y.-J., Jenkins M., Ghiorse W. C., Baveye P. 
C., & Parlange J.-Y. (2004). Preferential flow and transport of Cryptosporidium 
parvum oocysts through the vadose zone: experiments and modeling. Vadose Zone 
Journal, 3: 262-270. 
Davies, C. M., Ferguson C. M., Kaucner C., Altavilla N. & Deere D. A., (2005). Fate and 
transport of surface water pathogens in watersheds. Cooperative Research Centre 
for Water Quality and Treatment (Australia) and AWWA. AWWA Research 
Foundation. Denver, CO, USA, 261pp. 
Davies-Colley, R.J., Craggs, R.J., Park, J., Sukias, J.P.S. Nagels J.W. & Stott, R. (2005). Virus 
removal in a pilot-scale 'advanced' pond system as indicated by somatic and F-
RNA bacteriophages. Water Science and Technology, 51 (12), 107-110 
Dowd S.E., Pillai S.D., Wang S. & Corapcioglu M.Y (1998). Delineating the specific influence 
of virus isoelectric point and size on virus adsorption and transport through sandy 
soils. Applied Environmental Microbiology, 64(2): 405–410. 
Durán A.E., Muniesa M., Mocé-Llivina L., Campos C., Jofre J. & Lucena F. (2003). Usefulness 
of different groups of bacteriophages as model microorganisms for evaluating 
chlorination. Journal of Applied Microbiology, 2003, 95, 29–37 
Ebdon J., Muniesa, M. & Taylor, H. (2007). The application of a recently isolated strain of 
Bacteroides (GB-124) to identify human sources of fecal pollution in a temperate 
river catchment. Water Research, 41: 3683-3690. 
Emelko, M.B., Schmidt, P.J., & Reilly, P.M. (2010). Microbiological Data: Enabling Quantitative 
Rigor and Judicious Interpretation. Environmental Science and Technology, 44:461-472. 
Emelko, M.B., Schmidt, P.J., & Roberson, J.A. (2008). Quantification of Uncertainty in 
Microbial Data: Reporting and Regulatory Implications. Journal of the American 
Water Works Association, 100(3)94-104. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
75 
Erickson M. C. & Ortega Y.R. (2006). Inactivation of protozoan parasites in food, water and 
environmental systems. Journal of Food Protection, 69: 2786-2808. 
EU (2000). Directive (2000/60/EC) of the European of the Parliament and the Council of 23 
de October 2000 establishing a framework for Community action in the field of 
water policy. Journal of the European Union. 
EU (2006). Directive (2006/7/EC) of the European of the Parliament and the Council of 15 
February 2006 concerning the management of bathing water quality and repealing 
Directive 76/160/EEC. Journal of the European Union. 
Ferguson C.M, Davies C.M., Kaucner C., Krogh M., Rodehutskors M.K., Deere D.A. & 
Ashbold N. J. (2007). Field scale quantification of microbial transport from bovine 
faeces under simulated rainfall events. Journal of Water and Health, 5(1): 83-95. 
Fong T-T. & Lipp E.K. (2005). Enteric Viruses of Humans and Animals in Aquatic 
Environments: Health Risks, Detection, and Potential Water Quality Assessment 
Tools. Microbiology and Molecular Biology Reviews, 69(2): 357–371. 
Gerba C.P. (1987). Phage as indicators of fecal pollution, in Goyal S.M., Gerba C.P. and 
Bitton G. (eds.), Phage Ecology. Wiley. New York, USA, pp197-210. 
Gerba C. P. (2006). Bacteriophage as pollution indicators. In Calender R. (ed.) The 
Bacteriophages. Second edition. Oxford University Press. New York, USA. 
Gerba C .P. & Bitton G. (1984). Microbial pollutants: their survival and transport pattern to 
groundwater, p. 65-68 In G . Bitton and Gerba C .P. (eds.). Groundwater pollution 
microbiology, John Wiley & Sons Inc., New York, USA. 
Gerba C .P. & Rose J .B. (1990). Viruses in source and drinking water, p. 380-396. In McFeters 
G.A . (ed.), Drinking water microbiology: progress and recent development, Springer-
Verlag, New York, USA. 
Gitis V., Adin A., Nasser A., Gun J. & Lev O. (2002). Fluorescent dye labeled bacteriophages 
– as new tracer for the investigation of viral transport in porous media : 1. 
Introduction and characterization. Water Research, 36(17): 4227-4234 
Goyal S.M. 1983. Indicators of viruses in Berg, G. (ed), Viral Pollution of the Environment, CRC 
Press Inc., Boca Raton, FL, USA. 
Goyal S.M. & Gerba C.P. (1979). Comparative adsorption of human enteroviruses, simian 
rotavirus and selected bacteriophages to soils. Applied Environmental Microbiology, 
38:241-247. 
Grabow,1996. Waterborne diseases: Update on water quality assessment and control. Water 
S.A., 22: 193-202. 
Guzmán C., Mocé-Levina L., Lucena F. & Jofre J. (2008). Evaluation of Escherichia coli host 
strain (CB390) for simultaneous detection of somatic and F-specific coliphages. 
Applied Environmental Microbiology, 74: 531-534. 
Han, J., Jin Y. & Willson C.W. (2006). Effect of ionic strength and surface hydrophobicity on 
MS-2 and ΦX174 transport through saturated and unsaturated columns. 
Environmental Science and Technology, 40: 1547-1555. 
Hancock, C.M., Rose, J.B. & Callahan, C.M. 1998. Crypto and Giardia in US groundwater. 
Journal of the American Water Works Association, 90 (3): 58-61. 
Harter, T., Wagner, S. & Atwill, E.R. 2000. Colloid transport and filtration of Cryptosporidium 
parvum in sandy soils and aquifer sediments. Enviromental Science and Technology, 
34(1): 62-70. 
Harvey R.W., Kinner N.E., Bunn A., MacDonald D. & Metge D.W. (1995). Transport 
behavior of groundwater protozoa and protozoan-sized microspheres in sandy 





Harvey R.W. & Harms H. (2002). Tracers in groundwater: use of microorganisms and 
microspheres, in Bitton, G. (ed), Encyclopedia of Environmental Microbiology, John 
Wiley & Sons, New York, USA, pp 3194-3202. 
Harvey R.W., Mayberry N., Kinner N.E., Metge D.W. & Novarino F. (2002). Effect of growth 
conditions and staining procedure upon the subsurface transport and attachment 
behaviors of a groundwater protist. Applied Environmental Microbiology, 68:1872–1881. 
Harvey R.W. & Ryan J.N. (2004). Use of PRD1 bacteriophage in groundwater viral transport, 
inactivation, and attachments studies: FEMS Microbiology Ecology, 49 (1), 3-16. 
Harvey R.W., Harms H. & Landkamer L. (2007). Transport of microorganisms in the 
terrestrial subsurface: In situ and laboratory methods, in Hurst C.J., Crawford R.L., 
Garland J.L., Lipson D.A., Mills A.L., and Stetzenback L.D. (eds.), Manual of 
Environmental Microbiology. 3rd Edition, Washington, ASM Press, pp. 872-897. 
Havelaar, A.H. (1986). F-specific Bacteriophages as Model Viruses in Water Treatment Processes. 
Ph.D. thesis. University of Utrecht, Utrecht, Netherlands. 
Havelaar, A.H., Furuse K. & Hogeboom W.M. (1986). Bacteriophages and indicator bacteria 
in human and animal feces. Journal of Applied Bacteriology, 60: 255-262. 
Havelaar A.H. (1987). Bacteriophages as model organisms in water treatment. Microbiological 
Sciences, 4(12): 362-364. 
Havelaar A.H., Pot-Hogeboom W.M., Furuse K., Pot R. & Hormann M. P. (1990). F-specific 
RNA bacteriophages and sensitive host strains in faeces and wastewater of human 
and animal origin. Journal Applied Microbiology, 69(1): 30-37. 
Havelaar A.H. (1993). Bacteriophages as models of enteric viruses in water treatment 
processes. American Society for Microbiology News, 59: 614-619. 
Havelaar A.H., Vanophen M. & Drost Y.C. (1993). F-specific RNA bacteriophages are 
adequate model organisms for enteric viruses in freshwater. Applied Environmental 
Microbiology, 59 (9): 2956-2962. 
Health Canada (2004). Guidelines for Canadian Drinking Water Quality: Supporting 
Documentation. Protozoa: Giardia and Cryptosporidium. Enteric viruses. Prepared by 
the Federal-Provincial- Territorial Committee on Drinking Water. Ottawa, Ontario, 
Canada. 
Hsu F.C., Shieh Y.S., Van Duin J., Beekwilder M.J. & Sobsey M.D. (1995). Genotyping male 
specific RNA coliphages by hydridization with oligonucleotide probes. Appied 
Environmental Microbiology, 61 (11): 3960-3966. 
Hsu F.-C., Chang A., Amante A., Shieh Y.-S.C ., Wait D. & Sobsey M.C. (1996). 
Distinguishing human from animal feacal contamination in water by typing male-
specific RNA coliphages. AWWA Water Technology Conference 1996. 
IAWPRC Study Group on Health related water microbiology (1991). Bacteriophages as 
model viruses in water quality control. Water Research, 25: 529-545. 
ISO (1995). ISO 10705-1: Water quality: Detection and enumeration of bacteriophages. Part 1: 
Enumeration of F-specific RNA bacteriophages. International Organization for 
Standardization, Geneva, Switzerland. 
ISO (2000). ISO 10705-2 Water quality: Detection and enumeration of bacteriophages. Part 2: 
Enumeration of somatic coliphages. International Organization for Standardization, 
Geneva, Switzerland. 
ISO (2001). ISO 10705-4 Water quality: Detection and enumeration of bacteriophages. Part 4: 
Enumeration of bacteriophages infecting Bacteroides fragilis. International 
Organization for Standardization, Geneva, Switzerland. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
77 
Jofre J. (2009). Is the replication of coliphages in water environments significant? Journal of 
Applied Microbiology, 106(4):1059-69. 
Jofre J., Stewart J. R. & Grabow W. G. (2011). Phage Methods, in Hagedorn C. Blanch A.R 
and Harwood V.J. (eds.), Microbial Source Tracking: Methods, Applications, and Case 
Studies, 1st edition. Springer, NY, USA. 
John D.E. & Rose J.B. (2005). Review of factors affecting microbial survival in groundwater. 
Enviromental Science and Technology,. 39 (19): 7345–7356. 
Karanis P., Papadopoulou C., Kimura A., Economou E., Kourenti C., & Sakkas H. (2002). 
Cryptosporidium and Giardia in natural, drinking and recreational water of 
northwestern Greece. Acta Hydrochimica et Hydrobiologica, 30: 49-58. 
Keswick, B.H. & Gerba C.P. (1980). Viruses in groundwater. Environmental Science and 
Technology, 14: 1290-1297. 
Keswick, B.H., Gerba C.P., Secor S.L. & Cech I. (1982). Survival of enteric viruses and indicator 
bacteria in groundwater. Journal of Environmental Science and Health, A17: 903-912. 
LeChevallier M.W., Norton W.D. & Lee R.G. (1991). Giardia and Cryptosporidium spp. in 
filtered drinking water supplies. Applied Environmental Microbiology, 57(9): 2617-262. 
Leclerc H., Edberg S., Pierzo V. & Delattre J.M. (2000). Bacteriophages as indicators of 
enteric viruses and public health risk in groundwaters. Journal of Applied 
Microbiology, 88 (5): 5–21. 
Love D. & Sobsey M.D. (2007). Simple and rapid F+ coliphage culture, latex agglutination, 
and typing assay to detect and source track fecal contamination. Applied 
Environmental Microbiology, 73 (13): 4110-4118. 
Lucena F. & Jofre J. (2010). Potential use of bacteriophages as indicators of water quality and 
wastewater treatment processes, in Sabour P. M and Griffiths M.W. (eds), 
Bacteriophages in the Control of Food and Waterborne Pathogen, ASM Press, New York. 
Lucena, F., Ribas, F., Duran, A.E., Skraber, S., Gantzer, C., Campos,C., Morón, A., Calderón, 
E. & Jofre, J. (2006). Occurrence of bacterial indicators and bacteriophages infecting 
enteric bacteria in groundwater in different geographical areas. Journal of Applied 
Microbiology, 101 (1): 96-102. 
McGrath S. & van Sinderen D. (eds) (2007). In Bacteriophage: Genetics and Molecular 
Biology . First edition. Caister Academic Press, Cork, Ireland. 
McKay L.D., Sanford W.E. & Strong J.M. (2000). Field-scale migration of colloidal tracers in a 
fractured shale saprolite: Ground Water, 38: 139-147. 
Melnick J .L. & Gerba C .P. (1980). Viruses in water and soil. Public Health Rev. 9: 185-213. 
Méndez, J., Audicana A., Isern A., Llaneza J., Moreno B., Tarancón M. L., Jofre J. & F. 
Lucena. 2004. Standardized evaluation of the performance of a simple membrane 
filtration-elution method to concentrate bacteriophages from drinking water. 
Journal of Virological Methods, 117: 19-25. 
Mesquita M.M.F., Stimson J., Chae G-T, Tufenkji N., Ptacek C.J., Blowes D.W. & Emelko 
M.B. (2010). Optimal preparation and purification of PRD1-like bacteriophages for 
use in environmental fate and transport studies. Water Research, 44(4): 1114-1125. 
Metcalf T.G. (1978). Indicators for viruses in natural waters, in Mitchell D.J. (ed.), Water 
Pollution Microbiology, Vol. 2, Wiley Interscience Inc., NY, USA. 
Moce-Llivina, L., Lucena, F. & Jofre, J. (2005). Enteroviruses and bacteriophages in bathing 





Harvey R.W. & Harms H. (2002). Tracers in groundwater: use of microorganisms and 
microspheres, in Bitton, G. (ed), Encyclopedia of Environmental Microbiology, John 
Wiley & Sons, New York, USA, pp 3194-3202. 
Harvey R.W., Mayberry N., Kinner N.E., Metge D.W. & Novarino F. (2002). Effect of growth 
conditions and staining procedure upon the subsurface transport and attachment 
behaviors of a groundwater protist. Applied Environmental Microbiology, 68:1872–1881. 
Harvey R.W. & Ryan J.N. (2004). Use of PRD1 bacteriophage in groundwater viral transport, 
inactivation, and attachments studies: FEMS Microbiology Ecology, 49 (1), 3-16. 
Harvey R.W., Harms H. & Landkamer L. (2007). Transport of microorganisms in the 
terrestrial subsurface: In situ and laboratory methods, in Hurst C.J., Crawford R.L., 
Garland J.L., Lipson D.A., Mills A.L., and Stetzenback L.D. (eds.), Manual of 
Environmental Microbiology. 3rd Edition, Washington, ASM Press, pp. 872-897. 
Havelaar, A.H. (1986). F-specific Bacteriophages as Model Viruses in Water Treatment Processes. 
Ph.D. thesis. University of Utrecht, Utrecht, Netherlands. 
Havelaar, A.H., Furuse K. & Hogeboom W.M. (1986). Bacteriophages and indicator bacteria 
in human and animal feces. Journal of Applied Bacteriology, 60: 255-262. 
Havelaar A.H. (1987). Bacteriophages as model organisms in water treatment. Microbiological 
Sciences, 4(12): 362-364. 
Havelaar A.H., Pot-Hogeboom W.M., Furuse K., Pot R. & Hormann M. P. (1990). F-specific 
RNA bacteriophages and sensitive host strains in faeces and wastewater of human 
and animal origin. Journal Applied Microbiology, 69(1): 30-37. 
Havelaar A.H. (1993). Bacteriophages as models of enteric viruses in water treatment 
processes. American Society for Microbiology News, 59: 614-619. 
Havelaar A.H., Vanophen M. & Drost Y.C. (1993). F-specific RNA bacteriophages are 
adequate model organisms for enteric viruses in freshwater. Applied Environmental 
Microbiology, 59 (9): 2956-2962. 
Health Canada (2004). Guidelines for Canadian Drinking Water Quality: Supporting 
Documentation. Protozoa: Giardia and Cryptosporidium. Enteric viruses. Prepared by 
the Federal-Provincial- Territorial Committee on Drinking Water. Ottawa, Ontario, 
Canada. 
Hsu F.C., Shieh Y.S., Van Duin J., Beekwilder M.J. & Sobsey M.D. (1995). Genotyping male 
specific RNA coliphages by hydridization with oligonucleotide probes. Appied 
Environmental Microbiology, 61 (11): 3960-3966. 
Hsu F.-C., Chang A., Amante A., Shieh Y.-S.C ., Wait D. & Sobsey M.C. (1996). 
Distinguishing human from animal feacal contamination in water by typing male-
specific RNA coliphages. AWWA Water Technology Conference 1996. 
IAWPRC Study Group on Health related water microbiology (1991). Bacteriophages as 
model viruses in water quality control. Water Research, 25: 529-545. 
ISO (1995). ISO 10705-1: Water quality: Detection and enumeration of bacteriophages. Part 1: 
Enumeration of F-specific RNA bacteriophages. International Organization for 
Standardization, Geneva, Switzerland. 
ISO (2000). ISO 10705-2 Water quality: Detection and enumeration of bacteriophages. Part 2: 
Enumeration of somatic coliphages. International Organization for Standardization, 
Geneva, Switzerland. 
ISO (2001). ISO 10705-4 Water quality: Detection and enumeration of bacteriophages. Part 4: 
Enumeration of bacteriophages infecting Bacteroides fragilis. International 
Organization for Standardization, Geneva, Switzerland. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
77 
Jofre J. (2009). Is the replication of coliphages in water environments significant? Journal of 
Applied Microbiology, 106(4):1059-69. 
Jofre J., Stewart J. R. & Grabow W. G. (2011). Phage Methods, in Hagedorn C. Blanch A.R 
and Harwood V.J. (eds.), Microbial Source Tracking: Methods, Applications, and Case 
Studies, 1st edition. Springer, NY, USA. 
John D.E. & Rose J.B. (2005). Review of factors affecting microbial survival in groundwater. 
Enviromental Science and Technology,. 39 (19): 7345–7356. 
Karanis P., Papadopoulou C., Kimura A., Economou E., Kourenti C., & Sakkas H. (2002). 
Cryptosporidium and Giardia in natural, drinking and recreational water of 
northwestern Greece. Acta Hydrochimica et Hydrobiologica, 30: 49-58. 
Keswick, B.H. & Gerba C.P. (1980). Viruses in groundwater. Environmental Science and 
Technology, 14: 1290-1297. 
Keswick, B.H., Gerba C.P., Secor S.L. & Cech I. (1982). Survival of enteric viruses and indicator 
bacteria in groundwater. Journal of Environmental Science and Health, A17: 903-912. 
LeChevallier M.W., Norton W.D. & Lee R.G. (1991). Giardia and Cryptosporidium spp. in 
filtered drinking water supplies. Applied Environmental Microbiology, 57(9): 2617-262. 
Leclerc H., Edberg S., Pierzo V. & Delattre J.M. (2000). Bacteriophages as indicators of 
enteric viruses and public health risk in groundwaters. Journal of Applied 
Microbiology, 88 (5): 5–21. 
Love D. & Sobsey M.D. (2007). Simple and rapid F+ coliphage culture, latex agglutination, 
and typing assay to detect and source track fecal contamination. Applied 
Environmental Microbiology, 73 (13): 4110-4118. 
Lucena F. & Jofre J. (2010). Potential use of bacteriophages as indicators of water quality and 
wastewater treatment processes, in Sabour P. M and Griffiths M.W. (eds), 
Bacteriophages in the Control of Food and Waterborne Pathogen, ASM Press, New York. 
Lucena, F., Ribas, F., Duran, A.E., Skraber, S., Gantzer, C., Campos,C., Morón, A., Calderón, 
E. & Jofre, J. (2006). Occurrence of bacterial indicators and bacteriophages infecting 
enteric bacteria in groundwater in different geographical areas. Journal of Applied 
Microbiology, 101 (1): 96-102. 
McGrath S. & van Sinderen D. (eds) (2007). In Bacteriophage: Genetics and Molecular 
Biology . First edition. Caister Academic Press, Cork, Ireland. 
McKay L.D., Sanford W.E. & Strong J.M. (2000). Field-scale migration of colloidal tracers in a 
fractured shale saprolite: Ground Water, 38: 139-147. 
Melnick J .L. & Gerba C .P. (1980). Viruses in water and soil. Public Health Rev. 9: 185-213. 
Méndez, J., Audicana A., Isern A., Llaneza J., Moreno B., Tarancón M. L., Jofre J. & F. 
Lucena. 2004. Standardized evaluation of the performance of a simple membrane 
filtration-elution method to concentrate bacteriophages from drinking water. 
Journal of Virological Methods, 117: 19-25. 
Mesquita M.M.F., Stimson J., Chae G-T, Tufenkji N., Ptacek C.J., Blowes D.W. & Emelko 
M.B. (2010). Optimal preparation and purification of PRD1-like bacteriophages for 
use in environmental fate and transport studies. Water Research, 44(4): 1114-1125. 
Metcalf T.G. (1978). Indicators for viruses in natural waters, in Mitchell D.J. (ed.), Water 
Pollution Microbiology, Vol. 2, Wiley Interscience Inc., NY, USA. 
Moce-Llivina, L., Lucena, F. & Jofre, J. (2005). Enteroviruses and bacteriophages in bathing 





Montemayor M., Costan A., Lucena F., Jofre J. Munoz J., Dalmau E., Mujeriego R. & Sala 
(2008). The combined performance of UV light and chlorine during reclaimed 
water disinfection. Water  Science and Technology, 57(6): 35-940. 
Morinigo M.A., Wheeler D., Berry C., Jones C. Munoz M.A, Cornax R., Borrego J.J. (1992). 
Evaluation of different bacteriophage groups as faecal indicators in contaminated 
natural waters in Southern England. Water Research, 26(3): 267. 
Murray J.P. & Parks G.A. (1980). Particulates in Water, in Leckie M.C., Kavanaugh M. and 
Leckie J.O. (eds), Advances in Chemistry Series 189, American Chemical Society, 
Washington DC. USA. 
Noonan M.J. & McNabb J.F. (1979). Contamination of Canterbury groundwater by viruses, 
in Noonan M. (ed), The Quality and Movement of Groundwater in Alluvial Aquifers of 
New Zealand, Technical Publication No 2., Department of Agricultural 
Microbiology, Lincoln College, Canterbury, New Zealand.  
Payment P. & Franco E. (1993). Clostridium perfringens and somatic coliphages as indicators 
of the efficiency of drinking water treatment for viruses and protozoan cysts. 
Applied Environmental Microbiology, 59(8): 2418-2424. 
Payment P., Trudel, M. & Plante R. (1985). Elimination of viruses and indicator bacteria each 
step of treatment during preparation of drinking water at seven water treatment 
plants. Applied Environmental Microbiology, 49(6): 1418–1428. 
Payment P., Berte A., Prevost M., Menard B. & Barbeau B. (2000). Occurrence of pathogenic 
microorganisms in the Saint Lawrence River (Canada) and comparison of health 
risks for populations using it as their source of drinking water. Canadian Journal of 
Microbiology, 46: 565-576. 
Payment P. & Locas A. (2011). Pathogens in water: value and limits of correlation with 
microbial indicators. Ground Water 49(1): 4-11. 
Persson F., Langmark, J., Heinicke, G., Hedbergb, T., Tobiasonc, J., Stenstro, T. & 
Hermanssona, M. (2005). Characterization of the behavior of particles in biofilters 
for pre-treatment of drinking water. Water Research, 39 (16): 3791-3800. 
Pieper A.P., Ryan J.N., Harvey R.W., Gary L.A., Illangasekore T.H. & Metge D.W. (1997). 
Transport and recovery of bacteriophage PRD1 in a sand and gravel aquifer: effect of 
sewage derived organic matter. Environmental science and Technology, 31: 1163-1170. 
Pina S., Puig M., Lucena F., Jofre J., & Girones R.. (1998). Viral pollution in the environment 
and in shellfish: human adenovirus detection by PCR as an index of human 
viruses. Applied Environmental Microbiology, 64: 3376-3382. 
Powelson D.K., Simpson G.R. & Gerba C.P. (1990). Virus transport and survival in saturated and 
unsaturated flow through soil columns. Journal of Environmental Quality, 19: 396-401 
Powelson, D. K. & Gerba C. P. (1994). Virus removal from sewage effluents during saturated 
and unsaturated flow through soil columns. Water Research, 28: 2175-2181. 
Rose, J.B. 1997. Environmental ecology of Cryptosporidium and public health concerns. 
Annual Review of Public Health, 18: 135-161. 
Rehmann L.L.C., Welty C. & Harvey R. W. (1999). Stochastic analysis of virus transport in 
aquifers . Water Resources Research, 35(7): 1987-2006. 
Rice E.W., Fox K.R., Miltner R.J., Lytle D.A. & Johnson C.H. (1996). Evaluating plant 
performance with endospores. Journal of the American Water Works Association, 88(9): 
122-130. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
79 
Rossi, P. (1994). Advances in Biological Tracer Techniques for Hydrology and Hydrogeology using 
Bacteriophages: Optimization of the Methods and Investigation of the Behaviour of 
Bacterial Viruses in Surface Waters and in Porous and Fractured Aquifers. Ph.D Thesis. 
University of Neufchâtel, Neufchâtel, Switzerland. 
Rossi P., Doerfliger N., Kennedy K., Müller I. & Aragno M. (1998). Bacteriophages as surface 
and ground water tracers. Hydrology and Earth System Sciences, 2: 101-110. 
Ryan J.N. & Elimelech M. (1996). Colloid Mobilization and Transport in Groundwater. 
Colloids and Surfaces 107: 1-56. 
Ryan J.N., Elimelech M., Ard R.A., Harvey R.W. & Johnson P.R. (1999). Bacteriophage PRD1 
and silica colloid transport and recovery in an iron oxide-coated sand aquifer. 
Environmental Science and Technology, 33: 63-73. 
Ryan J.N., Harvey R.W., Metge D, .Elimelech M., Navigato T. & Pieper A.P. (2002). Field and 
laboratory investigations of inactivation of viruses (PRD1 and MS2) attached to iron 
oxide-coated quartz sand. Environmental Science and Technology, 36 (11): 2403-2413. 
Runge J. & Mann J. (2008). State of the industry report 2008: Charting the course ahead. 
Journal of The American water Works Association, 100(10): 61-74. 
Sadeghi G., Schijven J.F., Behrends T.,  Hassanizadeh S.M., Gerritse J. &  Kleingeld P.J. 
(2011). Systematic study of effects of pH and ionic strength on attachment of phage 
PRD1. Ground Water, 49 (1): 12-19. 
Schijven, J.F. (2001). Virus Removal from Groundwater by Soil Passage - Modeling, Field and 
Laboratory Experiments. Ph.D. thesis. University of Delft. Delft, the Netherlands. 
Schijven J.F. & Hassanizadeh M.S (2000). Removal of Viruses by Soil Passage: Overview of 
Modeling, Processes and Parameters. Critical Reviews in Environmental Science and 
Technology, 30(1): 49-127. 
Schijven J.F., Hassanizadeh M.S.,  Dowd S.E. & Pillai S.D. (2000). Modeling Virus 
Adsorption in Batch and Column Experiments. Quantitative Microbioogy, 2 (1): 5-20. 
Schijven, J. F. Hassanizadeh, S. M. & de Roda Husman, A. M. (2010). Vulnerability of 
unconfined aquifers to virus contamination. Water Research, 44 (4): 1170-1181. 
Schmidt, P.J., Reilly, P.M., & Emelko, M.B. (2010). Quantification of Methodological 
Recovery in Particle and Microorganism Enumeration Methods. Environmental 
Science and Technology, 44:51705-1712. 
Schulze-Makuch D., Guan H. & Pillai S.D. (2003). Effects of pH and geological medium on 
bacteriophage MS-2 transport in a model aquifer. Geomicrobiology, 20: 73-84. 
Scott T.M., Rose J.B., Jenkins T.M., Farrah S.R. & Lukasik J. (2002). Microbial source tracking: 
current methodology and future directions. Applied Environmental Microbiology, 
68(12): 5796-5803. 
Sen T. K. (2011). Processes in pathogenic biocolloidal contaminants transport in saturated 
and unsaturated porous media: A review. Water, Air and Soil Pollution, 216: 239-256. 
Sinton, L.W., Finlay R.K., Pang L. & Scott D.M. (1997). Transport of bacteria and 
bacteriophages in irrigated effluent into and through an alluvial gravel aquifer. 
Water Air and Soil Pollution, 98: 17-42. 
Sobsey M.D., Shields P.A., Hauchman F.H., Hazard R.L. & Caton III L.W. (1986). Survival 
and transport of hepatitis A virus in soils, groundwater and wastewater. Water 
Science and Technology, 18: 97-106. 
Sobsey M. D., Schwab K. J. & Hanzel T.R. (1990). A simple membrane filter method to 





Montemayor M., Costan A., Lucena F., Jofre J. Munoz J., Dalmau E., Mujeriego R. & Sala 
(2008). The combined performance of UV light and chlorine during reclaimed 
water disinfection. Water  Science and Technology, 57(6): 35-940. 
Morinigo M.A., Wheeler D., Berry C., Jones C. Munoz M.A, Cornax R., Borrego J.J. (1992). 
Evaluation of different bacteriophage groups as faecal indicators in contaminated 
natural waters in Southern England. Water Research, 26(3): 267. 
Murray J.P. & Parks G.A. (1980). Particulates in Water, in Leckie M.C., Kavanaugh M. and 
Leckie J.O. (eds), Advances in Chemistry Series 189, American Chemical Society, 
Washington DC. USA. 
Noonan M.J. & McNabb J.F. (1979). Contamination of Canterbury groundwater by viruses, 
in Noonan M. (ed), The Quality and Movement of Groundwater in Alluvial Aquifers of 
New Zealand, Technical Publication No 2., Department of Agricultural 
Microbiology, Lincoln College, Canterbury, New Zealand.  
Payment P. & Franco E. (1993). Clostridium perfringens and somatic coliphages as indicators 
of the efficiency of drinking water treatment for viruses and protozoan cysts. 
Applied Environmental Microbiology, 59(8): 2418-2424. 
Payment P., Trudel, M. & Plante R. (1985). Elimination of viruses and indicator bacteria each 
step of treatment during preparation of drinking water at seven water treatment 
plants. Applied Environmental Microbiology, 49(6): 1418–1428. 
Payment P., Berte A., Prevost M., Menard B. & Barbeau B. (2000). Occurrence of pathogenic 
microorganisms in the Saint Lawrence River (Canada) and comparison of health 
risks for populations using it as their source of drinking water. Canadian Journal of 
Microbiology, 46: 565-576. 
Payment P. & Locas A. (2011). Pathogens in water: value and limits of correlation with 
microbial indicators. Ground Water 49(1): 4-11. 
Persson F., Langmark, J., Heinicke, G., Hedbergb, T., Tobiasonc, J., Stenstro, T. & 
Hermanssona, M. (2005). Characterization of the behavior of particles in biofilters 
for pre-treatment of drinking water. Water Research, 39 (16): 3791-3800. 
Pieper A.P., Ryan J.N., Harvey R.W., Gary L.A., Illangasekore T.H. & Metge D.W. (1997). 
Transport and recovery of bacteriophage PRD1 in a sand and gravel aquifer: effect of 
sewage derived organic matter. Environmental science and Technology, 31: 1163-1170. 
Pina S., Puig M., Lucena F., Jofre J., & Girones R.. (1998). Viral pollution in the environment 
and in shellfish: human adenovirus detection by PCR as an index of human 
viruses. Applied Environmental Microbiology, 64: 3376-3382. 
Powelson D.K., Simpson G.R. & Gerba C.P. (1990). Virus transport and survival in saturated and 
unsaturated flow through soil columns. Journal of Environmental Quality, 19: 396-401 
Powelson, D. K. & Gerba C. P. (1994). Virus removal from sewage effluents during saturated 
and unsaturated flow through soil columns. Water Research, 28: 2175-2181. 
Rose, J.B. 1997. Environmental ecology of Cryptosporidium and public health concerns. 
Annual Review of Public Health, 18: 135-161. 
Rehmann L.L.C., Welty C. & Harvey R. W. (1999). Stochastic analysis of virus transport in 
aquifers . Water Resources Research, 35(7): 1987-2006. 
Rice E.W., Fox K.R., Miltner R.J., Lytle D.A. & Johnson C.H. (1996). Evaluating plant 
performance with endospores. Journal of the American Water Works Association, 88(9): 
122-130. 
Bacteriophages as Surrogates for the Fate and Transport 
 of Pathogens in Source Water and in Drinking Water Treatment Processes 
 
79 
Rossi, P. (1994). Advances in Biological Tracer Techniques for Hydrology and Hydrogeology using 
Bacteriophages: Optimization of the Methods and Investigation of the Behaviour of 
Bacterial Viruses in Surface Waters and in Porous and Fractured Aquifers. Ph.D Thesis. 
University of Neufchâtel, Neufchâtel, Switzerland. 
Rossi P., Doerfliger N., Kennedy K., Müller I. & Aragno M. (1998). Bacteriophages as surface 
and ground water tracers. Hydrology and Earth System Sciences, 2: 101-110. 
Ryan J.N. & Elimelech M. (1996). Colloid Mobilization and Transport in Groundwater. 
Colloids and Surfaces 107: 1-56. 
Ryan J.N., Elimelech M., Ard R.A., Harvey R.W. & Johnson P.R. (1999). Bacteriophage PRD1 
and silica colloid transport and recovery in an iron oxide-coated sand aquifer. 
Environmental Science and Technology, 33: 63-73. 
Ryan J.N., Harvey R.W., Metge D, .Elimelech M., Navigato T. & Pieper A.P. (2002). Field and 
laboratory investigations of inactivation of viruses (PRD1 and MS2) attached to iron 
oxide-coated quartz sand. Environmental Science and Technology, 36 (11): 2403-2413. 
Runge J. & Mann J. (2008). State of the industry report 2008: Charting the course ahead. 
Journal of The American water Works Association, 100(10): 61-74. 
Sadeghi G., Schijven J.F., Behrends T.,  Hassanizadeh S.M., Gerritse J. &  Kleingeld P.J. 
(2011). Systematic study of effects of pH and ionic strength on attachment of phage 
PRD1. Ground Water, 49 (1): 12-19. 
Schijven, J.F. (2001). Virus Removal from Groundwater by Soil Passage - Modeling, Field and 
Laboratory Experiments. Ph.D. thesis. University of Delft. Delft, the Netherlands. 
Schijven J.F. & Hassanizadeh M.S (2000). Removal of Viruses by Soil Passage: Overview of 
Modeling, Processes and Parameters. Critical Reviews in Environmental Science and 
Technology, 30(1): 49-127. 
Schijven J.F., Hassanizadeh M.S.,  Dowd S.E. & Pillai S.D. (2000). Modeling Virus 
Adsorption in Batch and Column Experiments. Quantitative Microbioogy, 2 (1): 5-20. 
Schijven, J. F. Hassanizadeh, S. M. & de Roda Husman, A. M. (2010). Vulnerability of 
unconfined aquifers to virus contamination. Water Research, 44 (4): 1170-1181. 
Schmidt, P.J., Reilly, P.M., & Emelko, M.B. (2010). Quantification of Methodological 
Recovery in Particle and Microorganism Enumeration Methods. Environmental 
Science and Technology, 44:51705-1712. 
Schulze-Makuch D., Guan H. & Pillai S.D. (2003). Effects of pH and geological medium on 
bacteriophage MS-2 transport in a model aquifer. Geomicrobiology, 20: 73-84. 
Scott T.M., Rose J.B., Jenkins T.M., Farrah S.R. & Lukasik J. (2002). Microbial source tracking: 
current methodology and future directions. Applied Environmental Microbiology, 
68(12): 5796-5803. 
Sen T. K. (2011). Processes in pathogenic biocolloidal contaminants transport in saturated 
and unsaturated porous media: A review. Water, Air and Soil Pollution, 216: 239-256. 
Sinton, L.W., Finlay R.K., Pang L. & Scott D.M. (1997). Transport of bacteria and 
bacteriophages in irrigated effluent into and through an alluvial gravel aquifer. 
Water Air and Soil Pollution, 98: 17-42. 
Sobsey M.D., Shields P.A., Hauchman F.H., Hazard R.L. & Caton III L.W. (1986). Survival 
and transport of hepatitis A virus in soils, groundwater and wastewater. Water 
Science and Technology, 18: 97-106. 
Sobsey M. D., Schwab K. J. & Hanzel T.R. (1990). A simple membrane filter method to 





Stetler R.E. (1984). Coliphages as indicators of enteroviruses. Applied Environmental 
Microbiology, 48(3): 668-670. 
Simpson , J.M.; Santo Domingo J.W. & Reasoner D.J. (2002). Microbial source tracking: state 
of the science. Environmental Science and Technology,. 36(24): 5279-5288. 
Tartera C. & Jofre J. (1987). Bacteriophages active against Bacteroides fragilis in sewage-
polluted waters. Appl. Environ. Microbiol. 53(7): 1632-1637. 
Tartera C., Lucena F. & Jofre J. (1989). Human origin of Bacteroides fragilis bacteriophages 
present in the environment. Applied Environmental Microbiology, 55(10): 2696–2701. 
Thurston-Enriquez J. A., Haas C. N., Jacangelo J., Riley K., & Gerba C. P. (2003). Inactivation 
of feline calicivirus and adenovirus type 40 by UV radiation. Applied Environmental 
Microbiology, 69: 577-582. 
Tufenkji, N. and Emelko, M.B. (2011) Groundwater Pollution: Impacts on Human Health: 
Fate and Transport of Microbial Contaminants. In Encyclopedia of Environmental 
Health, J. Nriagu, Ed., Elsevier Publishing Inc. 
UNICEF, WHO (2009). Diarrhoea: Why children are still dying and what can be done. The United 
Nations Children’s Fund (UNICEF)/ World Health Organization (WHO). 
US-EPA (2001a). Method 1601. Male-specific (F+) and somatic coliphage in water by two-step 
enrichment procedure. US-Environmental Protection Agency, Washington, DC. 
US-EPA (2001b). Method 1602. Male-specific (F+) and somatic coliphage in water by single agar 
layer (SAL) procedure. US-Environmental Protection Agency, Washington, DC. 
US-EPA (1989a, 2002). Surface Water Treatment Rules (SWTR). US-Environmental Protection 
Agency. Washington DC. 
US-EPA (2003). Draft Ultraviolet Disinfection Guidance Manual. US-EPA report No 815-D-03-
007. US-Environmental Protection Agency. Washington DC. 
US-EPA (2006). Ground Water Rule (GWR). US-Environmental Protection Agency 215-F-06-
003. Washington DC. 
WHO (2004). Water, sanitation and hygiene links to health: Facts and figures. World Health 
Organization, Geneva, Switzerland. 
WHO (2011). Guidelines for drinking-water quality. 4th edition. World Health 
Organization, Geneva, Switzerland. 
Vaughan J.M., Landry E.F., Thomas M.Z. (1983). Entrainment of viruses from septic tank 
leach fields through a shallow sandy soil aquifer. Applied Environmental 
Microbiolog,. 45:1474-1480. 
Yates M.V., Gerba C.P. & Kelley L.M. (1985). Virus persistence in groundwater. Applied 
Environmental Microbiology, 49 (4):778-781. 
Yates M.V., Yates S.R., Wagner J. & Gerba C.P. (1987). Modeling virus survival and transport 
in the subsurface. Journal of Contaminants Hydrology, 1: 329-345. 
Zhuang J. & Jin Y. (2003). Virus retention and transport through Al-oxide coated sand 
columns: effects of ionic strength and composition. Journal of Contaminants 
Hydrology, 60(3-4): 193 – 209. 
5 
Bacteriophages in Dairy Industry:  
PCR Methods as Valuable Tools 
Beatriz del Río, María Cruz Martín, Víctor Ladero, Noelia Martínez,  
Daniel M. Linares, María Fernández and Miguel A. Alvarez  
Instituto de Productos Lácteos de Asturias, IPLA-CSIC, 
Spain 
1. Introduction 
Microorganisms have been empirically used since ancestral times to produce fermented 
dairy products from milk. In the actual dairy industry, milk is subjected to large scale 
fermentation processes that involve microorganisms mostly belonging to the Lactic Acid 
Bacteria (LAB) group. Bacteriophages that infect LAB have been claimed as one of the 
principal sources of fermentation failure (spoilage or delay) on the manufacture of many 
dairy products (Brüssow et al., 1998; Josephsen & Neve, 1998; Garneau & Moineau, 2011). 
Some estimates assume that virulent phages are the primary direct responsible of the 
largest-economic loss of dairy factories, since they affect negatively up to the 10% of all milk 
fermentations (Moineau & Levesque, 2005).  
Starter cultures consisting in selected bacterial strains are added to the fermentation vats to 
enhance the fermentative process and also to improve or influence the flavor and texture of 
the cultured products. The starter culture population grows through the fermentation 
process and reaches high levels inside the industrial vat. This is the perfect environment 
where bacteriophages can infect sensitive bacteria. The lysis of the infected host-bacteria can 
decrease several folds the total number of starter cells with consequences ranging from the 
delay of the acidification with quality changes of the final product, to the total failure of the 
fermentation.  
Even with frequent cleaning, disinfestations and sterilization of all the facilities, the total 
absence of phages in the dairy plants is a utopia. The number and types of phages that are 
introduced within the system, presumably as a consequence of the constant supply of wild 
phages, is very variable and different subpopulations can prevalence as soon as a 
susceptible strain is introduced in the fermentation scheme (Neve et al., 1995; Bruttin et al., 
1997; Chibani-Chennoufi et al., 2004; Kleppen et al., 2011). In fact, bacteriophages have been 
detected in variable titer in the milk, appliances of the factory, additives and starter cultures.  
Since dairy bacteriophages are one of the mayor dairy threats, great research efforts have 
been made to reduce its load on dairy plants and to design new monitoring methods for 
their early detection (Magadán et al., 2009; Garneau & Moineau, 2011). Classical 
microbiological assays are routinely used on dairy plants to test the presence of 
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been made to reduce its load on dairy plants and to design new monitoring methods for 
their early detection (Magadán et al., 2009; Garneau & Moineau, 2011). Classical 
microbiological assays are routinely used on dairy plants to test the presence of 





more frequently employed (Svensson & Christiansson, 1991; Neve et al., 1995; Capra et al., 
2006, 2009; Atamer et al., 2009). These microbiological assays are based on the inhibitory 
effect of the bacteriophages in the host strain growth. The culture activity is measured in 
such a way that the presence of a bacteriophage in the tested sample inhibits the growth of 
the host strain and also decreases the production of lactic acid.  
Although the microbiological detection methods are economically accessible, they have 
undesirable features such us the long processing time, since they take at least 24 hours to be 
completed. In addition, bacteriophages are extremely host-specific, so one phage can only 
infect one or few strains of bacteria, forcing to maintain a big collection of LAB strains that 
can be tested. Furthermore, a negative result on the spot/plaque assay or the 
turbidity/growth test does not guarantee the sample is phage-free, but it could also indicate 
that the host strain chosen is not sensitive to the bacteriophage on the sample.  
Due to all these disadvantages, classical microbiological methods have being ousted by 
more sensitive, faster, and accurate genetic tools as the polymerase chain reaction (PCR). 
This is a specific and sensitive technology used to detect and identify (traditional PCR), and 
also to quantify (quantitative PCR) minimal amounts of bacteriophage DNA from samples 
of different dairy sources. Therefore, the PCR is a fast and reliable approach to screen a great 
number of samples for phage DNA. In most cases, low quantities of the sample (milk, whey, 
yogurt, etc) can be directly checked for bacteriophage presence by PCR.  
Since the traditional PCR generates DNA fragments of specific size, different protocols have 
been designed not only to detect but to identify, by fragment size discrimination, 
bacteriophages that infect the main dairy LAB species used in the dairy industry such as 
Lactobacillus casei/paracasei, Lactobacillus delbrueckii, Lactobacillus helveticus, Streptococcus 
thermophilus, and Lactococcus lactis (Labrie & Moineau, 2000; Binetti et al., 2005; Quiberoni et 
al., 2006, 2010; Zago et al., 2006, 2008; del Río et al., 2007). One of the advantages of the PCR-
based methods is that they can be applied in the raw milk received in the fermentation plant 
and within hours, each milk batch can be classified for its phage type content and it could be 
rapidly distributed. For example, if Lb. delbrueckii phages are detected in the raw milk, the 
batch cannot be used for the elaboration of yoghurt but the milk could be redirected to 
elaborate cheese, buttermilk, bottled to drink milk or dried to skim milk, thus allowing for 
an efficient distribution of the raw material. PCR-based approaches have been also applied 
for routine checking of lysogenic strains in starter cultures, which contain hidden temperate 
bacteriophages that have the potential to become lytic and compromise the fermentation 
process (Martín et al., 2006).  
A step forward is the use of the quantitative real-time PCR (qPCR), which allows the 
quantification of phage particles in the sample, is faster and more sensitive than the 
traditional PCR. Additionally, the use of different fluorochromes enables the identification 
of multiple bacteriophage species in the same reaction (del Río et al., 2008; Martín et al., 
2008; Verreault et al., 2011). 
The detection by PCR-based methods might be easily incorporated into dairy industry 
routines to monitor the presence of phages and be included as part of the prevention 
strategy for controlling phage contamination. This methodology allows the detection of 
bacteriophages directly in a small input volume of industrial samples. It also reduces the 
screening time, since the sample can be directly checked for bacteriophages, avoiding 
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previous enrichment steps with the sensitive host, needed for most of the microbiological 
methods. The correct and rapid identification and quantification of bacteriophages 
potentially able to attack starter cultures allows for rapid decisions with regard to the 
destination of contaminated milk that can be used for elaboration processes in which the 
phages detected do not constitute a threat. The possibility to reduce the milk storage time 
plays an important strategic role with economic implications for the dairy industry.  
2. Traditional PCR 
The PCR (polymerase chain reaction) is a broadly used molecular biology technique 
developed in 1983 by Kary Mullis and collaborators (Saiki et al., 1985; Mullis & Faloona, 
1987), in which a single or a few copies of a specific DNA fragment present in a sample are 
amplified by a DNA polymerase in a thermal cycler to produce up to 235 copies in few 
hours. At the end of the amplification reaction, the product is analyzed on an agarose gel 
and the DNA fragments are separated by size. To ensure the specificity of the reaction, both 
the target DNA sequence and the flanking primers are chosen in such a way that only 
samples containing the specific DNA are PCR-positives and yield DNA fragments of known 
size. Fig. 1 shows a graphic representation of the process to detect and identify 
bacteriophages that infect different LAB species from dairy samples by PCR amplification 
and subsequent size discrimination on agarose gel. 
During the last fifteen years, the PCR-based methodology has been applied in several stages 
of dairy product manufacturing to rapid detect, identify and characterize different 
bacteriophages that infect LAB strains (e.g. S. thermophilus, Lactobacillus sp. and Lb. 
casei/paracasei). The technique has been adapted to detect phages in milk samples (Binetti et 
al., 2005; Dupont et al., 2005; del Río et al., 2007), in cheese whey (Brüssow et al., 1994; Labrie 
and Moineau, 2000), in the equipment within the factory (Verreault et al., 2011, Kleppen et 
al., 2011) or even from air samples (Verrault et al., 2011) with a detection limit of 103-104 
phage particles per milliliter.  
 
Fig. 1. Detection of bacteriophages in dairy samples by PCR. A variety of dairy samples can 
be checked for bacteriophage presence. The sample is loaded in a tube with the PCR mix 
and subjected to amplification in a thermocycler. At the end of the process, the amplified 
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more frequently employed (Svensson & Christiansson, 1991; Neve et al., 1995; Capra et al., 
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previous enrichment steps with the sensitive host, needed for most of the microbiological 
methods. The correct and rapid identification and quantification of bacteriophages 
potentially able to attack starter cultures allows for rapid decisions with regard to the 
destination of contaminated milk that can be used for elaboration processes in which the 
phages detected do not constitute a threat. The possibility to reduce the milk storage time 
plays an important strategic role with economic implications for the dairy industry.  
2. Traditional PCR 
The PCR (polymerase chain reaction) is a broadly used molecular biology technique 
developed in 1983 by Kary Mullis and collaborators (Saiki et al., 1985; Mullis & Faloona, 
1987), in which a single or a few copies of a specific DNA fragment present in a sample are 
amplified by a DNA polymerase in a thermal cycler to produce up to 235 copies in few 
hours. At the end of the amplification reaction, the product is analyzed on an agarose gel 
and the DNA fragments are separated by size. To ensure the specificity of the reaction, both 
the target DNA sequence and the flanking primers are chosen in such a way that only 
samples containing the specific DNA are PCR-positives and yield DNA fragments of known 
size. Fig. 1 shows a graphic representation of the process to detect and identify 
bacteriophages that infect different LAB species from dairy samples by PCR amplification 
and subsequent size discrimination on agarose gel. 
During the last fifteen years, the PCR-based methodology has been applied in several stages 
of dairy product manufacturing to rapid detect, identify and characterize different 
bacteriophages that infect LAB strains (e.g. S. thermophilus, Lactobacillus sp. and Lb. 
casei/paracasei). The technique has been adapted to detect phages in milk samples (Binetti et 
al., 2005; Dupont et al., 2005; del Río et al., 2007), in cheese whey (Brüssow et al., 1994; Labrie 
and Moineau, 2000), in the equipment within the factory (Verreault et al., 2011, Kleppen et 
al., 2011) or even from air samples (Verrault et al., 2011) with a detection limit of 103-104 
phage particles per milliliter.  
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be checked for bacteriophage presence. The sample is loaded in a tube with the PCR mix 
and subjected to amplification in a thermocycler. At the end of the process, the amplified 
DNA is analyzed in an agarose gel and the bacteriophage is identified by the fragment size. 
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S. thermophilus bacteriophages have been identified in industry milk fermentation samples 
as yogurt and cheese whey, after phage DNA extraction and subsequent PCR (Brüssow et 
al., 1994) or by direct PCR of milk (Binetti et al., 2005; Dupont et al., 2005, del Río et al., 
2007). A PCR protocol to detect Lb. casei/paracasei bacteriophages from milk and other 
commercial samples as fermented milk and cheese whey was also designed (Binetti et al., 
2008). In addition, Lb. delbrueckii bacteriophages have been detected in milk and yogurt 
samples (del Río et al., 2007). Moreover, several protocols have been published to detect and 
identify the three species of Lc. lactis bacteriophages most frequently found in milk plants 
(c2, 936 and 335), in cheese whey samples (Labrie & Moineau, 2000; Dupont et al., 2005; 
Deveau et al., 2006; Szczepańska et al., 2007; Suárez et al., 2008; Kleppen et al., 2011), milk 
(del Río et al., 2007) and even in the factory equipment (Verreault et al., 2011; Kleppen et al., 
2011) or air samples (Verrault et al., 2011). 
2.1 Multiplex PCR 
The manufacture of a great number of cultured milk products implies the addition of starter 
cultures. The composition of modern dairy starter cultures is increasing on complexity and 
they are actually made of a variety of strains. This variety of strains raises the total number 
of different bacteriophage species that might affect the starter culture and therefore the 
quality of the final product. Usually, one PCR protocol is designed to specifically amplify 
and detect only one species of bacteriophage in a sample, so more than one PCR would be 
needed to detect all the phage types that could be present in a sample of a product 
manufactured with a complex starter culture.  
An elegant and efficient solution for such a problem has been proposed by different authors 
who have developed multiplex PCR assays to check for more than one phage species in a 
single reaction. There are different multiplex assays towards multi-type bacteriophage 
detection in the literature (Labrie & Moineau, 2000; Quiberoni et al., 2006; del Río et al., 
2007). In 2000, Labrie and Moineau designed a multiplex PCR method to detect in a single 
reaction the presence of the three Lc. lactis phages species considered as problematic in dairy 
companies, namely 936, c2, and P335. The assay was optimized for detection and 
identification of the three phage types from whey samples. Later on, del Río et al. (2007) 
extended the PCR for the detection of two additional phage groups: bacteriophages 
infecting S. thermophilus and Lb. delbrueckii, starters of common use for the elaboration of 
yoghurt. This simple and rapid multiplex PCR method detects the presence of 
bacteriophages infecting LAB species most commonly used as starters in dairy 
fermentations: the three genetically distinct groups of Lc. lactis phages species (P335, 936 and 
c2) plus phages infecting S. thermophilus and Lb. delbrueckii.  
2.2 PCR-detection of lysogenic strains in starter cultures 
Phages are ubiquitous organisms, in the particular case of dairy fermentations, the main 
source of phages is the raw milk, from where they spread and contaminate the dairy 
facilities. Other external sources of phage contamination that must be considered are the 
starter strains that carry prophages into their genome. The analysis of bacterial genomes 
revealed that prophages are more widespread than previously thought (Canchaya et al., 
2003; Mercanti et al., 2011).  
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Numerous LAB belonging to different genera are lysogenic bacteria, meaning that carry one 
or several inducible prophages integrated into their genomes. Functional prophages has 
been identified in species usually used in dairy fermentations such as Lc. lactis subsp. lactis, 
Lc. lactis subsp. cremoris, S. thermophilus, Lb. delbrueckii, Lb. casei, Lactobacillus rhamnosus or 
Bifidobacterium longum (Chopin et al., 2001; Desiere et al., 2002; Proux et al., 2002; Ventura et 
al., 2006, 2007, 2009; Zago et al., 2007; Durmaz et al., 2008).  
The lysogenic strains are introduced and maintained in fermentation vats for extended 
periods of time where they are subjected to the stressful fermentation conditions. This 
environment may induce prophages into lytic cycle and release the viral. The risk for 
prophage induction and its consequences on the final product quality must be carefully 
evaluated when developing industrial fermentation processes thorough the selection of 
suitable prophage-free strains as starters. 
Ideally, bacterial strains should be tested in conditions that mimic industrial fermentation 
processes for the induction of putative prophages. In this context, PCR can be used as a tool 
for the rapid screening towards the identification of lysogenic strains in large culture 
collections (Martín et al., 2006). The potential lysogenic strains should be further tested for 
their capacity to release phage particles. In fact, PCR methods could, overcome frequent 
problems of prophage induction assays such as lack of detection of the bacteriophages 
released due to a low viral production, the high sensitivity of the screened strain to the 
induction agent or the lack of a suitable host strain for the phage.  
The cells can be tested by a direct phage-specific PCR assay. If no amplification is obtained, 
the problem strains can be tagged as phage-free. However, if the strain gives positive PCR 
result, it can be further assayed for prophage induction by using a known induction agent as 
mitomycin C (MitC). The presence of viral particles in the cell-free supernatant can be 
evaluated again with the same phage-specific PCR assay. Only those strains able to liberate 
functional phage particles would result in a positive PCR amplification and consequently 
should be discarded as starter strains (Fig. 2).  
 
Fig. 2. PCR evaluation of putative lysogenic strain cultures induced with mitomycin C 
(MitC) (adapted from Martín et al., 2006). The optical density was measured in a control 
culture and in a culture induced with MitC after 4 hour. The Cells were PCR tested for the 
presence of prophages in the genome (c), and cleared supernatants of the induced cultures 
were also PCR tested (s). (A) Strain with no prophages. (B) Strain with no inducible 
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Those strains carrying not inducible prophages could be used as starters, although their use 
it is not recommended since they could constitute a pool of genes that can be transferred to 
incoming lytic phages by homologous recombination, thus expanding their host range 
(Bouchard & Moineau, 2000; Durmaz & Klaenhammer, 2000). 
2.3 Bacteriophages typification by PCR and amplicon sequencing  
The rotation of starter cultures that share similar technological properties but with a different 
pattern of phage susceptibility is the usual and most successful strategy to reduce the impact 
of phage attacks in dairy industries (Edmon & Moineau, 2007; Kleppen et al., 2011). Therefore, 
the establishment of a system that allows not only to detect, but to classify the detected phages 
based on their host range would permit a rational modification of the strain rotation scheme.  
In some detection methods, once a sample is confirmed for bacteriophage presence by PCR 
amplification, it is possible to get additional information from the amplicon nucleotide 
sequence. In this sense it has been described a PCR assay that correlates the host range of a 
bacteriophage and the nucleotide sequence of the amplified fragment (Binetti et al., 2005). 
This test is based on the amplification of the VR2 variable region of orf18, the antireceptor 
gene of S. thermophilus phages that was claimed as responsible for host specificity (Duplessis 
& Moineau, 2001). The sequence of the VR2 variable sequence can be used to classify the 
detected phages within a host range and consequently to establish a rational rotation of the 
available starter cultures. 
When a phage is detected by PCR the obtained sequence will classify it in a VR2 type (Binetti 
et al., 2005; Guglielmotti et al., 2009). This VR2 type would indicate those strains that are 
sensitive and those that are resistant to that phage in particular. The susceptible strains cannot 
be introduced in the elaboration routine and should be substituted for other similar strains that 
are not included in the same VR2 type thus being resistant to that particular phage. In other 
words, it is possible to know which strains are susceptible to be infected by the detected 
phages. This is a very useful tool for the dairy industry, since it allows preventing phage attack 
by designing a rational starter rotation system based on the phage types detected. 
3. Quantitative PCR 
Even though the PCR-based technology is a fast and sensitive approach to detect 
bacteriophages, traditional PCR has an important disadvantage since it is a qualitative but 
not a quantitative method for bacteriophage screening. In this sense it is important to note 
that 105 phage particles per millilitre of milk has been estimated as the threat threshold 
(Neve & Teuber, 1991; Emond & Moineau, 2007; Magadán et al., 2009). Therefore, the mere 
presence of phage particles might be not enough to guaranty the useless of the material and 
quantitative approaches would avoid the disposal of milk that could still be useful. 
The traditional PCR methodology is being changed towards a faster, more sensitive and useful 
technique, the quantitative PCR (qPCR). This is a new technology based on the traditional PCR 
that not only adds specificity, accuracy and speed to former PCR screening methods, but also 
allows the quantification of the number of copies of the target DNA, in this case bacteriophage 
particles in a dairy sample. Additionally, the qPCR collects the data in real time throughout 
the reaction and not just at the end point as the conventional PCR. This feature could be of 
great value for the dairy industry since it saves time and speed up the decision towards the 
use of the analyzed material, in case it is contaminated with bacteriophages. 
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The qPCR technology monitors the increase of fluorescence emitted during the synthesis of 
the newly synthesized DNA fragment in each cycle. The reactions are characterized by the 
cycle in which the amplification of a target DNA results in a fluorescent signal that reaches 
the detection level of the equipment; this cycle is namely the threshold cycle (Ct) and it is 
directly proportional to the initial copies of target DNA in the sample (Logan et al., 2001). 
Absolute numbers are obtained by comparing the sample Ct value against a standard curve 
that is prepared with templates carrying a known titer of bacteriophages (Fig. 3).  
 
 
    
Fig. 3. qPCR analysis of 10-fold dilutions of milk artificially infected with a Lb. delbrueckii 
bacteriophage (YAB phage) (adapted from Martín et al., 2008). (A) Amplification plot of 
bacteriophage DNA in serial diluted samples starting at 10 PFU/sample. (B) A linear 
correlation is established between the CT value and the logarithm of the number of phage 
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To detect the amplified DNA, non-specific fluorescent dyes that bind to any double-
stranded DNA (e.g. SYBR® Green) or specific DNA probes (e.g. TaqMan® probes) could be 
used. The non-specific fluorescent dyes are flexible, inexpensive and accurate, but the 
formation of primers dimmers could led to detect false positives and the use of an internal 
positive control is not possible. Compare to DNA binding dyes, the fluorescence probe 
technology provides an additional level of specificity to the reaction, since in addition to the 
PCR primers a third oligonucleotide labeled with a fluorochrome (the probe) is added. 
Other significant advantage of using probe chemistry is that different probes can be labeled 
with different reporter dyes and be combined in a single reaction (multiplex qPCR). As each 
fluorescent signal is individually detected, the qPCR technology could be used as a 
qualitative tool to identify different bacteriophage species present in a sample. In addition, it 
allows the addition of an internal positive control to the PCR mix which is especially useful 
in dairy sample analysis, since in some food matrixes as milk many PCR inhibitors can be 
present and some screened samples could be annotated as false negatives (for a review see 
Martínez et al., 2011).  
Several qPCR protocols based on DNA fluorescent probes have been described to detect, 
quantify and identify bacteriophages present in dairy samples. Martín et al. (2008) 
developed a qPCR method to quantify Lb. delbrueckii bacteriophages present in milk 
samples. The assay combines two different TaqMan MGB probes, one which identify the 
phage and another for an internal positive control that is added to all the samples. The assay 
allows the quantification of 102 Lb. delbrueckii bacteriophage particles per reaction and it 
could be also applied to test other dairy niches such as starter cultures and fermented milks.  
As was described above, a multiplex qPCR assay has been applied to identify in a single 
reaction more than one different bacteriophage type. In this context, del Río et al. (2008) 
designed a multiplex assay to detect two types of S. thermophilus bacteriophages (cos and 
pac) in milk samples combining three probes individually labeled with different 
fluorochromes (one for each bacteriophage and another one for the internal control). The 
assay shown to be highly specific, since no false-positive or false-negative results were 
obtained even when the analyzed milk samples were artificially contaminated with Lb. 
delbrueckii or Lc. lactis bacteriophages. 
Concerning to Lc. lactis phages, Verreault et al. (2011) recently developed a qPCR method 
using the SYBR green fluorescence technology to quantify bacteriophages belonging to the 
936 and c2 groups in aerosol and surface samples of a typical cheese manufacturing plant. 
Even though the qPCR technology has shown to be a great platform to detect and quantify 
virulent phages in dairy plants, further advancements are needed in order to improve the 
automation of the process, the sensitivity of the detection in dairy samples susceptible of 
contain PCR inhibitors and to expand the possibility to target simultaneously a bigger 
number of different bacteriophages in a single reaction.  
4. Discussion/conclusions 
Bacteriophages that attack bacteria used as starters cause great economic losses to global 
dairy industry. Even though strict sanitation programs and rigorous culture handling are 
established on the dairy plants, the bacteriophage presence is ubiquitous in all the facilities 
in variable titer. PCR-based methods for early and fast detection and quantification of 
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bacteriophage that might jeopardize the survival of the culture starters are shown to be 
effective and might be incorporated as routine control of bacteriophages in the dairy industry.  
The machinery, surfaces and aerosols within the facilities of the dairy plant can be checked 
to ensure the absence or at least the low titer of bacteriophages that otherwise would be 
incorporated on the fermentative process. Surely, PCR can be applied to determine the 
potential uses of a batch of milk, but also could be applied to samples collected all through 
the fermentative process, starting with the raw milk and ending with the final product. 
Since PCR protocols are much faster than traditional microbiological methods, the raw milk 
can be checked for bacteriophages in an acceptable time, allowing decisions for the better 
use of contaminated material, which could be diverted toward procedures in which 
bacteriophages are deactivated or do not require a fermentative step with LAB starters. In 
consequence, whole tanks of raw milk are not kept for big periods of time and also the 
subsequent fermentative process is not on risk.  
The presence of PCR inhibitors such calcium ions, plasmin, proteins, fat…, is a fact that 
should be taken into account in the design of PCR protocols to analyze dairy products. 
Special care must be taken when dairy samples are used directly as templates, because the 
presence of inhibitors may interfere with the PCR amplification and leads false negative 
results (Wilson, 1997; Ercolini et al., 2004). Magnetic capture hybridization (Dupont et al., 
2005) or a previous DNA isolation from the sample, as is described for detecting pathogens 
in dairy samples (Cremonesi et al., 2007), are some of the additional steps that could be 
included in the PCR methods to remove PCR inhibitors and/or reduce the effect of the 
components of the dairy matrix.  
Given that some qPCR-based protocols can confirm the bacteriophage presence in just 30 
minutes, they are a great tool for fast detection of bacteriophage breakouts in a failed 
fermentative process and may help in the substitution of starter strain for another resistant 
to the detected phage. The qPCR methods save performing time compared to the traditional 
PCR, since the post-amplification processing is not generally needed. However, when the 
SYBR® Green is the qPCR technology of choice, a further processing of the amplicon 
(melting point or dissociation curve analysis) is essential in order to detect non-specific 
amplifications or primer-dimmers. The SYBR® Green chemistry could be the cheapest option 
for the screening of a large number of samples, but requires an extensive optimization of the 
protocols designed and also the complete analysis of the samples would take longer than the 
probe-based methods.  
Both, traditional and real-time PCR techniques are extremely specific and their reliability 
depends on the design of the protocol to specifically target one bacteriophage species. 
However, a critical point and a potential limitation to design new specific PCR protocols, is 
the need of some prior information about the nucleotide sequence of the bacteriophage 
target gene. In this context, the new sequencing techniques are a valuable tool to 
characterize new bacteriophages isolated from the raw milk or within the facilities and 
hence, to increase the available phage genomic data. qPCR protocols should be updated 
with the new sequences as they become available. 
The fact that a sample can be quickly assessed for bacteriophage presence by a qPCR assay 
do not necessary implies its classification as infective or non-infective for the starter cultures 
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the fermentative process, starting with the raw milk and ending with the final product. 
Since PCR protocols are much faster than traditional microbiological methods, the raw milk 
can be checked for bacteriophages in an acceptable time, allowing decisions for the better 
use of contaminated material, which could be diverted toward procedures in which 
bacteriophages are deactivated or do not require a fermentative step with LAB starters. In 
consequence, whole tanks of raw milk are not kept for big periods of time and also the 
subsequent fermentative process is not on risk.  
The presence of PCR inhibitors such calcium ions, plasmin, proteins, fat…, is a fact that 
should be taken into account in the design of PCR protocols to analyze dairy products. 
Special care must be taken when dairy samples are used directly as templates, because the 
presence of inhibitors may interfere with the PCR amplification and leads false negative 
results (Wilson, 1997; Ercolini et al., 2004). Magnetic capture hybridization (Dupont et al., 
2005) or a previous DNA isolation from the sample, as is described for detecting pathogens 
in dairy samples (Cremonesi et al., 2007), are some of the additional steps that could be 
included in the PCR methods to remove PCR inhibitors and/or reduce the effect of the 
components of the dairy matrix.  
Given that some qPCR-based protocols can confirm the bacteriophage presence in just 30 
minutes, they are a great tool for fast detection of bacteriophage breakouts in a failed 
fermentative process and may help in the substitution of starter strain for another resistant 
to the detected phage. The qPCR methods save performing time compared to the traditional 
PCR, since the post-amplification processing is not generally needed. However, when the 
SYBR® Green is the qPCR technology of choice, a further processing of the amplicon 
(melting point or dissociation curve analysis) is essential in order to detect non-specific 
amplifications or primer-dimmers. The SYBR® Green chemistry could be the cheapest option 
for the screening of a large number of samples, but requires an extensive optimization of the 
protocols designed and also the complete analysis of the samples would take longer than the 
probe-based methods.  
Both, traditional and real-time PCR techniques are extremely specific and their reliability 
depends on the design of the protocol to specifically target one bacteriophage species. 
However, a critical point and a potential limitation to design new specific PCR protocols, is 
the need of some prior information about the nucleotide sequence of the bacteriophage 
target gene. In this context, the new sequencing techniques are a valuable tool to 
characterize new bacteriophages isolated from the raw milk or within the facilities and 
hence, to increase the available phage genomic data. qPCR protocols should be updated 
with the new sequences as they become available. 
The fact that a sample can be quickly assessed for bacteriophage presence by a qPCR assay 
do not necessary implies its classification as infective or non-infective for the starter cultures 





traditional microbiological tests, using a collection of potential bacterial host. That process is 
cost- and time-inefficient for the dairy industry. Nevertheless, traditional PCR and amplicon 
sequencing have been successfully applied in dairy phages infecting S. thermophilus (Binetti 
et al., 2005) and Lc. lactis (Stuer-Lauridsen et al., 2003; Dupont et al., 2004), to correlate a 
specific nucleotide sequence with the host range of each phage. qPCR and PCR methods can 
be sequentially combined, applying first the qPCR method for a fast screening of a large 
batch of samples, followed by a traditional PCR in which the host range of the phage could 
be assessed and the potential host strains identified and discarded as starters for 
fermentative processes.  
Continuous efforts are being made in order to improve the PCR-based protocols for the 
detection and quantification of bacteriophages from samples of any origin within the dairy 
plant. PCR-based methods could be included in the Hazard Analysis and Critical Control 
Points (HACCP) protocol to prevent phage accumulation niches and reduce their impact in 
dairy fermentations. 
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1. Introduction 
Natto is a fermented soybean food, which is produced and consumed mainly in Japan 
(Nagai & Tamang, 2010). The Japanese usually eat natto with cooked rice, after mixing it 
with seasonings attached in a package or with soy sauce (Fig. 1). Natto has a characteristic 
odour of short-chain fatty acids and ammonia (Ikeda et al., 1984; Kanno & Takamatsu, 1987), 
and a highly viscous polymer, poly-γ-glutamate (PGA, see Section 3). 
Bacillus natto, named after “natto” when isolated from it for the first time, is the sole 
microorganism used for natto fermentation (Sawamura, 1906). However, the species was 
regarded as a “probable synonym” of B. subtilis in Bergey's Manual of Determinative 
Bacteriology, 8th Edition (Gibson and Gordon, 1974). This classification was supported by the 
fact that the chromosomal DNA of B. natto has a high level of homology with that of B. 
subtilis (Seki et al., 1975). Phylogenetic analysis of B. natto (meaning Bacillus isolates from 
natto) and typical B. subtilis strains by sequencing of the 16S rRNA gene also showed that B. 
subtilis (natto) and B. subtilis are the same species (Tamang et al., 2002). Although the 
scientific name “B. natto” was abandoned, the informal name “B. subtilis (natto)” is often 
used in the food industry, and even in the scientific field, to emphasize that B. subtilis (natto) 
isolates have the ability to produce natto unlike the type strain of B. subtilis. 
Commercial B. subtilis (natto) starters for natto fermentation are sold by three companies 
(Miura, Naruse and Takahashi) in Japan. The key strains for natto fermentation were 
isolated from the starters and characterized (Kiuchi et al., 1987; Sulistyo et al., 1988), and the 
characteristics, including PGA production and flavor, were found to be very similar among 
the strains. 
Until the early 20th century, natto had been produced by packing boiled soybeans in a bag 
made of rice straw, which B. subtilis (natto) inhabit as soil bacteria (Fig. 1 C). Since the 
discovery of B. subtilis (natto) by Sawamura (1906) and the development of sanitary 
containers (Fig. 1 A & B) as substitutes for bags made of rice straw, the process of natto 
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A) brown package, sauce; yellow package, mustard. B) Natto is very stringy because of PGA production 
(see Section 3). C) This natto is for a souvenir, so the straw is sterilized for hygien unlike the real classic 
type of natto. After sterilization, a spore suspension of B. subtilis (natto) is inoculated as shown in Fig. 2. 
Fig. 1. Modern natto (A and B) and a classic type of natto (C)  
 




BN, Bacillus subtilis (natto). The production conditions shown on the left of the flow chart are cited from 
reviews on natto fermentation (Ueda, 1989; Kiuchi & Watanabe, 2004). 
Fig. 2. Process of natto fermentation 
The process of natto fermentation is so simple that very small factories, even homes, can 
produce natto in 2 or 3 days (Ueda, 1989; Kiuchi & Watanabe, 2004) (Fig. 2). After being 
selected and washed, soybeans are soaked in water at 10°C for 18 hr. Soybeans are cooked 
(steamed or boiled) and a suspension of spores of B. subtilis (natto) is sprayed on the boiled 
soybeans while they are hot to prevent the soybeans from being contaminated with other 
kinds of bacteria or phages. The soybeans are packed in containers made of polystyrene 
paper together with packed seasonings (typically, sauce and mustard; Fig. 1 A) and 
incubated at 50°C for 16–18 hr and then kept at 3–10°C for 8 hr to mature the natto further. 
Natto products are delivered to markets or stores through a cold chain system, keeping the 
products at a low temperature until consumers buy them. This simplicity of the process of 
natto fermentation, including a limited number of starters of natto, can result in devastating 
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2. Classification of Bacillus subtilis (natto) phages 
The viscous polymer PGA on natto is an important characteristic. However, natto products 
without the polymer were often found in the market, despite normal synthesis of PGA just 
after fermentation in a factory. In some cases, the viscosity of natto decreased rapidly while 
mixing with seasonings. Fujii et al. (1967) found a bacteriophage from such an abnormal 
natto and named it PN-1. Fermentation of soybeans with B. subtilis (natto) and PN-1 resulted 
in the production of natto with no viscous polymer, indicating that PN-1 is attributed to a 
loss of polymer on natto. This was the first report on a B. subtilis (natto) phage. 
Yoshimoto et al. (1970) surveyed contamination by B. subtilis (natto) phages in natto factories 
all over Japan. Among 60 factories, 28 were contaminated with phages at densities ranging 
from 5 PFU/cm3 sample to 2000. Forty-two phages were isolated from the samples and 
classified into 4 groups based on host ranges, and finally into two serological groups, NP-4 
and NP-38 groups, using four anti-phage serums. 
 
Group MAFF no. Strain Source & month and year of isolation 
I 
270104 JNCHUP natto, Oct. 1980 
270105 JNDMP natto, Feb. 1981 
270106 JNHMP natto, Feb. 1981 
II 
270101 P-1 abnormal natto, Jan. 1980 
270102 DMP natto, May 1980 
270103 MIP natto, May 1980 
270107 MOP abnormal natto, Jul. 1981 
270108 THP abnormal natto, Jul. 1981 
270109 THAP abnormal natto, Dec. 1981 
270110 SUP abnormal natto, Dec. 1981 
270111 KKP abnormal natto, Mar. 1982 
270112 KKP-GE industrial sewage, Mar. 1982 
270113 SS1P abnormal natto, Dec. 1983 
270114 SS2P abnormal natto, Dec. 1983 
270115 ONPA abnormal natto, Aug. 1984 
270116 ONPB abnormal natto, Aug. 1984 
270117 ONPC abnormal natto, Sep. 1985 
270118 FUKUSHOGUNP abnormal natto, Oct. 1985 
270119 ONPD abnormal natto, Aug. 1986 
270120 SUP-SS1P not recorded 
Note: These phage isolates are distributed by the NIAS Genebank (acronym, MAFF; web site, 
http://www.gene.affrc.go.jp/index_en.php). 
Table 1. Bacillus subtilis (natto) phages used in classification 
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Twenty B. subtilis (natto) phages were isolated from abnormally fermented natto, effluent 
from natto factories and soil of paddy fields in Kyushu Island, southern Japan (Fujii et al., 
1975). The phages, including PN-1, were classified into three groups based on host ranges, 
immunological reaction, and morphologies. All tested B. subtilis (natto) strains were infected 
by 21 B. subtilis (natto) phages, and some strains of B. subtilis also were infected by 17 
phages. Three representative phages, PN-3, PN-6 and PN-19, from three serological groups 
were studied using an electron microscope. They had a head (diameter, 80–90 nm) and a 
contractile tail (length, 165–175 nm). Although PN-3 and PN-6 did not resemble each other 
in shape, judging from their morphologies on somewhat obscure photographs, they were 
found to belong to the same group (Nagai & Yamasaki, 2009). 
Nagai and Yamasaki (2009) classified 20 phages [deposited in the NIAS Genebank (Tsukuba, 
Japan) with accession numbers from MAFF 270101 to MAFF 270120 (Table 1)], mainly 
isolated from abnormally fermented natto, into two groups based on DNA-DNA 
hybridization (Fig. 3). No cross hybridized band is visible in the photograph, indicating that 
group I phages and group II phages are genetically independent of each other. 
Representative phages from the two groups were further characterized. Phage JNDMP 
(Group I) has a head (diameter, 60 nm) and a flexible tail (7 x 200 nm) (Fig. 4 A) and requires 
magnesium ions for amplification. Phage ONPA (Group II) has a head (diameter, 89 nm) 
and a contractile tail (9 x 200 nm) with a sheath (width, 23 nm) and does not require 
additional magnesium ions (Fig. 4 B). Plaques of ONPA were clearer than those of JNDMP. 
Other characteristics of JNDMP and ONPA are summarized in Table 2. 
 
Group type I II 
 JNDMP(MAFF 270105) ONPA (MAFF 270115) 
Head (nm) 60 89 
Tail (nm) 7 x 200 9 x 200 
Genome DNA (kb) 42 91 
Latent time (min) 35 50 
Burst size 46 72 
Heat stability (°C)1) 53 63 
Mg ion requirement + - 
Host range2) 
Miura (MAFF 118100) - + 
Naruse (MAFF 118103) + + 
Takahashi (MAFF 118105) + + 
Marburg - - 
1)Temperature at which about 1% of phage particles in suspension can survive after 10-min heating in a 
water bath. 
2) Miura, Naruse and Takahashi are commercial starters for natto fermentation. 
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A) An agarose gel electrophoresis of fragments of phage DNA after digestion with a restriction enzyme, 
HindIII. B and C) Southern hybridization of the gel using genomic DNA of JNDMP (B) or ONPA (C) as 
a probe. (from Nagai & Yamasaki, 2009, with permission) 
Fig. 3. Analysis of Southern hybridization of phage genome DNA 
 




A) JNDMP, B) ONPA. Bar = 100 nm. (from Nagai and Yamasaki, 2009, with permission) 
Fig. 4. Electron microscope photographs of B. subtilis (natto) phages 
The phages of Yoshimoto’s group (1970) had been discarded, and so genetic relationships 
among their two types of phages and ONPA or JNDMP could not be investigated. However, 
NP-4 and NP-38 had the same morphologies as JNDMP (Group I) and ONPA (Group II), 
respectively. Using DNA-DNA hybridization, type strains of Fujii et al. (1975), PN-3, PN-6 
and PN-19, were found to belong to Group I, I and II, respectively (Nagai & Yamasaki, 
2009). 
3. Polyglutamate degrading enzyme 
3.1 Polyglutamate 
B. subtilis (natto) produces a very viscous polymer of DL-glutamic acid, which has two 
carboxyl groups on α- and γ-carbons (Fig. 5A), with extremely high degrees of 
polymerization. Unlike proteins, in which amino acid residues bind via α-carboxyl groups 
and amino groups (Fig. 5B), the glutamic acids in this polymer, poly-γ-glutamate (PGA, Fig. 
5C), are synthesized by binding a γ-carboxyl group and an amino group of an adjacent 
glutamic acid via a hyperphosphorylated intermediate (Fig. 5D) (Ashiuchi et al., 2001). 
Genes related to the production of PGA were cloned and expressed well in Escherichia coli 
cells (Ashiuchi et al., 1999). The gene pgsBCA is homologous with genes for capsular PGA 
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2001). On the other hand, a regulatory gene for PGA production was cloned and found to be 
comP, which codes for a sensor protein kinase of the ComP-ComA two-component signal 
transduction system (Nagai et al., 2000). Recently, PGA cross-linked by γ-radiation was 
found to hold a large quantity of water and to be useful for greening of desert areas by 
scattering the PGA resin in which seeds (e.g. soybeans) are embedded (Hara, 2006). Thus, 
PGA is becoming an important industrial material. 
 
Fig. 5. Glutamic acid (A), tri-α-glutamic acid (B), tri-γ-glutamic acid (C), and the mechanism 
of synthesis of poly-γ-glutamic acid (D) 
3.2 Polyglutamate depolymerase 
It was found that a B. subtilis (natto) lysogenic strain could not accumulate PGA in the 
culture, whereas a nonlysogenic strain accumulated it under the same conditions (Hongo & 
Yoshimoto, 1968). In the culture of the lysogenic strain, bacteriophages were induced at a 
high density of 109 PFU/ml from the early stage of the experiment. Around the peak of 
production of phages, PGA depolymerase appeared to be released from the lysogenic 
strains to the culture. The enzyme was also produced extracellularly, when B. subtilis (natto) 
was infected by phages. After infection with phage NP-1 cl (Yoshimoto & Hongo, 1970), 
depolymerase was synthesized in parallel with the production of phage particles in host 
cells (Hongo & Yoshimoto, 1970a). The depolymerase digested PGA by endopeptidase-type 
action, resulting in the rapid loss of viscosity of PGA. Chromatographic studies showed that 
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the products of the reaction were di-γ-glutamate and tri-γ-glutamate (Hongo & Yoshimoto, 
1970b). Optimal pH and temperature of the depolymerase were pH 6–8 and 40–50°C, 
respectively. The depolymerase was stable at pH values ranging from 4 to 9 and below 70°C. 
The depolymerase was not linked to phage particles. 
3.3 Poly-γ-glutamate hydrolase, PghP 
Culture supernatant of B. subtilis (natto) infected with a phage ΦNIT1, which had been 
isolated from natto containing a small amount of PGA, caused the viscosity of PGA to 
decrease rapidly, and degraded PGA with a molecular weight of 106 Daltons to oligo-γ-
glutamyl peptides (Kimura & Itoh, 2003). From the culture supernatant, a 25-kDa 
monomeric enzyme was purified through five column chromatographic steps and was 
named PghP for “γ-PGA hydrolase of phage”. Analysis of the products of enzymatic 
reaction on PGA showed that they were tri-γ-glutamate, tetra-γ-glutamate and penta-γ-
glutamate. PghP was inhibited with monoiodoacetate and EDTA and the activity inhibited 
by EDTA was restored by adding Zn2+ or Mn2+, indicating that a cisteine residue(s) of PghP 
and these ions participated in the hydrolase reaction. 
The gene for PghP was cloned based on a nucleotide sequence predicted from the N-
terminal amino acid sequence of purified PghP, and sequenced (Kimura & Itoh, 2003). The 
predicted PghP was a 22.9-kDa protein with 203 amino acid residues, in which the first 
methionine was eliminated posttranslationally. PghP was a unique protein: similar proteins 
were not detected in the database by a BLAST search program. PghP is distributed in a 
variety of B. subtilis (natto) phages including some phages isolated from B. subtilis strains 
which produce no PGA. PghP of ΦNIT1 has a different substrate specificity from the PGA 
depolymerase in Section 3.2 (Hongo & Yoshimoto, 1970b). 
ΦNIT1 could amplify in both encapsulated and non-encapsulated B. subtilis (natto). On the 
other hand, B. subtilis phage BS5 (Ackermann et al., 1995), which produced no PghP, could 
amplify only in non-encapsulated B. subtilis (natto). BS5, however, could amplify in 
encapsulated B. subtilis (natto) in the presence of additive PghP. These results indicate that B. 
subtilis (natto) produces PGA for physical protection from attacks by phages (Kimura & Itoh, 
2003). 
Apparently opposite results were also reported: that PGA production made the cells 
susceptible to B. subtilis (natto) phages (Hara et al., 1984). In their study, B. subtilis (natto) 
phages could infect B. subtilis (natto) producing PGA. After curing of plasmid pUH1, which 
harboured genes controlling PGA production, of B. subtilis (natto) strains, the cured strains 
could no longer be infected by the phages. B. subtilis Marburg, which was not infected by the 
B. subtilis (natto) phages and did not produce PGA by nature, and the cured B. subtilis (natto) 
strains became susceptible to the phages after transformation with DNA from B. subtilis 
(natto). Hara et al. thought that “PGA might be associated with phage absorption” from the 
results. However, a cured B. subtilis (natto) strain was susceptible to phage ΦBN100, 
indicating basically that the plasmid did not control phage absorption (Nagai & Itoh, 1997). 
The experiments conducted by Hara et al. examined three factors: the existence of pUH1-
type plasmids, PGA productivity and γ-glutamyl transpeptidase (γ-GTP) (at the time, γ-GTP 
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genes, respectively [Aumayr et al., 1981; Hara et al., 1981], but pUH1 was found to harbour 
no genes for PGA production [Nagai et al., 1997]), so the situation might make the results 
difficult to interpret accurately. This discrepancy remains to be elucidated. 
Natto without PGA has no commercial value as a food on the market, but might have a 
value as an ingredient of natto fried rice or natto snack foods because of its ease of 
manufacturing in food factories (Kimura, 2008). Thus, PghP could be useful in the food 
industry. 
4. Phage contamination in natto factories 
The first report on contamination of natto by phages was reported by Fujii et al. (1967). At 
that time, the authors did not search the factory for phages where the contaminated natto 
had been made. In 1975, the authors investigated contamination by phages in the same 
factory. Phages were not detected in the factory, but in effluent from it because of 
modernization of the factory (Fujii et al., 1975). 
Yoshimoto et al. (1970) searched natto factories throughout Japan for contamination by 
phages. Phages were detected in 28 factories (47%) among 60 factories at a density ranging 
from 5 to over 1000 PFU/cm3 of sample. Phages were very often detected in old factories, 
the walls of which were made of clay (common in old Japanese buildings). The surfaces of 
clay walls have too many asperities to clean off soybean debris perfectly, resulting in 
amplification of phages in their host cells on soybean debris. The walls of modern factories 
are made of clean stainless steel, so phages were rarely detected. In factories contaminated 
by phages, the phages were detected most frequently in the fermentation rooms. Fujii et al. 
also reported that 25% of factories (2/8 factories in Kyushu Island, west Japan) were 
polluted with phages (Fujii et al., 1975). 
Nakajima (1995) investigated contamination by B. subtilis (natto) phages in four natto 
factories in Ibaraki prefecture, central Japan (Fig. 6). Before inoculation of natto starter to 
soybeans, phages were detected only on the floor of the washing room in a factory and its 
detection rate was very low. The phages might have been brought in with raw soybeans or 
dust in the air. After inoculation, the detection rate rose to 100%. These results indicate that 
perfect cleaning to ensure that no soybean debris remains in machines or on floors is 
essential, especially after soybeans have been sprayed with a spore suspension of B. subtilis 
(natto). The author did not mention contamination by phages of natto products made by the 
four factories. Another report showed that phage contamination was not detected in any 
natto made in factories in Iwate prefecture, northern Japan (Yamamoto, 1986). In total, 
contamination of natto products by phages has decreased drastically, but B. subtilis (natto) 
phages still exist in natto factories, fields, and waste water. 
Improvement of a factory highly polluted with phages and bacteria was reported (Takiguchi 
et al., 1999). When phages and bacteria were detected in natto made by the factory, a manual 
was compiled to ensure strict separation of the entrance and exit, hand-washing, removal of 
abnormal natto from the factory as soon as possible, dilution of starter with sterilized water, 
installation of UV lighting, replacement of wooden parts with those made of stainless steel, 
including periodical cleaning and hygiene education. After these efforts, no contamination 
was detected in the natto. 
 




Four independent factories (indicated by different color bars) were surveyed for B. subtilis (natto) 
phages in several facilities in the process of natto fermentation (the right flow chart, also see Fig. 2) and 
the floors near the facilities. 
BN, Bacillus subtilis (natto) 
Detection rate (%) = no. of detections / no. of samples x 100 
Fig. 6. Contamination by B. subtilis (natto) phages in natto factories (adapted from Nakajima, 
1995) 
The following disinfectants were effective against B. subtilis (natto) phages: benzalkonium 
chloride, chloramine-T, sodium hypochlorite, TEGO-51 and Vantocil IB (Fujii et al., 1983). 
The most important measure is cleaning the machines and floors of natto factories to remove 
soybean debris on which B. subtilis (natto) and phages can propagate. 
5. Other topics on B. subtilis (natto) phages 
5.1 Generalized transducing phage for B. subtilis (natto) 
For genetic transfer of DNA between B. subtilis (natto) strains by transduction, a phage 
ΦBN100 was screened in laboratory stock strains (Nagai & Itoh, 1997). The phage could 
transduce prototroph genes (for adenine, uracil or leucine requirement) to auxotrophs at 
rates ranging from 3.8 x 10-8 to 1.6 x 10-6 (number of transductants per phage particle). The 
phage was also used for analysis of transposon insertional mutagenesis on a gene 
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are made of clean stainless steel, so phages were rarely detected. In factories contaminated 
by phages, the phages were detected most frequently in the fermentation rooms. Fujii et al. 
also reported that 25% of factories (2/8 factories in Kyushu Island, west Japan) were 
polluted with phages (Fujii et al., 1975). 
Nakajima (1995) investigated contamination by B. subtilis (natto) phages in four natto 
factories in Ibaraki prefecture, central Japan (Fig. 6). Before inoculation of natto starter to 
soybeans, phages were detected only on the floor of the washing room in a factory and its 
detection rate was very low. The phages might have been brought in with raw soybeans or 
dust in the air. After inoculation, the detection rate rose to 100%. These results indicate that 
perfect cleaning to ensure that no soybean debris remains in machines or on floors is 
essential, especially after soybeans have been sprayed with a spore suspension of B. subtilis 
(natto). The author did not mention contamination by phages of natto products made by the 
four factories. Another report showed that phage contamination was not detected in any 
natto made in factories in Iwate prefecture, northern Japan (Yamamoto, 1986). In total, 
contamination of natto products by phages has decreased drastically, but B. subtilis (natto) 
phages still exist in natto factories, fields, and waste water. 
Improvement of a factory highly polluted with phages and bacteria was reported (Takiguchi 
et al., 1999). When phages and bacteria were detected in natto made by the factory, a manual 
was compiled to ensure strict separation of the entrance and exit, hand-washing, removal of 
abnormal natto from the factory as soon as possible, dilution of starter with sterilized water, 
installation of UV lighting, replacement of wooden parts with those made of stainless steel, 
including periodical cleaning and hygiene education. After these efforts, no contamination 
was detected in the natto. 
 




Four independent factories (indicated by different color bars) were surveyed for B. subtilis (natto) 
phages in several facilities in the process of natto fermentation (the right flow chart, also see Fig. 2) and 
the floors near the facilities. 
BN, Bacillus subtilis (natto) 
Detection rate (%) = no. of detections / no. of samples x 100 
Fig. 6. Contamination by B. subtilis (natto) phages in natto factories (adapted from Nakajima, 
1995) 
The following disinfectants were effective against B. subtilis (natto) phages: benzalkonium 
chloride, chloramine-T, sodium hypochlorite, TEGO-51 and Vantocil IB (Fujii et al., 1983). 
The most important measure is cleaning the machines and floors of natto factories to remove 
soybean debris on which B. subtilis (natto) and phages can propagate. 
5. Other topics on B. subtilis (natto) phages 
5.1 Generalized transducing phage for B. subtilis (natto) 
For genetic transfer of DNA between B. subtilis (natto) strains by transduction, a phage 
ΦBN100 was screened in laboratory stock strains (Nagai & Itoh, 1997). The phage could 
transduce prototroph genes (for adenine, uracil or leucine requirement) to auxotrophs at 
rates ranging from 3.8 x 10-8 to 1.6 x 10-6 (number of transductants per phage particle). The 
phage was also used for analysis of transposon insertional mutagenesis on a gene 





mutants on production of branched short-chain fatty acids for preparation of odorless natto 
(Takemura et al., 2000). ΦBN100 is a synonym for JNDMP (see Section 2). 
5.2 B. subtilis (natto) phage PM1 and a phage detection system by PCR 
A phage was newly isolated from natto producing no PGA and characterized (Umene et al., 
2009). The morphology of the phage, PM1, was very similar to that of JNDMP, and the size 
of its genomic DNA was found to be 50 kb using field inversion gel electrophoresis, 10 kb 
smaller than that of JNDMP. The genome of PM1 was a linear double-stranded DNA, and 
might be circularly permuted and have no definite termini, like T4 phage. 
Based on a sequence of a 1.1-kb EcoRI fragment of genomic DNA, which did not have 
significant homology with any sequences deposited at the DNA database so far, the 
following pair of primers for PCR to amplify a 0.53-kb region in the 1.1-kb EcoRI fragment 
was designed: 
5’-CGCACTGGAAGCAATCAAGTCGG-3’ (corresponding to nt 33–55) 
5’-CAACCCTCTGACCGACTTTTCCC-3’ (corresponding to nt 538–560) 
Among ten B. subtilis (natto) phage isolates in the authors’ laboratory, eight were target 
sequences of amplified with the primer set, suggesting that PM1 phages are distributed over 
a large area of Japan. 
5.3 Bacillus phage isolated from chungkookjang 
Chungkookjang is a Korean soybean food fermented by Bacillus subtilis. From the fermented 
soybeans, a virulent Bacillus phage was isolated and named Bp-K2 (Kim et al., 2011). Bp-K2 
resembled ONPA in morphology, but had a smaller head (width, 80 nm) and genomic DNA 
(21 kb). Bp-K2 had a contractile tail with a sheath (85–90 nm x 28 nm), a tail fiber (80–85 nm 
x 10 nm) and a basal plate (29 nm x 47 nm). Bp-K2 could develop plaques on not only B. 
subtilis strains isolated from chungkookjang but also B. subtilis (natto). 
5.4 Defective phage of B. subtilis (natto) 
As B. subtilis Marburg strain produces a defective phage PBSX (Seaman et al., 1964; 
Anderson & Bott, 1985; Zahler, 1993 for a review), which cannot amplify in host cells, B. 
subtilis (natto) IAM 1207 produces defective phage PBND8 after induction with bleomycin 
(Tsutsumi et al., 1990). Although PBND8 resembled PBSX in morphology, the size of DNA 
contained in heads of PBND8 was 8 kb, 5 kb smaller than that of PBSX (13 kb). SDS-
polyacrylamide gel electrophoresis of component proteins of the phage particles showed that 
PBND8 was clearly distinct from PBSX and PBSY, a defective phage from B. subtilis W23. 
Seaman et al. (1964) also showed the production of PBSX-like particles from B. natto. The 
particles neutralized antiserum against PBSX particles, indicating that the PBSX-like 
particles from B. natto were very closely related to PBSX. At least two kinds of defective 
phages might be produced by strains belonging to a B. subtilis (natto) group (i.e., PBND8 and 
PBSX-like defective phage). 
 




B. subtilis (natto) phages that have been isolated in Japan are classified into two groups 
(Groups I and II), which are genetically independent of each other judging from DNA-DNA 
hybridization analysis. Phage JNDMP (Group I) has a head (diameter, 60 nm) and a flexible 
tail (7 x 200 nm) and requires magnesium ions for amplification. Phage ONPA (Group II) 
has a head (diameter, 89 nm) and a contractile tail (9 x 200 nm) with a sheath (width, 23 nm) 
and does not require additional magnesium ions. JNDMP was found to be a generalized 
transducing phage for B. subtilis (natto). Natto contaminated with phages is not covered with 
PGA, which is an important factor of the quality of natto. The loss of PGA is attributed to 
PGA hydrolase, PghP, or its relevant enzyme, which is expressed from a gene on phage 
genomic DNA in infected host cells. The enzymes digest PGA by endopeptidase-type action, 
resulting in a rapid loss of viscosity of PGA. Contamination of natto products by phages can 
be prevented by cleaning the facilities and floors of natto factories. Until 1980, 
contamination by phages had caused devastating damage to natto factories, but such 
trouble is now rare thanks to the modernization of natto factories and hygiene education for 
workers. 
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Bacteriophages of Ralstonia solanacearum: 
Their Diversity and Utilization 
 as Biocontrol Agents in Agriculture 
Takashi Yamada   
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 Japan 
1. Introduction   
Bacterial wilt is one of the most important crop diseases, and is caused by the soil-borne 
Gram-negative bacterium Ralstonia solanacearum. R. solanacearum was formerly classified as 
Pseudomonas solanacearum or Bacterium solanacearum (Smith, 1986; Yabuuchi et al., 1995). This 
bacterium has an unusually wide host range, infecting more than 200 species belonging to 
more than 50 botanical families, including economically important crops (Hayward, 1991; 
Hayward, 2000). R. solanacearum strains represent a heterogeneous group, subdivided into 
five races based on host range, and into five biovars based on physiological and biochemical 
characteristics (Hayward, 2000). There is no general correlation between races and biovars, 
and the five races of R. solanacearum have different geographical distributions. Race 1 is a 
poorly defined group with a very wide host range, and is endemic to tropical, subtropical, 
and warm areas. Strains of race 2 mainly infect bananas, and are found primarily in 
Southeast Asia and Central America. Race 3 strains are distributed worldwide, and are 
principally associated with potato. Strains of race 4 infect ginger in areas of Asia and 
Hawaii, and race 5 strains infect mulberries in China. Recently, a new classification system 
for R. solanacearum strains, based on phylogenetic information, has been proposed, where 
strains are sub-grouped into four phylotypes roughly corresponding to their geographic 
origin. Phylotype I includes strains originating primarily from Asia, phylotype II from 
America, phylotype III from Africa and surrounding islands in the Indian Ocean, and 
phylotype IV from Indonesia (Fegan & Prior, 2005).  
In the field, R. solanacearum is easily disseminated via soil, contaminated irrigation water, 
surface water, farm equipment, and infected material (Janse, 1996). Bacterial cells can 
survive for many years in association with alternate hosts. Once identified as being infected, 
plants in cropping fields, gardens, or greenhouses must be destroyed, and soil and water 
draining systems that could potentially be contaminated with the bacteria must be treated 
with chemical bacteriocides. Soil fumigation with methyl bromide, vapam, or chloropicrin is 
of limited efficacy. Methyl bromide depletes the stratospheric ozone layer; therefore, the 
production and use of this gas was phased out in 2005, under the Montreal Protocol and the 
Clean Air Act. The limited effectiveness of the current integrated management strategies has 
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meant that bacterial wilt continues to be an economically serious problem for field-grown 
crops in many tropical, subtropical, and warm areas of the world (Hayward, 1991; 
Hayward, 2000). For example, bacterial wilt of potato has been estimated to affect 3.75 
million acres in approximately 80 countries, with global damage estimates currently 
exceeding $950 million per year (Momol et al., 2006). At present, protection from losses by 
bacterial wilt is provided mainly by early detection and subsequent eradication by 
destroying the host. Development of effective disease management strategies and 
improvement in detection and monitoring tools are required. 
Various kinds of bacteriophage with characteristic features have been isolated recently 
(Yamada et al., 2007), and have paved the way for new methods of biocontrol of bacterial 
wilt. These phages may be useful as tools for effective detection (diagnosis) of the pathogen 
in cropping ecosystems and in growing crops. They also have potential uses in eradication 
of the pathogen from contaminated soil or prevention of bacterial wilt in economically 
important crops. Like other methods of biological control, one advantage of phage 
biocontrol is the reduction in the use of chemical agents against pathogens. This prevents 
the problems of multiple environmental pollution, ecosystem disruption, and residual 
chemicals on the crops. Phage biocontrol in agricultural settings was extensively explored 
40–50 years ago as a means of controlling plant pathogens (Okabe & Goto, 1992). Two major 
problems arose in those practical trials; (i) extracellular polysaccharides produced by 
pathogenic bacteria prevented phage adsorption, and (ii) there were various degrees of 
susceptibility among bacterial strains (Goto, 1992). Nevertheless, over recent decades, the 
use of phage biocontrol to restrict the growth of plant-based bacterial pathogens has been 
explored with increasing enthusiasm. Certain bacteriophages of R. solanacearum have 
already been isolated and some of their physical and physiological properties have been 
characterized. The virulent phage P4282, and its related phages, have a polyhedral head (69 
nm in diameter) and a short tail (20 nm in length) (Tanaka et al., 1990), and contain a circular 
39.3-kbp dsDNA genome (Ozawa et al., 2001). Another phage, PK-101, was isolated from 
soil, and has a linear 35-kbp dsDNA genome (Toyoda et al., 1991). Both of these phages 
show very narrow host ranges and infect only a few strains of R. solanacearum. Phage P4282, 
which infects strain M4S, was used to control bacterial wilt of tobacco plants in laboratory 
experiments and possible phage-mediated protection was observed (Tanaka et al., 1990). 
However, for practical use of phages as biocontrol agents against bacterial wilt, multiple 
phages with wide host-ranges and strong lytic activity are required.  
2. Characterization and classification of bacteriophages infecting R. 
solanacearum 
Recently, Yamada et al. (2007) isolated and characterized several different kinds of phage 
that specifically infect R. solanacearum strains belonging to different races and/or biovars. 
Two of the phages, RSS1 and RSM1, are filamentous, Ff-like phages (Inoviridae). As 
demonstrated for coliphage M13, filamentous phages are very useful as vectors to display 
proteins on the virion surface in the bacteriophage-display method (Smith, 1985; Smith, 
1991). In the same way, RSS1 and RSM1 may be utilized to display a tag protein on the 
virion surface in diagnosis or monitoring applications (Kawasaki et al., 2007a). Another 
phage, RSA1, is a P2-like head-tailed virus (Myoviridae), and has the widest host range; all 
but one of 18 strains tested of races 1, 3, or 4 and biovar 1, N2, 3, or 4 were susceptible to this 
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phage. RSL1 is another myovirus having a very large genomic DNA of approximately 240 
kbp and strongly lysed 17 of 18 different strains. Another lytic phage, RSB1, shows a T7-
like morphology (Podoviridae) and also has a wide-host-range (15 of 18 strains of races 1, 3, 
or 4 were susceptible). RSB1 vigorously lyses host cells and forms very large clear plaques 
that extend for 10–15 cm on assay plates. The characteristics and host ranges of these phages 
are summarized in Table 1. Further surveys for phages infecting different strains of R. 
solanacearum detected many interesting examples, some of which were induced from 
lysogenic strains. Searching through the genomic databases for the sequences determined 
for these phages also revealed similar sequences integrated in various bacterial genomes 
(prophages). Such phages and prophages of R. solanacearum and related bacterial species are 
roughly grouped into six phage-types as follows: RSS phages, RSM phages, RSB phages, 
RSA phages, RSL phages, RSC phages , and others. 
 
Fig. 1. Electron micrographs showing morphology of bacteriophages infecting R. 
solanacearum.  
RSS1 (A) and RSM1 (B) are filamentous phages of Inoviridae. RSA1 (C) and RSL1 (E) are 
myoviruses (Myoviridae) with a contractile tail. RSB1 is a podovirus (Podoviridae) with a 
head and a short tail (D). Several RSB1 particles are seen attached to a membrane vesicle. 
RSC1 is a  like phage (Siphoviridae) with a non-contractile tail (F). TS, tail sheath. Bar 
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Phage susceptibility is shown as sensitive (+) or resistant (-). Some original data are updated (Yamada et 
al., 2007; Askora et al., 2009). ND, Not determined. 
Table 1. Host specificity of bacteriophages infecting R. solanacearum  
 
Phage susceptibility is shown as sensitive (+) or resistant (-). Some original data are updated (Yamada et 
al., 2007; Askora et al., 2009). ND, Not determined. 
Table 2. Host specificity of different phages of RSS and RSM groups 
2.1 RSS phages of the Inoviridae 
RSS1 was isolated from a soil sample collected from tomato crop fields. It infected 10 of 18 
strains tested and gave relatively small and turbid plaques on assay plates. RSS1 particles 
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have a flexible filamentous shape of 1100 ± 100 nm in length and 10 ± 0.5 nm in width (Fig. 
1), giving a morphology resembling coliphage fd (Buchen-Osmod, 2003; ICTVdB). Infection 
with RSS1 phage does not cause host cell lysis, but establishes a persistent association 
between the host and phage, releasing phage particles from the growing and dividing host 
cells. The RSS1 particles contain single-stranded (ss)DNA as the genome. Therefore, RSS1 
belongs to Ff-like phages or inoviruses. In general, the genome of Ff-phages is organized in 
a module structure, in which functionally related genes are grouped (Hill et al., 1991; 
Rasched & Oberer, 1986). Three functional modules are always present: the replication 
module, the structural module, and the assembly and secretion module. The replication 
module, contains the genes encoding rolling-circle DNA replication and single-strand DNA 
(ssDNA) binding proteins; gII, gV, and gX (Model & Russel, 1988). The structural module 
contains genes for the major (gVIII) and minor coat proteins (gIII, gVI, gVII, and gIX), and 
gene gIII encodes the host recognition or adsorption protein pIII (Armstrong et al., 1981). 
The assembly and secretion module contains the genes (gI, and gIV) for morphogenesis and 
extrusion of the phage particles (Marvin,1998). Gene gIV encodes protein pIV, an aqueous 
channel (secretin) in the outer membrane, through which phage particles exit from the host 
cells. Some phages encode their own secretins, whereas others use host products (Davis et 
al., 2000). The genome of RSS1 is 6,662 nt long (DDBJ accession No. AB259124), with a GC 
content of 62.6 %, which is comparable to that of R. solanacearum GMI1000 (66.97 %, 
Saranoubat et al., 2002). There are 11 open reading frames (ORFs), located on the same 
strand (Fig. 2A). Frequently, the termination codon of the preceding gene overlaps with the 
initiation codon of the following gene. The coding sequence occupied by these ORFs 
accounts for 91.6% of the total RSS1 sequence. A survey of the databases for amino acid 
sequences of RSS1 ORFs leads to the gene organization as shown in Fig. 2A. The RSS1 
genes fit well with the general arrangement of Ff-like phages. Homology searches revealed 
that the dsDNA plasmid pJTPS1, found in a strain R. solanacearum (accession no. AB015669), 
has significant nucleotide sequence similarity to RSS1 DNA. The size of pJTPS1 is 6,633 bp; 
29 bp smaller than that of RSS1. Nucleotide sequence identity between the two DNAs was 
95%. Compared with pJTPS1, two major different regions in the RSS1 DNA are evident: 
One region (RSS1 positions 2,674-3,014) corresponds to ORF7, putatively encoding pIII, 
which is a minor coat protein at one end of the phage particle required to recognize and 
adsorb host cells (Marvin, 1998, Model and Russel, 1988). The other extended change was 
found at positions 6,632-6,657 corresponding to the IG (intergenic region), which is highly 
conserved in other Ff-like phages (Model and Russel, 1988). This region may be involved in 
the rolling circle DNA replication mechanism, producing phage genomic ssDNA molecules. 
These results suggest that pJTPS1 may have been derived from a RSS1-like phage, followed 
by changes in the phage DNA. We tested the phage nature of pJTPS1 in strain M4S, where 
pJTPS1 was initially identified as a circular dsDNA plasmid (Negishi, et al., 1993). We could 
not detect dsDNA plasmid in strain M4S, but found a RSS1-related sequence integrated 
into the M4S genome. According to the pJTPS1 sequence, the corresponding sequence was 
amplified by PCR and circularized by self-ligation. When the resulting DNA was introduced 
in M4S cells, plaques appeared on assay plates. The nucleotide sequence of the phage 
coincided with pJTPS1 (Kawasaki et al., 2007a). The plaque size was relatively small and the 
frequency was relatively low, indicating that pJTPS1 is a ccc form of a RSS1-related phage 
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Table 1. Host specificity of bacteriophages infecting R. solanacearum  
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Table 2. Host specificity of different phages of RSS and RSM groups 
2.1 RSS phages of the Inoviridae 
RSS1 was isolated from a soil sample collected from tomato crop fields. It infected 10 of 18 
strains tested and gave relatively small and turbid plaques on assay plates. RSS1 particles 
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have a flexible filamentous shape of 1100 ± 100 nm in length and 10 ± 0.5 nm in width (Fig. 
1), giving a morphology resembling coliphage fd (Buchen-Osmod, 2003; ICTVdB). Infection 
with RSS1 phage does not cause host cell lysis, but establishes a persistent association 
between the host and phage, releasing phage particles from the growing and dividing host 
cells. The RSS1 particles contain single-stranded (ss)DNA as the genome. Therefore, RSS1 
belongs to Ff-like phages or inoviruses. In general, the genome of Ff-phages is organized in 
a module structure, in which functionally related genes are grouped (Hill et al., 1991; 
Rasched & Oberer, 1986). Three functional modules are always present: the replication 
module, the structural module, and the assembly and secretion module. The replication 
module, contains the genes encoding rolling-circle DNA replication and single-strand DNA 
(ssDNA) binding proteins; gII, gV, and gX (Model & Russel, 1988). The structural module 
contains genes for the major (gVIII) and minor coat proteins (gIII, gVI, gVII, and gIX), and 
gene gIII encodes the host recognition or adsorption protein pIII (Armstrong et al., 1981). 
The assembly and secretion module contains the genes (gI, and gIV) for morphogenesis and 
extrusion of the phage particles (Marvin,1998). Gene gIV encodes protein pIV, an aqueous 
channel (secretin) in the outer membrane, through which phage particles exit from the host 
cells. Some phages encode their own secretins, whereas others use host products (Davis et 
al., 2000). The genome of RSS1 is 6,662 nt long (DDBJ accession No. AB259124), with a GC 
content of 62.6 %, which is comparable to that of R. solanacearum GMI1000 (66.97 %, 
Saranoubat et al., 2002). There are 11 open reading frames (ORFs), located on the same 
strand (Fig. 2A). Frequently, the termination codon of the preceding gene overlaps with the 
initiation codon of the following gene. The coding sequence occupied by these ORFs 
accounts for 91.6% of the total RSS1 sequence. A survey of the databases for amino acid 
sequences of RSS1 ORFs leads to the gene organization as shown in Fig. 2A. The RSS1 
genes fit well with the general arrangement of Ff-like phages. Homology searches revealed 
that the dsDNA plasmid pJTPS1, found in a strain R. solanacearum (accession no. AB015669), 
has significant nucleotide sequence similarity to RSS1 DNA. The size of pJTPS1 is 6,633 bp; 
29 bp smaller than that of RSS1. Nucleotide sequence identity between the two DNAs was 
95%. Compared with pJTPS1, two major different regions in the RSS1 DNA are evident: 
One region (RSS1 positions 2,674-3,014) corresponds to ORF7, putatively encoding pIII, 
which is a minor coat protein at one end of the phage particle required to recognize and 
adsorb host cells (Marvin, 1998, Model and Russel, 1988). The other extended change was 
found at positions 6,632-6,657 corresponding to the IG (intergenic region), which is highly 
conserved in other Ff-like phages (Model and Russel, 1988). This region may be involved in 
the rolling circle DNA replication mechanism, producing phage genomic ssDNA molecules. 
These results suggest that pJTPS1 may have been derived from a RSS1-like phage, followed 
by changes in the phage DNA. We tested the phage nature of pJTPS1 in strain M4S, where 
pJTPS1 was initially identified as a circular dsDNA plasmid (Negishi, et al., 1993). We could 
not detect dsDNA plasmid in strain M4S, but found a RSS1-related sequence integrated 
into the M4S genome. According to the pJTPS1 sequence, the corresponding sequence was 
amplified by PCR and circularized by self-ligation. When the resulting DNA was introduced 
in M4S cells, plaques appeared on assay plates. The nucleotide sequence of the phage 
coincided with pJTPS1 (Kawasaki et al., 2007a). The plaque size was relatively small and the 
frequency was relatively low, indicating that pJTPS1 is a ccc form of a RSS1-related phage 





infection. Interestingly, the pJTPS1 phage (RSS2) infected RSM1-sensitive strains, 
including M4S (see below) and did not infect RSS1-sensitive strains, including strain C319. 
This may be because of the specific difference in a region of pIII host recognition protein 
between RSS1 and RSS2. 
 
According to the E. coli M13-model (Model and Russel, 1988; Marvin, 1998), ORFs identified on the 
phage genome are grouped in the functional modules for replication (R), structure (S), and assembly-
secretion (A-S). IG, large intergenic region. Among RSS1-related phages (A), RSS0, RSS2 and RSS3 
were derived from prophages of strains C319, M4S, and MAFF106611, respectively. P12J and PE226 are 
phages of Ralstonia pickettii (accession no. AY374414) and Korean strains of R. solanacearum (Murugaiyan 
et al., 2010). Of RSM1-related phages (B), RSM3, RSM4, RSM5, and RSM6 are prophages of strains 
MAFF730139, UW551 (race 3, biovar 2; Gabriel et al., 2006), IPO1609 (race 3, biovae 2; Remenant et al., 
2010), and CMR15 (phylotype III, Remenant et al., 2010), respectively. A similar prophage found in 
Ralstonia pickettii 12J is also shown. 
Fig. 2. Genomic organization of RSS1-related phages (A) and RSM1-related phages (B). 
Genomic Southern blot hybridization showed frequent examples of RSS1-related sequences 
integrated in the genomes of various R. solanacearum strains (Yamada et al., 2007). As seen 
above, RSS2 is integrated in the genome of strain M4S. RSS1 was also found to exist as a 
lysogenic phage in strain C319 (Kawasaki et al., 2007). By analyzing the host genomic 
sequences flanking the RSS1 region, its integration site was determined to correspond to 
RSS1 position 6,629 in the IG region, 34 nt upstream from ORF1. However, the nucleotide 
Bacteriophages of Ralstonia solanacearum: 
Their Diversity and Utilization as Biocontrol Agents in Agriculture 
 
119 
sequence around this RSS1 showed no significant homology to the core sequences involved 
in the XerC/D recombination system (Kawasaki et al., 2007a). Tasaka et al. (unpublished 
data) further characterized the nucleotide sequences in the neighborhood of the RSS1-
integration site in strain C319. It was revealed that RSS1 is a truncated form of a larger 
phage (designated as RSS0) of 7,288 nt in size, 626 nt larger than RSS1 (Fig. 2A). The 626 nt 
RSS0 sequence missing from RSS1 DNA contains two nucleotide sequence elements that 
repeat at both attL and attR, the latter of which has the sequence 5’-TATTT AACAT AAGAT 
AAAT, corresponding to dif of R. solanacearum (Carnoy and Roten, 2009). Thus, RSS0 is 
integrated at a dif site, similarly to CTX of Vibrio cholerae, which uses the host XerC/D 
recombination system (Huber and Waldor, 2002). Interestingly, one RSS0 ORF (ORF13; 156 
amino acid residues), located within the region missing in the RSS1 DNA, shows sequence 
homology to DNA-binding phage regulator (accession no. B5SCX5, E-value 1e-29). This may 
function as a phage repressor for immunity, because C319 (RSS0 lysogen) is resistant to 
second infection by RSS0 (Table 2). C319 is susceptible to RSS1, thus RSS1 (without 
ORF13) may be an escaped superinfective phage. 
Another form of RSS1-type prophage was found in strain MAFF106601 (Tasaka et al., 
unpublished data). This prophage (designated as RSS3) has an extended size (8,193 nt) 
caused by an insertion of an IS1405 element (transposase) within the IG (positions 6,250-
6,251 of RSS1). The map of RSS3 is compared with other related phages in Fig. 2A. This 
phage was active when its genomic DNA was amplified from the MAFF106601 genome by 
PCR and introduced into MAFF106603 as a host. It is interesting to note that RSS3 may 
exploit the transposase to move or transmit itself among genomes. A chimeric form of a 
RSS1-type phage is seen in the structure of RSS4, a prophage in strain MAFF211271 
(Kawasaki et al., unpublished data). This phage (7,618 nt in size) is integrated at the host 
gene for arginine tRNA (CGG) as attB and it contains a 58 nt sequence corresponding to the 
3’-portion of arginine tRNA (CGG) as attP. An ORF of 363 aa residues is closely associated 
with attP and this unit (attP/Int) is almost identical to that of RSA1 (Fujiwara et al., 2008), a 
P2-type myovirus as described below. The map of RSS4 is shown in Fig. 2A. As can be 
seen, an approximately 2.2 kb region (corresponding to the structure module) containing 
ORF4 to ORF8 and an ORF of assembly-secretion module (ORF9) are almost identical 
between RSS1 and RSS4, but most of the replication module in RSS4 is replaced with that 
of phage P12J infecting Ralstonia pickettii (accession no. AY374414). The replication module 
of RSS4 is inserted with an ORF (ORF2) and attP; ORF 2 shows amino acid sequence 
similarity to Burkholderia pseudomallei bacteriophage integrase (accession no. Q63PM9, E-
value e-100). A similar, but significantly smaller, phage, PE226, infecting R. solanacearum 
strains was recently reported (Murugaiyan et al., 2010). The RSS4 structure suggests that 
RSS phages can exchange each of the Ff-phage modules (Model and Russel, 1988) among 
related phages and evolve to a new characteristic phage. 
2.2 RSM phages of the Inoviridae 
RSM1 was isolated from a soil sample and can form small plaques on assay plates with 
limited strains (7 of 18 strains tested) as a host. RSM1 particles show a long fibrous shape of 
1400 ± 300 µm in length and 10 ± 0.7 nm in width by electron microscopy (Fig. 1), giving a 
shape similar to coliphage M13 (Buchen-Osmond, 2003; ICTVdB). The infection cycle of 





infection. Interestingly, the pJTPS1 phage (RSS2) infected RSM1-sensitive strains, 
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Ralstonia pickettii 12J is also shown. 
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Genomic Southern blot hybridization showed frequent examples of RSS1-related sequences 
integrated in the genomes of various R. solanacearum strains (Yamada et al., 2007). As seen 
above, RSS2 is integrated in the genome of strain M4S. RSS1 was also found to exist as a 
lysogenic phage in strain C319 (Kawasaki et al., 2007). By analyzing the host genomic 
sequences flanking the RSS1 region, its integration site was determined to correspond to 
RSS1 position 6,629 in the IG region, 34 nt upstream from ORF1. However, the nucleotide 
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sequence around this RSS1 showed no significant homology to the core sequences involved 
in the XerC/D recombination system (Kawasaki et al., 2007a). Tasaka et al. (unpublished 
data) further characterized the nucleotide sequences in the neighborhood of the RSS1-
integration site in strain C319. It was revealed that RSS1 is a truncated form of a larger 
phage (designated as RSS0) of 7,288 nt in size, 626 nt larger than RSS1 (Fig. 2A). The 626 nt 
RSS0 sequence missing from RSS1 DNA contains two nucleotide sequence elements that 
repeat at both attL and attR, the latter of which has the sequence 5’-TATTT AACAT AAGAT 
AAAT, corresponding to dif of R. solanacearum (Carnoy and Roten, 2009). Thus, RSS0 is 
integrated at a dif site, similarly to CTX of Vibrio cholerae, which uses the host XerC/D 
recombination system (Huber and Waldor, 2002). Interestingly, one RSS0 ORF (ORF13; 156 
amino acid residues), located within the region missing in the RSS1 DNA, shows sequence 
homology to DNA-binding phage regulator (accession no. B5SCX5, E-value 1e-29). This may 
function as a phage repressor for immunity, because C319 (RSS0 lysogen) is resistant to 
second infection by RSS0 (Table 2). C319 is susceptible to RSS1, thus RSS1 (without 
ORF13) may be an escaped superinfective phage. 
Another form of RSS1-type prophage was found in strain MAFF106601 (Tasaka et al., 
unpublished data). This prophage (designated as RSS3) has an extended size (8,193 nt) 
caused by an insertion of an IS1405 element (transposase) within the IG (positions 6,250-
6,251 of RSS1). The map of RSS3 is compared with other related phages in Fig. 2A. This 
phage was active when its genomic DNA was amplified from the MAFF106601 genome by 
PCR and introduced into MAFF106603 as a host. It is interesting to note that RSS3 may 
exploit the transposase to move or transmit itself among genomes. A chimeric form of a 
RSS1-type phage is seen in the structure of RSS4, a prophage in strain MAFF211271 
(Kawasaki et al., unpublished data). This phage (7,618 nt in size) is integrated at the host 
gene for arginine tRNA (CGG) as attB and it contains a 58 nt sequence corresponding to the 
3’-portion of arginine tRNA (CGG) as attP. An ORF of 363 aa residues is closely associated 
with attP and this unit (attP/Int) is almost identical to that of RSA1 (Fujiwara et al., 2008), a 
P2-type myovirus as described below. The map of RSS4 is shown in Fig. 2A. As can be 
seen, an approximately 2.2 kb region (corresponding to the structure module) containing 
ORF4 to ORF8 and an ORF of assembly-secretion module (ORF9) are almost identical 
between RSS1 and RSS4, but most of the replication module in RSS4 is replaced with that 
of phage P12J infecting Ralstonia pickettii (accession no. AY374414). The replication module 
of RSS4 is inserted with an ORF (ORF2) and attP; ORF 2 shows amino acid sequence 
similarity to Burkholderia pseudomallei bacteriophage integrase (accession no. Q63PM9, E-
value e-100). A similar, but significantly smaller, phage, PE226, infecting R. solanacearum 
strains was recently reported (Murugaiyan et al., 2010). The RSS4 structure suggests that 
RSS phages can exchange each of the Ff-phage modules (Model and Russel, 1988) among 
related phages and evolve to a new characteristic phage. 
2.2 RSM phages of the Inoviridae 
RSM1 was isolated from a soil sample and can form small plaques on assay plates with 
limited strains (7 of 18 strains tested) as a host. RSM1 particles show a long fibrous shape of 
1400 ± 300 µm in length and 10 ± 0.7 nm in width by electron microscopy (Fig. 1), giving a 
shape similar to coliphage M13 (Buchen-Osmond, 2003; ICTVdB). The infection cycle of 





accession No. AB259123) with a GC content of 59.9%, which is lower than that of R. 
solanacearum GMI1000 (66.97%). There are 12 putative ORFs located on the same strand and 
two on the opposite strand. Compared with the conserved gene arrangement of Ff-like 
phages, the RSM1 genes can be drawn as Fig. 2B (Kawasaki et al., 2007a). Here, ORF13 and 
ORF14 (reversely oriented) are inserted between ORF11, corresponding to pII as a 
replication protein, and ORF1, corresponding to an ssDNA-binding protein like pV, in the 
putative replication module. ORF13 and ORF14 show amino acid sequence similarity to a 
proline-rich transmembrane protein and a resolvase/DNA invertase–like recombinase, 
respectively. There are two additional ORFs (ORF2 and ORF3) between the replication and 
structural modules. The functions of these ORF-encoded proteins are not known. In 
genomic Southern blot hybridization, two different types of RSM1-related prophage 
sequences were detected in R. solanacearum strains. Strains of type A include MAFF211270 
and produce RSM1 itself, and strains of type B (giving different restriction patterns) are 
resistant to RSM1 infection, but serve as hosts for RSS1 with different nature and host 
range as described above (Kawasaki et al., 2007a). By determining the nucleotide sequences 
of junction regions of the RSM1-prophage in the MAFF211270 chromosomal DNA, an 
attP/attB core sequence was identified as 5’-TGGCGGAGAGGGT-3’, corresponding to 
positions 8,544-8,556 of RSM1 DNA, located between ORF14 and ORF1. Its nucleotide 
sequence is identical to the 3’-end of the host R. solanacearum gene for serine tRNA(UCG) in 
the reverse orientation. By PCR with appropriate primers containing these att sequences, a 
RSM1-like prophage (type B) in strain MAFF730139 (designated RSM3) was obtained 
(Askora et al., 2009). Compared with the RSM1 genome, the RSM3 prophage sequence 
(8,929 bp) is 75 bp shorter. The sequences show 93% nucleotide identity and major 
differences are found within two regions; positions 400-600 and positions 2,500-3,000 in the 
RSM1 sequence. The former region corresponds to ORF2, which is inserted between the 
replication module (R) and the structural module (S), and the latter falls into the possible D2 
domain of ORF9 (pIII), as described below. All 14 ORFs identified along the RSM3 
sequence show high amino acid sequence homology (more than 90% amino acid identity) 
with their counterparts on the RSM1 genomic DNA, except for ORF2 (no similarity) and 
ORF9 (79% identity). It is interesting that the amino acid sequence of ORF14 (putative DNA 
invertase/recombinase) is 100% identical in the two phages. The gene arrangements are 
compared in Fig. 2B. During database searches for homologous sequences, we found that an 
approximately 8 kbp region of the R. solanacearum UW551 genome (accession no. 
DDBJ/EMBL/GenBank AAKL00000000; RS-UW551-Contig0570-70-86K) at positions 3,039-
10,984 shows significant DNA sequence homology with RSM1 and RSM3. The prophage 
of UW551 (designated RSM4, Askora et al., 2009) contains 7,929 bp flanked by att 
sequences, as in RSM1, comprising 13-bp of the 3’-end of serine tRNA (UCG). The 7,929-bp 
RSM4-prophage sequence shows 72% nucleotide sequence identity with RSM1 DNA. 
There are three deletions in RSM4 compared with the RSM1 gene arrangement; ORF3, 
ORF13, and part (positions 5,370-5,800) of the intergenic region (IG) are missing. Other ORFs 
identified in the RSM4 sequence show variable amino acid sequence similarity to their 
counterparts in RSM1: no similarity in ORF2, moderate similarity in ORF4 (57% amino acid 
identity), ORF5 (77%), and ORF9 (73%), and high similarity in ORF1 (93%), ORF6 (98%), 
ORF7 (98%), ORF8 (93%), ORF10 (86%), ORF11 (89%), ORF12 (89%), and ORF14 (81%). The 
gene arrangement of RSM4 prophage DNA is also included in the comparison shown in 
Fig. 2B.  
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One of the major differences in the predicted genes between RSM1 and RSM3 is confined 
within the middle part of ORF9, corresponding to pIII, the host recognition and adsorption 
minor coat protein. Interestingly, this internal region of RSM3 (also 67% identical in 
RSM4) shows a significant similarity (79%) to the corresponding region of RSS1, which 
shows a different host range from RSM1 (Yamada et al., 2007). These results predict that 
RSM3 and RSM4 share a common host range, which differs from that of RSM1, and 
suggest that the host range determined by the pIII-D2 domain may be exchangeable among 
phages. This was experimentally confirmed. The circularized RSM3 PCR product was 
introduced into MAFF211272 and resulting phage with the expected DNA restriction 
pattern was subjected to host-range assay. The results are summarized in Table 2. The host 
range of RSM3 is incompatible with that of RSM1; namely RSM1-susceptible strains are 
resistant to RSM3 and vice versa, except for strains Ps74 and MAFF211270, which are 
susceptible to both phages. RSM3 has a wider host range, and all 15 strains are susceptible 
to either RSM1 or RSM3. The host range of RSM3 partially overlaps with that of RSS1 
(Yamada et al., 2007), but RSS1 recognizes only ten strains (Table 2), suggesting the 
involvement of some additional factors in RSS1 host recognition. To confirm the host 
recognition by the D2 domain of pIII in RSM1 and RSM3, this domain of RSM1 was 
replaced with the corresponding region of RSM3. The resulting phage (designated as 
RSM13) did not retain the host range of RSM1 but showed the exactly same host range as 
that of RSM3 (Table 2). The entire nucleotide sequence of RSM13 DNA is completely the 
same as that of RSM1, except for a 350-bp region corresponding to the pIII-D2 of RSM3; 
therefore, the change of host range must have been determined by the D2 domain of pIII of 
RSM3 (Askora et al., 2009). The differences in the pIII-D2 domain among RSM phages 
correspond well to the strain-specific pili types. A minor pilin of approximately 30 kDa 
varies in size, depending on the strain; slightly smaller proteins correspond to RSM1-
susceptible strains and slightly larger proteins correspond to RSM3-susceptible strains 
(Askora et al., 2009).  
As described above, the genomes of RSM phages are sometimes found to be integrated in 
the host genome. Askora et al. (2011) demonstrated that the integration is mediated by the 
phage-encoded recombinase (ORF14 of RSM1), which has significant homology to 
resolvases/DNA invertases (small serine recombinases) at the sites, attP/attB corresponding 
to the 3’ end of the host serine tRNA (UCG) gene in the reverse orientation. The same unit of 
integration (RSM Int/attP) was found in a R. pickettii 12J phage and in B. pseudomallei 668 
prophages. Together with these phages, it is not surprising that similar int-containing 
filamentous phages occur widely in the natural world. 
2.3 RSB phages of the Podoviridae 
RSB1 was isolated from a soil sample from a tomato crop field and was selected for its 
ability to form large clear plaques on plate cultures of R. solanacearum strain M4S. Plaques 
formed on assay plates were 1.0 to 1.5 cm in diameter. This phage has a wide host range and 
infected 15 of 18 strains tested, including strains of races 1, 3, and 4, and of biovars 3, 4, and 
N2. Under laboratory conditions, host cells of R. solanacearum strains lyse after 2.5 to 3 h 
postinfection (p.i.) (with an eclipse period of 1.5 to 2 h), releasing approximately 30 to 60 pfu 





accession No. AB259123) with a GC content of 59.9%, which is lower than that of R. 
solanacearum GMI1000 (66.97%). There are 12 putative ORFs located on the same strand and 
two on the opposite strand. Compared with the conserved gene arrangement of Ff-like 
phages, the RSM1 genes can be drawn as Fig. 2B (Kawasaki et al., 2007a). Here, ORF13 and 
ORF14 (reversely oriented) are inserted between ORF11, corresponding to pII as a 
replication protein, and ORF1, corresponding to an ssDNA-binding protein like pV, in the 
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proline-rich transmembrane protein and a resolvase/DNA invertase–like recombinase, 
respectively. There are two additional ORFs (ORF2 and ORF3) between the replication and 
structural modules. The functions of these ORF-encoded proteins are not known. In 
genomic Southern blot hybridization, two different types of RSM1-related prophage 
sequences were detected in R. solanacearum strains. Strains of type A include MAFF211270 
and produce RSM1 itself, and strains of type B (giving different restriction patterns) are 
resistant to RSM1 infection, but serve as hosts for RSS1 with different nature and host 
range as described above (Kawasaki et al., 2007a). By determining the nucleotide sequences 
of junction regions of the RSM1-prophage in the MAFF211270 chromosomal DNA, an 
attP/attB core sequence was identified as 5’-TGGCGGAGAGGGT-3’, corresponding to 
positions 8,544-8,556 of RSM1 DNA, located between ORF14 and ORF1. Its nucleotide 
sequence is identical to the 3’-end of the host R. solanacearum gene for serine tRNA(UCG) in 
the reverse orientation. By PCR with appropriate primers containing these att sequences, a 
RSM1-like prophage (type B) in strain MAFF730139 (designated RSM3) was obtained 
(Askora et al., 2009). Compared with the RSM1 genome, the RSM3 prophage sequence 
(8,929 bp) is 75 bp shorter. The sequences show 93% nucleotide identity and major 
differences are found within two regions; positions 400-600 and positions 2,500-3,000 in the 
RSM1 sequence. The former region corresponds to ORF2, which is inserted between the 
replication module (R) and the structural module (S), and the latter falls into the possible D2 
domain of ORF9 (pIII), as described below. All 14 ORFs identified along the RSM3 
sequence show high amino acid sequence homology (more than 90% amino acid identity) 
with their counterparts on the RSM1 genomic DNA, except for ORF2 (no similarity) and 
ORF9 (79% identity). It is interesting that the amino acid sequence of ORF14 (putative DNA 
invertase/recombinase) is 100% identical in the two phages. The gene arrangements are 
compared in Fig. 2B. During database searches for homologous sequences, we found that an 
approximately 8 kbp region of the R. solanacearum UW551 genome (accession no. 
DDBJ/EMBL/GenBank AAKL00000000; RS-UW551-Contig0570-70-86K) at positions 3,039-
10,984 shows significant DNA sequence homology with RSM1 and RSM3. The prophage 
of UW551 (designated RSM4, Askora et al., 2009) contains 7,929 bp flanked by att 
sequences, as in RSM1, comprising 13-bp of the 3’-end of serine tRNA (UCG). The 7,929-bp 
RSM4-prophage sequence shows 72% nucleotide sequence identity with RSM1 DNA. 
There are three deletions in RSM4 compared with the RSM1 gene arrangement; ORF3, 
ORF13, and part (positions 5,370-5,800) of the intergenic region (IG) are missing. Other ORFs 
identified in the RSM4 sequence show variable amino acid sequence similarity to their 
counterparts in RSM1: no similarity in ORF2, moderate similarity in ORF4 (57% amino acid 
identity), ORF5 (77%), and ORF9 (73%), and high similarity in ORF1 (93%), ORF6 (98%), 
ORF7 (98%), ORF8 (93%), ORF10 (86%), ORF11 (89%), ORF12 (89%), and ORF14 (81%). The 
gene arrangement of RSM4 prophage DNA is also included in the comparison shown in 
Fig. 2B.  
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One of the major differences in the predicted genes between RSM1 and RSM3 is confined 
within the middle part of ORF9, corresponding to pIII, the host recognition and adsorption 
minor coat protein. Interestingly, this internal region of RSM3 (also 67% identical in 
RSM4) shows a significant similarity (79%) to the corresponding region of RSS1, which 
shows a different host range from RSM1 (Yamada et al., 2007). These results predict that 
RSM3 and RSM4 share a common host range, which differs from that of RSM1, and 
suggest that the host range determined by the pIII-D2 domain may be exchangeable among 
phages. This was experimentally confirmed. The circularized RSM3 PCR product was 
introduced into MAFF211272 and resulting phage with the expected DNA restriction 
pattern was subjected to host-range assay. The results are summarized in Table 2. The host 
range of RSM3 is incompatible with that of RSM1; namely RSM1-susceptible strains are 
resistant to RSM3 and vice versa, except for strains Ps74 and MAFF211270, which are 
susceptible to both phages. RSM3 has a wider host range, and all 15 strains are susceptible 
to either RSM1 or RSM3. The host range of RSM3 partially overlaps with that of RSS1 
(Yamada et al., 2007), but RSS1 recognizes only ten strains (Table 2), suggesting the 
involvement of some additional factors in RSS1 host recognition. To confirm the host 
recognition by the D2 domain of pIII in RSM1 and RSM3, this domain of RSM1 was 
replaced with the corresponding region of RSM3. The resulting phage (designated as 
RSM13) did not retain the host range of RSM1 but showed the exactly same host range as 
that of RSM3 (Table 2). The entire nucleotide sequence of RSM13 DNA is completely the 
same as that of RSM1, except for a 350-bp region corresponding to the pIII-D2 of RSM3; 
therefore, the change of host range must have been determined by the D2 domain of pIII of 
RSM3 (Askora et al., 2009). The differences in the pIII-D2 domain among RSM phages 
correspond well to the strain-specific pili types. A minor pilin of approximately 30 kDa 
varies in size, depending on the strain; slightly smaller proteins correspond to RSM1-
susceptible strains and slightly larger proteins correspond to RSM3-susceptible strains 
(Askora et al., 2009).  
As described above, the genomes of RSM phages are sometimes found to be integrated in 
the host genome. Askora et al. (2011) demonstrated that the integration is mediated by the 
phage-encoded recombinase (ORF14 of RSM1), which has significant homology to 
resolvases/DNA invertases (small serine recombinases) at the sites, attP/attB corresponding 
to the 3’ end of the host serine tRNA (UCG) gene in the reverse orientation. The same unit of 
integration (RSM Int/attP) was found in a R. pickettii 12J phage and in B. pseudomallei 668 
prophages. Together with these phages, it is not surprising that similar int-containing 
filamentous phages occur widely in the natural world. 
2.3 RSB phages of the Podoviridae 
RSB1 was isolated from a soil sample from a tomato crop field and was selected for its 
ability to form large clear plaques on plate cultures of R. solanacearum strain M4S. Plaques 
formed on assay plates were 1.0 to 1.5 cm in diameter. This phage has a wide host range and 
infected 15 of 18 strains tested, including strains of races 1, 3, and 4, and of biovars 3, 4, and 
N2. Under laboratory conditions, host cells of R. solanacearum strains lyse after 2.5 to 3 h 
postinfection (p.i.) (with an eclipse period of 1.5 to 2 h), releasing approximately 30 to 60 pfu 





stained phage particles revealed short-tailed icosahedral structures resembling those of the 
family Podoviridae. The particles consist of a head of approximately 60 nm in diameter and a 
stubby tail of 20 nm in length (Fig. 1). The RSB1 genome is linear double-stranded DNA of 
43,079 bp and includes direct terminal repeats of 325 bp (accession no. AB276040). The G + C 
content of the genome is 61.7%. This value is lower than the G + C values of the large and 
small replicons of the R. solanacearum GMI1000 genome (67.04% and 66.86%, respectively) 
(Salanoubat et al., 2002). A total of 47 potential ORFs oriented in the same direction were 
assigned on the genome (Fig. 3A). Patchy or local nucleotide sequence homologies were 
detected in the genomic sequences of various phages, including Xanthomonas oryzae phages 
Xop411 (accession no. DQ777876) and Xp10 (accession no. AY299121) (Yuzenkova et al., 
2003), Pseudomonas aeruginosa phages KMV (accession no. AJ505558) (Lavigne et al., 2003), 
Erwinia amylovora phage Era103 (accession no. EF160123), and Burkholderia cenocepacia phage 
BcepB1A (accession no. AY616033). All of these are members of the family Podoviridae. The 
genome of coliphage T7, the representative of T7-like viruses of the Podoviridae, generally 
consists of three functional gene clusters: one for early functions (class I), one for DNA 
metabolism (class II), and the other for structural proteins and virion assembly (class III) 
(Dunn & Studier, 1983). These gene clusters are essentially conserved in the RSB1 genome. 
Figure 3A shows the putative ORFs identified on the RSB1 genome compared with ORFs 
from other phages: Xanthomonas phage Xop411 (giving the highest local similarities), 
Pseudomonas phage KMV (showing marginal similarity but longest regions of similarity), 
and coliphage T7. One of the characteristic features found in the RSB1 gene organization is 
that the predicted gene for RNA polymerase (RNAP) of RSB1 (orf26) is not located in the 
early gene region (class I), but at the end of the class II region (Fig. 3A). Another exception is 
the gene for DNA ligase (DNAL), orf25, encoding the RSB1 DNAL, is in 5’ to the RNAP 
ORF (orf26), whereas the gene encoding T7 DNAL is downstream of the gene for RNAP, at 
the end of the class I cluster (Dunn & Studier, 1983). In Pseudomonas phages KMV, LKD16, 
and LKA1, the DNAL gene is upstream of the gene for DNA polymerase in the class II gene 
cluster (Fig. 3A). T7-like phages are generally known as absolute lytic phages, with a few 
exceptions, such as integrase-coding phages, e.g., prophage 3 of Pseudomonas putida 
(Molineux, 1999) and the cyanophage P-SSP7 (Lindell et al., 2004). Occasionally, nucleotide 
sequences related to T7-like phages are found in conjunction with other temperate phages, 
such as -like phages that are integrated in various bacterial genomes (Brussow et al., 2004; 
Canchaya et al., 2003; Casjens, 2003; Hendrix et al., 2003). A sequence highly homologous to 
RSB1 was found to be embedded in a large (85-kbp)  like prophage sequence (1026b) 
integrated in the genome of Burkholderia pseudomallei 1710b (accession no. CP000124). The 
homologous region of the 1710b prophage contains eight ORFs encoding DNA primase, 
DNA helicase, DNAL, DNA polymerase, exonuclease, and RNAP, etc. These correspond to 
the class II genes of RSB1, as shown in Fig. 3A. Both Ralstonia and Burkholderia belong to the 
Betaproteobacteria and may share common bacteriophages (Fujiwara et al., 2008).  
Searching for core promoter-like sequences conserved in phages T3, T7, or SP6 in the RSB1 
intergenic regions did not reveal any significant homologies. Instead, a set of sequence 
elements (possible promoter elements) consisting of a GC-rich stretch and TTGT, TCTGG, 
and CGGGCAC motifs preceding an AG-rich Shine-Dalgarno sequence were found. The 
activity of transcriptional promoters of such elements on the RSB1 genome was 
demonstrated using a green fluorescent protein (GFP)-expressing single-copy plasmid, 
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T7-like arrangements of 47 ORFs identified on the RSB1 genome (43,079 bp, Kawasaki et al., 2009) and 
50 ORFs on the RSB2 genome are compared with those of E. coli T7 (39,937 bp, NC_00164) and 
Pseudomonas aeruginosa KMV (42,519 bp, AJ50558)(A). According to the T7-gene-organaization, ORFs 
are grouped into three classes (Kawasaki et al., 2009). Corresponding major ORFs are connected by 
shading (DNAL, DNA ligase; DNAP, DNA polymerase; MCP, major capsid protein; LYS lysozyme). P2-
like arrangement of 51 ORFs on the RSA1 genome (38,760 bp, Fujiwara et al., 2008) and 52 ORFs on 
RSX (40,713 bp), a prophage found on the genome of strain GMI1000 (Salanoubat et al., 2002). Shading 
indicates similar regions among the phages (B). In the map of RSL1 genome (231,255), a total of 343 
ORFs are grouped into 4 genomic regions according to their clustering with the same orientation (C). 
Fig. 3. Genomic organization of RSB1-related phages (A), RSA1-related phages (B), and 
RSL1 (C). 
pRSS12 (Kawasaki et al., 2007b). A switch from host RNAP to RSB1 RNAP occurs between 
75 min p.i. and 90 min p.i., and the late stages of RSB1 replication are independent of 
rifampin. A phage, RSB3, from our phage collection also showed a similar gene 
arrangement to RSB1, but its genome size is significantly larger (tentatively 44,242 bp) than 
RSB1 and the nucleotide sequence similarity are entirely marginal between the two phages. 
The host range of RSB3 is narrower (5 of 15 strains tested are susceptible). Another phage 
in our collection, which was obtained from a potato field, gave large clear plaques with 10 of 
15 strains tested as hosts. Electron microscopy revealed a typical podoviral morphology of 
this phage (designated as RSB2), an icosahedral head of 45 ± 5 nm in diameter, and a short 
tail of 12.5 ± 2 nm in length. The RSB2 genome is linear double-stranded DNA of 40,411 bp 
and includes direct terminal repeats of 214 bp (accession no. AB597179). The G + C content 
of the genome is 61.7%. A total of 50 ORFs were identified along the genome. Homology 
searches through the databases revealed a general organization of this phage similar to T7-
like phages, consisting of three gene classes; Class I (ORF1-ORF21), Class II (ORF22-ORF34), 
and Class III (ORF35-ORF50) (Fig. 3A). In contrast to RSB1, the gene for RNAP associated 
with dnal (encoding DNAL) is located within Class I. The position of lys (encoding 





stained phage particles revealed short-tailed icosahedral structures resembling those of the 
family Podoviridae. The particles consist of a head of approximately 60 nm in diameter and a 
stubby tail of 20 nm in length (Fig. 1). The RSB1 genome is linear double-stranded DNA of 
43,079 bp and includes direct terminal repeats of 325 bp (accession no. AB276040). The G + C 
content of the genome is 61.7%. This value is lower than the G + C values of the large and 
small replicons of the R. solanacearum GMI1000 genome (67.04% and 66.86%, respectively) 
(Salanoubat et al., 2002). A total of 47 potential ORFs oriented in the same direction were 
assigned on the genome (Fig. 3A). Patchy or local nucleotide sequence homologies were 
detected in the genomic sequences of various phages, including Xanthomonas oryzae phages 
Xop411 (accession no. DQ777876) and Xp10 (accession no. AY299121) (Yuzenkova et al., 
2003), Pseudomonas aeruginosa phages KMV (accession no. AJ505558) (Lavigne et al., 2003), 
Erwinia amylovora phage Era103 (accession no. EF160123), and Burkholderia cenocepacia phage 
BcepB1A (accession no. AY616033). All of these are members of the family Podoviridae. The 
genome of coliphage T7, the representative of T7-like viruses of the Podoviridae, generally 
consists of three functional gene clusters: one for early functions (class I), one for DNA 
metabolism (class II), and the other for structural proteins and virion assembly (class III) 
(Dunn & Studier, 1983). These gene clusters are essentially conserved in the RSB1 genome. 
Figure 3A shows the putative ORFs identified on the RSB1 genome compared with ORFs 
from other phages: Xanthomonas phage Xop411 (giving the highest local similarities), 
Pseudomonas phage KMV (showing marginal similarity but longest regions of similarity), 
and coliphage T7. One of the characteristic features found in the RSB1 gene organization is 
that the predicted gene for RNA polymerase (RNAP) of RSB1 (orf26) is not located in the 
early gene region (class I), but at the end of the class II region (Fig. 3A). Another exception is 
the gene for DNA ligase (DNAL), orf25, encoding the RSB1 DNAL, is in 5’ to the RNAP 
ORF (orf26), whereas the gene encoding T7 DNAL is downstream of the gene for RNAP, at 
the end of the class I cluster (Dunn & Studier, 1983). In Pseudomonas phages KMV, LKD16, 
and LKA1, the DNAL gene is upstream of the gene for DNA polymerase in the class II gene 
cluster (Fig. 3A). T7-like phages are generally known as absolute lytic phages, with a few 
exceptions, such as integrase-coding phages, e.g., prophage 3 of Pseudomonas putida 
(Molineux, 1999) and the cyanophage P-SSP7 (Lindell et al., 2004). Occasionally, nucleotide 
sequences related to T7-like phages are found in conjunction with other temperate phages, 
such as -like phages that are integrated in various bacterial genomes (Brussow et al., 2004; 
Canchaya et al., 2003; Casjens, 2003; Hendrix et al., 2003). A sequence highly homologous to 
RSB1 was found to be embedded in a large (85-kbp)  like prophage sequence (1026b) 
integrated in the genome of Burkholderia pseudomallei 1710b (accession no. CP000124). The 
homologous region of the 1710b prophage contains eight ORFs encoding DNA primase, 
DNA helicase, DNAL, DNA polymerase, exonuclease, and RNAP, etc. These correspond to 
the class II genes of RSB1, as shown in Fig. 3A. Both Ralstonia and Burkholderia belong to the 
Betaproteobacteria and may share common bacteriophages (Fujiwara et al., 2008).  
Searching for core promoter-like sequences conserved in phages T3, T7, or SP6 in the RSB1 
intergenic regions did not reveal any significant homologies. Instead, a set of sequence 
elements (possible promoter elements) consisting of a GC-rich stretch and TTGT, TCTGG, 
and CGGGCAC motifs preceding an AG-rich Shine-Dalgarno sequence were found. The 
activity of transcriptional promoters of such elements on the RSB1 genome was 
demonstrated using a green fluorescent protein (GFP)-expressing single-copy plasmid, 
Bacteriophages of Ralstonia solanacearum: 




T7-like arrangements of 47 ORFs identified on the RSB1 genome (43,079 bp, Kawasaki et al., 2009) and 
50 ORFs on the RSB2 genome are compared with those of E. coli T7 (39,937 bp, NC_00164) and 
Pseudomonas aeruginosa KMV (42,519 bp, AJ50558)(A). According to the T7-gene-organaization, ORFs 
are grouped into three classes (Kawasaki et al., 2009). Corresponding major ORFs are connected by 
shading (DNAL, DNA ligase; DNAP, DNA polymerase; MCP, major capsid protein; LYS lysozyme). P2-
like arrangement of 51 ORFs on the RSA1 genome (38,760 bp, Fujiwara et al., 2008) and 52 ORFs on 
RSX (40,713 bp), a prophage found on the genome of strain GMI1000 (Salanoubat et al., 2002). Shading 
indicates similar regions among the phages (B). In the map of RSL1 genome (231,255), a total of 343 
ORFs are grouped into 4 genomic regions according to their clustering with the same orientation (C). 
Fig. 3. Genomic organization of RSB1-related phages (A), RSA1-related phages (B), and 
RSL1 (C). 
pRSS12 (Kawasaki et al., 2007b). A switch from host RNAP to RSB1 RNAP occurs between 
75 min p.i. and 90 min p.i., and the late stages of RSB1 replication are independent of 
rifampin. A phage, RSB3, from our phage collection also showed a similar gene 
arrangement to RSB1, but its genome size is significantly larger (tentatively 44,242 bp) than 
RSB1 and the nucleotide sequence similarity are entirely marginal between the two phages. 
The host range of RSB3 is narrower (5 of 15 strains tested are susceptible). Another phage 
in our collection, which was obtained from a potato field, gave large clear plaques with 10 of 
15 strains tested as hosts. Electron microscopy revealed a typical podoviral morphology of 
this phage (designated as RSB2), an icosahedral head of 45 ± 5 nm in diameter, and a short 
tail of 12.5 ± 2 nm in length. The RSB2 genome is linear double-stranded DNA of 40,411 bp 
and includes direct terminal repeats of 214 bp (accession no. AB597179). The G + C content 
of the genome is 61.7%. A total of 50 ORFs were identified along the genome. Homology 
searches through the databases revealed a general organization of this phage similar to T7-
like phages, consisting of three gene classes; Class I (ORF1-ORF21), Class II (ORF22-ORF34), 
and Class III (ORF35-ORF50) (Fig. 3A). In contrast to RSB1, the gene for RNAP associated 
with dnal (encoding DNAL) is located within Class I. The position of lys (encoding 





Searching for core promoter-like sequences conserved in phages T3, T7, or SP6 in the RSB2 
intergenic region identified 14 elements with a consensus sequence 5’ 
ATTAACCCACACTRYAGGARRRS. The actual activity of the transcriptional promoters of 
some of these elements was demonstrated using GFP-expressing single-copy plasmid, 
pRSS12 (Kawasaki et al., unpublished data).  
In early studies to control R. solanacearum, a few bacteriophages were isolated and their 
physical and physiological properties were partially characterized. The virulent phage 
P4282, and related phages, have a polyhedral head (69 nm in diameter) and a short tail (20 
nm in length) (Tanaka et al., 1990), and contain a 39.3-kbp dsDNA genome (Ozawa et al., 
2001), giving characteristic features of podoviruses. Another phage, PK-101, was isolated 
from soil, and characterized to have a linear 35-kbp dsDNA genome (Toyoda et al., 1991). 
The morphological feature of this phage is unknown. Both of these phages show very 
narrow host ranges and infect only a few strains of R. solanacearum. A recently isolated 
phage, RSB4 showed a typical podoviral morphology by electron microscopy. Nucleotide 
sequence of a 40 kbp DNA fragment from the RSB4 genome perfectly accorded with that of 
the P4282 gene encoding bacteriolytic protein (accession no. AB048798) (Ozawa et al., 2001). 
Genomic characterization of this phage is now underway.  
2.4 RSA phages of the Myoviridae 
RSA1 spontaneously appeared from strain MAFF211272 (Yamada et al., 2007). It consists of 
an icosahedral head of 40 ± 5 nm in diameter, a tail of 110 ± 8 nm in length and 3 ± 0.2 nm 
diameter, and a tail sheath (40 ± 6 nm in length and 17 ± 1.5 nm in diameter) located at the 
bottom of the tail (Fig. 1). This generates a racket-frame-like structure that resembles the 
morphology reported for Burkholderia cepacia phage KS5 (Seed and Dennis, 2005; Lynch et 
al., 2010). A tail sheath was often observed attached at the bottom of the tail, but sometimes 
at intermediate position along the tail, suggesting a movable nature of the sheath along the 
tail. Sometimes, structures resembling the tail sheath were observed connected in a chain. 
RSA1 has a 38,760-bp dsDNA genome (65.3% G + C) with a 19-bp 5’-extruding cohesive 
end (cos). The genome contains 51 open reading frames (accession no. AB276040, Fujiwara 
et al., 2008). Two-thirds of the RSA1 genomic region on the left side encodes the phage 
structural modules, which are very similar to those of coliphage P2 and P2-like phages (Fig. 
3B). Genes for DNA replication, host lysis, and regulatory functions have been identified on 
the genome, but there are no apparent pathogenesis-related genes. A late-expression 
promoter sequence motif (Ogr-binding sequence) was predicted for the RSA1 genes as 5’ 
TGTTGT-(X)13-ACAACA. It is interesting to compare this sequence with that identified for 
the P2 family members as TGT-(N)12-ACA (Julien & Calendar, 1995). The entire genomic 
sequence of RSA1 showed significant similarity to the genomes of Burkholderia pseudomallei 
phage 52237 (accession no. DQ087285) and Pseudomonas aeruginosa phage CTX (accession 
no. AB008550, Nakayama et al., 1999). Extended comparison of the RSA1 sequence with 
these phage sequences by the matrix plot method revealed characteristic features of the 
phage gene organization: the sequence homology was broken by small AT-islands 
(designated R-regions). One such region (R2) on the RSA1 DNA contained an ORF (ORF34) 
showing 100% amino acid sequence identity with transposase ISRSO15, which was found in 
the chromosomal DNA (positions 2,780,153 to 2,781,370; accession no. AL646070) as well as 
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the megaplasmid DNA (positions 111,895 to 113,185; accession no. AL646085) of R. 
solanacearum GMI1000. ORF34 is on an IS of 1,319 bp with a terminal repeat of seven A 
residues. These regions might have been horizontally transferred and been serving as anchor 
points for genome rearrangements. RSA1 uses the lipopolysaccharide core as a receptor site 
on the cell surface and requires Ca2+ ions to bind to the receptor. Its lifecycle takes 60–90 min 
for one round and the burst size is approximately 200 pfu/cell. Like P2 phages, RSA1 
encodes an ORF for integrase and attP, suggesting a lysogenic cycle. In fact, a RSA1-like 
phage was found to be integrated into at least three different strains of R. solanacearum. In 
addition, the chromosomal integration site (attB) was identified as the 3’ portion (45 bases) of 
the arginine tRNA (CCG) gene (Fujiwara et al., 2008). However, �RSA1 can also infect strains 
that contain a lysogenized RSA1-like phage; all 18 strains of R. solanacearum tested were 
susceptible to this phage. Therefore, RSA1 itself may be a kind of immunity-deficient or 
super-infective phage. This property of RSA1 is very important for avoiding the problem of 
lysogenization by a therapeutic phage, and thus avoids passive import of pathogenicity-
related genes (Merril et al., 2003; Brussow 2005). Compared to cells (strain M4S) without 
RSA1 sequences, the lysogenic cells (newly established with RSA1-original phage) showed 
no obvious changes in growth rate, cell morphology, colony morphology, pigmentation, or 
extracellular polysaccharide production in culture. No obvious enhanced pathogenicity has 
been observed so far with RSA1-related lysogenic cells by plant virulence assays in tobacco 
plants. It is interesting to note that a prophage previously detected on the genome of R. 
solanacearum strain GMI1000 (Salanoubat et al., 2002) was characterized as a RSA1-related 
prophage (RSX) in the light of the RSA1 genome sequence. The exact size of RSX is 40,713 
bp, and its ORFs share very high amino acid identity with their RSA1 counterparts. The RSX 
attachment site corresponds to a 15-base 3’ portion of the serine tRNA (GGA).  
2.5 RSL phages of the Myoviridae 
RSL1 is a large-tailed phage (jumbo phage) belonging to the family Myoviridae, and was 
isolated from crop fields (Yamada et al., 2007; Yamada et al., 2010). Phage particles consist of 
a 125 nm diameter icosahedral head and a long contractile tail that is 110 nm long and 22.5 
nm wide (Fig. 3C). RSL1 gives clear plaques with various strains of race 1 and 3 and biovar 
3 and 4; 17 of 18 strains tested were susceptible to this phage. The infection cycle of RSL1 
with strain M4S as a host has an eclipse phase of 90 min and a latent period of 150 min, 
followed by a rise period of 90 min (Yamada et al., 2010). The average burst size is 80-90 pfu 
per infected cell. One characteristic feature of RSL1 infection is a lasting host killing effect. 
The large�RSL1 dsDNA genome of 231,255 bp (G + C = 58.2%) contains 343 ORFs and 
three tRNA genes (including one pseudogene) (accession no. AB366653). According to the 
orientation of the ORFs, four major genomic regions are apparent (Fig. 3C): The largest, 
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58.4%), which encodes 102 ORFs mostly located in a counterclockwise orientation. ORFs are 
generally tightly organized, with little intergenic space. In many cases, the stop codon of an 
ORF was found to overlap the start codon of the following ORF. RSL1 ORFs showed no 





Searching for core promoter-like sequences conserved in phages T3, T7, or SP6 in the RSB2 
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the megaplasmid DNA (positions 111,895 to 113,185; accession no. AL646085) of R. 
solanacearum GMI1000. ORF34 is on an IS of 1,319 bp with a terminal repeat of seven A 
residues. These regions might have been horizontally transferred and been serving as anchor 
points for genome rearrangements. RSA1 uses the lipopolysaccharide core as a receptor site 
on the cell surface and requires Ca2+ ions to bind to the receptor. Its lifecycle takes 60–90 min 
for one round and the burst size is approximately 200 pfu/cell. Like P2 phages, RSA1 
encodes an ORF for integrase and attP, suggesting a lysogenic cycle. In fact, a RSA1-like 
phage was found to be integrated into at least three different strains of R. solanacearum. In 
addition, the chromosomal integration site (attB) was identified as the 3’ portion (45 bases) of 
the arginine tRNA (CCG) gene (Fujiwara et al., 2008). However, �RSA1 can also infect strains 
that contain a lysogenized RSA1-like phage; all 18 strains of R. solanacearum tested were 
susceptible to this phage. Therefore, RSA1 itself may be a kind of immunity-deficient or 
super-infective phage. This property of RSA1 is very important for avoiding the problem of 
lysogenization by a therapeutic phage, and thus avoids passive import of pathogenicity-
related genes (Merril et al., 2003; Brussow 2005). Compared to cells (strain M4S) without 
RSA1 sequences, the lysogenic cells (newly established with RSA1-original phage) showed 
no obvious changes in growth rate, cell morphology, colony morphology, pigmentation, or 
extracellular polysaccharide production in culture. No obvious enhanced pathogenicity has 
been observed so far with RSA1-related lysogenic cells by plant virulence assays in tobacco 
plants. It is interesting to note that a prophage previously detected on the genome of R. 
solanacearum strain GMI1000 (Salanoubat et al., 2002) was characterized as a RSA1-related 
prophage (RSX) in the light of the RSA1 genome sequence. The exact size of RSX is 40,713 
bp, and its ORFs share very high amino acid identity with their RSA1 counterparts. The RSX 
attachment site corresponds to a 15-base 3’ portion of the serine tRNA (GGA).  
2.5 RSL phages of the Myoviridae 
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proportion of ORFans (i.e. genes lacking detectable homologs in the current databases) was 
very high; of the 343 ORFs, 251 ORFs (73%) showed no significant sequence similarity in the 
publicly available databases (E-value < 0.001). Of 83 homologs in UniProt or in the NCBI 
environmental sequence collection, 53 ORFs (15.5%) showed best sequence similarities in 
bacteria, 10 ORFs (2.9%) in viruses/plasmids, one ORF (0.3%) in eukaryotes, one ORF (0.3%) 
in archaea, and 18 ORFs (5.3%) in environmental sequences. It is notable that only a few 
RSL1 ORFs were similar to sequences in R. solanacearum spp., given that the genomic 
sequences are available for strain GMI1000 and UW551. Viruses/plasmid best hits include 
five homologs in myoviruses, three in siphoviruses, one in a eukaryotic virus (Mimivirus), 
and one in a plasmid. These results suggest that RSL1 may have access to the gene pools of 
largely different families of bacteria and viruses. At present, putative functions have been 
assigned to 47 RSL1 ORFs by examination of homologous search results, including 
enzymes for the salvage pathway of NAD+ and for the biosynthetic pathways of lipid, 
carbohydrates, and homospermidine in addition to proteins required for phage 
replication (Yamada et al., 2010). A chitinase-like protein was found to be a potential lysis 
enzyme. Expression patterns of these RSL1 genes were characterized using a DNA 
microarray during the infection cycle. Most genes showing early expression (10-30 min 
p.i.) and later repression by 90 min p.i. (designated as early-intermediate genes) were 
confined within region I. In contrast, genes that showed increased expression during 30-
90 min p.i. (designated as intermediate-late genes) are mostly concentrated around both 
extremities of region I, as well as in the entire region IV. The intermediate-late genes also 
included several genes located in region II and region III. Putative genes for phage 
structural proteins are intermediate-late genes. Genes involved in DNA metabolism are 
also intermediate-late, except for ORF065, which encodes NAD+-dependent DNA ligase. 
Putative promoter elements for these differential genes’ expressions have been identified 
(Yamada et al., 2010). 
Several myoviruses are known to have large genomes over 200 kbp, and are designated as 
“jumbo phages” (Hendrix, 2009). These include Pseudomonas aeruginosa phage KZ (280 kbp, 
Mesyanzhinov et al., 2002), EL (211 kbp, Herveldt et al., 2005), and PA3 (309 kbp, Monson 
et al., 2011), Vibrio parahaemolyticus phage KVP40 (245 kbp, Miller et al., 2003), 
Stenotrophomonas maltophila phage SMA5 (250 kbp, Chang et al., 2005), and Yersinia 
enterocolitica phage R1-37 (270 kbp, Kiljunen et al., 2005). Jumbo phages were also reported 
for Sinorhizobium meliloti (phage N3, 207 kbp, Martin and Long, 1984) and Bacillus 
megaterium (phage G, 670 kbp, Sun and Serwer, 1997). According to their large genomes, 
they contain many genes, most of which are unknown and might function in the interaction 
with their hosts. Jumbo phages have only recently been identified and there is too little 
information about them to discuss their interrelationships. Currently, only a handful of 
jumbo phages have been isolated. Jumbo phages might have been missed in ordinary 
screenings because of their large size: they diffuse too slowly in the top agar gels typically 
used to plaque phages. Reducing the top agar concentration from 0.7-0.8% to 0.45-0.5% 
allowed us to plaque RSL1. A similar observation was reported by Serwer et al. (2007) for 
Bacillus phage G. It is very likely that more jumbo phages will be isolated by adapting these 
plaquing conditions. RSL1 is highly virulent, and shows no sign of genomic integration, 
both of these properties making it suitable for use as a biocontrol agent. Two specific 
advantages of this phage are its abundant yields (1011 pfu/ml) and easy purification using 
only centrifugation (15,000 × g) from routine cultures.  
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2.6 RSC phages of the Siphoviridae 
RSC1 spontaneously appeared from a culture of strain MAFF301558. It gave turbid plaques 
with 15 of 18 strains tested as host (Table 1). Genomic Southern blot hybridization showed 
that two resistant strains, MAFF211271 and MAFF301558, are lysogenic with RSC1 and that 
RSC1 was easily induced by UV irradiation. These strains were isolated from wilted potato 
and classified as strains of race 3, biovar N2, and phylotype IV. Electron microscopic 
observation of negatively stained RSC1 particles revealed an icosahedral head of 48 ± 3 nm 
in diameter, a non-contractile tail of 220 ± 15 nm in length, and tail fibers of 30 ± 2 nm, 
giving a -like morphology (Fig. 1). RSC1 gave a single 40 kbp DNA band by pulsed-field 
gel electrophoresis, indicating a 40 kbp linear DNA as the genome. Partially determined 
nucleotide sequences of RSC1 DNA fragments showed high homology with prophage 
sequences of R. solanacesrum strains; for example, RSc0863 and RSc0875 of strain GMI1000, 
RSMK00228 of strain Molk2, and RSIPO_02158 of strain IPO1609. Effects of lysogenic 
integration of RSC1 on the host strain are largely unknown.  
2.7 Other prophages 
Recent genomic analyses of several strains of R. solanacearum belonging to different races, 
biovars, and/or phylotypes revealed many strain specific gene clusters (Remenant et al., 
2010). Some of these variable regions contained phage-like sequences. There are five phage-
related sequences in the chromosome of strain GMI1000 (race 1, biovar 3, and phylotype I), 
two of which corresponded to RSX (RSc1896-RSc1948) and RSC1-like sequences (around 
RSc0863-RSc0967) (accession no. AL646052), as described above. Another region around 
RSc1680-RSc1696 resembles -like phage HK022 and Bacillus subtilis temperate phage 105. 
In the chromosome of strain UW551 (race 3, biovar 2, and phylotype II), a cluster of 38 
probable prophage genes (RRSL02400-RRSL02437) is remarkable (accession no. 
NZ_AAKL00000000). This gene cluster was present in all race 3/biovar 2 (R3B2) strains 
tested, from a wide variety of geographical sources (Gabriel et al., 2006). As described above, 
RSM4 is also a filamentous prophage of the RSM group. There are at least two possible 
prophage regions in the chromosome of strain IPO1609 (race 3, biovar 2, and phylotype IIB); 
the region around RSIPO02143-RSIPO002171 (resembling RSC1) and that around 
RSIPO04993-RSIPO05020 (accession no. CU694438). Four regions of the chromosome of strain 
Molk2 (race 2, biovar 1, and phylotype IIB) also contained prophage sequences (accession no. 
CU644397); regions around RSMK00219-RSMK00259, RSMK01452-RSMK01464 (105-like), 
RSMK01633-RSMK01646 (HK022-like). The recently reported genomes of three other strains, 
belonging to different phylotypes, contained 2-4 prophage sequences, including strains 
CMR15 (phylotype III, accession no. FP885895), PSI07 (phylotype IV, accession no. FP885906), 
and CFBP2957 (phylotype IIA, accession no. FP885897).  
It is becoming increasingly clear that phages play important roles in the evolution and 
virulence of many pathogenic bacteria (Canchaya et al., 2003; Brussow et al., 2004). Phages 
are important vehicles for horizontal gene exchange between different bacterial species, as 
well as between different strains of the same species. When a temperate phage integrates 
into the host genome (lysogenization), it may affect the host cells in several ways: (i) 
disrupting host genes, (ii) changing the expression levels of host genes, (iii) serving as 
recombinational hot spots, (iv) protection from lytic infection, (v) lysis of the cells by 
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genes). Such lysogenic conversion genes may change the host phenotype drastically. Such 
lysogenic conversion genes (cargo genes) are sometimes called “morons”. Morons are not 
required for the phage life cycle. Instead, many morons from prophages in pathogenic 
bacteria encode proven or suspected virulence factors. Therefore, prophages, especially 
those found commonly in a certain group of R. solanacearum, are vital for understanding the 
specific virulence of such a group. Through identification and characterization of lysogenic 
conversion genes, pathogenesis mechanism of R. solanacearum will be clarified. 
3. Phage prophylaxis and treatment of bacterial wilt 
For phage biocontrol or therapy, only lytic phages are usually used, thereby avoiding the 
problem of lysogeny. A phage cocktail has been recommended to prevent the problem of 
resistance, which contains several phages with different host specificities, different 
replication mechanisms, and/or different infection cycles (Gill and Abedon, 2003; Jones et 
al., 2007). Fujiwara et al. (2011) used three lytic phages, RSA1, RSB1, and RSL, for 
biocontrol of tomato bacterial wilt caused by R. solanacearum. Although RSA1 and RSB1 
infection resulted in quick lysis of host cells, multi-resistant cells arose approximately 30 h 
post infection. By contrast, cells infected solely with RSL1 kept a steady low level of cell 
density for a long period. Under laboratory culture conditions, when host R. solanacearum 
cells were quickly lysed by treatment with RSA1 or RSB1, resistant cells (presumably pre-
existing in the population at a very low frequency) were raised after 30 h post infection (pi). 
Killing susceptible cells, the majority of the cell population, by phages may allow minor cells 
to predominate in subsequent generations. The recovering cells were somehow resistant to 
both RSA1 and RSB1: mixed treatment with these phages resulted in the same killing and 
recovering pattern of bacterial cells as did sole treatment. The resistance mechanisms used 
by these cells are unknown. A cocktail containing three phages, RSA1, RSB1, and RSL1, 
also failed to stably prevent bacterial growth. By contrast, cells infected solely with RSL1 
kept a steady low level of cell density for a long period. Pretreatment of tomato seedlings 
with RSL1 drastically limited the penetration, growth, and movement of inoculated 
bacterial cells. Treated plants survived for as long as four months. Either RSA1 or RSB1, 
which kills cells quickly, could not bring about similar plant-protecting effects. Using these 
observations, Fujiwara et al. (2011) proposed an alternative phage biocontrol method using a 
unique phage, such as RSL1, instead of a phage cocktail containing highly lytic phages. 
With this method, bacterial cells are not killed completely, but a sustainable state of phage-
bacteria coexistence (with a low level of bacterial population) is maintained. 
Phages are utilized for controlling plant pathogens either in the rhizosphere or phylosphere. 
Application of phages to the phylosphere, namely directly to aerial tissues of the plant, must 
involve a serious phage stability problem (Jones et al., 2007). Field and laboratory studies 
have demonstrated that phages are inactivated rapidly by exposure to sunlight (UV-A and 
UV-B, 280-400 nm), high temperature, high and low pH, oxidative conditions, and washing-
down by water (Ignoffo and Garcia, 1992, Iriarte et al., 2007). However, in the case of 
bacterial wilt, phages for biocontrol can be applied to the rhizosphere. Sunlight UV, the 
most destructive environmental factor, and oxidative inactivation, can be relieved in this 
case. RSL1 was shown to be relatively stable in soil conditions, especially at higher 
temperatures (bacterial wilt occurs at higher temperatures). Prolonged disease control may 
be possible if RSL1 is applied to plants at the seedling stage. 
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There is another method of phage biocontrol of bacterial wilt. As described above, 
filamentous RSM phages cause loss of virulence in the infected host cells. Infection with 
RSM phages does not cause host cell lysis, but establishes a persistent association between 
the host and phage, releasing phage particles from the growing and dividing host cells. 
Therefore, these phages are also good candidates for bacterial wilt biocontrol agents. In 
addition, RSM-infected bacterial cells protect their pre-treated tomato plants from a second 
infection of virulent cells (Addy et al., unpublished data). Once plants are treated with 
RSM-infected cells, the prevention effect lasts for up to two months. Two months after 
treatment with RSM-infected cells, the second infected virulent cells could not cause 
wilting symptoms. Using a mixture of RSM1 and RSM3 seems to be especially effective, 
because the two phages have different host ranges (complementary to each other) and most 
strains of different races and/or biovars are expected to be susceptible to either of the two 
phages (Askora et al., 2009). Furthermore, plants inoculated with RSM-infected R. 
solanacearum cells showed stable resistance to virulent bacterial cells inoculated thereafter. 
This resistance was induced as early as one day post inoculation and lasted for up to two 
months. Therefore, RSM phages also give an additional possibility to prevent bacterial wilt, 
namely utilization as “vaccine against bacterial wilt of many crops”.  
An additional potential application is the use of phage genes or gene products as 
therapeutic agents (Loesnner, 2005; Hermoso et al., 2007; Fischetti, 2005). Ozawa et al. (2001) 
isolated the bacteriolytic gene from a R. solanacearum phage P4282. The 71 kDa phage 
protein consists of 687 amino acids and showed strong bacteriolytic activities against several 
field-isolated strains of R. solanacearum. Although the biochemical and enzymatic nature of 
this protein is not fully characterized, homologous sequences are integrated in several 
bacterial genomes (database accession no. A1H7Z4 and A4JD43). This phage gene was 
suggested to be useful for generating transgenic plants that are resistant to bacterial wilt 
(Ozawa et al., 2001). Phage-encoded endolysin, which disrupts the peptidoglycan matrix of 
the bacterial cell wall, and phage-encoded holins, which permeabilize the bacterial 
membrane, could also be effective against bacterial pathogens. Practically, these phage 
proteins are probably not effective for field use, but could have applications in local plant 
therapy or disease prevention. 
4. Detection of R. solanacearum cells in plants and soil and diagnosis of 
bacterial wilt 
Effective bacterial diagnosis is always required for successful biocontrol. A variety of 
methods have been developed to detect R. solanacearum, including typical bioassays, 
dilution plating on semi-selective media, fatty-acid analysis, immunofluorescence 
microscopy, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reaction 
(PCR) (Janse,1988; Seal et al. 1993; Elphinstone et al., 1996; Van der Wolf et al., 2000; Weller 
et al., 2000; Priou et al., 2006; Kumar et al., 2002). However, none of these methods can 
reliably detect the pathogen both in plants and soils, and in soil-related habitats. Recently, 
interest in the use of phages for direct detection and identification of bacterial pathogens has 
rapidly increased. A number of phage-based bacterial diagnoses exist: (i) Lysis of bacterial 
cells by specific phages results in release of intracellular molecules that may be assayed 
using various methods. For example, ATP release can be easily detected by the use of firefly 





genes). Such lysogenic conversion genes may change the host phenotype drastically. Such 
lysogenic conversion genes (cargo genes) are sometimes called “morons”. Morons are not 
required for the phage life cycle. Instead, many morons from prophages in pathogenic 
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bacteria coexistence (with a low level of bacterial population) is maintained. 
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UV-B, 280-400 nm), high temperature, high and low pH, oxidative conditions, and washing-
down by water (Ignoffo and Garcia, 1992, Iriarte et al., 2007). However, in the case of 
bacterial wilt, phages for biocontrol can be applied to the rhizosphere. Sunlight UV, the 
most destructive environmental factor, and oxidative inactivation, can be relieved in this 
case. RSL1 was shown to be relatively stable in soil conditions, especially at higher 
temperatures (bacterial wilt occurs at higher temperatures). Prolonged disease control may 
be possible if RSL1 is applied to plants at the seedling stage. 
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be monitored by measuring specific enzyme activities released by phage-mediated cell lysis. 
(ii) The phage amplification assay detects the increase in phage particles in target bacterial cells 
after infection (Mole & Maskell, 2001). (iii) The phage-tagging method is another phage-based 
approach for bacterial detection. In this method, which is well established with coliphage M13 
(Smith 1985; Smith 1991), a tag protein, for example green fluorescent protein (GFP), can be 
displayed on the phage particle and may then be detected by several methods, including 
epifluorescence microscopy, flow cytometry, or by a fluorescent plate reader after adsorption 
into host cells (Goodridge et al., 1999). (iv) Reporter phages, defined here as recombinant 
phages expressing reporter genes in host cells after infection, are also used to monitor phage 
infection. A variety of reporter genes are available, such as those encoding GFP and luciferase. 
In the case of R. solanacearum, the filamentous phages RSS1 and RSM1 may be useful tools 
for phage-based diagnoses of bacterial wilt. In general, the genomes of inoviruses (Ff-like 
phages) are organized in a three-module structure in which functionally related genes are 
grouped (Rasched & Oberer, 1986; Model & Russel, 1988). The replication module contains 
the genes encoding rolling-circle DNA replication and the ssDNA binding proteins, gpII, 
gpV, and gpX. The structural module contains genes for the major (gpVIII) and minor (gpIII, 
gpVI, gpVII, and gpIX) coat proteins. Among these, gpIII is the host recognition or 
adsorption protein (Armstrong et al., 1981). The assembly and secretion module contains 
genes gI and gIV for morphogenesis and extrusion of the phage particles. The genome of 
RSS1 is 6,662 nt and encodes 11 ORFs arranged in a generally conserved module structure 
(Kawasaki et al., 2007a). The genomic DNA of RSM1 is a little longer (9,004 nt), and 
encodes 14 ORFs, 12 of which are located on the same strand in a similar manner to RSS1, 
and two of which are in the opposite orientation in the replication module (Kawasaki et al., 
2007a). All strains tested were susceptible to either RSM1 or RSM3. Similar compensating  
host ranges are also detected between RSS1 and RSS2. Selective recognition of the host 
with different types of pili is mediated by the minor coat protein pIII of these phages. When 
the gene for GFP was inserted in the intergenic region (IG) of both RSS1 and RSM1 
genomic DNAs, the resulting phages exhibited strong green fluorescence in phage-infected 
host cells, and each phage caused large plaques to appear on the host bacterial lawn (Fig. 4). 
The efficiency of infection and host specificity of the phages were unchanged (unpublished 
results). These phages can be used as reporter phages to quantify bacterial cell number in 
the natural environment, because they propagate in the host cells, but do not cause death. A  
 
Fig. 4. Green fluorescence emission from plaques of RSS1-GFP-infected R. solanacearum 
cells (right). ND, Not determined. 
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tag protein on RSS1 and RSM1 particles, such as GFP or luciferase, would lead to rapid 
and direct detection of the pathogen. For practical use of this method, the following three 
requirements should be met: (i) a set of phages with different host specificities covering all 
phylotypes of R. solanacearum strains should be prepared; (ii) the intensity of tag-signals 
should be increased; and (iii) an appropriate, simple device for sensitive detection of the tag-
signals should be developed.  
These phages would also be very useful in both basic and applied research for monitoring 
infection of bacterial cells in plant tissues, and for observing bacterial behavior in ecological 
systems. Kawasaki et al. (2007b) obtained mini-replicons from RSS1 and RSM1. pRSS11 is 
a 2.2 kbp-region of RSS1 containing the entire replication module (ORF1-ORF3) and IG 
connected to the Km-cassette (1.5 kbp). pRSM12 is a 3.4 kbp-RSM1 fragment containing 
ORF1, ORF12, and IG connected to the Km cassette (1.5 kbp). Both plasmids are very stably 
maintained in R. solanacearum cells of different races and biovars, even without selective 
pressure. Almost 100% of transformed cells retained the plasmids after cultivation for 100 
generations (12 d) in CPG medium without Km. This stability makes pRSS11 and pRSM12 
valuable vectors for studies on R. solanacearum in natural ecosystems, where selective 
pressure cannot be applied. To demonstrate the usefulness of these plasmids, a GFP-
expressing plasmid (pRSS12, 4.7 kbp) was derived from pRSS11 by connecting the GFP 
gene, and was introduced into various strains of R. solanacearum (Kawasaki et al., 2007b). As 
expected, pRSS12 was stably maintained in all the transformants and expressed strong green 
fluorescence. To monitor cell behavior, pRSS12-transformed cells were infected into tomato 
plants and tobacco BY-2 cells, and were also introduced into soil samples. The strong green 
fluorescence emitted from pRSS12-transformed cells was easily observed in tomato stems, 
petioles, and roots (Kawasaki et al., 2007b; Fujie et al., 2010). Bacterial cells adhered to BY-2 
cell surfaces preferentially by one pole, possibly via pili on the cell surface. These phage-
derived plasmids can serve as an easy-to-use GFP-tagging tool for any given strain of R. 
solanacearum in cytological or field studies. Although there have been several reports on the 
expression of GFP-fused proteins in R. solanacearum cells, all the vectors used were selective-
pressure-dependent (Huynh, 1989; Aldon et al., 2000). Transposons have also been used for 
the constitutive expression of GFP in R. solanacearum cells. Random chromosomal insertion 
of the pAG408 mini-transposon (Suarez et al., 1997) was used to label the wild-type strain 
GMI1000 (Aldon et al., 2000). To monitor the movement of individual cells, and their 
chemotactic behaviors, Tn5-GFP-tagged R. solanacearum strains were examined (Liu et al., 
2001; Yao & Allen, 2006). However, there are intrinsic problems in using transposition 
techniques. Transposon insertion may affect the genetic background of the host cells. The 
GFP expression itself may be affected by the genetic environment around the insertion site 
(position effects). Moreover, under natural environmental conditions with various physical 
and biological stresses, some transposons are unstable, and are easily moved or lost. pRSS12 
is easily introduced by electroporation and is stably maintained in R. solanacearum cells of 
different races and biovars; therefore, it serves as an easy-to-use GFP-tagging tool for any 
given R. solanacearum strain in the wild-type background. By monitoring pRSS12-
transformed cells, the following may be studied in detail: (i) differences in the virulence 
traits among strains; (ii) differences in the resistance level (responses) of plant hosts against 
a given bacterial strain; (iii) effects of environmental factors during establishment of 
infection; and (iv) evaluation of therapeutic effects in the development of new agricultural 





be monitored by measuring specific enzyme activities released by phage-mediated cell lysis. 
(ii) The phage amplification assay detects the increase in phage particles in target bacterial cells 
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genomic DNAs, the resulting phages exhibited strong green fluorescence in phage-infected 
host cells, and each phage caused large plaques to appear on the host bacterial lawn (Fig. 4). 
The efficiency of infection and host specificity of the phages were unchanged (unpublished 
results). These phages can be used as reporter phages to quantify bacterial cell number in 
the natural environment, because they propagate in the host cells, but do not cause death. A  
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tag protein on RSS1 and RSM1 particles, such as GFP or luciferase, would lead to rapid 
and direct detection of the pathogen. For practical use of this method, the following three 
requirements should be met: (i) a set of phages with different host specificities covering all 
phylotypes of R. solanacearum strains should be prepared; (ii) the intensity of tag-signals 
should be increased; and (iii) an appropriate, simple device for sensitive detection of the tag-
signals should be developed.  
These phages would also be very useful in both basic and applied research for monitoring 
infection of bacterial cells in plant tissues, and for observing bacterial behavior in ecological 
systems. Kawasaki et al. (2007b) obtained mini-replicons from RSS1 and RSM1. pRSS11 is 
a 2.2 kbp-region of RSS1 containing the entire replication module (ORF1-ORF3) and IG 
connected to the Km-cassette (1.5 kbp). pRSM12 is a 3.4 kbp-RSM1 fragment containing 
ORF1, ORF12, and IG connected to the Km cassette (1.5 kbp). Both plasmids are very stably 
maintained in R. solanacearum cells of different races and biovars, even without selective 
pressure. Almost 100% of transformed cells retained the plasmids after cultivation for 100 
generations (12 d) in CPG medium without Km. This stability makes pRSS11 and pRSM12 
valuable vectors for studies on R. solanacearum in natural ecosystems, where selective 
pressure cannot be applied. To demonstrate the usefulness of these plasmids, a GFP-
expressing plasmid (pRSS12, 4.7 kbp) was derived from pRSS11 by connecting the GFP 
gene, and was introduced into various strains of R. solanacearum (Kawasaki et al., 2007b). As 
expected, pRSS12 was stably maintained in all the transformants and expressed strong green 
fluorescence. To monitor cell behavior, pRSS12-transformed cells were infected into tomato 
plants and tobacco BY-2 cells, and were also introduced into soil samples. The strong green 
fluorescence emitted from pRSS12-transformed cells was easily observed in tomato stems, 
petioles, and roots (Kawasaki et al., 2007b; Fujie et al., 2010). Bacterial cells adhered to BY-2 
cell surfaces preferentially by one pole, possibly via pili on the cell surface. These phage-
derived plasmids can serve as an easy-to-use GFP-tagging tool for any given strain of R. 
solanacearum in cytological or field studies. Although there have been several reports on the 
expression of GFP-fused proteins in R. solanacearum cells, all the vectors used were selective-
pressure-dependent (Huynh, 1989; Aldon et al., 2000). Transposons have also been used for 
the constitutive expression of GFP in R. solanacearum cells. Random chromosomal insertion 
of the pAG408 mini-transposon (Suarez et al., 1997) was used to label the wild-type strain 
GMI1000 (Aldon et al., 2000). To monitor the movement of individual cells, and their 
chemotactic behaviors, Tn5-GFP-tagged R. solanacearum strains were examined (Liu et al., 
2001; Yao & Allen, 2006). However, there are intrinsic problems in using transposition 
techniques. Transposon insertion may affect the genetic background of the host cells. The 
GFP expression itself may be affected by the genetic environment around the insertion site 
(position effects). Moreover, under natural environmental conditions with various physical 
and biological stresses, some transposons are unstable, and are easily moved or lost. pRSS12 
is easily introduced by electroporation and is stably maintained in R. solanacearum cells of 
different races and biovars; therefore, it serves as an easy-to-use GFP-tagging tool for any 
given R. solanacearum strain in the wild-type background. By monitoring pRSS12-
transformed cells, the following may be studied in detail: (i) differences in the virulence 
traits among strains; (ii) differences in the resistance level (responses) of plant hosts against 
a given bacterial strain; (iii) effects of environmental factors during establishment of 
infection; and (iv) evaluation of therapeutic effects in the development of new agricultural 





5. Phage biocontrol in other phytopathogen systems 
To date, phage-mediated biocontrol of plant pathogens has been successfully attempted in 
several other pathogen–plant systems. Historical applications in this area are described in the 
reviews by Gill and Abedon (2003) and Jones et al., (2007). Effective phage applications have 
been observed in systems using Streptomyces phage to disinfest Streptomyces scabies-infected 
potato seed-tubers (McKenna et al., 2001), in Xanthomonas pruni-associated bacterial spot of 
peaches (Sacchardi et al., 1993; Civerolo & Kiel, 1969; Randhawa & Civerolo, 1986), in 
Xanthomonas leaf bright of onion (Lang et al., 2007), to control soft rot caused by Erwinia spp. 
(Eayre et al., 1990), in fire blight of pear and apple associated with Erwinia amylovora (Gill et al., 
2003; Schnabel et al., 1998; Schnabel, 2001), and using phage Xav to manage bacterial leaf spot 
of mungbean (Borah et al., 2000). Phage biocontrol has also been successfully extended using 
host-range phage mutants (h-mutants) of Xanthomonas to bacterial blight of geraniums caused 
by Xanthomonas hortorum pv. pelargonii (Flaherty et al., 2000) and bacterial spot of tomatoes 
caused by X. perforans (Balogh et al., 2003). Moreover, phages have been used against bacterial 
blotch of mushrooms caused by Pseudomonas tolassii (Munisch & Olivier, 1995).  
6. Future prospects 
To meet increasing food demands, there is a need to reconstruct agricultural systems that are 
much more efficient, economical, sustainable, and free from the problems arising from 
agrichemical use. Phage biocontrol has many advantages: the application is relatively easy; it 
is relatively low cost; it does not disturb larger ecological systems; and it is safe for humans, 
animals, and plants. However, it should be acknowledged that phage biocontrol is not a 
panacea against plant pathogens. Extrapolation of practices from one pathogen-plant system, 
even if fully successful, to other systems may not always be applicable. Several factors can 
influence the success of phage biocontrol: (i) the niche where the target pathogen population 
resides; (ii) stability, decay, and diffusion of phage particles in the applied ecosystems; (iii) 
timing of phage application during the crop-growing cycle; (iv) phage host-range and 
emergence of phage-resistant host derivatives; and (v) the density of target bacteria and 
applied phages. The optimal conditions for the most effective phage biocontrol should be 
established for each pathogen–host system. Furthermore, detailed understanding of the 
properties and behavior of each specific phage-bacterium system will help to optimize phage 
biocontrol. Like an arms race, both phages and their host bacteria have evolved a variety of 
mechanisms to resist each other during their long history of interaction. Such mechanisms can 
be deduced from the genomes of both phages and host bacteria. Genomic information of major 
pathogenic bacterial species is accumulating rapidly, and newly isolated phages are also 
subjects for immediate genomic analysis. Molecular mechanisms deduced from genomic 
information on phage–host interactions, no matter how general or specific, could be useful for 
establishing long-lasting phage biocontrol systems. These include, for example, general 
interactions (Comeau & Krisch, 2007), restriction/antirestriction systems (Tock & Dryden, 
2005; Hoskisson & Smith, 2007), and phage receptor/host adsorption interactions (Goldberg et 
al., 1994; Tetart et al., 1998; Thomassen et al., 2003).  
7. References  
Aldon, D., Brito, B., Boucher, C., & Genin, S. (2000). A bacterial sensor of plant cell contact 
controls the transcriptional induction of Ralstonia solanacearum pathogenicity genes. 
EMBO J., 19, pp. 2304-2314. 
Bacteriophages of Ralstonia solanacearum: 
Their Diversity and Utilization as Biocontrol Agents in Agriculture 
 
133 
Armstrong, J., Perharm, R. N., & Walker, J. E. (1981). Domain structure of bacteriophage fd 
adsorption protein. FEBS Lett., 135, pp. 167-172. 
Askora, A., Kawasaki, T., Usami, S., Fujie, M., & Yamada, T. (2009). Host recognition and 
integration of filamentous phage RSM in the phytopathogen, Ralstonia 
solanacearum. Virology, 384, pp. 69-76. 
Askora, A., Kawasaki, T., Fujie, M., & Yamada, T. (2011). Resolvase-like serine recombinase 
mediates integration/excision in the bacteriophage RSM. J. Biosci. Bioeng., 111, pp. 
109-116. 
Borah, P. K., Jindal, J. K., & Verma, J. P. (2000). Integrated management of bacterial leaf spot 
of mungbean with bacteriophages of Xav and chemicals. J. Mycol. Plant Pathol., 30, 
pp. 19-21. 
Balogh, B., Jones, J. B., Momol, M. T., Olson, S. M., Obradovic, A., King, P., & Kackson, L. E. 
(2003). Improved efficacy of newly formulated bacteriophages for management of 
bacterial spot of tomato. Plant Dis., 87, pp. 949-954. 
Brussow, H. (2005). Phage therapy: the Escherichia coli experience. Microbiology, 151, pp. 
2133-2140. 
Brussow, H., Canchaya, C., & Hardt, W.-D. (2004). Phages and the evolution of bacterial 
pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. 
Biol. Rev., 68, pp. 560-602. 
Buchen-Osmond, C. (2003). Inoviridae. In: ICTVdB-The Universal Virus Database, version 3. A. 
Z. Oracle, (Ed.), ICTVdB Management, The Earth Institute, Biosphere 2 Center, 
Columbia University. 
Buchen-Osmond, C. (2003). Myoviridae. In: ICTVdB-The Universal Virus Database, version 3. 
A. Z. Oracle, (Ed.), ICTVdB Management, The Earth Institute, Biosphere 2 Center, 
Columbia University.  
Canchaya, C., Proux, C., Fournous, G., Bruttin, A., & Brussow, H. (2003). Prophage 
genomics. Microbiol. Mol. Biol. Rev., 67, pp. 238-276. 
Carnoy, C. & Roten, C.-A. (2009). The dif/Xer recombination systems in Proteobacteria. 
PLoS ONE, 4. Issue 9, e6531.  
Casjens, S. (2003). Prophages and bacterial genomics: what have we learned so far? Mol. 
Microbiol., 49, pp. 277-300. 
Chang, H.-C., Chen, C.-R., Lin, J.-W., Shen, G.-H., Chang, K.-M., Tseng, Y.-H., & Weng, S.-F., 
(2005). Isolation and characterization of novel giant Stenotrophomonas maltophila 
phage SMA5. Appl. Environ. Microbiol., 71, pp. 1387-1393. 
Civerolo, E. L., & Kiel, H. L. (1969). Inhibition of bacterial spot of peach foliage by 
Xanthomonas pruni bacteriophage. Phytopathology, 59, pp. 1966-1967. 
Comeau, A. M., & Krisch, H. M. (2007). War is peace- dispatches from the bacterial and 
phage killing fields. Curr. Opin. Microbiol., 8, pp. 488-494. 
Davis, B. M., Lawson, E. H., Sandkvist, M., Ali, A., Sozhamannan, S., & Waldor, M. K. 
(2000). Convergence of the secretory pathways for cholera toxin and the 
filamentous phage, CTX. Science, 288, pp. 333-335. 
Dunn, J. J., & Studier, F. W. (1983). Complete nucleotide sequence of bacteriophage T7 DNA 
and the locations of T7 genetic elements. J. Mol. Biol., 166, pp. 477-535. 
Eayre, C. G., Concelmo, D. E., & Bartz, J. A. (1990). Control of soft rot Erwinia with 





5. Phage biocontrol in other phytopathogen systems 
To date, phage-mediated biocontrol of plant pathogens has been successfully attempted in 
several other pathogen–plant systems. Historical applications in this area are described in the 
reviews by Gill and Abedon (2003) and Jones et al., (2007). Effective phage applications have 
been observed in systems using Streptomyces phage to disinfest Streptomyces scabies-infected 
potato seed-tubers (McKenna et al., 2001), in Xanthomonas pruni-associated bacterial spot of 
peaches (Sacchardi et al., 1993; Civerolo & Kiel, 1969; Randhawa & Civerolo, 1986), in 
Xanthomonas leaf bright of onion (Lang et al., 2007), to control soft rot caused by Erwinia spp. 
(Eayre et al., 1990), in fire blight of pear and apple associated with Erwinia amylovora (Gill et al., 
2003; Schnabel et al., 1998; Schnabel, 2001), and using phage Xav to manage bacterial leaf spot 
of mungbean (Borah et al., 2000). Phage biocontrol has also been successfully extended using 
host-range phage mutants (h-mutants) of Xanthomonas to bacterial blight of geraniums caused 
by Xanthomonas hortorum pv. pelargonii (Flaherty et al., 2000) and bacterial spot of tomatoes 
caused by X. perforans (Balogh et al., 2003). Moreover, phages have been used against bacterial 
blotch of mushrooms caused by Pseudomonas tolassii (Munisch & Olivier, 1995).  
6. Future prospects 
To meet increasing food demands, there is a need to reconstruct agricultural systems that are 
much more efficient, economical, sustainable, and free from the problems arising from 
agrichemical use. Phage biocontrol has many advantages: the application is relatively easy; it 
is relatively low cost; it does not disturb larger ecological systems; and it is safe for humans, 
animals, and plants. However, it should be acknowledged that phage biocontrol is not a 
panacea against plant pathogens. Extrapolation of practices from one pathogen-plant system, 
even if fully successful, to other systems may not always be applicable. Several factors can 
influence the success of phage biocontrol: (i) the niche where the target pathogen population 
resides; (ii) stability, decay, and diffusion of phage particles in the applied ecosystems; (iii) 
timing of phage application during the crop-growing cycle; (iv) phage host-range and 
emergence of phage-resistant host derivatives; and (v) the density of target bacteria and 
applied phages. The optimal conditions for the most effective phage biocontrol should be 
established for each pathogen–host system. Furthermore, detailed understanding of the 
properties and behavior of each specific phage-bacterium system will help to optimize phage 
biocontrol. Like an arms race, both phages and their host bacteria have evolved a variety of 
mechanisms to resist each other during their long history of interaction. Such mechanisms can 
be deduced from the genomes of both phages and host bacteria. Genomic information of major 
pathogenic bacterial species is accumulating rapidly, and newly isolated phages are also 
subjects for immediate genomic analysis. Molecular mechanisms deduced from genomic 
information on phage–host interactions, no matter how general or specific, could be useful for 
establishing long-lasting phage biocontrol systems. These include, for example, general 
interactions (Comeau & Krisch, 2007), restriction/antirestriction systems (Tock & Dryden, 
2005; Hoskisson & Smith, 2007), and phage receptor/host adsorption interactions (Goldberg et 
al., 1994; Tetart et al., 1998; Thomassen et al., 2003).  
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1. Introduction 
For more than half a century, the doctors and clinicians have been relying primarily on 
antibiotics to treat infectious diseases caused by pathogenic bacteria. However, the 
emergence of bacterial resistance to antibiotics following widespread clinical, veterinary, 
and animal or agricultural usage has made antibiotics less and less effective (Fischetti, 2008; 
Perisien et al., 2008). These days scientists are now facing the threat of superbugs, i.e. 
pathogenic bacteria resistant to most or all available antibiotics (Livemore, 2004; Fischetti, 
2006). During the last 30 years, no new classes of antibiotics have been found, even with the 
help of modern biotechnology such as genetic engineering. Pharmaceutical companies have 
mainly focused on the development of new products derived from the known classes of 
antibiotics (Carlton, 1999; Sulakvelidze et al., 2001) which is a cause of major concern. Thus, 
exploring alternative approaches to develop antibacterial products is also a worthwhile task, 
and re-examining the potential of promising older methods might be of value. One of the 
possible replacements for antibiotics is the use of bacteriophages or simply phages as 
antimicrobial agents (Shasha et al., 2004; Vinodkumar et al., 2008). Phage therapy involves 
the use of lytic phages for the treatment of bacterial infections, especially those caused by 
antibiotic resistant bacteria. In general, there are two major types of phages, lytic and 
lysogenic. Only the lytic phages (also known as virulent phages) are a good choice for 
developing therapeutic phage preparations (Sandeep, 2006; Borysowski and Gorski, 2008). 
The bactericidal ability of phages has been used to treat human infections for years as a 
complement or alternative to antibiotic therapy (Alisky et al., 1998; Matsuzaki et al., 2005; 
Kysela & Turner, 2007). Bacteriophages, nature's tiniest viruses and it is estimated that there 
are about 1031 phages on earth making viruses the most abundant life form on earth 
(Ashelford et al., 2000; Hendrix, 2002; Dabrowska et al., 2005). Bacteriophages not only help 
in the treatments of bacterial infections in animals and human beings but also used in birds, 
fishes, plants, food material and biofilm eradication (Flaherty et al., 2000; Goode et al., 2003; 
Leverentz et al., 2003; Park & Nakai, 2003; Curtin & Donlan, 2006). 
2. Benefits of phage therapy over antibiotics 
Phages appear to be better therapeutic agents as they have several advantages over 
traditional antibiotics (Pirisi, 2000; Sulakvelidze et al., 2001; Matsuzaki et al., 2005). Majority 
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1. Introduction 
For more than half a century, the doctors and clinicians have been relying primarily on 
antibiotics to treat infectious diseases caused by pathogenic bacteria. However, the 
emergence of bacterial resistance to antibiotics following widespread clinical, veterinary, 
and animal or agricultural usage has made antibiotics less and less effective (Fischetti, 2008; 
Perisien et al., 2008). These days scientists are now facing the threat of superbugs, i.e. 
pathogenic bacteria resistant to most or all available antibiotics (Livemore, 2004; Fischetti, 
2006). During the last 30 years, no new classes of antibiotics have been found, even with the 
help of modern biotechnology such as genetic engineering. Pharmaceutical companies have 
mainly focused on the development of new products derived from the known classes of 
antibiotics (Carlton, 1999; Sulakvelidze et al., 2001) which is a cause of major concern. Thus, 
exploring alternative approaches to develop antibacterial products is also a worthwhile task, 
and re-examining the potential of promising older methods might be of value. One of the 
possible replacements for antibiotics is the use of bacteriophages or simply phages as 
antimicrobial agents (Shasha et al., 2004; Vinodkumar et al., 2008). Phage therapy involves 
the use of lytic phages for the treatment of bacterial infections, especially those caused by 
antibiotic resistant bacteria. In general, there are two major types of phages, lytic and 
lysogenic. Only the lytic phages (also known as virulent phages) are a good choice for 
developing therapeutic phage preparations (Sandeep, 2006; Borysowski and Gorski, 2008). 
The bactericidal ability of phages has been used to treat human infections for years as a 
complement or alternative to antibiotic therapy (Alisky et al., 1998; Matsuzaki et al., 2005; 
Kysela & Turner, 2007). Bacteriophages, nature's tiniest viruses and it is estimated that there 
are about 1031 phages on earth making viruses the most abundant life form on earth 
(Ashelford et al., 2000; Hendrix, 2002; Dabrowska et al., 2005). Bacteriophages not only help 
in the treatments of bacterial infections in animals and human beings but also used in birds, 
fishes, plants, food material and biofilm eradication (Flaherty et al., 2000; Goode et al., 2003; 
Leverentz et al., 2003; Park & Nakai, 2003; Curtin & Donlan, 2006). 
2. Benefits of phage therapy over antibiotics 
Phages appear to be better therapeutic agents as they have several advantages over 
traditional antibiotics (Pirisi, 2000; Sulakvelidze et al., 2001; Matsuzaki et al., 2005). Majority 




Phages are highly effective in killing their 
targeted bacteria i.e., their action is 
bactericidal 
Some antibiotics are bacteriostatic, i.e., they 
inhibit the growth of bacteria, rather than 
killing them (e.g., chloramphenicol). 
Production is simple and cheap. Production is complex and expensive. 
Phages are an ‘intelligent’ drug. They 
multiply at the site of the infection until 
there are no more bacteria. Then they are 
excreted.  
They are metabolized and eliminated from 
the body and do not necessarily concentrate 
at the site of infection. 
The pharmacokinetics of bacteriophage 
therapy is such that the initial dose 
increases exponentially if the susceptible 
bacterial host is available. In such cases, 
there is no need to administer the phages 
repeatedly. 
Repeated doses of antibiotic is required to 
cure the bacterial disease. 
The high selectivity/specificity of 
bacteriophages permits the targeting of 
specific pathogens, without affecting 
desirable bacterial flora which means that 
phages are unlikely to affect the 
“colonization pressure" of the patients 
Antibiotics demonstrate bactericidal or 
bacteriostatic effects not only on the cause of 
bacterial disease, but on all microorganisms 
present in the body including the host 
normal microflora.. Thus their non-selective 
action affects the patient's microbial balance, 
which may lead to various side effects. 
Because of phages specificity, their use is 
not likely to select for phage resistance in 
other (non-target) bacterial species 
The broad spectrum activity of antibiotics 
may select for resistant mutants of many 
pathogenic bacterial species. 
Humans are exposed to phages throughout 
life, and well tolerate them. No serious side 
effects have been described. 
Multiple side effects, including intestinal 
disorders, allergies, and secondary infections 
(e.g., yeast infections) have been reported.  
Phage-resistant bacteria remain susceptible 
to other phages having a similar host range.
Resistance to antibiotics is not limited to 
targeted bacteria. 
Phages are found throughout nature. This 
means that it is easy to find new phages 
when bacteria become resistant to them. 
Selecting a new phage (e.g., against phage-
resistant bacteria) is a rapid process and 
frequently can be accomplished in days.  
 Developing a new antibiotic (against 
antibiotic resistant bacteria) is a time 
consuming process and may take several 
years to accomplish. 
Phages may be considered as good 
alternative for patients allergic to 
antibiotics. 
If patient is allergic to antibiotic, treatment is 
very difficult 
Table 1. Comparison of phages and antibiotics regarding their prophylactic and therapeutic 
use. 
 
Application of Therapeutic Phages in Medicine 141 
There are also some disadvantages with the phage therapy approach. These include: 
 The problem which requires attention is the rapid clearance of phage by the spleen, 
liver and other filtering organs of reticuloendothelial system (Carlton, 1999). This can be 
taken care by doing serial passage in mice (Merril et al., 1996) so as to obtain a phage 
mutant capable of evading the reticuloendothelial system and therefore capable of long 
circulation in the blood. The minor variations in their coat proteins enable some 
variants to be less easily recognized by the RES organs, allowing them in the circulation 
for longer periods than the “average” wild-type phage.  
 This therapy can not be used for intracellular bacteria as the host is not available for 
interaction.  
 Theoretically development of neutralizing antibodies against phages could be an 
obstacle to the use phage therapy in recurrent infections. This needs to be confirmed 
experimentally. However, in the immunocompromised host where the immune system 
is depressed such as chronic infections, the phage therapy may work in this situation 
(Skurnik & Strauch, 2006). 
 The shelf life of phages varies and needs to be tested and monitored. 
 Phages are more difficult to administer than antibiotics. A physician needs special 
training in order to correctly prescribe and use phages. 
3. Safety of the therapeutic phage preparation 
During the long history of using phages as therapeutic agents through Eastern Europe and 
the former Soviet Union, there has been no report of serious complications associated with 
their use (Sulakvelidze & Morris, 2001). Phages are extremely common in environment and 
regularly consumed in foods (Bergh et al. 1989). In fact humans are exposed to phages from 
birth itself and therefore these constitute the normal microflora of the human body. They 
have been commonly found in human gastrointestinal tract, skin and mouth, where they are 
harboured in saliva and dental plaques (Bachrach et al., 2003). Phages are also abundant in 
environment including saltwater, freshwater, soil, plants and animals and they have been 
shown to be unintentional contents of some vaccines and sera commercially available in 
United States (Merril et al., 1972; Geier et al., 1975; Milch & Fornosi, 1975). Phages have high 
specificity for specific bacterial strains, a characteristic which requires careful targetting 
(Merril et al. 2003; Bradbury 2004). Therefore, phage therapy can be used to lyse specific 
pathogens without disturbing normal bacterial flora and phages pose no risk to anything 
other than their specific bacterial host (Lorch, 1999; Sulakvelidze et al., 2001; Duckworth & 
Gulig, 2002).  
 From a clinical standpoint, phage therapy appears to be very safe. Efficacy of natural 
phages against antibiotic-resistant Streptococci, Escherichia, Pseudomonas, Proteus, Salmonella, 
Shigella, Serratia, Klebsiella (Kumari et al., 2010), Enterobacter, Campylobacter, Yersinia, 
Acinetobacter and Brucella are being evaluated by researchers (Matsuzaki et al., 2005). 
However, in the last few years, modified phages are being explored increasingly, due to the 
limitations of phage therapy using lytic phages. The safety concerns regarding 
spontaneously propagating live microorganisms and the inconsistency of phage therapy 
results in the treatment of bacterial infections specifically induced scientists to explore more 
controllable phages (Skurnik et al., 2007). Phages can be modified to be an excellent 
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There are also some disadvantages with the phage therapy approach. These include: 
 The problem which requires attention is the rapid clearance of phage by the spleen, 
liver and other filtering organs of reticuloendothelial system (Carlton, 1999). This can be 
taken care by doing serial passage in mice (Merril et al., 1996) so as to obtain a phage 
mutant capable of evading the reticuloendothelial system and therefore capable of long 
circulation in the blood. The minor variations in their coat proteins enable some 
variants to be less easily recognized by the RES organs, allowing them in the circulation 
for longer periods than the “average” wild-type phage.  
 This therapy can not be used for intracellular bacteria as the host is not available for 
interaction.  
 Theoretically development of neutralizing antibodies against phages could be an 
obstacle to the use phage therapy in recurrent infections. This needs to be confirmed 
experimentally. However, in the immunocompromised host where the immune system 
is depressed such as chronic infections, the phage therapy may work in this situation 
(Skurnik & Strauch, 2006). 
 The shelf life of phages varies and needs to be tested and monitored. 
 Phages are more difficult to administer than antibiotics. A physician needs special 
training in order to correctly prescribe and use phages. 
3. Safety of the therapeutic phage preparation 
During the long history of using phages as therapeutic agents through Eastern Europe and 
the former Soviet Union, there has been no report of serious complications associated with 
their use (Sulakvelidze & Morris, 2001). Phages are extremely common in environment and 
regularly consumed in foods (Bergh et al. 1989). In fact humans are exposed to phages from 
birth itself and therefore these constitute the normal microflora of the human body. They 
have been commonly found in human gastrointestinal tract, skin and mouth, where they are 
harboured in saliva and dental plaques (Bachrach et al., 2003). Phages are also abundant in 
environment including saltwater, freshwater, soil, plants and animals and they have been 
shown to be unintentional contents of some vaccines and sera commercially available in 
United States (Merril et al., 1972; Geier et al., 1975; Milch & Fornosi, 1975). Phages have high 
specificity for specific bacterial strains, a characteristic which requires careful targetting 
(Merril et al. 2003; Bradbury 2004). Therefore, phage therapy can be used to lyse specific 
pathogens without disturbing normal bacterial flora and phages pose no risk to anything 
other than their specific bacterial host (Lorch, 1999; Sulakvelidze et al., 2001; Duckworth & 
Gulig, 2002).  
 From a clinical standpoint, phage therapy appears to be very safe. Efficacy of natural 
phages against antibiotic-resistant Streptococci, Escherichia, Pseudomonas, Proteus, Salmonella, 
Shigella, Serratia, Klebsiella (Kumari et al., 2010), Enterobacter, Campylobacter, Yersinia, 
Acinetobacter and Brucella are being evaluated by researchers (Matsuzaki et al., 2005). 
However, in the last few years, modified phages are being explored increasingly, due to the 
limitations of phage therapy using lytic phages. The safety concerns regarding 
spontaneously propagating live microorganisms and the inconsistency of phage therapy 
results in the treatment of bacterial infections specifically induced scientists to explore more 
controllable phages (Skurnik et al., 2007). Phages can be modified to be an excellent 
therapeutic agent by directed mutation of the phage genome, recombination of phage 
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genomes, artificial selection of phages in vivo, chimeric phages and other rational designs 
which confer new properties on the phages. These new modified phages have been shown 
to successfully overcome challenges to earlier phage therapy (Moradpour & Ghasemian, 
2011). 
As with antibiotic therapy and other methods of countering bacterial infections, endotoxins 
(lipopolysaccharide) are released by the gram negative bacteria as a component of outer 
membrane. This can cause symptoms of fever, or in extreme cases, toxic shock (Herxheimer 
reaction) (Theil, 2004). To address the endotoxin release issue, recombinant phage derived 
from P. aeruginosa filamentous phage Pf3 was constructed by genetic modifications and the 
results showed that this filamentous phages could be used as effective anti-infection agent 
(Hagen & Blasi, 2003; Hagens et al. 2004). This phage had the benefit of minimizing the 
release of membrane associated endotoxins during phage therapy (Parisien et al., 2008). In 
order not to compromise on the issue of the safe use of therapeutic phage preparation, 
rigorous characterizations of each phage to be used therapeutically should be done, in 
particular, especially looking for potentially harmful genes in their genome (Payne & Jensen, 
2000; Carlton et al., 2005; Hanlon, 2007; Mattey & Spencer, 2008).  
4. Clinical application of bacteriophages 
4.1 Whole phage as antimicrobial agents 
4.1.1 Phage therapy in Humans 
However, although d’Hérelle carried out the first human therapeutic phage trial, the first 
article documenting phage therapy was on research conducted in Belgium by Bruynoghe 
and Maisin in 1921. They reported that phages when injected in six patients targeted 
staphylococcus near the base of cutaneous boils (furuncles and carbuncles), resulted in 
improvement within 48 hours and reduction in pain, swelling and fever. Merabishvili and 
workers (2009) used phage cocktail, consisting of exclusively lytic bacteriophages for the 
treatment of Pseudomonas aeruginosa and Staphylococcus aureus infections in burn wound 
patients in the Burn Centre of the Queen Astrid Military Hospital in Brussels, Belgium. The 
first controlled clinical trial of a therapeutic bacteriophage preparation (Biophage-PA) showed 
efficacy and safety in chronic otitis because of drug resistant P. aeruginosa in UCL Ear Institute 
and Royal National Throat, Nose and Ear Hospital, London, UK (Wright et al., 2009). Several 
clinical trials on phage therapy in humans were reported with the majority coming from 
researchers in Eastern Europe and the former Soviet Union (Abdul-Hassan et al., 1990; 
Sulakvelidze et al., 2001). One of the most extensive studies evaluating the application of 
therapeutic phages for prophylaxis of infectious diseases was conducted in Tbilisi, Georgia, 
during 1963 and 1964 and involved phages against bacterial dysentery (Babalova et al., 1968). 
The most detailed English language reports on phage therapy in humans were by Slopek 
and co workers who published a number of papers on the effectiveness of phages against 
infections caused by several bacterial pathogens, including multidrug-resistant mutants 
(Slopek et al., 1983, 1984, 1985; Kucharewicz-Krukowska et al., 1987; Weber-Dabrowska et 
al., 1987). Phages have been reported to be effective in treating various bacterial diseases 
such as cerebrospinal meningitis in a newborn (Stroj et al., 1999), skin infections caused by 
Pseudomonas, Staphylococcus, Klebsiella, Proteus, E. coli (Cislo et al., 1987), recurrent 
subphrenic and subhepatic abscesses (Kwarcinski et al., 1987), Staphylococcal lung infections 
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((Ioseliani et al., 1980; Kaczkowski et al., 1990), Pseudomonas aeruginosa infections in cystic 
fibrosis patients (Shabalova et al., 1995), eye infections (Proskurov, 1970), neonatal sepsis 
(Pavlenishvili & Tsertsvadze, 1993), urinary tract infections (Perepanova et al., 1995), and 
cancer (Weber-Dabrowska et al., 2001). Abdul-Hassan et al. (1990) reported on the treatment of 
30 cases of burn-wound associated antibiotic-resistant Pseudomonas aeruginosa sepsis. Bandages 
soaked with 1010 phages/ml were applied three times daily. Half of the cases were found to be 
improved. Markoishvili et al., (2002) reported the use of PhagoBioDerm, the phage 
impregnated polymer, to treat infected venous stasis skin ulcers. To patients that had failed to 
respond to other treatment approaches, PhagoBioDerm was applied to ulcers both alone and, 
where appropriate, in combination with other treatment strategies. Complete healing of ulcers 
was observed in 70% of the patients. Mushtaq et al., (2005) reported that a bacteriophage 
encoded enzyme, endosialidase E (endo E) selectively degrades the linear homopolymeric a-
2, 8-linked N acetylneuraminic acid capsule associated with the capacity of E. coli K1 strain 
to cause severe infection in the newborn infant. In one of the study, PhagoBioDerm (a 
wound-healing preparation consisting of a biodegradable polymer impregnated with 
ciprofloxacin and bacteriophages) was used in three Georgian lumberjacks from the village 
of Lia who were exposed to a strontium-90 source from two Soviet-era radiothermal 
generators they found near their village. In addition to systemic effects, two of them 
developed severe local radiation injuries which subsequently became infected with 
Staphylococcus aureus. Approximately 1 month after hospitalization, treatment with phage 
bioderm was initiated. Purulent drainage stopped within 2–7 days. Clinical improvement 
was associated with rapid (7 days) elimination of the S. aureus resistant to many antibiotics 
(including ciprofloxacin), but susceptible to the bacteriophages contained in the 
PhagoBioDerm preparation (Jikia et al., 2005). Leszczynski and co workers (2006) described 
the use of oral phage therapy for targeting Methicillin Resistant Staphylococcus aureus 
(MPSA) in a nurse who was a carrier. She had MRSA colonized in her gastrointestinal tract 
and also had a urinary tract infection. The result of phage therapy was complete elimination 
of culturable MRSA (Leszczynski et al., 2006).  
4.1.2 Animal trials 
In Britain, Smith and Huggins (1982, 1983) carried out a series of excellent, well-controlled 
studies on the use of phages in systemic E. coli infections in mice and then in diarrheic 
disease in young calves and pigs. Bogovazova et al., (1991) studied the effectiveness of 
specific phage therapy in non inbred white mice, caused by intraperitoneal injection of K. 
pneumoniae K25053 into the animals. Soothill, (1994) examined the ability of bacteriophage to 
prevent the rejection of skin grafts of experimentally infected guinea pigs. His findings 
demonstrated that the phage-treated grafts were protected in six of seven cases, while 
untreated grafts failed uniformly, suggesting that phage might be useful for the prevention 
of P. aeruginosa infections in patients with burn wounds. Phage therapy has been 
successfully used to remove E. coli 0157:H7 from livestock (Barrow et al., 1998; Kudva et al., 
1999; Tanji et al., 2004). One of the most successful studies was carried out by Biswas and 
coworkers (2002). These workers suggested that a single i.p. injection of 3 ×108 PFU of the 
phage strain, administered 45 minutes after the bacterial challenge (vancomycin-resistant 
Enterococcus faecium (VRE) was sufficient to rescue 100% of the animals. Even when 
treatment was delayed to the point where all animals were moribund, approximately 50% of 
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prevent the rejection of skin grafts of experimentally infected guinea pigs. His findings 
demonstrated that the phage-treated grafts were protected in six of seven cases, while 
untreated grafts failed uniformly, suggesting that phage might be useful for the prevention 
of P. aeruginosa infections in patients with burn wounds. Phage therapy has been 
successfully used to remove E. coli 0157:H7 from livestock (Barrow et al., 1998; Kudva et al., 
1999; Tanji et al., 2004). One of the most successful studies was carried out by Biswas and 
coworkers (2002). These workers suggested that a single i.p. injection of 3 ×108 PFU of the 
phage strain, administered 45 minutes after the bacterial challenge (vancomycin-resistant 
Enterococcus faecium (VRE) was sufficient to rescue 100% of the animals. Even when 
treatment was delayed to the point where all animals were moribund, approximately 50% of 
 
Bacteriophages 144 
them were rescued by a single injection of the phage. The protective effect of bacteriophage 
was assessed against experimental S. aureus infection in mice. Subsequent intraperitoneal 
administration of purified ØMR11 (MOI of 0.1) suppressed S. aureus–induced lethality. This 
lifesaving effect coincided with the rapid appearance of ØMR11 in the circulation, which 
remained at substantial levels until the bacteria were eradicated (Matsuzaki et al. 2003). 
Benedict & Flamiano, (2004) evaluated the use of bacteriophages as therapy for Escherichia 
coli-induced bacteremia in mice. This experimental study showed clearly that a single dose 
of crude phage lysates administered by i.p. injection was enough to rescue bacteremic mice 
back to normal health after having been challenged with a lethal concentration of E. coli. 
Vinodkumar and co-workers (2005) studied the ability of bacterial viruses to rescue septicemic 
mice with multidrug resistant (MDR) Klebsiella pneumoniae isolated from neonatal 
septicemia. A single i.p. injection of 3x108 PFU of the phage strain administered 45 minutes 
after the bacterial challenge rescued 100% of the animals. Wills and colleagues (2005) also 
demonstrated the efficacy of bacteriophage therapy against S. aureus in a rabbit abscess model. 
2 x 109 PFU of staphylococcal phage prevented abscess formation in rabbits when it was 
injected simultaneously with S. aureus (8 x 107 CFU) into the same subcutaneous site. Phage 
multiplied in the tissues. The sewerage-derived bacteriophage reduced the abscess area and 
the count of S. aureus in the abscess was lowered in a bacteriophage dose dependent way 
(Will et al., 2005). Marza et al. (2006) reported the treatment of a dog with chronic bilateral 
otitis external that had consistently grown P. aeruginosa. This infection had failed to be 
resolved after repeated courses of topical and systemic antibiotics. After inoculation with 
400 PFU of bacteriophage into the auditory canal there was a marked improvement in the 
clinical signs, 27 hours after treatment. Wang et al., (2006) examined the effectiveness of 
phages in the treatment of imipenem resistant Pseudomonas aeruginosa (IMPR-Pa) infection in 
an experimental mouse model. A single i.p. inoculation of the phage strain ØA392 (MOI > 
0.01) at up to 60 min after the bacterial challenge was sufficient to rescue 100% of the 
animals. The workers demonstrated that the ability of the phage to rescue bacteremic 
animals was due to the functional capabilities of the phage and not to a non-specific 
immune effect. McVay and co-workers (2007) examined the efficacy of phage therapy in 
treating fatal Pseudomonas aeruginosa infections in mouse burn wound model. The results 
showed that a single dose of the Pseudomonas aeruginosa phage cocktail could significantly 
decrease the mortality of thermally injured, Pseudomonas aeruginosa-infected mice (from 6% 
survival without treatment to 22 to 87% survival with treatment) and that the route of 
administration was particularly important to the efficacy of the treatment, with the i.p. route 
providing the most significant (87%) protection. Watanabe et al. (2007) examined the 
efficacy of bacteriophage by using a gut-derived sepsis model caused by Pseudomonas 
aeruginosa in mice. Oral administration of a newly isolated lytic phage strain (KPP10) 
significantly protected mice against mortality with survival rates, 66.7% for the phage-
treated group as compared to 0% survival in saline treated control group. Mice treated with 
phage also had significantly lower numbers of viable Pseudomonas aeruginosa cells and lower 
level of inflammatory cytokines (tumor necrosis factor alpha TNF-α, interleukin-1ß [IL-1ß], 
and IL-6) in their blood and different organs such as liver and spleen.  
In recent years the phage therapy has received lot of attention due to an increase in the 
prevalence of antibiotic resistant strains in clinical settings. A numbers of recent 
experimental studies have proved the efficacy of phages in treating different infections. 
Chhibber & co workers (2008) had reported the therapeutic potential of phage SS in treating 
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Klebsiella pneumoniae induced respiratory infection in mice. A single intraperitoneal injection 
of (MOI of 200) phage (SS) administered immediately after i.n. challenge was sufficient to 
rescue 100% of animals from K. pneumoniae-mediated respiratory infections. The use of lytic 
bacteriophages to rescue septicemic mice with multidrug-resistant (MDR) Pseudomonas 
aeruginosa infection was evaluated (Vinodkumar et al., 2008). A single i.p. injection of 109 
PFU of the phage strain, administered 45 min after the bacterial challenge (107), was 
sufficient to rescue 100% of the animals. Malik & Chhibber (2009) investigated the protective 
effect of K. pneumoniae–specific bacteriophage KØ1 isolated from the environment in a 
mouse model of burn wound infection caused by K. pneumoniae. A substantial decrease in 
the bacterial load of blood, peritoneal lavage, and lung tissue was noted following treatment 
with the bacteriophage preparation. Recently in other studies, workers have successfully 
employed well characterized phages to treat burn wound infection induced by Klebsiella 
pneumoniae in mice. In this study, a single dose of phages, intraperitoneally (i.p.) at an MOI 
of 1.0, resulted in significant decrease in mortality, and this dose was found to be sufficient 
to completely cure K. pneumoniae infection in the burn wound model. Maximum decrease in 
bacterial counts in different organs was observed at 72 hours post infection (Kumari et al., 
2009). Kumari and co- workers (2010) evaluated the therapeutic potential of a well 
characterized phage Kpn5 in treating burn wound infection in mice as a single topical 
application of this phage was able to rescue mice from infection caused by K. pneumoniae 
B5055 in comparison to multiple applications of honey and Aloe vera gel (Kumari et al., 
2010). Recently, Kumari and co-workers (2011) evaluated the efficacy of silver nitrate and 
gentamicin in the treatment of burn wound infection and compared it with phage therapy 
using an isolated and well-characterized Klebsiella -specific phage, Kpn5. Phage Kpn5 mixed 
in hydrogel was applied topically at an MOI of 200 on the burn wound site. The efficacy of 
these antimicrobial agents was assessed on the basis of percentage survival of infected mice 
following treatment. The results showed that a single dose of phage Kpn5 resulted in a 
significant reduction in mortality (P<0.001) as compared to daily application of silver nitrate 
and gentamicin (Kumari et al., 2011). 
4.1.3 Phages in the eradication of biofilms 
Biofilms are densely packed communities of microorganisms growing on a range of biotic 
and abiotic surfaces and surround themselves with secreted extracellular polymer (EPS). 
Many bacterial species form biofilms and it is an important bacterial survival strategy. 
Biofilm formation is thought to begin when bacteria sense environmental conditions that 
trigger the transition to life on a surface. The structural and physiological complexity of 
biofilms has led to the idea that they are coordinated and cooperative groups, analogous to 
multicellular organisms (Passerini et al., 1992). In humans biofilms are responsible for many 
pathologies, most of them associated with the use of medical devices. A major problem of 
biofilms is their inherent tolerance to host defences and antibiotic therapies. Therefore there 
is an urgent need to develop alternative ways to prevent and control biofilm-associated 
clinical infections (Azeredo & Sutherland, 2008). Bacteriophages have been suggested as 
effective antibiofilm agents (Donlan, 2009). Use of indwelling catheters was often 
compromised as a result of biofilm formation. Curtin and Donlan (2006) investigated if 
hydrogel-coated catheters pretreated with coagulase negative bacteriophage would reduce 
Staphylococcus epidermidis biofilm formation. In our laboratory, efficacy of bacteriophage was 
assessed alone or in combination with amoxicillin, for the eradication of biofilm produced 
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them were rescued by a single injection of the phage. The protective effect of bacteriophage 
was assessed against experimental S. aureus infection in mice. Subsequent intraperitoneal 
administration of purified ØMR11 (MOI of 0.1) suppressed S. aureus–induced lethality. This 
lifesaving effect coincided with the rapid appearance of ØMR11 in the circulation, which 
remained at substantial levels until the bacteria were eradicated (Matsuzaki et al. 2003). 
Benedict & Flamiano, (2004) evaluated the use of bacteriophages as therapy for Escherichia 
coli-induced bacteremia in mice. This experimental study showed clearly that a single dose 
of crude phage lysates administered by i.p. injection was enough to rescue bacteremic mice 
back to normal health after having been challenged with a lethal concentration of E. coli. 
Vinodkumar and co-workers (2005) studied the ability of bacterial viruses to rescue septicemic 
mice with multidrug resistant (MDR) Klebsiella pneumoniae isolated from neonatal 
septicemia. A single i.p. injection of 3x108 PFU of the phage strain administered 45 minutes 
after the bacterial challenge rescued 100% of the animals. Wills and colleagues (2005) also 
demonstrated the efficacy of bacteriophage therapy against S. aureus in a rabbit abscess model. 
2 x 109 PFU of staphylococcal phage prevented abscess formation in rabbits when it was 
injected simultaneously with S. aureus (8 x 107 CFU) into the same subcutaneous site. Phage 
multiplied in the tissues. The sewerage-derived bacteriophage reduced the abscess area and 
the count of S. aureus in the abscess was lowered in a bacteriophage dose dependent way 
(Will et al., 2005). Marza et al. (2006) reported the treatment of a dog with chronic bilateral 
otitis external that had consistently grown P. aeruginosa. This infection had failed to be 
resolved after repeated courses of topical and systemic antibiotics. After inoculation with 
400 PFU of bacteriophage into the auditory canal there was a marked improvement in the 
clinical signs, 27 hours after treatment. Wang et al., (2006) examined the effectiveness of 
phages in the treatment of imipenem resistant Pseudomonas aeruginosa (IMPR-Pa) infection in 
an experimental mouse model. A single i.p. inoculation of the phage strain ØA392 (MOI > 
0.01) at up to 60 min after the bacterial challenge was sufficient to rescue 100% of the 
animals. The workers demonstrated that the ability of the phage to rescue bacteremic 
animals was due to the functional capabilities of the phage and not to a non-specific 
immune effect. McVay and co-workers (2007) examined the efficacy of phage therapy in 
treating fatal Pseudomonas aeruginosa infections in mouse burn wound model. The results 
showed that a single dose of the Pseudomonas aeruginosa phage cocktail could significantly 
decrease the mortality of thermally injured, Pseudomonas aeruginosa-infected mice (from 6% 
survival without treatment to 22 to 87% survival with treatment) and that the route of 
administration was particularly important to the efficacy of the treatment, with the i.p. route 
providing the most significant (87%) protection. Watanabe et al. (2007) examined the 
efficacy of bacteriophage by using a gut-derived sepsis model caused by Pseudomonas 
aeruginosa in mice. Oral administration of a newly isolated lytic phage strain (KPP10) 
significantly protected mice against mortality with survival rates, 66.7% for the phage-
treated group as compared to 0% survival in saline treated control group. Mice treated with 
phage also had significantly lower numbers of viable Pseudomonas aeruginosa cells and lower 
level of inflammatory cytokines (tumor necrosis factor alpha TNF-α, interleukin-1ß [IL-1ß], 
and IL-6) in their blood and different organs such as liver and spleen.  
In recent years the phage therapy has received lot of attention due to an increase in the 
prevalence of antibiotic resistant strains in clinical settings. A numbers of recent 
experimental studies have proved the efficacy of phages in treating different infections. 
Chhibber & co workers (2008) had reported the therapeutic potential of phage SS in treating 
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Klebsiella pneumoniae induced respiratory infection in mice. A single intraperitoneal injection 
of (MOI of 200) phage (SS) administered immediately after i.n. challenge was sufficient to 
rescue 100% of animals from K. pneumoniae-mediated respiratory infections. The use of lytic 
bacteriophages to rescue septicemic mice with multidrug-resistant (MDR) Pseudomonas 
aeruginosa infection was evaluated (Vinodkumar et al., 2008). A single i.p. injection of 109 
PFU of the phage strain, administered 45 min after the bacterial challenge (107), was 
sufficient to rescue 100% of the animals. Malik & Chhibber (2009) investigated the protective 
effect of K. pneumoniae–specific bacteriophage KØ1 isolated from the environment in a 
mouse model of burn wound infection caused by K. pneumoniae. A substantial decrease in 
the bacterial load of blood, peritoneal lavage, and lung tissue was noted following treatment 
with the bacteriophage preparation. Recently in other studies, workers have successfully 
employed well characterized phages to treat burn wound infection induced by Klebsiella 
pneumoniae in mice. In this study, a single dose of phages, intraperitoneally (i.p.) at an MOI 
of 1.0, resulted in significant decrease in mortality, and this dose was found to be sufficient 
to completely cure K. pneumoniae infection in the burn wound model. Maximum decrease in 
bacterial counts in different organs was observed at 72 hours post infection (Kumari et al., 
2009). Kumari and co- workers (2010) evaluated the therapeutic potential of a well 
characterized phage Kpn5 in treating burn wound infection in mice as a single topical 
application of this phage was able to rescue mice from infection caused by K. pneumoniae 
B5055 in comparison to multiple applications of honey and Aloe vera gel (Kumari et al., 
2010). Recently, Kumari and co-workers (2011) evaluated the efficacy of silver nitrate and 
gentamicin in the treatment of burn wound infection and compared it with phage therapy 
using an isolated and well-characterized Klebsiella -specific phage, Kpn5. Phage Kpn5 mixed 
in hydrogel was applied topically at an MOI of 200 on the burn wound site. The efficacy of 
these antimicrobial agents was assessed on the basis of percentage survival of infected mice 
following treatment. The results showed that a single dose of phage Kpn5 resulted in a 
significant reduction in mortality (P<0.001) as compared to daily application of silver nitrate 
and gentamicin (Kumari et al., 2011). 
4.1.3 Phages in the eradication of biofilms 
Biofilms are densely packed communities of microorganisms growing on a range of biotic 
and abiotic surfaces and surround themselves with secreted extracellular polymer (EPS). 
Many bacterial species form biofilms and it is an important bacterial survival strategy. 
Biofilm formation is thought to begin when bacteria sense environmental conditions that 
trigger the transition to life on a surface. The structural and physiological complexity of 
biofilms has led to the idea that they are coordinated and cooperative groups, analogous to 
multicellular organisms (Passerini et al., 1992). In humans biofilms are responsible for many 
pathologies, most of them associated with the use of medical devices. A major problem of 
biofilms is their inherent tolerance to host defences and antibiotic therapies. Therefore there 
is an urgent need to develop alternative ways to prevent and control biofilm-associated 
clinical infections (Azeredo & Sutherland, 2008). Bacteriophages have been suggested as 
effective antibiofilm agents (Donlan, 2009). Use of indwelling catheters was often 
compromised as a result of biofilm formation. Curtin and Donlan (2006) investigated if 
hydrogel-coated catheters pretreated with coagulase negative bacteriophage would reduce 
Staphylococcus epidermidis biofilm formation. In our laboratory, efficacy of bacteriophage was 
assessed alone or in combination with amoxicillin, for the eradication of biofilm produced 
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by Klebsiella pneumoniae B5055 (Bedi et al., 2009). Similarly Verma et. al. (2009) also evaluated 
the efficacy of lytic bacteriophage KPO1K2 alone or in combination with another antibiotic, 
ciprofloxacin for eradicating the biofilm of Klebsiella pneumoniae in vitro (Verma et al., 2009). 
Despite the efficacy of antibiotics as well as bacteriophages in the treatment of bacterial 
infections, their role in treatment of biofilm associated infections is still under consideration 
especially in case of older biofilms. The ability of bacteriophage and their associated 
polysaccharide depolymerases was investigated to control enteric biofilm formation. The 
action of combined treatments of disinfectant and phage enzyme as a potentially effective 
biofilm control strategy was evaluated and the results showed that the combination of 
phage enzyme and disinfectant was found to be more effective than either of these when 
used alone (Tait et al., 2002). Since age of biofilm is a decisive factor in determining the 
outcome of antibiotic treatment, in one recent study, biofilm of K. pneumoniae was grown for 
extended periods and treated with ciprofloxacin and/or depolymerase producing lytic 
bacteriophage (KPO1K2). The reduction in bacterial numbers of older biofilm was greater 
after application of the two agents in combination as ciprofloxacin alone could not reduce 
bacterial biomass significantly in older biofilms (Verma et al., 2010).  
4.2 Phage products or phage lysins 
With the increasing worldwide prevalence of antibiotic resistant bacteria, bacteriophage 
endolysins represent a very promising novel alternative class of antibacterial in the fight 
against infectious disease. Pathogenic bacteria are increasingly becoming resistant to 
antibiotics. For nearly a century, scientists have attempted to treat bacterial infections with 
whole phages. Vincent Fischetti (1940) was the first, however, to focus on the deadly 
weapons, the potent and specific enzymes called lysins produced by these viruses. These 
lysins create lethal holes in bacterial cell walls. Fischetti has identified lysins that can kill a 
wide range of Gram-positive pathogenic bacteria, and have proven their effectiveness in 
both preventing and treating infections in mice, an important step towards their potential 
application in human disease (Fischetti, 2008). As an alternative to "classic" bacteriophage 
therapy, in which whole viable phage particles are used, one can also apply bacteriophage-
encoded lysis-inducing proteins, either as recombinant proteins or as lead structures for the 
development of novel antibiotics. Phage endolysins, or lysins, are enzymes that damage the 
cell walls' integrity by hydrolyzing the four major bonds in its peptidoglycan component 
(Loessner et al., 1997; Lopez et al., 2004). A number of studies have shown the enormous 
potential of the use of phage endolysins, rather than the intact phage, as potential 
therapeutics. The great majority of human infections such as viral or bacterial start at a 
mucous membrane site (upper and lower respiratory, intestinal, urogenital, and ocular) 
which are the reservoir for many pathogenic bacteria found in the environment (i.e., 
pneumococci, staphylococci, streptococci), many of which are reported to be resistant to 
antibiotics (Young, 1994). Therefore, various animal models of mucosal colonization were 
used to test the efficacy of phage lysins to kill organisms on these surfaces. An oral 
colonization model was developed for prevention and elimination of upper respiratory 
colonization of mice by group A streptococci by using a purified C1 phage lysin C1 (Nelson 
et al., 2001). Phage lytic enzymes have recently been proposed for the reduction of 
nasopharyngeal carriage of S. pneumoniae (Loeffler et al., 2001, 2003). In both these cases, 
when the animals were colonized with their respective bacteria and treated with a small 
amount of lysin specific for the colonizing organism, the animals were found to be free of 
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colonizing bacteria two to five hours after lysin treatment. Group B streptococci are the 
leading cause of neonatal meningitis and sepsis all over the world. A vaginal model for 
group B streptococci was established to remove colonization of the vagina and oropharynx 
of mice with a phage lysin (named PlyGBS). A single dose of PlyGBS significantly reduced 
bacterial colonization in both the vagina and oropharynx (Cheng et al., 2005). These results 
support the idea that such enzymes may be used in specific high-risk populations to control 
the reservoir of pathogenic bacteria and therefore control the disease. These phage enzymes 
are so efficient in killing pathogenic bacteria that they may be considered as valuable tools 
in controlling biowarfare bacteria. To determine the feasibility of this approach, Schuch and 
co workers (2002) identified a lytic enzyme PlyG from the gamma phage that is specific for 
Bacillus anthracis. This approach may be used in post-exposure cases of anthrax, in which 
individuals can be treated intravenously with PlyG to control the bacilli entering the blood 
after germination because higher doses of phage lysin or multiple doses will result in nearly 
100% protection. Recently, antimicrobial therapy of recombinant Cpl-1, a phage lysin 
specific for Streptococcus pneumoniae was reported to be effective in experimental 
pneumococcal meningitis using infant Wistar rats (Grandgirard et al., 2008).  
5. Phage application in food industry 
Food contamination is a serious issue because it results in foodborne diseases. Food 
contamination can be microbial or environmental, with the former being more common. 
Meat and poultry can become contaminated during slaughter through cross-contamination 
from intestinal fecal matter. Similarly, fresh fruits and vegetables can be contaminated if 
they are washed using water contaminated with animal manure or human sewage. During 
food processing, contamination is also possible from infected food handlers. Food 
contamination usually causes abdominal discomfort and pain, and diarrhea, but symptoms 
vary depending on the type of infection. At the present time, the leading causes of death due 
to foodborne bacterial pathogens are Listeria and Salmonella, followed closely by other 
foodborne pathogens such as Escherichia coli (E. coli O157:H7, in particular) and 
Campylobacter jejunii. Bacteriophages may provide a natural, non-toxic, safe, and effective 
means for significantly reducing or eliminating contamination of foods with specific 
pathogenic bacteria, thereby eliminating the risk, or significantly reducing the magnitude 
and severity, of foodborne illness caused by the consumption of foods contaminated with 
those bacteria (Meadet et al., 1999; Atturbury et al., 2003). The effectiveness of phage 
administration for the control of fish diseases and for food disinfection has also been 
documented. Nakai and co-workers (1999) and some other workers succeeded in saving the 
lives of cultured fish challenged by Lactococcus garvieae and Pseudomonas plecoglossicida, 
which are fish pathogens (Nakai et al., 1999; Nakai & Park, 2002; Park & Nakai, 2003). The 
need for control of pathogens during the manufacture of food is reflected by the incidence of 
foodborne bacterial infections. The use of phage or phage products in food production has 
recently become an option for the food industry as a novel method for biocontrol of 
unwanted pathogens, enhancing the safety of especially fresh and ready-to-eat food 
products (Hagens & Loessner, 2010). Phages were also shown to be effective for the 
elimination of food poisoning pathogens such as Listeria monocytogenes (Leverentz et al., 
2003), Campylobacter jejuni (Atterbury et al., 2003) and Salmonella spp. (Leverentz et al., 2001; 
Goode et al., 2003) from the surface of foods. The bacterial spot pathogen of tomato plants, 
Xanthomonas campestris pv. vesicatoria was successfully controlled with bacteriophage 
(Flaherty et al., 2000).  
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by Klebsiella pneumoniae B5055 (Bedi et al., 2009). Similarly Verma et. al. (2009) also evaluated 
the efficacy of lytic bacteriophage KPO1K2 alone or in combination with another antibiotic, 
ciprofloxacin for eradicating the biofilm of Klebsiella pneumoniae in vitro (Verma et al., 2009). 
Despite the efficacy of antibiotics as well as bacteriophages in the treatment of bacterial 
infections, their role in treatment of biofilm associated infections is still under consideration 
especially in case of older biofilms. The ability of bacteriophage and their associated 
polysaccharide depolymerases was investigated to control enteric biofilm formation. The 
action of combined treatments of disinfectant and phage enzyme as a potentially effective 
biofilm control strategy was evaluated and the results showed that the combination of 
phage enzyme and disinfectant was found to be more effective than either of these when 
used alone (Tait et al., 2002). Since age of biofilm is a decisive factor in determining the 
outcome of antibiotic treatment, in one recent study, biofilm of K. pneumoniae was grown for 
extended periods and treated with ciprofloxacin and/or depolymerase producing lytic 
bacteriophage (KPO1K2). The reduction in bacterial numbers of older biofilm was greater 
after application of the two agents in combination as ciprofloxacin alone could not reduce 
bacterial biomass significantly in older biofilms (Verma et al., 2010).  
4.2 Phage products or phage lysins 
With the increasing worldwide prevalence of antibiotic resistant bacteria, bacteriophage 
endolysins represent a very promising novel alternative class of antibacterial in the fight 
against infectious disease. Pathogenic bacteria are increasingly becoming resistant to 
antibiotics. For nearly a century, scientists have attempted to treat bacterial infections with 
whole phages. Vincent Fischetti (1940) was the first, however, to focus on the deadly 
weapons, the potent and specific enzymes called lysins produced by these viruses. These 
lysins create lethal holes in bacterial cell walls. Fischetti has identified lysins that can kill a 
wide range of Gram-positive pathogenic bacteria, and have proven their effectiveness in 
both preventing and treating infections in mice, an important step towards their potential 
application in human disease (Fischetti, 2008). As an alternative to "classic" bacteriophage 
therapy, in which whole viable phage particles are used, one can also apply bacteriophage-
encoded lysis-inducing proteins, either as recombinant proteins or as lead structures for the 
development of novel antibiotics. Phage endolysins, or lysins, are enzymes that damage the 
cell walls' integrity by hydrolyzing the four major bonds in its peptidoglycan component 
(Loessner et al., 1997; Lopez et al., 2004). A number of studies have shown the enormous 
potential of the use of phage endolysins, rather than the intact phage, as potential 
therapeutics. The great majority of human infections such as viral or bacterial start at a 
mucous membrane site (upper and lower respiratory, intestinal, urogenital, and ocular) 
which are the reservoir for many pathogenic bacteria found in the environment (i.e., 
pneumococci, staphylococci, streptococci), many of which are reported to be resistant to 
antibiotics (Young, 1994). Therefore, various animal models of mucosal colonization were 
used to test the efficacy of phage lysins to kill organisms on these surfaces. An oral 
colonization model was developed for prevention and elimination of upper respiratory 
colonization of mice by group A streptococci by using a purified C1 phage lysin C1 (Nelson 
et al., 2001). Phage lytic enzymes have recently been proposed for the reduction of 
nasopharyngeal carriage of S. pneumoniae (Loeffler et al., 2001, 2003). In both these cases, 
when the animals were colonized with their respective bacteria and treated with a small 
amount of lysin specific for the colonizing organism, the animals were found to be free of 
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colonizing bacteria two to five hours after lysin treatment. Group B streptococci are the 
leading cause of neonatal meningitis and sepsis all over the world. A vaginal model for 
group B streptococci was established to remove colonization of the vagina and oropharynx 
of mice with a phage lysin (named PlyGBS). A single dose of PlyGBS significantly reduced 
bacterial colonization in both the vagina and oropharynx (Cheng et al., 2005). These results 
support the idea that such enzymes may be used in specific high-risk populations to control 
the reservoir of pathogenic bacteria and therefore control the disease. These phage enzymes 
are so efficient in killing pathogenic bacteria that they may be considered as valuable tools 
in controlling biowarfare bacteria. To determine the feasibility of this approach, Schuch and 
co workers (2002) identified a lytic enzyme PlyG from the gamma phage that is specific for 
Bacillus anthracis. This approach may be used in post-exposure cases of anthrax, in which 
individuals can be treated intravenously with PlyG to control the bacilli entering the blood 
after germination because higher doses of phage lysin or multiple doses will result in nearly 
100% protection. Recently, antimicrobial therapy of recombinant Cpl-1, a phage lysin 
specific for Streptococcus pneumoniae was reported to be effective in experimental 
pneumococcal meningitis using infant Wistar rats (Grandgirard et al., 2008).  
5. Phage application in food industry 
Food contamination is a serious issue because it results in foodborne diseases. Food 
contamination can be microbial or environmental, with the former being more common. 
Meat and poultry can become contaminated during slaughter through cross-contamination 
from intestinal fecal matter. Similarly, fresh fruits and vegetables can be contaminated if 
they are washed using water contaminated with animal manure or human sewage. During 
food processing, contamination is also possible from infected food handlers. Food 
contamination usually causes abdominal discomfort and pain, and diarrhea, but symptoms 
vary depending on the type of infection. At the present time, the leading causes of death due 
to foodborne bacterial pathogens are Listeria and Salmonella, followed closely by other 
foodborne pathogens such as Escherichia coli (E. coli O157:H7, in particular) and 
Campylobacter jejunii. Bacteriophages may provide a natural, non-toxic, safe, and effective 
means for significantly reducing or eliminating contamination of foods with specific 
pathogenic bacteria, thereby eliminating the risk, or significantly reducing the magnitude 
and severity, of foodborne illness caused by the consumption of foods contaminated with 
those bacteria (Meadet et al., 1999; Atturbury et al., 2003). The effectiveness of phage 
administration for the control of fish diseases and for food disinfection has also been 
documented. Nakai and co-workers (1999) and some other workers succeeded in saving the 
lives of cultured fish challenged by Lactococcus garvieae and Pseudomonas plecoglossicida, 
which are fish pathogens (Nakai et al., 1999; Nakai & Park, 2002; Park & Nakai, 2003). The 
need for control of pathogens during the manufacture of food is reflected by the incidence of 
foodborne bacterial infections. The use of phage or phage products in food production has 
recently become an option for the food industry as a novel method for biocontrol of 
unwanted pathogens, enhancing the safety of especially fresh and ready-to-eat food 
products (Hagens & Loessner, 2010). Phages were also shown to be effective for the 
elimination of food poisoning pathogens such as Listeria monocytogenes (Leverentz et al., 
2003), Campylobacter jejuni (Atterbury et al., 2003) and Salmonella spp. (Leverentz et al., 2001; 
Goode et al., 2003) from the surface of foods. The bacterial spot pathogen of tomato plants, 
Xanthomonas campestris pv. vesicatoria was successfully controlled with bacteriophage 
(Flaherty et al., 2000).  
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6. Phages as antibacterial nanomedicines 
Nowadays, apart from phage therapy, phages are also being used for phage display, DNA 
vaccine delivery, therapeutic gene delivery and bacterial typing Recently whole 
bacteriophage was constructed by fusing immunogenic peptides to modified coat proteins, 
which was found to be highly efficient DNA vaccine delivery vehicle (phage-display 
vaccination). Similarly the other approach has been incorporation of a eukaryotic promoter-
driven vaccine gene within the phage genome (phage DNA vaccination) (Clark & March, 
2006; Gao et al., 2010). Bacteriophages (phages) have been used for about two decades as 
tools for the discovery of specific target-binding proteins and peptides, and for almost a 
decade as tools for vaccine development. Drug-carrying phage represents a versatile 
therapeutic nanoparticle which because of tailoring of its coat can be equipped with a 
targeting moiety, and its massive drug-carrying capacity may become an important general 
targeting drug-delivery platform. In comparison to particulate drug-carrying devices, such 
as liposomes or virus-like particles, the arrangement of drug that is conjugated in high 
density on the external surface of the targeted particle is unique. A dense coating of the 
phage with aminoglycosides and other drugs might produce advantages that have been 
regarded as challenges in the application of phages as therapeutic agent. Most important 
issue in this field is the immunogenicity of bacteriophages on in vivo administration. This 
problem can be tackled as it has been shown that drug-carrying phages are hardly 
recognized by commercial antiphage antibodies and generate significantly lower antiphage 
antibody titers when used to vaccinate mice (in comparison to ‘naked' phages). Filamentous 
bacteriophages are the workhorse of antibody engineering and are gaining increasing 
importance in nanobiotechnology because of its nanometric dimentions (Yacoby et al., 2007). 
Vaks and Benhar (2011) described a new application in the area of antibacterial 
nanomedicines where antibody targeted, chloramphenicol drug loaded filamentous phage 
(M13) was used for inhibiting the growth of Staphylococcus aureus bacteria. Systemic 
administration of chemotherapeutic agents, in addition to its anti-tumor benefits, results in 
indiscriminate drug distribution and severe toxicity. Therefore to solve this problem, Bar 
and co workers (2008) used targeted anti-cancer therapy in the form of targeted drug-
carrying phage nanoparticles. The bacteriophages are also being currently evaluated for 
their biosensor potential. In a recent study it has been proposed to develop a unique and 
innovative biosensor based on induced luminescence of captured Biowarfare bacterial 
agents and organic light emitting diode (OLED) technology. The system would use array of 
bacteriophage engineered to express fluorescent protein in infected Biowarfare agents 
(Gooding, 2006). The specificity of the phage provides capture of only targets of interest, 
while the infection of the bacteria and natural replication of the expressed protein will 
provide the detection signal. Using novel OLED arrays, a phage array chip can be 
constructed similar to DNA chips for multianalyte detection.  
7. Conclusion 
Phage therapy for eliminating multidrug resistant bacteria is gaining importance. The 
abundance of phages in the environment makes it a relatively simple task to isolate phages 
against any given pathogen which can be characterized using a series of known protocols. 
The timescale and costs for the development of a new phage(s) for therapy will be a fraction 
of those for introducing a new antibiotic. Currently, many pathogenic bacteria have 
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acquired multiple drug resistance, which is a serious clinical problem. Phages, when 
properly selected, offer the most cost-effective alternative to antibiotics. These have proved 
to be efficient in bacterial elimination on single application and recently accepted for food 
treatment as well to counter food contamination during storage. Phages should be 
essentially free of contaminating bacterial toxin and also capable of evading the clearance by 
reticulendothelial system. Although some problems remain to be solved, many experts are 
of the opinion that phage therapy will find a niche in modern Western medicine in the 
future. Phage lytic enzymes have a broad application in the treatment of bacterial diseases. 
Whenever there is a need to kill bacteria, phage enzymes may be freely utilized. They may 
be used not only to control pathogenic bacteria on human mucous membranes, but may find 
application in the food industry to control disease causing bacteria. Phage lytic enzymes 
have yet to be exploited. Because of the serious problems of resistant bacteria in hospitals, 
day care centers, and nursing homes, particularly staphylococci and pneumococci, such 
enzymes may be of immediate benefit in these environments.  
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1. Introduction 
Bacteriophages are numerous in the ecosystem and play a central role in bacterial ecology 
(Ashelford et al., 2000; Brabban et al., 2005; Breitbart et al., 2003; Danovaro et al., 2001; 
Fuhrman, 1999). Bacteriophages have frequently been isolated from various environmental 
sources and the gastrointestinal tract of animals (Adams et al., 1966; Bielke et al., 2007a; 
Breitbart et al., 2003; Callaway et al., 2003, 2006; Dhillon et al., 1976; Filho et al., 2007; 
Higgins et al., 2008; Klieve & Bauchop, 1988; Klieve & Swain, 1993; Kudva et al., 1999; Orpin 
& Munn, 1973; Raya et al., 2006; Smith & Huggins, 1982). Breitbart and co-workers (2003) 
found bacteriophages to be the second most abundant uncultured biological group in their 
analysis of human feces and Furhman (1999) suggests that bacteriophages could be 
responsible for as much as 50% of bacterial death in surface waters. It has been suggested 
that bacteriophages in cattle help maintain microbial diversity and balance, allowing the 
ecology of the gut, particularly the rumen, to adapt to changes in feed and water intake 
(Klieve and Swain 1993; Swain et al., 1996). Bacteriophages lytic for E. coli and Salmonella 
were isolated from cattle feedlots with no correlation between presence of E. coli O157:H7 or 
Salmonella and bacteriophages against the specific pathogen (Callaway et al., 2006). 
Salmonella targeted bacteriophages were isolated from Salmonella-positive poultry farms, 
with bacteriophages found at only one Salmonella-negative farm. A total of seven 
bacteriophages were isolated from farms that were Salmonella-positive, and two 
bacteriophages from the single Salmonella-negative chicken house (Higgins et al., 2008). This 
might suggest that as environmental Salmonella increased, a near-simultaneous increase in 
bacteriophages may have also occurred. The hypothesis corresponds with other reports 
where it was found that bacteriophages within treated animals remained in the animal for 
the duration of the infection, but once the bacterial host was no longer present, the presence 
of bacteriophages also rapidly dropped (Barrow et al., 1998; Calloway et al., 2003; Hurley et 
al., 2008; Smith and Huggins, 1987). 
Because bacteriophages are a natural component of gastrointestinal microbial populations, 
they are presumably a potentially effective control strategy against bacterial pathogens. 
However, in vivo attempts have yielded mixed results (Bach et al., 2003; Bielke et al., 2007b, 
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Hurley et al., 2008; Kudva et al., 1999; O’Flynn et al., 2004; Higgins et al., 2007; Smith and 
Huggins, 1983, 1987; Toro et al., 2005). This chapter will review both successes and failures 
in research aimed to reduce enterobacterial infections of the gastrointestinal tract. During 
the last approximately 60 years, there have been sporadic published reports of efficacy in 
treating Enterobacteriaceae infections systemically and within the gastrointestinal tract. 
While a number of reports have rather consistently indicated that systemic or tissue-
associated infections were treatable by parenteral administration of appropriate 
bacteriophage cocktails, reports of successful treatment of enteric Enterobacteriaceae are 
much more sporadic, and are interspersed with a number of reports of failed attempts for 
enteric treatment. The present chapter will discuss selected successes and failures and 
describe the possible differences in these studies and the potential for development of more 
effective strategies.  
Bacteriophages can be regarded as natural enemies of bacteria, and therefore are logical 
candidates to evaluate as agents for the control of bacterial pathogens. Bacteriophages can 
be selected to kill bacterial pathogen target cells, and not affect desired bacteria such as 
starter cultures, commensals in the gastrointestinal tract or on skin, or accompanying 
bacterial flora in the environment. Bacteriophages harbor the potential for precise targeting 
of bacterial contamination, without compromising the viability of beneficial microorganisms 
in the habitat. Additionally, since bacteriophages are generally composed entirely of 
proteins and nucleic acids, the eventual breakdown products consist exclusively of amino 
acids and nucleotides, and, unlike antibiotics and antiseptic agents, their introduction into 
and distribution within a given environment may be seen as a natural process. With respect 
to their potential application for the biocontrol of pathogens, it should be considered that 
bacteriophages are the most abundant self-replicating units in our environment, and are 
present in significant numbers in water and foods of various origins, and most surfaces in 
our environment (Sulakvelidze and Barrow, 2005). A test of the safety of bacteriophages 
when administered orally to human volunteers revealed no adverse side effects (Bruttin and 
Brüssow, 2005). Very low levels of bacteriophage were found in the serum, suggesting low 
passage from the intestinal lumen to the blood flow, liver enzymes were not affected by 
bacteriophage ingestion, and no antibodies to the bacteriophages were detected. Mai and co-
workers (2010) noted that treatment of mice with anti-Listeria bacteriophages did not 
significantly affect gastrointestinal microflora diversity. Additionally, Carlton et al. (2005) 
reported no adverse effects in rats after five continuous days of oral bacteriophage 
administration, suggesting that bacteriophages can in fact be regarded as safe. 
Prior to the discovery of antibiotics, bacteriophages were researched as bacterial control 
agents (For a review, see Alisky et al., 1998). However, a lack of understanding of 
mechanisms resulted in therapeutic difficulties and resulted in poor experimental results. 
When treating bacterial infections, the goal is to take advantage of the lytic cycle of 
bacteriophages, rather than the lysogenic cycle in which bacteria are not killed (Figure 1). 
With an increase in bacterial pathogens that are resistant to traditional antibiotics, the 
scientific community has developed a renewed interest in using bacteriophages and they are 
currently being investigated in numerous laboratories and companies as alternative 
treatments for a variety of problems. Indeed, for some specific applications, bacteriophage 
therapy holds significant promise, and there is growing evidence that bacteriophage may be 
effective for some applications, with the caveat that these viruses are incredibly specific by 
definition, and selection of product for specific applications may be of critical importance.  
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in which the bacteriophage inserts its DNA into the host cell and replicates to make multiple 
copies of the bacteriophage virus before lysing the cell wall, and releasing daughter viruses to 
repeat the cycle. Bacteriophages can also enter a lysogenic cycle. Instead of using the cell to 
replicate large numbers of virus particles, the bacteriophage genome can remain in the host’s 
genome and replicate through binary fission of the cell. Some lysogenic bacteriophages are 
capable of entering into the lytic cycle, while others will remain lysogenic.  
2. Successes 
The bacteriocidal effects of bacteriophages have long been studied for their usefulness in 
treating gastrointestinal infections. Early studies originating from the former Soviet Union, 
Eastern Europe, and Western Asia suggested bacteriophages could prevent and treat Vibrio 
cholera infections (Dubos et al., 1943; Dutta, 1963; Marčuk et al., 1971; Sayamov, 1963). In the 
1980s, Slopek and co-workers (1983a-b, 1984, 1985a-c, 1987) published numerous papers 
showing the promising results of treating septic patients with bacteriophages. While the 
validity of these studies has been questioned, in part due to relaxed scientific rigor in these 
regions during the time when these studies were completed (Alisky et al, 1998; Merril et al., 
2003) and are not often cited by bacteriophage researchers in recent years, they have served 
as an inspiration for continued research into the possibility that bacteriophages can cure 
gastrointestinal diseases in humans and animals. 
Some bacteriophage research has also focused on the treatment of animals to cure a variety 
of diseases. In relatively recent years, Smith and Huggins (1982) compared the efficacy of 
 
Bacteriophages 160 
Hurley et al., 2008; Kudva et al., 1999; O’Flynn et al., 2004; Higgins et al., 2007; Smith and 
Huggins, 1983, 1987; Toro et al., 2005). This chapter will review both successes and failures 
in research aimed to reduce enterobacterial infections of the gastrointestinal tract. During 
the last approximately 60 years, there have been sporadic published reports of efficacy in 
treating Enterobacteriaceae infections systemically and within the gastrointestinal tract. 
While a number of reports have rather consistently indicated that systemic or tissue-
associated infections were treatable by parenteral administration of appropriate 
bacteriophage cocktails, reports of successful treatment of enteric Enterobacteriaceae are 
much more sporadic, and are interspersed with a number of reports of failed attempts for 
enteric treatment. The present chapter will discuss selected successes and failures and 
describe the possible differences in these studies and the potential for development of more 
effective strategies.  
Bacteriophages can be regarded as natural enemies of bacteria, and therefore are logical 
candidates to evaluate as agents for the control of bacterial pathogens. Bacteriophages can 
be selected to kill bacterial pathogen target cells, and not affect desired bacteria such as 
starter cultures, commensals in the gastrointestinal tract or on skin, or accompanying 
bacterial flora in the environment. Bacteriophages harbor the potential for precise targeting 
of bacterial contamination, without compromising the viability of beneficial microorganisms 
in the habitat. Additionally, since bacteriophages are generally composed entirely of 
proteins and nucleic acids, the eventual breakdown products consist exclusively of amino 
acids and nucleotides, and, unlike antibiotics and antiseptic agents, their introduction into 
and distribution within a given environment may be seen as a natural process. With respect 
to their potential application for the biocontrol of pathogens, it should be considered that 
bacteriophages are the most abundant self-replicating units in our environment, and are 
present in significant numbers in water and foods of various origins, and most surfaces in 
our environment (Sulakvelidze and Barrow, 2005). A test of the safety of bacteriophages 
when administered orally to human volunteers revealed no adverse side effects (Bruttin and 
Brüssow, 2005). Very low levels of bacteriophage were found in the serum, suggesting low 
passage from the intestinal lumen to the blood flow, liver enzymes were not affected by 
bacteriophage ingestion, and no antibodies to the bacteriophages were detected. Mai and co-
workers (2010) noted that treatment of mice with anti-Listeria bacteriophages did not 
significantly affect gastrointestinal microflora diversity. Additionally, Carlton et al. (2005) 
reported no adverse effects in rats after five continuous days of oral bacteriophage 
administration, suggesting that bacteriophages can in fact be regarded as safe. 
Prior to the discovery of antibiotics, bacteriophages were researched as bacterial control 
agents (For a review, see Alisky et al., 1998). However, a lack of understanding of 
mechanisms resulted in therapeutic difficulties and resulted in poor experimental results. 
When treating bacterial infections, the goal is to take advantage of the lytic cycle of 
bacteriophages, rather than the lysogenic cycle in which bacteria are not killed (Figure 1). 
With an increase in bacterial pathogens that are resistant to traditional antibiotics, the 
scientific community has developed a renewed interest in using bacteriophages and they are 
currently being investigated in numerous laboratories and companies as alternative 
treatments for a variety of problems. Indeed, for some specific applications, bacteriophage 
therapy holds significant promise, and there is growing evidence that bacteriophage may be 
effective for some applications, with the caveat that these viruses are incredibly specific by 
definition, and selection of product for specific applications may be of critical importance.  
Successes and Failures of Bacteriophage Treatment  
of Enterobacteriaceae Infections in the Gastrointestinal Tract of Domestic Animals 161 
 
Figure provided by Dr. Jack Higgins. 
Fig. 1. Life Cycle of Bacteriophages. Bacteriophages are capable of entering either a lytic cycle, 
in which the bacteriophage inserts its DNA into the host cell and replicates to make multiple 
copies of the bacteriophage virus before lysing the cell wall, and releasing daughter viruses to 
repeat the cycle. Bacteriophages can also enter a lysogenic cycle. Instead of using the cell to 
replicate large numbers of virus particles, the bacteriophage genome can remain in the host’s 
genome and replicate through binary fission of the cell. Some lysogenic bacteriophages are 
capable of entering into the lytic cycle, while others will remain lysogenic.  
2. Successes 
The bacteriocidal effects of bacteriophages have long been studied for their usefulness in 
treating gastrointestinal infections. Early studies originating from the former Soviet Union, 
Eastern Europe, and Western Asia suggested bacteriophages could prevent and treat Vibrio 
cholera infections (Dubos et al., 1943; Dutta, 1963; Marčuk et al., 1971; Sayamov, 1963). In the 
1980s, Slopek and co-workers (1983a-b, 1984, 1985a-c, 1987) published numerous papers 
showing the promising results of treating septic patients with bacteriophages. While the 
validity of these studies has been questioned, in part due to relaxed scientific rigor in these 
regions during the time when these studies were completed (Alisky et al, 1998; Merril et al., 
2003) and are not often cited by bacteriophage researchers in recent years, they have served 
as an inspiration for continued research into the possibility that bacteriophages can cure 
gastrointestinal diseases in humans and animals. 
Some bacteriophage research has also focused on the treatment of animals to cure a variety 
of diseases. In relatively recent years, Smith and Huggins (1982) compared the efficacy of 
 
Bacteriophages 162 
bacteriophages with that of antibiotics in treating both generalized and cerebral infections in 
mice. They isolated anti-K1 bacteriophages that were able to lyse K1+ E. coli. When 
administered by intramuscular injection at the same time as, or eight hours after, infection 
with E. coli. These bacteriophages were able to cure infection, even when used at a low titer. 
The same effects were seen with intracerebrally infected mice treated with bacteriophages 16 
hours after infection. The bacteriophages were more effective than numerous types of 
antibiotics at curing mice. Smith and Huggins (1983) also successfully used bacteriophage 
therapy to treat calves, pigs, and lambs that had been infected with E. coli. They selected a 
bacteriophage that would lyse E. coli and also selected a second bacteriophage that would 
lyse E. coli cultures that had become resistant to the first bacteriophage. Key to the success of 
this selection method was the idea that, by selecting a bacteriophage that affected the K 
antigens of E. coli, resistance would require a modification to an important component of 
virulence for the cell. Resistant E. coli strains had different colony morphology on agar 
plates and were K-negative. Treatment consisted of two bacteriophages, one that resulted in 
a K-negative strain as resistance was developed, and a second to lyse the K-negative cells. 
The combination of bacteriophages to combat resistance was better able to prevent death in 
calves with diarrhea than a single bacteriophage or no bacteriophage treatment. Sheng et al. 
(2006) followed a similar method to select bacteriophages against E. coli O157:H7. They 
selected bacteriophage that attached to LPS on the cell surface so that resistant cells had to 
change LPS expression with the idea that it would decrease the pathogenicity of the bacteria. 
Resistant cultures had rough colony morphology instead of the usual smooth mucoid 
texture of many typical pathogenic Enterobacteriaceae. When bacteriophage KH1, selected 
to attach to LPS, was administered alone it did not reduce E. coli O157:H7 recovery in sheep. 
However, when combined with another bacteriophage, recovery of E. coli O157:H7 was 
reduced. In 1987, Smith and Huggins used bacteriophages to treat calves with E. coli-caused 
diarrhea. They selected their bacteriophages by administering E. coli to a calf followed by a 
bacteriophage cocktail. Bacteriophages able to survive the gastrointestinal tract were 
collected in the feces 24 hours post-administration. These bacteriophages were used to treat 
subsequent calves. Calves given bacteriophages within 24 hours of the onset of diarrhea 
recovered within 20 hours. Also, sick calves placed on bedding that had been sprayed with 
bacteriophages recovered from diarrhea. Smith and Huggins noted that during the period of 
disease, bacteriophages continued to persist in the feces, but after recovery, bacteriophage 
numbers dropped dramatically. 
Biswas et al. (2002) successfully cured vancomycin-resistant Enterococcus faecium-infected 
mice with bacteriophage therapy. Mice were treated with bacteriophages just 45 minutes 
after infection with bacteria. Treatment at a multiplicity of infection (MOI) level of 0.3 to 3.0 
was able to cure all of the infected mice. However, lower multiplicity of infection ratios 
(MOI) of 0.03 to 0.003 resulted in just 60% and 40% survival of mice, respectively. They also 
noted that bacteriophage treatment could be delayed for up to five hours after infection. 
However, if treatment was delayed for 18 or 24 hours, only 50% recovery was seen. In other 
studies, preparations of the appropriate bacteriophage have been able to protect mice and 
guinea pigs against systemic infections with strains of Pseudomonas aeruginosa and 
Acinetobacter baumanii and have been able to inhibit the rejection of skin grafts caused by P. 
aeruginosa infections (Soothill 1992, 1994). Interestingly, a very low MOI of 10-6, one 
bacteriophage to one million bacteria, was able to protect mice against infection with P. 
aeruginosa (Soothill, 1992). 
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While each of these studies was successful at curing the infected animals, treatment was 
given simultaneously with the bacteria, or just a few hours after infection. These would not 
be practical conditions for treating disease under real world conditions because it is often 
not known that an animal is sick until clinical signs are noticed several days after the 
infection begins. Furthermore, key to the success of these experiments, is knowledge that the 
selected host is susceptible to the bacteriophage (or combination of bacteriophages) which 
was administered. As discussed below, multiple researchers have focused on improving 
food safety by treating animals pre-harvest with bacteriophages targeted against foodborne 
pathogens. 
One such pathogen has been Escherichia coli O157:H7 in ruminants. Much research has 
investigated the ability of bacteriophages to treat E. coli O157:H7 infections in sheep and 
cattle. Enterohemorrhagic E. coli, such as E. coli O157:H7, cause severe enterohemorrhagic 
enteritis, renal uremic syndrome, and are capable of causing death, especially among young 
children, immune-suppressed individuals, and the elderly (Gyles, 2007; Rangel et al., 2005). 
Cattle and sheep are the primary sources of waterborne and foodborne cases, and with an 
infectious dose of approximately 100 cells, control of this pathogen is of utmost importance 
to meat processors (Besser et al., 1999; Chapman et al., 2001; Grauke et al., 2002; Wells et al., 
1991; Zhao et al., 1995). Like other E. coli, the primary site of infection for cattle and sheep is 
the hindgut. Grauke et al. (2002) noted a correlation between positive fecal samples and 
isolation from the rumen and duodenum while Naylor et al. (2003) found the primary site of 
infection in the recto-anal junction. Other reports have confirmed the rectum and cecum as 
primary sites of infection in cattle (Buchko et al., 2000; Dean-Nystrom et al., 1999). These 
findings suggest that oral bacteriophage treatment, with bacteriophages selected for 
anaerobic activity, may affect E. coli O157:H7 colonization in sheep and cattle. In fact, 
multiple studies have focused on the application of anaerobically active bacteriophages to 
ruminants for the control of E. coli O157:H7, as described below. 
Bacteriophage CEV1, isolated from sheep with short and transient E. coli O157:H7 infections, 
was found to be lytic against 20 pathogenic strains of E. coli and had both aerobic and 
anaerobic in vitro activity. Oral administration of CEV1 to infected sheep, three days post-
infection, showed reduced levels of E. coli O157:H7 in the ruminal, cecal, and rectal contents 
two days after bacteriophage treatment (Raya et al., 2006). Similarly, rectal administration of 
bacteriophage KH1 and SH1 to cattle infected with E. coli O157:H7 was able to reduce the 
levels of recovered pathogen. The same bacteriophages eliminated detectable levels of E. coli 
O157:H7 in mice (Sheng et al., 2006). In 2008 Calloway et al. isolated bacteriophages from 
cattle feces and noted an effectiveness of these bacteriophages at reducing E. coli O157:H7 
levels throughout the intestine of sheep. Bacteriophages were selected in vitro for their 
ability to lyse E. coli O157:H7, and eight different bacteriophages were included in the 
culture to combat resistance by the bacteria. While each of these studies effectively reduced 
the levels of E. coli O157:H7 in sheep and cattle, the researchers noted that bacteriophages 
may not prove a long-term treatment and application should be considered immediately 
prior to processing for maximum effectiveness. The principle reason for this is that as with 
antimicrobial chemicals, serial applications have often led to selection of bacteriophage-
resistant bacteria.  
Like E. coli O157:H7, researchers have attempted to reduce multiple serovars of Salmonella in 
poultry, a frequent source of cases of Salmonella in humans. Salmonella enterica serovars 
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continue to be among the most important foodborne pathogens worldwide due to the 
considerable human rates of illness reported and the wide range of hosts that are colonized 
by members of this genus, which serve as vectors and reservoirs for spreading these agents 
to animal and human populations (CDC 2005, 2006a,b, 2007, 2008a,b). Furthermore, public 
concern for the appearance of resistant strains to many antibiotics, particularly among 
zoonotic pathogens such as common Salmonella isolates, is also challenging several sectors of 
agriculture to find alternative means of control (Boyle et al., 2007). In the United States, it is 
estimated that 1.4 million humans contract salmonellosis and that the annual cost of this 
illness, including lost productivity, is $3 billion annually (WHO, 2006). In the year 2004, 
surveillance data indicated that the greatest number of foodborne illnesses was caused by 
Salmonella, comprising 42% of all laboratory diagnoses (FoodNet, 2005). Because many of 
these illnesses are associated with poultry and poultry products (Bean & Griffin, 1990; 
Persson & Jendteg, 1992), the reduction of microbial contamination during the production of 
poultry is important. Further considerations for bacteriophage treatment to control 
Salmonella in poultry are issues associated with antiobiotic treatment. Poultry harboring 
Salmonella infection can be treated with antibiotics with some success (Goodnough & 
Johnson, 1991; Muirhead, 1994). However, Manning and co-workers (1994, 1992) reported 
increased Salmonella colonization when chickens were treated with selected antibiotics, 
possibly due to reduction of normal bacterial flora in the gastrointestinal tract that serve as a 
natural barrier to Salmonella infection. Additionally, Kobland et al. (1987) and Gast et al. 
(1988) have recovered antibiotic resistant Salmonella from experimentally challenged birds 
treated with antibiotics. Recently, the United States Food and Drug Administration (FDA) 
has banned the use of enrofloxacin in poultry production because of concerns regarding an 
increase in resistant Campylobacter infections in humans (FDA, 2005). Recently, a ban on 
antibiotics and coccidiostats was put in place by European Parliament Council Directive 
1831/2003. The regulation stated that antibiotics, other than coccidiostats and 
histomonostats, had to be removed from feed by the end of 2005, and that anticoccidial 
substances would be prohibited by 2013. After these dates, medical substances in animal 
feeds will supposedly be limited to therapeutic use by veterinary prescription (European 
Parliamant and of the Council, 2003). Thus, it is increasingly important that effective and 
inexpensive methods or products to treat bacterial infections in food production animals be 
developed. 
Recently, Toro et al. (2005) reported using a combination of bacteriophages and competitive 
exclusion to treat Salmonella-infected chickens. They were able to reduce recovery of 
Salmonella Typhimurium (ST) from the ceca of chickens. In the successful experiments, 
chickens were challenged with ST during the course of treatment with bacteriophages. 
However, treatment with bacteriophages was not better than treatment with a competitive 
exclusion product. And, combination of competitive exclusion and bacteriophages did not 
further reduce ST recovery. Similarly, Filho and co-workers (2007) reported that 
administration of bacteriophage cocktails could temporarily reduce the incidence of 
Salmonella recovery in broiler chickens, but by 48 hours post-treatment there was no 
difference between treated and non-treated controls. Additionally, combining the 
bacteriophage cocktail with a probiotic culture had no effect on Salmonella recovery when 
compared to bacteriophages alone. The pattern was also noted by Higgins et al. (2007) when 
Salmonella was reduced to zero recovery, but 48 hours after administration recovery from 
bacteriophage-treated birds increased to higher than non-treated control groups. 
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In addition to control of paratyphoid Salmonella, much research has been completed on the 
study of bacteriophages in poultry for other diseases. The first reports of bacteriophage 
therapeutics in poultry were made by d’Herelle in 1922 when he reported successful 
treatment of at least 19 barnyards affected by fowl typhoid. Bacteriophages administered 
were selected specifically to target the pathogens involved. The pathogens causing the 
typhoid were either one or a combination of five different bacterial species. The data 
reported in these studies is anecdotal, with the statement “The sick recovered and the 
epizootic stopped at once” comprising all the results for those studies. However, treatment 
of a highly pathogenic and systemic host-adapted Salmonella, in this case, might be more 
effective as even a temporary reduction in pathogen levels could buy a critical amount of 
time for acquired immunity and eventual recovery of infected birds from the disease. This 
could be distinctly different than the case with the essentially non-pathogenic (for poultry) 
common paratyphoid isolates that are commonly implicated in food borne disease of 
humans. Supporting this hypothesis, other attempts to alleviate bacterial disease in poultry 
have focused on non-paratyphoid Salmonella. In 1926, Pyle isolated bacteriophages specific 
for Salmonella pullorum from the feces of birds affected with the disease. He demonstrated 
that even after 120 passages, strains of bacteriophage that were not initially lytic did not 
become lytic. Additionally he observed that two bacteriophage strains which were initially 
lytic became more lytic over 60 serial passages. Two experiments employing the lytic 
bacteriophages ensued. Salmonella pullorum and bacteriophages were injected 
simultaneously into the pectoral muscle of chickens in one treatment group, with the treated 
group receiving bacteriophage eight hours post-challenge. When compared to controls that 
received no bacteriophage treatment, mortality was delayed in both treatment groups. In the 
second experiment, the bacteriophages and S. pullorum were administered or the 
bacteriophages were administered eight hours post-challenge in the drinking water. Again, 
when compared to controls which did not receive bacteriophage treatment, the onset of 
mortality was delayed. 
Berchieri et al. (1991) treated birds infected with ST with bacteriophages and found that the 
levels of ST could be reduced by several log10, and mortality associated with this unusually 
pathogenic ST was reduced significantly. However, ST was not eliminated, and returned to 
original levels within six hours of treatment. Also, the bacteriophages did not persist in the 
gastrointestinal tract for as long as the Salmonella was present. In fact, bacteriophages 
persisted only as long as they were added to the feed. In order to be effective, 
bacteriophages had to be administered in large numbers, and soon after infection with ST. 
Similar to reports below (Hurley et al., 2008), the bacteriophages may have been killing the 
bacteria via lysis from without and, instead of infecting and replicating within the cell, the 
bacteriophages may have been killing the ST by an excess of penetration from the 
bacteriophages. This may explain the decline in bacteriophage numbers despite the presence 
of a host for replication. 
Multiple researchers have investigated the possibility of curing E. coli infections in poultry. 
In 1998 Barrow et al. prevented morbidity and mortality in chickens using bacteriophages 
lytic for E. coli. When chickens were challenged intramuscularly with E. coli and 
simultaneously treated with 106 – 108 pfu of bacteriophages, mortality was reduced by 100%. 
This study also demonstrated that bacteriophages can cross the blood brain barrier, and 
furthermore can amplify in both the brain and the blood. 
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In addition to control of paratyphoid Salmonella, much research has been completed on the 
study of bacteriophages in poultry for other diseases. The first reports of bacteriophage 
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epizootic stopped at once” comprising all the results for those studies. However, treatment 
of a highly pathogenic and systemic host-adapted Salmonella, in this case, might be more 
effective as even a temporary reduction in pathogen levels could buy a critical amount of 
time for acquired immunity and eventual recovery of infected birds from the disease. This 
could be distinctly different than the case with the essentially non-pathogenic (for poultry) 
common paratyphoid isolates that are commonly implicated in food borne disease of 
humans. Supporting this hypothesis, other attempts to alleviate bacterial disease in poultry 
have focused on non-paratyphoid Salmonella. In 1926, Pyle isolated bacteriophages specific 
for Salmonella pullorum from the feces of birds affected with the disease. He demonstrated 
that even after 120 passages, strains of bacteriophage that were not initially lytic did not 
become lytic. Additionally he observed that two bacteriophage strains which were initially 
lytic became more lytic over 60 serial passages. Two experiments employing the lytic 
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Huff et al. (2003) used bacteriophages to treat airsacculitis caused by E. coli in chickens. 
Marked efficacy was achieved when administering bacteriophage with the bacterial 
challenge inoculum, by injection in the thoracic air sac. However, drinking water 
administration of the same bacteriophages was ineffective at preventing the manifestation of 
the disease syndrome. This indicated that it is important to deliver bacteriophages directly 
to the site of infection. It was also shown that an aerosol treatment of bacteriophages, 
followed by an E. coli challenge on the same day, the next day, or three days later reduced 
morbidity and mortality associated with respiratory infection (Huff et al., 2002a). Thus, the 
study demonstrated a prophylactic ability of bacteriophages in the respiratory tract. 
However, given the evidence that bacteriophages do not typically remain in an environment 
without an appropriate host (Ashelford et al., 2000; Fiorentin et al., 2005; Hurley et al., 2008; 
Oot et al., 2005), prophylaxis could be difficult without continued administration or by 
knowing an animal had been exposed. 
In summary, there are few current reports of efficacy of bacteriophage treatment in chickens 
other than when treatment was administered at the same time as bacterial challenge or via 
injection. Outside of experimentally controlled situations, it is not usually possible to treat a 
disease at the same time as the challenge. Also, it is not practical to treat commercial poultry 
flocks by individual injection, though highly valuable breeder flocks might warrant the time 
and money involved. However, such of these limited successes do not necessarily translate 
into effective enteric treatments. Host-associated pressure against pathogen infections may 
predispose systemic bacteriophage therapy toward success. In these cases, where 
bacteriophages are used to treat systemic or tissue-associated infections, an acute efficacy of 
merely reducing the infection load by 90% or more, could greatly reduce mortality and 
reduce the duration and magnitude of disease by allowing time for acquired immunity in 
the animal host. In the intestinal lumen, host pressures against the infection may not be as 
severe and many Enterobacteriaceae are capable of free living status within the gut without 
eliciting robust acquired immune responses from the infected animal. In these cases, a 
temporary reduction in enteric colonization may not be as likely to be curative, as discussed 
below.  
3. Failures 
As the history of published successful bacteriophage treatments of enteric disease is 
reviewed, it is readily evident that such reports, while often dramatic in effect, are relatively 
sporadic during the last approximately 60 years. Given that experimental failures frequently 
are not published, as the cause of failure can often not be ascertained, the authors suspect 
that history is replete with unpublished examples of failures to treat enteric 
Enterobacteriaceae infections. Still, some reports of failures, or incomplete successes, have 
been documented and are described below. 
Bacteriophage KH1, shown to lyse 12 of 16 E. coli O157 strains tested, originally showed 
promise as results of in vitro tests demonstrated an ability to lyse bacterial cultures, by 
plaque formation, at both 37 °C and 4 °C (Kudva et al., 1999). However, when administered 
to E. coli O157:H7 infected sheep, bacteriophage KH1 did not effectively reduce levels of 
recovered pathogen, despite continued recovery of bacteriophages from the feces for eight 
days post-treatment (Sheng et al., 2006). Aerobic, instead of anaerobic, selection may have 
played a key role in the ability of this bacteriophage to effectively eliminate intestinal 
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carriage of E. coli O157:H7. Multiple researchers have suggested anaerobic environments can 
affect bacteriophage activity (Bach et al., 2003; Kudva et al., 1999; Raya et al., 2006; Tanji et 
al., 2005). When Bach and co-workers (2003) tested the effects of bacteriophage DC22 on E. 
coli O157:H7 in an in vitro fermentation system prior to treating infected sheep, 
bacteriophage DC22 only decreased microbial levels in the artificial ruminant set up at high 
multiplicities of infection (MOI), and failure of the bacteriophage to replicate and increase 
PFU over the course of 120 hours suggests that the bacteriophages may have reduced E. coli 
by lysis from without rather than by infecting, replicating within, and lysing the cells. 
Subsequent in vivo studies in sheep did not result in decreased shedding of E. coli O157:H7, 
and bacteriophages were found in the feces for only two days post-treatment. Similarly, 
Tanji et al., (2005) administered a bacteriophage with promising in vitro test results to E. coli 
O157:H7 mice with little success. These studies reinforce the need to understand how in vitro 
conditions relate to the in vivo infection parameters and show the need for an appreciation 
for the ecosystem where the bacteriophage will be used. 
In silico modeling was used by Hurley et al. (2008) to predict parameters for treating 
Salmonella-infected chickens with bacteriophage SP6 in an attempt to better comprehend the 
biological factors of the luminal ecosystem, Salmonella, and bacteriophages, and how they 
interact within the gastrointestinal tract. Among the factors considered were varying growth 
rates, feed and water intake, and Salmonella resistance to the bacteriophages. The results of 
these in silico test results were considered when an in vivo challenge was designed. 
However, after bacteriophage treatment Salmonella was detected at levels that did not differ 
from control groups not treated with bacteriophages. In fact, bacteriophage infection may 
have selected for resistant bacteria because half of the Salmonella isolates from a treated 
group were resistant to bacteriophage SP6 on day 29, one day after the second dose of 
bacteriophage treatment. Moreover, many of the Salmonella cultured from other samples of 
bacteriophage-treated birds showed at least a partial resistance to bacteriophages, with only 
partially clear plaques forming on soft agar overlays when, prior to bacteriophage 
treatment, the Salmonella isolate was susceptible and clear plaques routinely formed on soft 
agar overlays. The authors also noted a steady decrease in bacteriophage excretion, despite 
continued high levels of Salmonella recovery within the cecum. This data is similar to the 
results of Fiorentin et al. (2005), where Salmonella continued to be detected 21 days after 
inoculation, but bacteriophage levels had declined to undetectable levels. In another related 
study, bacteriophage treatment resulted in higher levels of Salmonella recovery in turkeys 48 
hours post-treatment after an initial decrease in Salmonella at 6, 12, and 24 hour post-
treatment time points (Higgins et al., 2007). These bacteriophages were selected for ability to 
survive low pH, to simulate passage through the ventriculus of poultry, and were 
administered with Mg(OH)2 to aid adhesion of bacteriophages to the cell walls of bacteria 
(Eisenstark, 1967). The authors also noted that bacteriophage resistance was common in all 
cultures.  
Our laboratory and others have demonstrated that resistance to bacteriophages selected 
against Salmonella isolates quickly occurs, often in a single passage (Bastias et al., 2010; 
Hurley et al., 2008; Fiorentin et al., 2005). When bacteriophage cocktails of 71 different 
bacteriophages selected for treatment of experimental Salmonella Enteritidis infections in 
chickens, a brief reduction in enteric colonization was noted during the first 24 hours, but 
rebound levels were similar to controls within 48 hours, even with repeated or continuous 
dosage of the bacteriophage cocktail (Higgins et al., 2007). Because of the demonstrated 
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temporary reduction in enteric colonization in these studies, effective bacteriophages were 
demonstrably able to pass to the lower gastrointestinal tract. As continued treatments failed 
to maintain this reduction, development of resistance by the enteric Salmonella Enteritidis is 
the most likely explanation.  
In order to potentially deliver higher levels of bacteriophage, several attempts to protect the 
bacteriophage cocktail through the upper gastrointestinal tract were made in our laboratory. 
Pre-treatment of infected poultry with antacid preparations designed to reduce the acidity 
of the proventriculus (the true stomach of birds) were successful in increasing the number of 
administered bacteriophage that successfully passed into the intestinal tract, but this 
treatment did not improve the outcome of bacteriophage treatment of Salmonella Enteritidis 
infection (Higgins et al., 2007).  
An alternative approach is to select for alternative non-pathogenic bacteriophage hosts 
which could potentially “carry” bacteriophage through the gastrointestinal tract and, with 
continuous dietary administration of the non-infected alternative host bacterium, provide a 
means of amplification within the gut of the host (Bielke et al., 2007a). Bielke and co-workers 
(2007b) demonstrated that non-pathogenic alternative hosts can be selected for some 
bacteriophages that were originally isolated using a Salmonella Enteritidis target. This 
approach, which has potential utility for amplification of large numbers of phage without 
the necessity to thoroughly separate bacteriophage from a pathogenic target host, was also 
used to create a potential “Trojan Horse” model for protecting the bacteriophages through 
the upper gastrointestinal tract, thus potentially providing a vehicle for enteric amplification 
of those surviving bacteriophages. In these studies, neither the Trojan Horse approach, nor 
the continuous feeding of the alternative host bacteria as a source of enteric amplification, 
were effective in producing even more than a transient reduction in enteric Salmonella 
infections.  
Through these failures, many investigators have concluded that the escape of even a 
minority of target bacteria within the enteric ecosystem allows for almost immediate 
selection of resistant target bacteria and rebound to pre-treatment levels of infection may 
even exceed the levels of non-treated controls in some cases.  
4. Potential strategies to overcome failures 
Bacteriophage resistance is an important component of therapy to overcome before 
bacteriophages can really be a viable antimicrobial for infection. The generation time for 
bacteria is typically short enough that mutants with bacteriophage resistance can emerge 
within hours (Higgins et al., 2007; Lowbury and Hood, 1953). One possible strategy to 
overcome this problem is administration of multiple bacteriophage isolates for treatment. 
Smith and Huggins (1983) selected a bacteriophage against E. coli K+, and then subsequently 
selected a bacteriophage against a resistant strain of E. coli K+. The combination of these two 
bacteriophages reportedly cured calves, pigs, and lambs of intestinal colibacillosis. Despite 
this success, resistance is difficult, if not impossible, to predict and combining the correct 
cocktail of bacteriophages to overcome resistance would be a blind guess in most cases. 
This, combined with the highly selective nature of individual bacteriophage isolates and 
even cocktails, as described above, is discouraging from the perspective of enteric 
therapeutic development, especially for very low level or opportunistic pathogens.  
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The most success is likely to come from treating points in the system that are continually 
bombarded with bacteria that have not been previously subjected to the bacteriophages 
being used for treatment. Also important for this system is keeping exposure of the bacteria 
to bacteriophages to a minimal amount of time. If the bacteriophages interact with the 
bacteria for long periods of time, the bacteria will become resistant as repeatedly 
demonstrated in the above discussion. Food and meat processing facilities are an excellent 
example. As live animals enter a slaughter/processing facility, the bacteria have not likely 
been exposed to the bacteriophages used to treat the infection, thus greatly increases the 
chances of success. Similar potential exists for hatchery applications, and applications to 
food products, as discussed below.  
Higgins and co-workers (2005) successfully treated turkey carcasses at a processing facility 
with bacteriophages specific to the Salmonella to which they were infected. This process was 
effective when either an autogenous bacteriophage treatment targeted to the specific 
Salmonella strain infecting the turkeys was used, or a cocktail of nine wide host-range 
Salmonella-targeting bacteriophage were used. Similarly, a bacteriophage treatment for cattle 
carcass contamination has been effective at reducing the E. coli 0157:H7 load at processing 
has been developed and commercially licensed in the United States. These successes avoid 
development of bacteriophage resistance by applying treatment at a single point during 
production, in an environment where proliferation of the target organism is extremely 
limited. In this way, since the target organism is never intentionally exposed twice to the 
same treatment, resistance is unlikely to ever increase beyond the naturally-occurring 
resistance to the bacteriophage (or cocktail) used.  
One of the most well documented successes of published treatment of enteric 
Enterobacteriaceae infections with bacteriophages was the study of Smith and Huggins 
(1983) as described above. It is notable that in this successful study, the bacteriophage 
cocktail used was a combination of two bacteriophages, but the second was isolated using 
the target organism which was resistant to the first bacteriophage. This approach of 
selecting for bacteriophage isolates using target bacteria that are resistant to sequential 
bacteriophage treatments was not used in the work of Higgins et al. (2007), or in several 
other published studies. Higgins and co-workers (2007) used a collection of bacteriophages, 
independently isolated from different sources and with several different plaque 
morphologies, suggesting that a number of different bacteriophages were employed – and 
failed to persistently reduce enteric colonization. Similarly, application of a bacteriophage 
combination failed to reduce S. Enteritidis PT4 infections in broilers (Fiorentin et al., 2005). 
However, some cocktails have been successful. A combination of three bacteriophages 
isolated from feces of patients infected with E. coli O157:H7 were applied to contaminated 
processed beef for reduction of the pathogen (O’Flynn et al., 2004). In 2006, Sheng et al. 
reported that a combination of two bacteriophages worked better at reducing E. coli 
O157:H7 in ruminants than each bacteriophage administered solely. Perhaps, with a defined 
method to select for bacteriophages that have become resistant to bacteriophages, a 
combination can overcome the resistance issue. However, the resistance acquired by the 
pathogen would have to be predictable and consistent. Smith and Huggins' (1983) method 
to first apply a bacteriophage specific for an antigen on the cell surface was successful, and 
may prove to be a procedure that could consistently overcome the issue of resistance in 
bacteriophage therapy. However, the ability to simultaneously target a broad range of wild-
type isolates under field conditions has not been explored.  
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independently isolated from different sources and with several different plaque 
morphologies, suggesting that a number of different bacteriophages were employed – and 
failed to persistently reduce enteric colonization. Similarly, application of a bacteriophage 
combination failed to reduce S. Enteritidis PT4 infections in broilers (Fiorentin et al., 2005). 
However, some cocktails have been successful. A combination of three bacteriophages 
isolated from feces of patients infected with E. coli O157:H7 were applied to contaminated 
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It is possible that one of the most notable exceptions to the many failures to treat enteric 
Enterobacteraceae infections during recent years, that of Smith and Huggins (1983), 
provides a singular clue as to the potential for enhancing the likelihood of enteric 
Enterobacteriaceae efficacy. It is possible that selection of multiple bacteriophages for the 
same target cell phenotype results in selection of bacteriophages that are effective through 
identical mechanisms of adhesion, penetration, replication, and release. When new 
bacteriophages are isolated for efficacy against sequentially resistant isolates of the target 
bacteria, and these are combined for administration as a cocktail, the ability of the target cell 
to shift phenotype may be severely limited, resulting in a much larger proportion of target 
cell reduction, thereby increasing the probability of elimination or cure. Multiple researchers 
have noticed a change in colony morphologies of E. coli that had become resistant to 
bacteriophages selected to adhere to key-components of pathogenicity of the organism, such 
as lipopolysaccharides (O’Flynn et al., 2004; Sheng et al., 2006). This change in morphology 
may relate to a decreased ability to cause infection because the bacteria may be inhibited as 
a result of the bacteriophage resistance. 
Another consideration for bacteriophage treatment could be the application of 
bacteriophages to foods post-processing. Multiple researchers have noticed a successful 
reduction of foodborne pathogens on meats, and fruits (Bielke et al., 2007c; Higgins et al., 
2005; Leverentz et al., 2001, 2003; O’Flynn et al., 2004). Treating processed poultry carcasses 
with different bacteriophages was able to eliminate S. Enteritidis (Bielke et al., 2007c) or field 
isolates of Salmonella to below detection limits (Higgins et al., 2005). A mixture of three 
different bacteriophages reduced the levels of E. coli O157:H7 detected on processed beef, 
though the bacteriophage treatment was not as effective at temperatures below 30 °C, 
making them ineffective at refrigeration temperatures (O’Flynn et al., 2004). Leverentz et al. 
(2001, 2003) successfully reduced the levels of Salmonella and Listeria monocytogenes on 
selected fruits with bacteriophage application. A loss of effectiveness was seen on cut fruits, 
possibly due to low pH of the fruit flesh. While this research appears promising, the studies 
do not report the long-term susceptibility of the contaminating bacteria to the 
bacteriophages. Perhaps, selection of a cocktail of bacteriophages to combat resistance, and 
for the ability to lyse bacteria at refrigeration temperatures could result in successful 
reduction of these foodborne pathogens. 
5. Conclusions 
While bacteriophage treatment of enteric infections has had some success, failures do occur 
and the system has not yet been perfected. Chemical antibiotics are often effective against 
multiple species of bacteria and do not require specific selection to treat infections. Unlike 
bacteriophages, which tend to be at least somewhat host specific and may not even kill 
bacterial isolates within the same species. Still, with the rise of antibiotic resistance, 
bacteriophages may be able to offer a line of defense in situations for which antibiotics are 
not available, or are not effective. For example, with the restriction or elimination of 
antibiotics usage in food animals, researchers have been investigating the possibility of 
bacteriophages to control foodborne pathogens. With the realization that resistance of 
pathogenic isolates of bacteria to bacteriophages can, and do, emerge, perhaps the best 
application would be to apply the bacteriophages immediately prior to slaughter. Thus, the 
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pathogen could be effectively reduced in the gastrointestinal tract, and subsequently reduce 
the risk of contamination during processing. With the frequency of reported failures, and 
the assumption that many are not reported, bacteriophage therapeutics has not been 
perfected well enough for widespread application. In addition to resistance, safety, 
specificity, and long-term effectiveness must be demonstrated, and although several 
products have been licensed in the United States and elsewhere, procedures for 
demonstration of these characteristics are not well established, providing an additional 
regulatory burden for commercialization.  
Clearly, widespread bacteriophage treatments with Enterobacteriaceae within the 
gastrointestinal tract have not been adopted for any animal species during the last 60 years 
and successful research in this area has been modest and sporadic. Nevertheless, the 
occasional reports by reputable scientists in solid journals must indicate that there is 
potential for improved therapeutic efficacy of bacteriophages for this purpose. With the 
diminution of new antimicrobial pharmaceuticals and the widespread resistance among 
many pathogenic enteric Enterobacteriaceaes, a breakthrough in this area is sorely 
needed.  
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Foodborne diseases are a growing public health problem worldwide with Campylobacter and 
Salmonella being the most common and widely distributed causative agents. These Gram-
negative bacteria are common inhabitant of the gut of warm-blooded animals, especially 
livestock, being transmitted to humans primarily through the consumption of contaminated 
food of animal origin. Poultry meat and derivatives are regarded as the most common 
source of human salmonellosis and campylobacteriosis.  
In addition to the high prevalence of such pathogens and the consequent health problems 
caused, control of these pathogens has become increasingly difficult due to the emergence of 
antibiotic-resistant strains. This emergence is a result of the misuse of antimicrobials in food 
animals, compromising the action of once effective antibiotics in the treatment of foodborne 
diseases in humans.  
Recent legislation restricting the use of antibiotics as growth promoters in animal 
production, together with the risk of antibiotic-resistant bacteria entering the human food 
chain have been the driving force for the development of alternative methods for pathogen 
control. (Bacterio)phages are naturally occurring predators of bacteria, ubiquitous in the 
environment, with high host specificity and capacity to evolve to overcome bacterial 
resistance which makes them an appealing option for the control of pathogens. Several 
studies have been carried to assess the potential use of phages in the control of Campylobacter 
and Salmonella in animals and food material in order to prevent transmission of these 
pathogens to humans. Overall, although eradication of the target bacteria is an extremely 
unlikely event, the proof of principle, that phages are able to reduce the number of these 
pathogens has been established. Even so, some considerations should be taken into account 
for an efficient application of phages. 
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This chapter aims at giving an overview of the two major foodborne pathogens (Campylobacter 
and Salmonella), discussing the problems and concerns related to their prevalence and 
control, focusing mainly on the potential use of phages as an alternative to other control 
measures. Consequently, the successes and drawbacks of different studies on the use of 
phages to control Campylobacter and Salmonella will be explored. Moreover several aspects of 
phage biocontrol will be addressed. These include considerations on phage characterization, 
phage dose and route of administration, and ways of overcoming the emergence of phage 
resistant-bacteria. Finally the requisites for an acceptable phage product and the issues 
related to its public acceptance will be discussed. 
2. Foodborne diseases  
Foodborne diseases are of major concern worldwide. The Centres for Disease Control and 
Prevention (CDC) estimates that 76 million cases of foodborne diseases occur every year in the 
United States causing roughly 5000 deaths (Nyachuba, 2010). In Australia the number of cases 
(5.4 million) has been estimated to have an associated cost of 1.2 billion dollars per year 
(OzFoodNet Working Group, 2009). The European Food Safety Authority (EFSA) reported a 
total of 5,550 foodborne outbreaks, causing 48,964 human cases, 4,356 hospitalizations and 46 
deaths in 2009 (European Food Safety Authority, 2011). While significant attention is usually 
given to major foodborne outbreaks, studies indicate that outbreaks only account for a small 
fraction of Campylobacter and Salmonella infections in humans (European Food Safety 
Authority, 2009). While a steady decline in the number of cases attributed to Salmonella has 
been observed since 2004, the number of Campylobacter infections has remained constant 
(Figure 1). Campylobacteriosis caused 198,252 confirmed human cases in 2009 with a fatality 
rate of 0.02 %, continuing to be the most commonly reported zoonosis in the European Union. 
A total of 108,614 confirmed human cases were attributed to Salmonella with a fatality rate of 
0.08 % in the same year. Moreover there is a considerable underreporting, and the true number 
of cases of illness caused by these two pathogens is likely to be 10-100 times higher than the 
reported number (European Food Safety Authority, 2011). 
 
Fig. 1. Number of reported campylobacteriosis and salmonellosis cases in humans 2001-2009 
(European Food Safety Authority, 2006; European Food Safety Authority, 2011) 
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2.1 The pathogens 
2.1.1 Campylobacter 
Campylobacter was first described in 1880 by Theodore Escherich and belongs to the 
Epsilonproteobacteria, in the order Campylobacterales which includes Helicobacter and 
Wolinella (Friedman et al., 2000; Keener et al., 2004). The name Campylobacter is derived from 
the Greek “kampulos” = curved and “bacter” = rod. In fact, bacteria belonging to the genus 
Campylobacter are non-spore forming, oxidase-positive, Gram-negative, curved or spiral 
(occasionally straight) rods with 0.2 µm to 0.8 µm wide and 0.5 µm to 5 µm long. When they 
form short or long chains they can appear as S-shaped, V-shaped or more rarely comma 
shaped. Campylobacter ssp. usually displays a long unsheathed polar flagellum at one (polar) 
or both (bipolar) ends of the cell which confer to this microorganism a rapid, darting and 
reciprocating motility (Keener et al., 2004). Campylobacter spp. cells tend to form coccoid and 
elongated forms on prolonged culture or upon exposure to oxygen (Moran & Upton, 1987). 
These cells may be associated to a viable but not culturable state (VBNC). However the 
association between cell culturability and cell morphology remains controversy (Keener et 
al., 2004). 
The genus Campylobacter now comprises 17 member species. The most commonly isolated 
are C. jejuni ssp. jejuni, C. coli and C. lari which are referred as thermophilic species. They can 
grow at 37ºC to 42ºC with a pH in the range of 4.9 to 9.0, but their optimum growth 
conditions include a temperature of 42ºC and a pH of 6.5 to 7.5. It is known that they cannot 
multiply below 30ºC and that they require a microaerobic atmosphere (approximately 5% 
oxygen and 10% carbon dioxide) (Butzler, 2004). 
Contrary to most bacteria, Campylobacter species do not obtain their energy from the 
metabolism of carbohydrates but instead from amino acids or tricarboxylic acid cycles 
intermediates. C. jejuni hydrolyzes hippurate and indoxyl metabolizes acetate and reduces 
nitrate (Butzler, 2004). 
2.1.2 Salmonella 
Investigations on the etiologic agent of the “swine plague” led Theobald Smith, in 1885, to 
the isolation of a Gram-negative bacillus named Bacterium suipestifer. The bacterium was 
further characterized by D. E. Salmon from whom the name Salmonella is derived. The non-
spore forming cells possess a straight rod-shaped morphology with sizes varying from 0.7 
µm to 1.5 µm in diameter and 2 µm to 5 µm in length. These cells are usually motile 
presenting peritrichous flagella. Salmonella spp. belong to the Enterobacteriaceae family and 
are chemoorganotrophs (organisms which use organic compounds as their energy source), 
facultative anaerobes and hydrogen sulphide producers (Bell & Kyriakides, 2002). 
The outer membrane (OM) of Salmonella, as with almost all Gram-negative bacteria, is 
composed of OM proteins (OMPs) and lipopolysaccharides (LPS). LPS plays an essential 
role in maintaining the cell structural integrity and protection from chemicals. In the host 
organisms they act as endotoxins and as a pyrogen displaying a strong immune response. 
Structurally they are composed by three distinct components: lipid A, core oligosaccharide 
and O-polysaccharide (Raetz & Whitfield, 2002). The O-polysaccharide (also O-antigen or O-
side-chain) together with the H-antigen (from flagella) and Vi (capsular antigens) are the 
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grouped in serotypes according to their agglutination pattern when reacted with specific 
commercial antisera (Bell & Kyriakides, 2002; Brenner et al., 2000). This classification led to 
the recognition of more than 2500 serotypes (Bell & Kyriakides, 2002), a number that 
increases every year. A revision of the nomenclature has established two species  (S. enterica 
and S. bongori) with the majority of the serotypes grouped into one of the six Salmonella 
subspecies of S. enterica (Bell & Kyriakides, 2002; Brenner et al., 2000; Velge et al., 2005). 
2.2 The diseases 
Campylobacter and Salmonella are common inhabitant of the gut of warm-blooded animals 
mainly livestock (such as cattle, sheep, pigs and chickens), domestic pets and wild animals, 
where they asymptomatically colonize and multiply (Antunes et al., 2003; Bell & Kyriakides, 
2002; Bryan & Doyle, 1995; Doyle & Erickson, 2006; Newell & Fearnley, 2003). As zoonotic 
agents, Campylobacter and Salmonella can be transferred between humans and other animals. 
The common route of these pathogens is the consumption of contaminated food of animal 
origin, particularly meat from pigs, cattle and poultry (and derivatives) and milk. Poultry 
and derivatives are repeatedly pointed out as the most common sources of infection since 
the pathogens are present at a high level in fresh poultry meat. Campylobacter and Salmonella 
strains may also reach humans via routes other than food, directly by the contact with 
contaminated animals, carcasses or the environment, for example, through drinking water 
(European Food Safety Authority & European Centre for Disease Prevention and Control, 
2011). Therefore, horizontal transmission appears to have a major role in the transmission of 
these foodborne pathogens. In contrast to Salmonella, vertical transmission of Campylobacter 
is generally considered a relatively unimportant route of flock colonization with the 
consequent general absence of Campylobacter in eggs, one of the most common routes of 
contamination by Salmonella (European Food Safety Authority, 2011; Newell & Fearnley, 
2003). 
These microorganisms have the ability to survive for considerable periods, especially in 
conditions that are moist, cool and out of direct sunlight. As a result, they can readily 
contaminate other hosts, as for example, humans where Campylobacter infection is usually 
associated with illness and for which doses as low as 500 organisms have been reported to 
cause gastrointestinal disorders (Friedman et al., 2000; Newell & Fearnley, 2003; Robinson, 
1981). As a consequence, bird-to-bird transmission within flocks is very rapid and it was 
demonstrated that once a broiler flock becomes infected with Campylobacter, close to 100% of 
birds are reported to become colonized in a very short time (Allen et al., 2007; Newell & 
Fearnley, 2003). Moreover it is known that, after in vivo-passage, organisms can exhibit an 
enhancement of colonization potential of at least 1,000-fold in most strains and up to 10,000-
fold in some strains (Berndtson et al., 1992; Keener et al., 2004). The most important 
Campylobacter species associated with human infections are C. jejuni, C. coli, C. lari and C. 
upsaliensis (European Food Safety Authority, 2011; Friedman et al., 2000; Robinson, 1981). 
Campylobacter has become the most recognized antecedent cause of Guillain-Barré syndrome 
(GBS), an acute post-infectious immune-mediated disorder affecting the peripheral nervous 
system that can be permanent, fatal or last several weeks and usually requires intensive care 
(Butzler, 2004; Nachamkin, 2002). 
The factors contributing for the high prevalence of these pathogens in poultry meat are bad 
slaughter conditions, cross-contamination, inadequate heat treatment, raw meat and 
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inappropriate food storage (European Food Safety Authority, 2011; Gorman et al., 2002; 
Hansson et al., 2005; Jacobs-Reitsma, 2000; Johannessen et al., 2007; Luber et al., 2006; van de 
Giessen et al., 2006). A European Union-wide baseline survey on Campylobacter demonstrated 
that in EU 71.2% of broilers are colonized by Campylobacter at the slaughterhouse (European 
Food Safety Authority, 2010). Therefore, controlling Campylobacter and Salmonella infections 
has become an important goal particularly for the poultry industry. 
Human infection by these pathogens results in a gastrointestinal infection, which is usually 
characterized by an inflammatory reaction, watery (sometimes bloody) diarrhoea, fever, 
vomiting, abdominal cramps and dehydration which can become severe and life-threatening 
as a result of tissue invasion and toxin production (Bell & Kyriakides, 2002; Butzler, 2004; 
Friedman et al., 2000; Nachamkin, 2002; Uzzau et al., 2000). Salmonella infections are 
influenced by the bacterium’s host range or degree of host adaptation, enabling the division 
of the bacteria in two groups: host adapted and ubiquitous. The higher the adaptation of 
Salmonella to a host, the higher the pathogenicity, with a consequent severity of the disease, 
usually leading to septicaemia (Bell & Kyriakides, 2002; Uzzau et al., 2000; Velge et al., 2005). 
The most prevalent and important Salmonella enterica serotypes reported worldwide are 
Enteritidis and Typhimurium. These are responsible for 99% of salmonellosis in humans 
and warm-blooded animals (Bell & Kyriakides, 2002; Brenner et al., 2000). 
2.3 Antibiotic resistance 
Antibiotics were introduced in the 1940s and have been widely used in the United States 
(US) and Europe (EU) in livestock and poultry since the 1950s. In the US at least 17 
antimicrobials were approved to be used in food animals. In Europe, all classes of antibiotics 
licensed for human medicine were allowed for use in animals. As a consequence, antibiotics 
were used in food animals therapeutically, prophylactically and as food supplements to 
promote faster growth by improving feed efficiency. The discovery of antibiotics growth-
enhancing effect became an important element of intense animal husbandry leading to their 
increased use, often in sub-therapeutic doses in healthy animals and without veterinary 
prescription (Castanon, 2007; Mathew et al., 2007; Sapkota et al., 2007; World Health 
Organization, 2002). 
The amount of antibiotics used in the absence of disease for non-therapeutic purposes in 
livestock far exceeds the amount of antimicrobials used in human medicine. It was 
estimated that 60 to 80% of the antibiotics produced in the US is used for this purpose. The 
use of antibiotics in livestock has become a major source of concern because of the 
possibility that they contribute to the declining efficacy of antibiotics used to treat bacterial 
infections in humans (Smith et al., 2002). This may happen because antimicrobial agents 
used for food-producing animals are frequently the same or belong to the same classes as 
those used in human medicine. The later includes tetracyclines, macrolides and 
fluoroquinolones (Aarestrup et al., 2008; Mellon et al., 2001; Sapkota et al., 2007). 
Two EU agencies, the European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC), reported recently on the high incidence of 
antibiotic resistance in Salmonella and Campylobacter, and stated their concern. In fact, the 
high percentage of Salmonella and Campylobacter isolates displaying resistance to 
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and warm-blooded animals (Bell & Kyriakides, 2002; Brenner et al., 2000). 
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licensed for human medicine were allowed for use in animals. As a consequence, antibiotics 
were used in food animals therapeutically, prophylactically and as food supplements to 
promote faster growth by improving feed efficiency. The discovery of antibiotics growth-
enhancing effect became an important element of intense animal husbandry leading to their 
increased use, often in sub-therapeutic doses in healthy animals and without veterinary 
prescription (Castanon, 2007; Mathew et al., 2007; Sapkota et al., 2007; World Health 
Organization, 2002). 
The amount of antibiotics used in the absence of disease for non-therapeutic purposes in 
livestock far exceeds the amount of antimicrobials used in human medicine. It was 
estimated that 60 to 80% of the antibiotics produced in the US is used for this purpose. The 
use of antibiotics in livestock has become a major source of concern because of the 
possibility that they contribute to the declining efficacy of antibiotics used to treat bacterial 
infections in humans (Smith et al., 2002). This may happen because antimicrobial agents 
used for food-producing animals are frequently the same or belong to the same classes as 
those used in human medicine. The later includes tetracyclines, macrolides and 
fluoroquinolones (Aarestrup et al., 2008; Mellon et al., 2001; Sapkota et al., 2007). 
Two EU agencies, the European Food Safety Authority (EFSA) and the European Centre for 
Disease Prevention and Control (ECDC), reported recently on the high incidence of 
antibiotic resistance in Salmonella and Campylobacter, and stated their concern. In fact, the 
high percentage of Salmonella and Campylobacter isolates displaying resistance to 





High resistance of Salmonella to tetracyclines, ampicillin and sulphonamides was also 
reported, as was Campylobacter resistance to high levels of tetracyclines. The EFSA report 
concluded that the animal antimicrobial usage might be an important factor accounting for 
the high proportion of resistant isolates (European Food Safety Authority, 2011; European 
Food Safety Authority & European Centre for Disease Prevention and Control, 2011; Gyles, 
2008; Rabsch et al., 2001). 
The resistance problem has led the World Health Organization (WHO) in 2002 to advise and 
encourage all countries to reduce the use of antibiotics outside human medicine and has 
already established some measures in the surveillance of foodborne diseases in order to 
reduce the emergence of resistant bacteria with special concern for Salmonella and 
Campylobacter (Smith et al., 2005; World Health Organization, 2002). This concern was 
already present in the EU where several countries have banned the use of antimicrobials 
that are used in human medicine as growth promoters. The consequent reduction of the 
selective pressure, has already resulted in a reduction of antimicrobial resistance in a 
national population of food animals (Aarestrup et al., 2001; Castanon, 2007; Emborg et al., 
2003; Smith et al., 2005; Swann, 1969; Tacconelli et al., 2008; Wierup, 2001; World Health 
Organization, 2002).  
Antibiotics are usually the last resource in pathogens control leaving no hope in the 
treatment of multiresistant bacteria for which no effective antimicrobial exists. 
Consequently, it can be concluded that an efficient alternative to antibiotics is critical and 
urgent. In order to control foodborne pathogens, the poultry industry decontaminates 
carcasses using both chemical and physical treatments. Chemical treatments include 
washing of carcasses in electrolyzed or chlorinated water, dipping carcasses in a solution 
containing acidified sodium chlorite before chilling, immersion in acetic or lactic acid or in 
sodium triphosphate solutions. Physical treatments include freezing of contaminated 
carcasses, heat-treatment of fresh broiler carcasses, dipping of fresh carcasses in hot water 
immediately before chilling, radiation, exposure to dry heat, and ultrasonic energy in 
combination with heat (Corry & Atabay, 2001; Keener et al., 2004). In spite of the effort that 
has been done to control these pathogens, they are still a major cause of foodborne diseases 
(European Food Safety Authority, 2011; Nyachuba, 2010)(Figure 1). 
Other possible control measures to eliminate or reduce the contamination of birds are still 
being developed and their cost-effectiveness and applicability to large-scale production 
remain to be determined. It includes: vaccination, the use of competitive exclusion, 
improving genetic resistance of birds and the use of probiotics, bacteriocins and 
bacteriophages (Chen & Stern, 2001; García et al., 2008; Joerger, 2001). 
3. Bacteriophages: Novel therapeutic agents 
(Bacterio)phages are viruses that are able to infect Bacteria. Phages are able to infect more 
than 150 bacterial genera, including aerobes and anaerobes, exospore and endospore 
formers, cyanobacteria, spirochetes, mycoplasmas, and chlamydias (Ackermann, 2001; 
Ackermann, 2009). 
Structurally they consist of a nucleic acid genome enclosed within a protein or lipoprotein 
coat and like all viruses are absolute parasites, inert particles outside their hosts, deprived of 
their own metabolism. Inside their hosts, phages are able to replicate using the host cell as a 
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factory to produce new phages particles identical to its ascendant, leading to cell lysis and 
consequent death of the host (Guttman et al., 2005). As a result of their bacterial parasitism, 
phages can be found wherever bacteria exist and have already colonized every conceivable 
habitat. Phages are an extremely diversified group and it has been estimated that ten phage 
particles exist for each bacterial cell. This fact accounts for an estimated size of the global 
phage population to be approximately 1031 particles making phages the most abundant 
living entities on earth (Rohwer, 2003). 
Their presence in the biosphere is especially predominant in the oceans presenting an excess 
of 107 to 108 phage particles per millilitre in coastal sea and in non-polluted water and 
comparably high numbers in other sources like sewage and faeces, soil, sediments, deep 
thermal vents and in natural bodies of water (Rohwer, 2003). In the absence of available 
hosts to infect, and as long as they are not damaged by external agents, phages can usually 
maintain their infective ability for decades (Guttman et al., 2005; Sharp et al., 1986). 
3.1 Phage therapy versus chemotherapy  
Phage therapy presents many potential advantages over the use of antibiotics which are 
intrinsic to the nature of phages. Phages are highly specific and very effective in lysing the 
target pathogen, preventing dysbiosis, that is, without disturbing the normal flora and thus 
reducing the likelihood of super-infection and other complications of normal-flora reduction 
that can often result following treatment with chemical antibacterials. This high specificity 
means that diagnosis of the bacteria involved in the infection is required before therapy is 
employed (Guttman et al., 2005; Marks & Sharp, 2000; Matsuzaki et al., 2009). The specificity 
of phages also enables their use in the control of pathogenic bacteria in foods since they will 
not harm useful bacteria, like starter cultures. Moreover, phages do not affect eukaryotic 
cells, or cause adverse side effects as revealed through their extensive clinical use in the 
former Soviet Union. Furthermore, phages are equally effective against multidrug-resistant 
pathogenic bacteria.  
It was also found that phages can rapidly distribute throughout the body reaching most 
organs including the prostate gland, bones and brain, that are usually not readily accessible 
to drugs and then multiply in the presence of their hosts (Dabrowska et al., 2005). The self-
replicating nature of phages reduces the need for multiple doses to treat infection diseases 
since they will replicate in their pathogenic host increasing their concentration over the 
course of treatment leading to a higher efficacy. This also implies that phages will be present 
and persist at a higher concentration where their hosts are present, which is where they are 
more needed, in the place of infection. Reciprocally, where and if the target organism is not 
present the phages will not replicate and will be removed from the system showing the 
other side of the self-replicating nature of phages, their self-limiting feature (Goodridge & 
Abedon, 2003; Petty et al., 2007). 
As it happens with antibiotics, bacteria also develop resistance to phages. The latter usually 
occurs through loss or modification of cell surface molecules (capsules, OMPs, LPS, pili, 
flagella) that the phage uses as receptors. Since some of these also function as virulence 
determinants their loss may in consequence dramatically decrease the virulence of the 
bacterium or reduce its competitiveness (Levin & Bull, 2004). A good example is that of 
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factory to produce new phages particles identical to its ascendant, leading to cell lysis and 
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phages can be found wherever bacteria exist and have already colonized every conceivable 
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not harm useful bacteria, like starter cultures. Moreover, phages do not affect eukaryotic 
cells, or cause adverse side effects as revealed through their extensive clinical use in the 
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that resistant K1 bacteria were far less virulent (Smith et al., 1987b). Furthermore, different 
phages binding to the same bacteria may recognize different receptors and resistance to a 
specific phage does not result in resistance to all phages. Phages are able to rapidly change 
in response to the appearance of phage-resistant mutants making them efficient in 
combating the emergence of newly arising bacterial threats (Matsuzaki et al., 2009; 
Sulakvelidze et al., 2001). In addition, the isolation of a new phage able to infect the resistant 
bacteria can be easily accomplished. It is much cheaper, faster and easier to develop a new 
phage system than a new antibiotic which is a long and expensive process (Petty et al., 2007).  
4. Phage potential in food safety 
Phages can be used to combat pathogens in food at all stages of production in the classic 
‘farm-to-fork’ continuum in the human food chain (García et al., 2008). Accordingly, in order 
to prevent transmission to humans, phages can be used:  
i. in livestock to prevent diseases or reduce colonization;  
ii. in food material (such as carcasses and other raw products) or in equipment and contact 
surfaces to reduce bacterial loads; 
iii. in foods as natural preservatives to extend their shelf life.  
Several studies have been carried to assess the potential use of phages in the control of 
Campylobacter and Salmonella in animals and foodstuff. Although very different results have 
been obtained it seems that the proof of principle has been established: phage therapy has 
potential in the control of foodborne pathogens (Johnson et al., 2008). The large scale, high 
throughput and mechanization of poultry production and industry, made poultry and 
products the most commonly used models for phage biocontrol (Atterbury, 2009). This is 
reflected in the studies that will be addressed below. 
4.1 Campylobacter and Salmonella phages 
4.1.1 Campylobacter 
There are relatively few reports on Campylobacter phages probably due to the fastidious 
growth conditions of their host and to unique features that their phages exhibit. This has 
hindered the use of conventional methods of phage isolation, propagation and 
characterization (Bigwood & Hudson, 2009; Tsuei et al., 2007). Recently Carvalho et al. (2010) 
described an improved method for Campylobacter phage isolation in which a pre-enrichment 
of the phages with potential host strains supplemented with divalent cations was used to 
promote phage adherence to the host (Carvalho et al., 2010b). Campylobacter-specific phages 
have been isolated from excreta of both broiler and layer chickens, retail poultry, and other 
sources including pig, cattle and sheep manure, abattoir effluents, and sewage (Connerton et 
al., 2011). Some of these phages have been characterized and form the basis of the United 
Kingdom phage typing scheme (Frost et al., 1999; Sails et al., 1998). 
The most frequently encountered Campylobacter phages belong to Caudovirales order, 
Myoviridae family with a double-stranded DNA genome enclosed in icosahedral heads 
(Connerton et al., 2008). Campylobacter phages have been characterized into three groups 
according to their genome size and head diameter (Sails et al., 1998): Group I - head 
diameters of 140 nm – 143 nm and large genome sizes of 320 kb; Group II - average head 
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diameters of 99 nm and average genome sizes of 184 kb; Group III - average head diameters 
of 100 nm and average genome sizes of 138 kb. Hansen et al. (2007) characterized 
Campylobacter phages according to their genome size and susceptibility of digestion by HhaI 
(Hansen et al., 2007). 
The DNA of most Campylobacter phages is difficult to extract, clone and sequence and is 
refractory to restriction enzyme digestion, which is probably due to tightly adherent and 
proteinase K resistant proteins (Carvalho et al., 2011; Hammerl et al., 2011; Kropinski et al., 
2011; Timms et al., 2010). As a consequence, the genome sequence of only five Campylobacter 
phages have been reported so far (Carvalho et al., 2011; Hammerl et al., 2011; Kropinski et al., 
2011; Timms et al., 2010). Interestingly, the phage genomes known are all related and also 
part of the T4 superfamily of phages (Petrov et al., 2010). 
There is little information available regarding the prevalence and influence of phages on 
Campylobacter-colonized poultry flocks. In fact, the prevalence of Campylobacter phages in 
poultry has essentially only been described in the UK. It was reported that C. jejuni phages 
were isolated from 20% of the caeca of chickens sampled in which there was a correlation 
between the presence of natural environmental phages and a reduction in the numbers of 
colonizing Campylobacter. Interestingly, birds that harbored phages had a significant 
difference (P < 0.001) in Campylobacter colony forming units (CFU) per gram in relation to 
those that did not have phages (Atterbury et al., 2005). Campylobacter phages were prevalent 
in the caecal contents of organic birds with 51% of Campylobacter-positive sampled birds also 
carrying phages. The higher value of phage positive samples in organic flocks can be 
explained by the fact that these birds are more exposed to the environment and therefore to 
a greater range of Campylobacter types and phages (El-Shibiny et al., 2005). 
It was also showed that, like Campylobacter, their phages are also transferred between flocks 
(Connerton et al., 2004). Moreover, phages were also recovered from chilled retail poultry, 
meaning that these phages can survive on retail chicken under commercial storage condition 
(Atterbury et al., 2003b). 
4.1.2 Salmonella 
Numerous phages infecting Salmonella have been isolated. The first report of a Salmonella 
phage dates back to 1918 and was described by Félix d’Hérelle. Since then, Salmonella 
phages have been isolated from different sources: wastewater plants, sewage, manure, 
faeces and caecal contents from different animals (e.g. poultry, turkey, pig, humans), zoo 
ponds, nests from poultry farms and many others (Andreatti Filho et al., 2007; Santos et al., 
2010; Sillankorva et al., 2010). The search for different Salmonella phages from different 
sources may be attributed to the interest prompted by the medical and veterinary 
significance of their pathogenic host. 
The great number and different specificity of Salmonella phages has enabled Salmonella 
classification through phage typing, a useful typing tool for subcategorizing the more 
common Salmonella enterica serotypes (i.e. S. Typhimurium, S. Enteritidis, S. Heidelberg) 
recommended by the WHO.  
Probably the best known Salmonella phages are the lytic phage Felix 01 and the temperate 
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been used as a diagnostic tool in the identification of Salmonella. Recently, a phage with a 
broader host range than Felix 01 has been described which presents great potential not only 
as a therapeutic agent but also as a diagnostic tool (Santos et al., 2010; Santos et al., 2011; 
Sillankorva et al., 2010) (Figure 2). 
 
Fig. 2. TEM observation of the broad host range myovirus Salmonella phage PVP-SE1 (Santos 
et al., 2010) 
A survey conducted by Ackermann identified 177 Salmonella phages of which 91% belong to 
the Caudovirales order. Their distribution by families is roughly equal with 24% Myoviridae, 
31% Siphoviridae and 33% Podoviridae. The 9% left are distributed in the Inoviridae, Leviviridae, 
Microviridae, and Tectiviridae families (Ackermann, 2007). A phylogenetic analysis relying on 
a proteomic comparison resulted in the recognition of at least five groups: P27-like, P2-like, 
lambdoid, P22-like, and T7-like. Nevertheless, three Salmonella phages (epsilon15, KS7, and 
Felix O1) are outliers since they could not be attributed to any of the previous groups 
(Kropinski et al., 2007). 
4.2 Phage biocontrol in livestock 
As already outlined above, contamination of meat products with Campylobacter and 
Salmonella, as well as other foodborne pathogens, often results from cross-contamination 
between carcasses and feces from infected animals during slaughter and processing and also 
during transportation, leading to an increase of bacterial loads. Phage biocontrol in livestock 
presents two major purposes: i) treatment of bacterial pathogens in animals to minimize its 
impact on animal health and production and, ii) control of foodborne pathogens 
contamination to humans through foodstuff or other vectors. Therefore, the use of phages to 
control pathogens in livestock seems to be a feasible and efficient approach.  
In this chapter the term phage therapy will refer only to the use of phages to control 
bacterial infections in living animals, whereas, the term biocontrol will be used where 
phages control pathogens in animals and foodstuff (independent of infection) (Hagens & 
Loessner, 2010). 
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4.2.1 Campylobacter  
There are only a few reports on phage biocontrol against Campylobacter-infected livestock, 
with all the studies being conducted on poultry. Wagenaar et al. (2005) assessed both 
preventive and therapeutic phage treatment (Wagenaar et al., 2005). In their study, multiple 
doses of a group III phage were administered to chicks before or after being orally 
challenged with a C. jejuni strain. In order to access the effect of phage administration on 
broilers, the Campylobacter colony forming units (CFU) and the phage plaque forming units 
(PFU) from caecal contents were enumerated throughout the experimental period. These 
values were obtained from the group receiving phages and from the control group (in which 
birds did not received phages). In both treatments, birds were orally challenged with a dose 
of 1X105 CFU C. jejuni ten days after hatching. Preventive treatment consisted in the oral 
administration of phage 71 (4X109 to 2X1010 PFU) for ten consecutive days, starting seven 
days after hatching. The phage treatment did not prevent the colonization of the caecum, 
but may had delayed it. In fact, initially the numbers of Campylobacter were reduced by 2 
log10 CFU/g but after one week the numbers leveled out at approximately 1 log10 below that 
of the controls. In the therapeutic treatment the phage was orally administrated five days 
after birds being challenged with C. jejuni and consecutively during the next six days. The 
numbers of Campylobacter had decreased 3 log10 CFU/g at 48h, but after five days stabilized 
to approximately 1 log10 CFU/g below the control group. In order to mimic the “farm 
condition” in which birds are normally slaughter at 42 days, birds were orally challenged 
with a dose of 1X105 CFU C. jejuni at 32 days after hatching. Seven days later phages 71 and 
69 were orally administered to these birds and for four consecutive days. As occurred with 
the previously described treated group, the values of Campylobacter counts dropped initially 
1.5 log10 CFU/g but then stabilized at 1 log10 unit lower than in the controls. 
In the study by Loc Carrillo et al. (2005), broiler chicks at 20 to 22-day-old were challenged 
with C. jejuni strains isolates HPC5 and GIIC8 from United Kingdom broiler ocks that have 
proved to be good colonizers (Loc Carrillo et al., 2005). The chicks received four different 
doses of HPC5 (2.7 log10 CFU, 3.8 log10 CFU, 5.8 log10 CFU and 7.9 log10 CFU) and after 48h 
the Campylobacter numbers in the caeca, upper and lower intestine were enumerated. The 
highest dose led to more reproducible colonization levels of all intestinal sites examined, 
with a mean value of 6.3 log10 CFU/g, 6.7 log10 CFU/g and 7.4 log10 CFU/g in the upper 
intestine, lower intestine and caeca respectively. Moreover these colonization levels, which 
are similar to those of naturally colonized birds (Rosenquist et al., 2006), were maintained 
over nine days. The phage treatment occurred five days after the C. jejuni challenge. Birds 
were treated orally with two phages (CP8 or CP34) independently at a dose of 105, 107 or 109 
PFU. The phages were administered in an antacid suspension (CaCO3) since it proved to 
protect phages from exposure to low pH during passage through the gastrointestinal tract. 
The administration of 107 PFU was the dose which led to the highest reduction (3.9 log10 
CFU/g) in the upper and lower intestine and caecal counts of Campylobacter at 24 h. The 
highest dose was less effective in the treatment probably due to the aggregation and 
nonspecific association of phages with digesta, non-host bacteria or bacterial cell debris 
resulting from “lysis from without” (Rabinovitch et al., 2003). Different host-phage 
combinations were tested in vivo, leading to different results. In fact, and contrarily to the 
results obtained in vitro, phage CP34 was more effective in the reduction of C. jejuni HPC5 at 
all intestinal sites compared to CP8. Conversely phage CP8 was efficient in the reduction of 





been used as a diagnostic tool in the identification of Salmonella. Recently, a phage with a 
broader host range than Felix 01 has been described which presents great potential not only 
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Fig. 2. TEM observation of the broad host range myovirus Salmonella phage PVP-SE1 (Santos 
et al., 2010) 
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impact on animal health and production and, ii) control of foodborne pathogens 
contamination to humans through foodstuff or other vectors. Therefore, the use of phages to 
control pathogens in livestock seems to be a feasible and efficient approach.  
In this chapter the term phage therapy will refer only to the use of phages to control 
bacterial infections in living animals, whereas, the term biocontrol will be used where 
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this initial reduction, the C. jejuni numbers started to increase 72 h after phage 
administration with the lower intestinal counts exhibiting signicant differences of 2.1 log10 
and 1.8 log10 CFU/g but with the upper intestinal counts showing no significant difference 
with the Campylobacter levels recorded for the control group. 
El-Shibiny et al. (2009) reported the administration of a group II Campylobacter phage (CP220) 
to C. coli and C. jejuni colonized chickens (El-Shibiny et al., 2009). The results showed that a 2 
log10 CFU/g reduction in Campylobacter counts was observed when a single 107 or 109 PFU 
dose of CP220 was administered to C. jejuni or C. coli colonized chickens, respectively. After 
this treatment, only 2% of the recovered Campylobacter displayed resistance to CP220.  
Recently, Carvalho et al. (2010) tested a phage cocktail composed by three group II 
Campylobacter phages (Figure 3) in chicks that were previously challenged with C. coli strain 
A11 or C. jejuni strain 2140 (Carvalho et al., 2010a). Again, colonization models were 
established before phage therapy experiments were performed in order to access the 
effective reduction in Campylobacter numbers. In order to determine the optimum dose of 
Campylobacter that should be given to birds, the animals were challenged with three 
different concentrations (104, 106 or 5.5×107 CFU) of an overnight culture of C. jejuni and 
sampling points were obtained during seven days. The results obtained revealed that the 
dose of Campylobacter appeared to have little effect on the outcome of subsequent 
colonization and that the mean level of colonization was 2.4×106 CFU/g, which is within the 
range of the infection levels found in commercial broilers (Rosenquist et al., 2006). Seven 
days post-infection, a single dose of a phage cocktail was administered to chicks by two 
different routes: oral gavage and incorporated into their feed. Sampling points were taken 
for seven days after phage administration and showed that the phage cocktail was able to 
reduce by approximately 2 log10 CFU/g the titre of both C. coli and C. jejuni in faeces of 
colonized chickens. This reduction persisted throughout the experimental period and none 
of the pathogens regained their former numbers. The administration in feed led to an earlier 
and more sustainable reduction of Campylobacter than administration by oral gavage. The 
phage titers from faecal samples of the chicks infected with Campylobacter remained 
approximately constant throughout the experimental period showing that phages delivered 
to chicks (either by oral gavage or in feed) were able to replicate and therefore able to reduce 
the Campylobacter populations. 
 
Fig. 3. TEM observation of the three Campylobacter phages, belonging to the family 
Myoviridae, which make up the cocktail used in the in vivo experiments by Carvalho et al. 
(2010): a) phiCcoIBB12, b) phiCcoIBB35, c) phiCcoIBB37 (Carvalho et al., 2010a) 
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The appearance of phage resistant mutants has always been seen as a major drawback of 
phage therapy. Nevertheless some of the above mentioned studies found that phage 
resistance can be associated with a reduced colonization potential in the chicken intestine, 
suggesting that there is a fitness cost to phage resistance in which phage-resistant 
Campylobacter revert to a sensitive phenotype when re-colonizing the chicken intestine in the 
absence of phage predation. It was also suggested that genomic instability of C. jejuni in the 
avian gut can be seen as a mechanism to temporarily survive phage predation and later 
competition for resources (Carvalho et al., 2010a; Loc Carrillo et al., 2005; Scott et al., 2007a; 
Scott et al., 2007b). Conversely, recent studies by Carvalho et al. (2010) reported that 
Campylobacter strains resistant to phage infection were recovered from phage-treated 
chickens at a frequency of 13% and that these resistant phenotypes did not exhibit a reduced 
ability to colonize the chicken guts and did not revert to sensitive types (Carvalho et al., 
2010a). 
4.2.2 Salmonella  
The importance and impact of Salmonella has elicited several studies on the use of phages on 
the control of this pathogen. Although poultry represents the most commonly used models, 
studies also exist in pigs. 
In 1991, Berchieri and colleagues used a chicken model to assess the potential of phages to 
control Salmonella Typhimurium in chickens. In the established model, oral infection with 
109 CFU of Salmonella was fatal in 53% of the chickens. Oral administration of phage at high 
concentration (greater than 1010 PFU/ml), soon after Salmonella infection, was able to 
significantly reduce mortality (from 60% to 3%) as well as the number of pathogens in the 
alimentary tract. The high dose required for the reduction of Salmonella suggests that control 
by the phage was made by “lysis from without” or by a single cycle of replication. Although 
pathogen numbers were reduced shortly after phage administration, they increased soon 
after. Moreover, the phage was only present in the intestine when Salmonella was found in 
numbers above 106 CFU/ml (Berchieri et al., 1991). Therefore, an efficient application of the 
phage required that administration should be right after infection and even so bacterial 
control was possible only for a short period. This may be attributed to the ability of 
Salmonella to internalize cells thus escaping from phages. As with the Campylobacter studies 
(see above) phage resistant bacteria were also found to present rough morphology and to 
display less virulence than the wild strain. More than one phage was used in this study and 
one of these, although lytic in vitro, was not effective in vivo showing the importance of in 
vivo trials.  
Fiorentin et al. (2005) used a cocktail of three phages to control S. Enteritidis PT4 in broilers. 
The phage dose administered was also very high (1011 PFUs of each phage). In this study 
phage was administered only seven days post infection and a 3.5 log10 CFU reduction per 
gram of caecal content was recorded five days later. This level remained for 25 days. It seems 
here that time of administration was not critical but phage dose was. Although a high dose 
and a cocktail of phages were used with the purpose of reducing the possibility of phage 
resistant bacteria emergence, the presence of such cells was not assessed (Fiorentin et al., 2005). 
When a similar dose (1011 PFUs) was given orally two days after infection, Atterbury et al. 
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phage therapy. Nevertheless some of the above mentioned studies found that phage 
resistance can be associated with a reduced colonization potential in the chicken intestine, 
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control Salmonella Typhimurium in chickens. In the established model, oral infection with 
109 CFU of Salmonella was fatal in 53% of the chickens. Oral administration of phage at high 
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and a cocktail of phages were used with the purpose of reducing the possibility of phage 
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When a similar dose (1011 PFUs) was given orally two days after infection, Atterbury et al. 





Typhimurium in broiler chickens by up to 4.2 log10 CFU/g. Lower doses were ineffective in 
achieving similar results. A third phage tested in this study against S. Hadar did not reduce 
bacterial counts despite its strong lytic activity in vitro against that strain. The emergence of 
resistant bacteria was here also a reality with the number of phage resistant Salmonella 
increasing with the PFUs administered. This subpopulation of resistant bacteria was able to 
recolonize the broiler chickens within 72 hours after phage treatment. Interestingly, when 
these resistant bacteria were used to colonize a new group of chickens, they reverted to their 
phage-sensitive phenotype (Atterbury et al., 2007). 
Borie et al. (2008) pretreated ten day old broiler chicks, by coarse spray or drinking water 
containing a cocktail of three phages 24 hours before administering roughly 106 CFUs of 
Salmonella Enteritidis (calculated multiplicity of infection (MOI) of 103). After ten days of 
infection phages were recovered from the intestinal and other organs. A significant 
reduction in Salmonella Enteritidis was obtained at that time for both routes of 
administration with a reduction of more than 1 log10 CFU/ml in challenged bacterial 
numbers. This study demonstrates not only that phages are able to reduce Salmonella 
bacterial loads in broiler chickens but also that aerosol spray and drinking water are 
conceivable routes of administration in the application of a phage product which will surely 
facilitate application and establishment of phage biocontrol in an industrial environment 
(Borie et al., 2008). In a later study these authors, using  seven days old  chicks were able to 
replicate the aerosol results. Moreover, they showed that phage treatment coupled with 
competitive exclusion resulted in even better Salmonella reductions than each of the 
treatments alone (Borie et al., 2009). 
Toro et al. (2005) and coworkers also tested the association of phage therapy and competitive 
exclusion in the treatment of chickens infected experimentally with Salmonella. Phage 
treatment was given orally and included a cocktail of three different phages with different 
host ranges. In all treated groups, with phage or competitive exclusion alone or together, a 
decrease in the Salmonella counts was observed with a reduction to marginal levels in the 
ileum and a six fold reduction in the caeca in the case of the group treated with the phage 
cocktail. Moreover, there was a marginally improved weight gain in the treated animals. 
Although both approaches were able to reduce the Salmonella counts, unlike the previous 
study (Borie et al., 2009) a synergistic effect was not observed (Toro et al., 2005). 
In 2007 Andreatti Filho and colleagues reported on the isolation and testing of two different 
phage cocktails (one with 4 phages and another with 45 phages) in the control of Salmonella 
in vivo and in vitro. In vitro test of these two preparations at concentrations of 105 to 109 
PFU/ml in simulated crop environment resulted in a 1.5 or 5 log10 reduction of Salmonella 
Enteritidis, respectively for the 4-phage and 45-phage cocktails in two hours after treatment. 
Although the 4-phage cocktail did not produce a reduction at six hours post-treatment, the 
45-phage cocktail was able to reduce bacterial counts by 6 log10. This study clearly shows the 
advantage of a cocktail with a large number of phages, probably enabling complementary 
host range between phages and broader action in bacteria. Phage cocktails were 
administered at 108 PFU by oral gavage to day-of-hatch chicks infected with 9x103 CFU of 
Salmonella Enteritidis. These showed significant reduction of Salmonella recovered from 
caecal tonsils after 24 hours of treatment but no difference was observed at 48 hours when 
compared with the control group. Another experiment combined the use of the 45-phage 
cocktail with a commercial probiotic (and controls with each alone) to treat day-of-hatch 
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chicks achieving significant reductions in Salmonella recovery from caecal tonsils at 24 hours 
but no additive or synergistic effect was observed when combining both approaches. Once 
again, phage therapy was only efficient during a short period and no long term protection 
was observed (Andreatti Filho et al., 2007). 
Recently, Wall et al. (2010) tested the efficacy of a cocktail to treat S. Typhimurium 
experimentally infected pigs shortly before processing in order to reduce carcass 
contamination. Administration of the phage at the time of infection resulted in a 2-3 log10 
reduction of Salmonella colonization (Wall et al., 2010). 
O'Flynn et al., (2006) isolated two broad host range Salmonella phages (st104a and st104b) 
which were partially resistant to the porcine gastric juice (pH 2.5). In vitro tests showed a 
reduction of more than 2 log10 in Salmonella numbers in just one hour demonstrating their 
potential in controlling Salmonella in pigs by oral administration. Even so, as seen in other 
studies, for an efficient assessment of their potential as therapeutic agents, in vivo tests are 
needed (O'Flynn et al., 2006). 
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chicken  Reduction of up to 3 log10 CFU/g in caecal samples 
(Wagenaar et al., 
2005) 
chicken  Reduction of more than 5 log10 CFU in caecal samples 
(Loc Carrillo et 
al., 2005) 
chicken  Reduction of up to 2 log10 CFU/g in caecal samples 
(El-Shibiny et al., 
2009) 
chicken  Reduction of up to 2 log10 CFU/g (faster reduction when administrated in feed) 








chicken  Reduction from 60% to 3% in chicken mortality  (Berchieri et al., 1991) 
chicken  Reduction of up to 3.5 log10 CFU/g of caecal content  
(Fiorentin et al., 
2005) 
chicken  Reduction of up to 4.2 log10 CFU of the caecal colonization 
(Atterbury et al., 
2007) 
chicken  Reduction of up to 1.63 log10 CFU/ml in Salmonella recovery from the intestine. 
(Borie et al., 2008; 
Borie et al., 2009) 
chicken  Reduction of up to marginal levels in the ileum and six fold in the caeca in the Salmonella counts
(Toro et al., 
2005) 
chicken  
Reduction of up to 6 log10 in simulated crop 
environment / 55% in recovery from caecal 
tonsils of chicks 
(Andreatti Filho 
et al., 2007) 
pig Reduction of up to 3 log10 reduction of Salmonella colonization 
(Wall et al., 
2010) 
pig Reduction of up to 2 log10 in Salmonella numbers (in vitro test) 
(O'Flynn et al., 
2006) 





Typhimurium in broiler chickens by up to 4.2 log10 CFU/g. Lower doses were ineffective in 
achieving similar results. A third phage tested in this study against S. Hadar did not reduce 
bacterial counts despite its strong lytic activity in vitro against that strain. The emergence of 
resistant bacteria was here also a reality with the number of phage resistant Salmonella 
increasing with the PFUs administered. This subpopulation of resistant bacteria was able to 
recolonize the broiler chickens within 72 hours after phage treatment. Interestingly, when 
these resistant bacteria were used to colonize a new group of chickens, they reverted to their 
phage-sensitive phenotype (Atterbury et al., 2007). 
Borie et al. (2008) pretreated ten day old broiler chicks, by coarse spray or drinking water 
containing a cocktail of three phages 24 hours before administering roughly 106 CFUs of 
Salmonella Enteritidis (calculated multiplicity of infection (MOI) of 103). After ten days of 
infection phages were recovered from the intestinal and other organs. A significant 
reduction in Salmonella Enteritidis was obtained at that time for both routes of 
administration with a reduction of more than 1 log10 CFU/ml in challenged bacterial 
numbers. This study demonstrates not only that phages are able to reduce Salmonella 
bacterial loads in broiler chickens but also that aerosol spray and drinking water are 
conceivable routes of administration in the application of a phage product which will surely 
facilitate application and establishment of phage biocontrol in an industrial environment 
(Borie et al., 2008). In a later study these authors, using  seven days old  chicks were able to 
replicate the aerosol results. Moreover, they showed that phage treatment coupled with 
competitive exclusion resulted in even better Salmonella reductions than each of the 
treatments alone (Borie et al., 2009). 
Toro et al. (2005) and coworkers also tested the association of phage therapy and competitive 
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cocktail. Moreover, there was a marginally improved weight gain in the treated animals. 
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chicken  Reduction of up to 3 log10 CFU/g in caecal samples 
(Wagenaar et al., 
2005) 
chicken  Reduction of more than 5 log10 CFU in caecal samples 
(Loc Carrillo et 
al., 2005) 
chicken  Reduction of up to 2 log10 CFU/g in caecal samples 
(El-Shibiny et al., 
2009) 
chicken  Reduction of up to 2 log10 CFU/g (faster reduction when administrated in feed) 








chicken  Reduction from 60% to 3% in chicken mortality  (Berchieri et al., 1991) 
chicken  Reduction of up to 3.5 log10 CFU/g of caecal content  
(Fiorentin et al., 
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chicken  Reduction of up to 4.2 log10 CFU of the caecal colonization 
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2007) 
chicken  Reduction of up to 1.63 log10 CFU/ml in Salmonella recovery from the intestine. 
(Borie et al., 2008; 
Borie et al., 2009) 
chicken  Reduction of up to marginal levels in the ileum and six fold in the caeca in the Salmonella counts
(Toro et al., 
2005) 
chicken  
Reduction of up to 6 log10 in simulated crop 
environment / 55% in recovery from caecal 
tonsils of chicks 
(Andreatti Filho 
et al., 2007) 
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pig Reduction of up to 2 log10 in Salmonella numbers (in vitro test) 
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4.3 Phage biocontrol in food material 
Another way that phages may be used to improve food safety is to apply them directly onto 
raw food products. The practical applicability of this approach may be compromised by the 
minimum density of host cells that are suggested to be required for phage replication (Payne 
et al., 2000; Payne & Jansen, 2001). Nevertheless it was demonstrated that phages can be 
effective biocontrol agents when the population of host cells is as low as 46 CFU/cm2 (Greer, 
1988). These contradictory results may be a consequence of differences in phage/host 
combinations, in the matrix used, in the presence of non-host decoys or even in the models 
applied. Therefore, the efficacy of phage-based biocontrol should be determined on a case-
by-case basis (Atterbury, 2009). 
The application of phages as biocontrol agents has been investigated in a variety of food 
matrices. Nevertheless most studies focus in poultry products, with Campylobacter and 
Salmonella being the most frequently targeted zoonotic pathogens. 
4.3.1 Campylobacter 
Most studies on the use of phages as biocontrol are devoted to pre-harvesting studies. In 
fact, there are only few studies reporting the efficacy of Campylobacter phages in foodstuff.  
Atterbury et al. (2003) studied the survival of C. jejuni and phages on chicken skin at 
temperatures of 4°C or -20°C. A dose of 106 CFU C. jejuni NCTC 12662 PT14 was inoculated 
on the surface of chicken skin and then samples were stored at these two temperatures for a 
period of one hour to ten days (Atterbury et al., 2003a). The results showed that there was a 
reduction of 1 or 2 log10 CFU on Campylobacter counts for skin stored at 4ºC or -20ºC, 
respectively. This reduction was lower than the value normally reported for Campylobacter 
cells stored at -20ºC (3 log10 CFU) (Chan et al., 2001), which indicates that chicken skin may 
have had a protective effect. Phage φ2 at 107 PFU was added to chicken skin samples and 
was show to survive for ten days at 4ºC and at -20 ºC. In order to access whether this phage 
would attach non-specifically to non-susceptible Campylobacter strains at 4ºC, this phage was 
added to C. coli NCTC 12667 at a MOI of 10 for ten days. In fact, Campylobacter counts and 
phage titer did not fall during the experimental period which indicates that a nonspecific 
adsorption did not occur. Conversely when the same phage was added to its susceptible 
host, under the same conditions described above, the Campylobacter numbers were reduced 
by 0.8 log10 CFU/ml (Atterbury et al., 2003a). 
In another experiment performed by the same authors, phage φ2 and C. jejuni NCTC 12662 
PT14 were added to chicken skin samples at different MOI ranging from 10-3 to 105 with 
samples stored at 4ºC and -20ºC for five days. The results again showed a significant 
reduction in Campylobacter counts when the virus were administered at the highest MOI: a 
1.1 log10 to 1.3 log10 CFU reduction in samples stored at 4ºC and a 2.3 log10 to 2.5 log10 CFU 
reduction for frozen samples. Overall, the treatment that showed the best reduction in 
Campylobacter counts in chicken skin was the one in which high phage titers were applied 
following by storage of samples at freezing temperatures. Nevertheless, in all the treatments 
phages were not able to replicate. Furthermore, Campylobacter strains recovered after phage 
treatments were shown to be identical to the inoculated strains and did not display 
resistance to this phage (Atterbury et al., 2003a). 
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Goode et al. (2003) also demonstrated the reduction in Campylobacter levels, after the 
application of a lytic phage to chicken skin, experimentally contaminated with C. jejuni. 
Chicken portions were initially inoculated with 104 CFU/cm2 of C. jejuni strain C222 and 
then half of the chicken pieces were treated with C. jejuni typing phage 12673 at an 
approximate density of 106 PFU/cm2. The samples were incubated at 4ºC and swabs were 
taken after 24h. The results obtained show that Campylobacter counts were reduced by 1.3 
log10 CFU comparing with the control. However, there was even a reduction of 
approximately 1 log10 CFU in the Campylobacter numbers from the non-phage-treated 
chicken portions, which meant that Campylobacter did not survive well on exposed chicken 
surfaces at 4ºC (Goode et al., 2003).  
In 2008 Bigwood et al. (2008) reported on an investigation into the use of phage Cj6 against 
C. jejuni inoculated on cooked and raw meat and incubated for 24h at two different 
temperatures (5ºC and 24ºC) in order to simulate refrigerated and room temperature 
storage. Experiments were performed using different conditions: low (<100 cells/cm2) or 
high (104 cells/cm2) host densities and low (10) or high (104) MOIs. When the experimental 
conditions were set for 5ºC, significant differences were obtained for samples inoculated 
with high MOI and high host density. A reduction of 2.4 log10 CFU/cm2 and 1.5 log10 
CFU/cm2 was obtained on cooked and raw meat, respectively. The titer of phages 
inoculated was also reduced by 10%, after 24h of incubation on cooked meat. When samples 
were stored at 24ºC, at high MOI and low host density, the reduction in Campylobacter 
counts was not significant. However when samples were inoculated at high MOI and high 
host density, reduction of 2.8 log10 CFU/cm2 (after 6h) and 2.2 log10 CFU/cm2 (after 24h) 
were obtained on cooked and raw meat, respectively. Nevertheless, Campylobacter counts 
were reduced, even in the untreated samples, which may be explained by their sensitivity to 
the experimental temperatures. Therefore the results did not allow an accurate assessment 
of the effective reduction by the phage treatment (Bigwood et al., 2008). 
Overall the studies suggest that high MOI values are more effective in the control of 
Campylobacter in foods. From the studies outlined above it is evident that Campylobacter are 
not able to grow and multiply under the conditions found on refrigerated raw meat, which 
renders unlikely phage replication. Nevertheless even if the phage cannot replicate at that 
temperatures, when reaching the human intestine, bacteria increases its metabolic activity 
and phages may eventually attach and lyse the target bacteria, leading to a control effect 
(Goode et al., 2003). 
4.3.2 Salmonella 
Different approaches have been used to assess the effectiveness of phages to control 
pathogens in foodstuff. Salmonella control in poultry products has been constantly 
highlighted. Goode et al. (2003) also used phages to treat chicken skin experimentally 
contaminated with Salmonella Enteritidis (103 CFU/cm2). Different MOIs were tested and for 
a MOI=1 the phages were able to replicate increasing their number with the consequent 
reduction of bacteria by less than 1 log10 in 24 hours. For higher MOIs (102 and 103) the levels 
of recovered Salmonella were reduced by roughly 2 log10 over 48h. Using even a higher MOI 
(105) to treat a more realistic Salmonella contamination level (<102 CFUs) no recoverable 
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The use of phages to reduce contamination of pig skin was studied by Hooton et al. (2011). 
In their study on pig skin artificially contaminated with Salmonella Typhimurium U288 (the 
most prevalent serovar found in pigs) at levels of 103 CFU, a cocktail of four phages which 
included Felix 01 was employed at a temperature of 4ºC. Although the application of the 
phage cocktail at MOI of 1 or less produce little or no reduction, the use of MOI above 10 led 
to a reduction of the pathogen below detectable levels (Hooton et al., 2011).  
The effectiveness of phages to control Salmonella in carcasses of broiler chickens and turkeys 
was tested by Higgins et al. (2005). In this study, 106 PFU of a phage applied to carcasses was 
deemed to be inefficient in the removal of S. Enteritidis at levels below 103. Instead, 
application of  108 PFU resulted in a marked reduction in the numbers of carcasses with 
recoverable Salmonella. Higgins et al. also used a cocktail composed of 72 different Salmonella 
phages to treat naturally contaminated turkey carcasses. The results are promising showing 
that the cocktail effectively reduced Salmonella recovery from the contaminated carcasses. 
These studies suggest that a high concentration of phage, preferably a cocktail of different 
phages, should be used to efficiently treat carcasses contaminated with Salmonella (Higgins 
et al., 2005). 
Control of Salmonella through the action of phages was also tested in raw and cooked beef 
by Bigwood et al. (2008). The samples were inoculated with Salmonella at low or high 
densities (respectively <102 or 104 CFU/cm2). Afterwards, phages were added at a MOI of 
101 or 104 and samples incubated at different temperatures to simulate refrigerated and 
room temperature storage (respectively 5ºC and 24ºC). Phages were able to reduce 
Salmonella counts in up to 2.3 log10 CFU/cm2 for samples incubated at 5ºC and in more than 
5.9 log10 CFU/cm2 for samples incubated at 24ºC when compared to controls (samples 
inoculated with Salmonella without phage). These results were obtained for both high 
densities of Salmonella (104 CFU/cm2) and phages applied at a high MOI (104) with samples 
incubated for 24h. The reductions were even higher after eight days of incubation. For low 
Salmonella densities the reductions were not significant for the majority of the samples. 
Interestingly, recovered Salmonella cells were found to still be sensitive to phage infection 
(Bigwood et al., 2008).  
The well-known broad host range Salmonella phage Felix 01 was used by Whichard et al. 
(2003) to treat chicken sausages contaminated with S. Typhimurium DT104 (300 CFU) and a 
reduction of up to 2.1 log10 in the Salmonella levels was obtained (Whichard et al., 2003). 
Control of Salmonella in foodstuff has not been restricted only to meat and derivates. A 
study carried by Leverentz and colleagues examined the efficiency of phage to control 
Salmonella on fresh-cut fruit, a rapidly developing industry. Treatment with a phage mixture 
was able to reduce the numbers of Salmonella by nearly 3.5 log10 CFU/g in honeydew melon 
slices stored at 5 ºC and 10ºC, temperatures at which Salmonella can survive or increase up to 
2 log10 respectively within a week. At 20ºC, where Salmonella loads can increase up to 5 log10, 
the decrease of Salmonella in slices was of 2.5 log10. The reductions obtained were greater 
than the maximal amount achieved using chemical sanitizers. Although this marked 
reduction in melons, in apple slices this did not happen. The reason may rely in the lower 
pH of apples that does not enables phage survival since it was not possible to reisolate 
phages in the apple 48 hours post treatment while in the melons the phage concentration 
was stable during this time period (Leverentz et al., 2001a).  
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Pao et al. (2004) used phages to treat sprouting seeds where it was found that Salmonella 
grows during soaking. Treatment with phages could reduce the numbers of Salmonella in 
1.37 log10 and 1.5 log10 in mustard seeds and in the soaking water of broccoli seeds by using 
one or two phages respectively (Pao et al., 2004).  
Cheese contamination by Salmonella was also subject of study on possible biocontrol with 
phages. Modi et al. (2001) following standard procedures made cheddar cheese from raw 
and pasteurized milk (an important vehicle of Salmonella transmission to humans) 
(European Food Safety Authority, 2011). The cheese was inoculated with 104 CFU/ml of S. 
Enteritidis and 108 PFU/ml of the Salmonella phage SJ2 (Modi et al., 2001). A decrease in 
Salmonella counts by 1 to 2 log10 was observed in raw and pasteurized milk cheeses while in 
the controls (cheeses made from milks inoculated with only Salmonella and no phage) an 
increase of 1 log10 was observed. After storage of the cheeses for 99 days at 8ºC Salmonella 
was present in the controls at a final concentration of 103 CFU/g. In the phage treated 
cheeses only 50 CFU/g were present in the ones from raw milk and no Salmonella was 
recovered from pasteurized milk cheeses after 89 days. 
Composting is a complex process used not only to obtain a nutrient-rich substrate but also 
to significantly reduce pathogen contamination. Even so, improperly composting may result 
in Salmonella survival and thus constitute a vehicle of Salmonella transmission to animals and 
humans. Heringa et al. (2010) used a cocktail of five phages to treat a dairy manure compost 
inoculated with S. Typhimurium and observed a 2 log10 reduction within four hours and 3 
log10 reduction within 34 hours compared to the controls (Heringa et al., 2010).  
Reduction of Salmonella through the action of phages was also investigated in wastewater. 
Turki et al. (2011) isolated three different phages and tested their ability to reduce Salmonella 
in TSB medium at two temperatures (30ºC and 37ºC). Phages were applied at three different 
MOI (100, 102 and 104) alone or as a cocktail of two or three phages. The three phage cocktail 
was able to reduce all Salmonella cultures at both temperatures when using a high MOI. 
Although, addition of individual or combination of two phages led to the emergence of 
phage resistant bacteria. Even so, the use of two phages presented better results than the use 
of an individual phage. The most important result was the eradication of Salmonella from the 
samples when the three phage cocktail was inoculated in raw wastewater (Turki et al., 2011). 
4.4 Considerations 
The above studies showed inconsistencies in the ability of phages to act as biocontrol agents 
of Campylobacter and Salmonella in livestock. Even so, it seems that the proof of principle, 
that phages are able to reduce the number of these pathogens (at least in a short period after 
treatment), has been established.  
At a first glance, in vivo biocontrol of foodborne pathogens made “on-farm” seems to be a 
good approach since, theoretically, the problem would be treated on its origin. Ideally, 
phages would be applied through the use of a sole administration of a low dose of phage. 
The virulent phage should then amplify at the expense of the target bacteria by repeated 
cycles of replication leading to the host eradication. The increasing number of the progeny 
phage would remain in the system for some period of time acting prophylactically in a 
possible subsequent infection. Although, as shown by several studies, eradication of the 
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chicken skin Reduction of up to 2 log10 on frozen samples 
(Atterbury et 
al., 2003a) 
chicken skin Reduction of up to 2.31 log10 CFU/g at 4ºC. 
(Goode et al., 
2003) 
raw and cooked 
meat 
Reduction of up to 2.8 log10 CFU on 
cooked meat 








chicken skin Reduction of up to no recoverable Salmonella 
(Goode et al., 
2003) 
pig skin Reduction of up to below detectable levels at 4ºC 




Reduction of up to 93% reduction in 
Salmonella recovery 
(Higgins et al., 
2005) 
raw and cooked 
meat 
Reduction of more than 5.9 log10 CFU on 
raw meat 
(Bigwood et al., 
2008) 




Reduction of up to 3.5 log10 in Salmonella 
numbers in honeydew melon slices 
stored at 5 ºC  
(Leverentz et 
al., 2001b) 
sprouting seeds  Reduction of up to 1.5 log10 in Salmonella numbers 
(Pao et al., 
2004) 
cheese  Reduction of up to no recoverable Salmonella in pasteurized milk cheeses 
(Modi et al., 
2001) 
dairy manure 
compost Reduction of up to 3 log10 
(Heringa et al., 
2010) 
Table 2. Studies on phage biocontrol in foodstuff 
resistant bacterial subpopulation. Eradication is even difficult in vivo since the number of 
Salmonella and Campylobacter is usually higher in broiler chicken intestines than in the 
carcasses and derived products. Moreover, the colonization of animals in herds or flocks 
spreads exponentially and infection may be through direct contact with pens and holding 
facilities which were used before by infected animals. Therefore, the on-farm treatment may 
lead to the emergence of phage resistant strains with their consequent spread to all animals 
in the farm. In addition, repeatedly use of phages may induce production of antibodies that 
will afterwards neutralize the phages, diminishing their effectiveness (Johnson et al., 2008). 
The emergence of phage resistant bacteria is a major concern in phage biocontrol and long 
term studies on the resistance and resistant bacteria should be performed. 
The consistent reduction of the target bacteria shortly after phage administration, and the 
need to avoid the emergence of phage-resistant strains, suggests that phages should be 
applied shortly before slaughter. Indeed, in the period preceding slaughter, the animal is an 
epidemiological endpoint and the phages, as well the bacteria, will be removed from the 
contaminated source. This will prevent the emergence, spread and establishment of phage-
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resistant strains and will not have an impact on the farm microbial balance. Moreover this 
approach constitutes a realistic application of phages enabling the administration of a single 
dose. This will result in a low number of pathogens during food processing with the 
consequent decrease of cross-contamination, contributing thus to the consumer safety. 
Even so, some considerations should be taken into account for an efficient application of 
phages. Phages can be administered by different routes that will have impact in the efficacy 
of the phage action but also economic and practical implications. Obviously, the most 
practical, and probably economical, route of phage application is through food and drinking 
water, at least for large scale treatments as is the treatment of Salmonella and Campylobacter 
in the poultry industry. These routes of administrations will require further studies on the 
dose (volume and concentration) that will be incorporated into food or added to water as 
well the need for a way to protect phages from the low pH of the gastrointestinal tract that 
was shown to often inactivate the majority of phages (Smith et al., 1987a). Protection may be 
enabled through the simultaneously administration of an antacid or through phage proper 
encapsulation as tested by Carvalho et al. (2010) with a Campylobacter phage, phiCcoIBB35 
(Carvalho et al., 2010a), and Ma et al. (2008) with Salmonella phage Felix 01 (Ma et al., 2008), 
respectively. Alternatively, higher phage concentrations and/or phage mutants resistant to 
low pH may be used to increase the efficacy of phage treatment. Intramuscular inoculation 
seems only feasible to treat a low number and/or animals which represent an added value. 
Another important consideration is the need for in vivo studies for each phage in an 
appropriate model able to mimic the system in which the particular phage is to be 
administered since in vitro behaviour usually does not reflects the phage behaviour in vivo, 
in part due to the immune system response. This fact has also been often observed in the 
above studies. 
In the case where phage therapy immediately before slaughter is not possible due to 
inefficiency or impracticability, treatment of meat and foodstuff is also a possible approach. 
When phages are applied in foodstuff (post-slaughter), as in the case of a pre-slaughter 
phage treatment, the emergence of phage-resistant is also prevented since the phages and 
bacterial populations will be removed from the contamination source. Some studies, as 
described above, have addressed the possibility of using phages in the control of foodborne 
pathogens in foodstuff although, the majority of the Salmonella studies were carried at a 
temperature that is the optimum for the target bacteria to grow. This may lead to erroneous 
phage efficacy assessment because phage behaviour is highly dependent on the bacterial 
physiology which in turn also depends on the temperature. Consequently, a reliable study 
should be carried at the same temperature and other conditions at which the foodstuff is 
prepared, processed and/or stored. Commercial storage conditions of carcasses, meat and 
other foodstuff often include a refrigerated temperature of 4ºC in order to halt bacterial 
growth. Experiments performed at this temperature with Campylobacter and Salmonella have 
shown that a relative high dose (high MOI) of phage is needed probably due to the reduced 
host growth that will prevent phage replication. Even so, this is not much different from 
what was observed at higher temperatures or even in studies in livestock where, as it is 
shown here, a high MOI seems to be a requirement to reduce pathogenic loads. The 
presented studies have shown that little or no reduction was observed for MOIs of 1 or less 
suggesting that the therapeutic effect of the phages is passive, without taking advantage of 
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will afterwards neutralize the phages, diminishing their effectiveness (Johnson et al., 2008). 
The emergence of phage resistant bacteria is a major concern in phage biocontrol and long 
term studies on the resistance and resistant bacteria should be performed. 
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in the poultry industry. These routes of administrations will require further studies on the 
dose (volume and concentration) that will be incorporated into food or added to water as 
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was shown to often inactivate the majority of phages (Smith et al., 1987a). Protection may be 
enabled through the simultaneously administration of an antacid or through phage proper 
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(Carvalho et al., 2010a), and Ma et al. (2008) with Salmonella phage Felix 01 (Ma et al., 2008), 
respectively. Alternatively, higher phage concentrations and/or phage mutants resistant to 
low pH may be used to increase the efficacy of phage treatment. Intramuscular inoculation 
seems only feasible to treat a low number and/or animals which represent an added value. 
Another important consideration is the need for in vivo studies for each phage in an 
appropriate model able to mimic the system in which the particular phage is to be 
administered since in vitro behaviour usually does not reflects the phage behaviour in vivo, 
in part due to the immune system response. This fact has also been often observed in the 
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In the case where phage therapy immediately before slaughter is not possible due to 
inefficiency or impracticability, treatment of meat and foodstuff is also a possible approach. 
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phage treatment, the emergence of phage-resistant is also prevented since the phages and 
bacterial populations will be removed from the contamination source. Some studies, as 
described above, have addressed the possibility of using phages in the control of foodborne 
pathogens in foodstuff although, the majority of the Salmonella studies were carried at a 
temperature that is the optimum for the target bacteria to grow. This may lead to erroneous 
phage efficacy assessment because phage behaviour is highly dependent on the bacterial 
physiology which in turn also depends on the temperature. Consequently, a reliable study 
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prepared, processed and/or stored. Commercial storage conditions of carcasses, meat and 
other foodstuff often include a refrigerated temperature of 4ºC in order to halt bacterial 
growth. Experiments performed at this temperature with Campylobacter and Salmonella have 
shown that a relative high dose (high MOI) of phage is needed probably due to the reduced 
host growth that will prevent phage replication. Even so, this is not much different from 
what was observed at higher temperatures or even in studies in livestock where, as it is 
shown here, a high MOI seems to be a requirement to reduce pathogenic loads. The 
presented studies have shown that little or no reduction was observed for MOIs of 1 or less 
suggesting that the therapeutic effect of the phages is passive, without taking advantage of 





“lysis from without” in which the adsorption and attachment of many phages to the 
bacterial surface of a single cell results in lysis without phage replication. The passive effect 
is corroborated by the results of Bigwood et al. (2008) who found that phages did not 
increase in numbers after reducing the Salmonella counts. This passive effect performed by 
the phages is not impaired at temperatures below the minimum for bacterial host growth as 
seen in these experiments performed at 4ºC and 5ºC reinforcing phage application in 
foodstuff at storage conditions (Atterbury et al., 2003a; Bigwood et al., 2008). Moreover, this 
passive effect seems to be less specific than the active one (where phages replicate inside 
their host) as has been observed by Goode et al. (2003) where Salmonella strains resistant to 
phage through restriction were also eliminated by passive effect of phages as long as the 
phages were able to attach (Goode et al., 2003). Consequently, treatment with high MOIs, 
although economically not so attractive due to the need of a higher dose, are able to reduce 
the emergence of phage-resistant strains. 
Another requirement of phage biocontrol is the need for broad host range phages and/or 
the use of a cocktail. Higher reductions in pathogenic bacteria were consistently obtained in 
livestock and foodstuff when a cocktail of phages with complementary host ranges and 
target receptors were used. The advantages of using cocktails and broad host range phages 
will be discussed below.  
Risk analysis modelling have shown that a reduction of 2 log10 in faeces of the slaughtered 
animal or in chicken carcasses can reduce the risk to consumers in 75% or 30 times 
respectively, in the incidence of campylobacteriosis associated with chickens consumption 
(Havelaar et al., 2007; Rosenquist et al., 2003). This 2 log10 reduction was shown in these 
studies to be a possible, practical and realistic goal. 
It can thus be concluded that (by using broad host range phages or cocktails of phages with a 
broad lytic spectrum, applied at high MOI, complemented with in vivo studies) both 
approaches (phage biocontrol in livestock at pre slaughter and in foodstuff) can be used in 
order to decrease the number of pathogenic bacteria in the food chain and consequently to 
reduce the incidence of foodborne diseases caused by Campylobacter and Salmonella. Although 
the studies only address the use of these two strategies separately, and because their 
effectiveness relies in the passive ability of phages to lyse the cells (and thus do not depends on 
the host concentration and physiological state), it can be argued that both approaches can be 
used together in order to achieve higher reductions of the pathogenic bacterial loads. 
5. Prerequisites for an acceptable phage product 
The better understanding of phage biology, infectious process and host-range specificity has 
been tracing the path by which the problems with early phage research may be partially or 
totally solved. Therefore the knowledge acquired so far coupled with the awareness of the 
mistakes committed, should be used to develop phage preparations which should meet 
several criteria whether they are intended to be applied in foodstuff or more importantly in 
animals and humans. Newly isolated phages should always be characterized in detail and 
biocontrol should not be attempted before the biology and genomics of the therapeutic 
phage is well understood. Consequently, the phage host range, virulence, stability and 
interaction with both innate and active immune systems should be determined. 
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5.1 Lytic phages 
In order to assure safety of phage therapy and eliminate potential risks of failure or even 
complications, it is critical that phages used in therapy are strictly lytic and without: 
transducing capabilities, gene sequences having significant homology with known major 
antibiotic resistance genes, genes for toxins and genes for other bacterial virulence factors 
(Carlton et al., 2005). Consequently, it is critical to avoid temperate phages. Reasons for this 
discrimination involve the fact that the latter phages will not kill all the target bacteria due 
to their ability to lysogenize them and probably more important, there is a high risk of 
possessing genes that can render the bacteria more virulent (Los et al., 2010). This can 
happen because certain temperate phages, such as those associated with Staphylococcus, E. 
coli, Salmonella, Corynebacterium and Clostridium actually carry virulence genes. In addition, 
during the transition between the lysogenic cycle and the lytic cycle, the excision of the 
prophage DNA may be accompanied with small pieces of the bacterial genome thus 
producing a specialized transducing phage. In addition, certain viruses such as Salmonella 
phage P22 are generalized transducers that are capable of randomly packaging any part of 
the host genome. Transducing phages will then transfer the host DNA fragments to newly 
infected bacteria producing changes in the bacterial genomes through recombination or 
reintegration. This may produce undesired phenotypic changes in their hosts such as 
resistance to antibiotics, restriction systems and increased bacterial virulence such as: 
bacterial adhesion, colonization, invasion and spread through human tissues, resistance to 
immune defences and exotoxin production (e.g. cholera toxin encoded by Vibrio cholerae-
phage CTX) (Los et al., 2010; Waldor & Mekalanos, 1996). Strictly lytic phages usually do not 
pose these risks but should be tested for transducing (Waddell et al., 2009). 
5.2 Cocktails and broad-host-range phages 
Within a given bacterial pathogen different mutants may exist with different susceptibility 
for a given phage. Although therapy should always match the phage with the target bacteria 
there are situations where treatment is urgently need, turning that approach impossible. 
Moreover, bacterial pathogens may mutate during the treatment time period and become 
resistant to the phage. This risk is real in part due to the narrow host range of phages. A way 
to circumvent these problems is by using a cocktail of phages targeting different receptors in 
the pathogen cell and with cross-resistant lytic activity. Consequently, if a bacterium is, or 
stays, resistant to one phage it is likely that it would not be resistant to a second phage 
which is immediately available in the cocktail and that targets a different receptor. This 
approach has been successfully used by Smith et al. (1987) in their E. coli diarrhoeal work 
(Smith et al., 1987b). 
An alternative to the phage cocktails is the use of broad host range phages that can be 
isolated through the use of common ubiquitous receptors in the target bacteria as in the case 
of phages that recognize TolC. In Salmonella this outer membrane protein is involved in the 
adhesion and invasion of host intestinal epithelial cells (Ricci & Piddock, 2010). Broad host 
range phages are polyvalent phages capable of infecting across bacterial species or genera 
and thus able to infect the majority of the target bacteria. These phages present a huge 
advantage as therapeutic agents and from the biotechnological point of view they are much 
more attractive because a single phage is far easier to characterize and get approved by the 
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few of them are known. Examples include Salmonella phage Felix O1 which infects most 
Salmonella serovars (Kallings, 1967) and Salmonella phage PVP-SE1 which presents a lytic 
spectrum even broader than that of Felix 01 (Santos et al., 2010). Nevertheless these phages 
may present a drawback if they are able to target other non-pathogenic bacteria causing 
dysbiosis. Therefore the ideal phage for use as biocontrol agent should have a broad host 
range among the target pathogen without infecting the commensal flora. Examples of these 
phages include two virulent coliphages which were able to lyse a high percentage of 
pathogenic E. coli strains of various serotypes whilst showed low lytic ability to lyse non-
pathogenic E. coli strains (Viscardi et al., 2008). These broad host range phages may also be 
used, not only as alternatives to cocktails, but also to design new cocktails with broader host 
ranges and consequently more efficient. Furthermore, phage cocktails and broad host range 
phages will also combat and prevent the emergence of phage resistant strains. Another 
possibility would be to engineer phages in order to target numerous receptors. Although 
very interesting and promising from a scientific point of view, this approach would hardly 
get acceptance from the food authorities (Kropinski, 2006). 
5.3 Genome sequencing 
A full knowledge of phage genome sequences is important to ensure that the phage does not 
carry obvious virulence factors, resistance or lysogeny genes. The identification of gene 
homologies requires detailed bioinformatics analysis. The latter is essential to evaluate 
possible complications that might arise during phage therapy. It was suggested that data 
from phage genome sequences could be used to establish a bank of “safe” therapeutic 
phages increasing the availability, safety and efficacy of phage therapy (Petty et al., 2007). 
Phages that break down the bacterial DNA to recycle bacterial host genome for their own 
DNA synthesis should be selected for therapy since this will hamper coexistence between 
phage and host. Such phages usually encode enzymes involved in nucleotide metabolism 
and the corresponding genes can be identified through sequence analysis (Carlton et al., 
2005). Even so, due to the usually high number of genes in the phage genome with 
unknown function, it is never possible to assure at 100% that no virulence factors, resistance 
or lysogeny genes exist. Correspondingly, the genome sequencing analysis enables to reject 
the use of phages for which genes were found to code for virulence, resistance or lysogeny 
but that does not present any experimental biologic evidence of it, that is, which never have 
shown to lysogenize a bacterium or increase the bacterium virulence and/or resistance. 
5.4 Models for host-phage interaction 
Phage therapy experimental design is not straightforward due to the self-replicating nature of 
phages. This means that for each phage, pharmacokinetic information is required which can be 
achieved by the determination of the phage infection parameters and by the use of a reliable 
population dynamic model able to predict the phage-bacteria behaviour. Understanding these 
dynamics will help the transference of in vitro results to in vivo predictions, explaining why a 
phage that replicates extremely well in the target bacteria in vitro fails to do it in vivo. It is 
expected that mathematical models may help to design experimental studies of population 
dynamics by identifying and evaluating the relative contribution of phage and bacteria in the 
course and outcome of an infection (Levin & Bull, 2004). Therefore, in vivo assessment of the 
phage, in a suitable animal model, should always be accomplished.  
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5.5 Phage production in a large-scale and storage 
The increasing interest in phages as therapeutic or biocontrol agents and the intention of 
commercially distribute a phage or a phage based product demands a large scale production 
that is not compatible with the conventional double-agar overlay method. Consequently, 
production of phages will certainly make use of bioreactors and a control and optimization 
of phage production will play an important role. Good manufacturing practice requirements 
demands for the development of methods that ensure phage preparations highly purified, 
free of bacteria, toxins, pyrogenic substances and other harmful components. Although in 
the majority of animal studies phages were administered as crude lysates without adverse 
effects for the animal, the removal of endotoxins, exotoxins and cell debris is very important 
for the safety of the phage product and also for an easier acceptance by the consumers. An 
option would be the propagation of phages in a non-pathogenic or in a non-toxin producer 
host (Santos et al., 2010). The storage should also be validated and suitable for the particular 
phage in order to assure that the preparations contain viable phage particles able to infect 
the target bacteria. Moreover, stability and pH control of the preparation is important as 
shown in the past by the rising problems observed when these facts were neglected 
(Merabishvili et al., 2009). 
6. Commercialization of phage-based products 
Despite the good scientific results and the economic viability of phage products an 
important issue that cannot be forgotten is the public acceptance which can constitute a 
serious obstacle to the introduction of phages in food. It is likely that consumers will feel an 
antipathy when knowing that live viruses are being added in their foods and that will be 
ingested by them. First of all, phages are viruses that only infect bacteria and not eukaryotic 
cells as the human cells. Moreover they are very specific to the target bacteria avoiding this 
way dysbiosis. It is also important to note that the use of a virus to combat a pathogen is not 
so strange since some vaccinations are carried out using live, albeit attenuated, eukaryotic 
viruses. Since phages have been identified in drinking water, and foods such a yoghurt and 
salami they are generally considered safe (Rohwer, 2003). Also, this means not only that 
phages are already inside our body but also that they are constantly being ingested. 
Different phages, applied at different doses, using different routes of administration in 
humans during the long history of phage therapy in the Eastern Europe did not produced 
serious complications (Sulakvelidze et al., 2001). Moreover, in a carefully controlled double-
blind study involving ingestion of phage T4 by volunteers, no side effects were reported 
(Bruttin & Brussow, 2005). These facts show that phages are nontoxic to animals and plants 
and apparently innocuous from a clinical standpoint. Along these lines, it can be conclude 
that the introduction of phages in human food-chain through the usage of phages as 
biocontrol agents in living animals or carcases can be considered safe and may be seen as a 
valuable alternative to the use of antibiotics in animal production. 
With respect to regulations, the introduction of a biocontrol phage product in animals and 
foodstuff may not be as stringent as its introduction in human therapy. The way for its 
introduction has been recently (2006) paved by the approval by the American Food and Drug 
Administration (FDA) of a mixed Listeria-phage preparation, ListShield (www.intralytix.com) 
to be used as a food additive in poultry derivatives and ready-to-eat meat. Another product 
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“generally recognized as safe” (GRAS) to be used in all food products in 2007. Other phage-
based products to control E. coli and Salmonella exist to be used at pre-slaughter 
(www.omnilytics.com and www.intralytix.com). The approval of such products proves the 
safety of phages and anticipates the development and introduction of new phage based 
products to be applied not only in foodstuff but also, at a long term, in animals and humans.  
7. Conclusions 
The emergence of multidrug-resistant bacteria has opened a second window for phage 
biocontrol. The recent work reviewed here shows that it has been established the proof-of-
principle and evidences are more than enough to state that phage biocontrol, if well-
conceived, is very effective in the treatment and prophylaxis of many problematic infectious 
diseases. Of particular interest is the potential that phage biocontrol has demonstrated 
against the global problematic multidrug-resistant bacteria. While the results of phage based 
products efficacy are very promising some consideration need to be taken into account. 
Efficient phage biocontrol requires the use of broad host range phages and administration of 
cocktails of phages with complementary host ranges and target receptors (showing thus 
cross-resistant lytic activity) in order to circumvent the emergence of phage resistant 
bacteria. Also, in vivo studies with suitable models should always be performed to assess the 
efficacy of the phage based product. From an economical and practical point of view, the 
best route of administration at an industrial scale is obviously through food and drinking 
water. For a successful application of phages it is important to understand the epidemiology 
of the pathogen against which the phage preparation is to be used in order to identify the 
critical intervention points in the processing cycle where phage application would be most 
beneficial. On the other hand, consistent pathogenic bacteria reduction is only achieved 
short after phage administration suggesting that phages should be applied in livestock 
shortly before slaughter and/or post-slaughter in carcasses and foodstuff. Besides reducing 
significantly the bacterial loads in the food chain with the consequent reduction in 
foodborne incidences it will impair the emergence of phage resistant bacteria. 
Finally, although the consumers may be reluctant to the introduction of phages in the food 
chain, they have already shown to be safe for the environment, animals and humans with 
high efficiency in the reduction of foodborne pathogens. Moreover, some phage products 
are already commercially available and thus the way for the introduction of new phage 
based products is now open. 
Overall, it can be concluded that phages can and should be used, not only as alternative, but 
also as substitutes of antibiotics and chemical antibacterials, in the control of foodborne 
pathogens in livestock and foodstuff. 
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1. Introduction 
Bacterial viruses were first reported in 1915 by Fredrick William Twort when he described a 
transmissible “glassy transformation” of micrococcus cultures that resulted in dissolution of 
the bacteria (Twort, 1915). Subsequently, Felix Hubert d’Hérelle reported a microscopic 
organism that was capable of lysing Shigella cultures on plates that resulted in clear spaces 
in the bacterial lawn that he termed “plaques” (d’Hérelle, 1917). The term “bacteriophage” 
was introduced by d’Hérelle (1917) as he attributed the replicate nature of this phenomenon 
to bacterial viruses. During 1919 d’Hérelle utilized phages isolated from poultry feces as a 
therapy to treat chicken typhus and further utilized this approach to successfully treat 
dysentery among humans (Summers, 2001). Prior to the discovery and widespread use of 
antibiotics, bacterial infections were treated by administering bacteriophages and were 
marketed by L’Oreal in France (Bruynoghe & Maisin, 1921). Although Eli Lilly Co. sold 
phage products for human use up until the 1940’s, early clinical studies with bacteriophages 
were not extensively undertaken in the United States and Western Europe after the 1930’s 
and ‘40’s. Bacteriophages were and continue to be sold in the Russian Federation and 
Eastern Europe as treatments for bacterial infections (Sulakvelidze et al., 2001). 
Bacteriophages have been identified in a variety of forms and may contain RNA or DNA 
genomes of varying sizes that can be single or double-stranded nucleic acid (Ackermann, 
1974; 2003; 2006; 2007). Of all the bacteriophages examined by the electron microscope, 95% 
of those reported are tailed with only 3.7% being filamentous, polyhedral or pleomorphic 
(Ackermann, 2007). The tailed bacteriophages contain a linear, double-stranded DNA 
genome that can vary from 11 to 500 kb in the order Caudovirales which is further divided 
into three families based on tail morphology (Ackermann, 2003; 2006). These bacterial 
viruses have icosohedral heads while those phages with contractile tails are placed in the 
Myoviridae, those phages with a long non-contractile tail are placed in the Siphoviridae and 
phages with short tail structures are members of the Podoviridae. Although bacteriophages of 
the Caudovirales (tailed-phages) may be physically similar it has been difficult to classify 
them by use of DNA or protein sequences due to the tremendous diversity because of 
                                                 
* Nikolay V. Volozhantsev2, Brian B. Oakley1, Cesar A. Morales1, Johnna K. Garrish1, Mustafa Simmons1, 
Edward A. Svetoch2 and Gregory R. Siragusa3 
1Poultry Microbiological Safety Research Unit, Agricultural Research Service, USDA, USA 
2State Research Center for Applied Microbiology & Biotechnology, Russian Federation 





World Health Organization (2002). The use of antimicrobials outside human medicine: 
information from the World Health Organization on the health consequences. 
Journal of Environmental Health, Vol. 64, No. 9, pp. 66, 62-. 
11 
Bacteriophages of Clostridium perfringens 
Bruce S. Seal et al.* 
Poultry Microbiological Safety Research Unit, Agricultural Research Service, USDA,  
USA 
1. Introduction 
Bacterial viruses were first reported in 1915 by Fredrick William Twort when he described a 
transmissible “glassy transformation” of micrococcus cultures that resulted in dissolution of 
the bacteria (Twort, 1915). Subsequently, Felix Hubert d’Hérelle reported a microscopic 
organism that was capable of lysing Shigella cultures on plates that resulted in clear spaces 
in the bacterial lawn that he termed “plaques” (d’Hérelle, 1917). The term “bacteriophage” 
was introduced by d’Hérelle (1917) as he attributed the replicate nature of this phenomenon 
to bacterial viruses. During 1919 d’Hérelle utilized phages isolated from poultry feces as a 
therapy to treat chicken typhus and further utilized this approach to successfully treat 
dysentery among humans (Summers, 2001). Prior to the discovery and widespread use of 
antibiotics, bacterial infections were treated by administering bacteriophages and were 
marketed by L’Oreal in France (Bruynoghe & Maisin, 1921). Although Eli Lilly Co. sold 
phage products for human use up until the 1940’s, early clinical studies with bacteriophages 
were not extensively undertaken in the United States and Western Europe after the 1930’s 
and ‘40’s. Bacteriophages were and continue to be sold in the Russian Federation and 
Eastern Europe as treatments for bacterial infections (Sulakvelidze et al., 2001). 
Bacteriophages have been identified in a variety of forms and may contain RNA or DNA 
genomes of varying sizes that can be single or double-stranded nucleic acid (Ackermann, 
1974; 2003; 2006; 2007). Of all the bacteriophages examined by the electron microscope, 95% 
of those reported are tailed with only 3.7% being filamentous, polyhedral or pleomorphic 
(Ackermann, 2007). The tailed bacteriophages contain a linear, double-stranded DNA 
genome that can vary from 11 to 500 kb in the order Caudovirales which is further divided 
into three families based on tail morphology (Ackermann, 2003; 2006). These bacterial 
viruses have icosohedral heads while those phages with contractile tails are placed in the 
Myoviridae, those phages with a long non-contractile tail are placed in the Siphoviridae and 
phages with short tail structures are members of the Podoviridae. Although bacteriophages of 
the Caudovirales (tailed-phages) may be physically similar it has been difficult to classify 
them by use of DNA or protein sequences due to the tremendous diversity because of 
                                                 
* Nikolay V. Volozhantsev2, Brian B. Oakley1, Cesar A. Morales1, Johnna K. Garrish1, Mustafa Simmons1, 
Edward A. Svetoch2 and Gregory R. Siragusa3 
1Poultry Microbiological Safety Research Unit, Agricultural Research Service, USDA, USA 
2State Research Center for Applied Microbiology & Biotechnology, Russian Federation 





horizontal gene transfer (Casjens, 2005). Also, Unlike the case for Bacteria and Archaea, both 
of which can be classified using the 16S rRNA gene (Woese and Fox, 1977), due to the 
mosaic nature of bacteriophage genomes (Hendrix et al., 1999), there appears not to be one 
candidate conserved gene that can be utilized to categorize all phages for a suitable 
classification scheme (Nelson, 2004). One approach has been to construct a “phage 
proteomic tree” based on predicted protein sequences of a bacterial virus (Rohwer and 
Edwards, 2002) while another approach is to divide bacteriophages based on genome type 
(ssRNA or DNA) with a further demarcation by physical characteristics such as tailed or 
filamentous types (Lawrence et al., 2002). Proux et al. (2002) proposed a phage taxonomy 
scheme based on comparative genomics of a single structural gene module (head or tail 
genes). This partially phylogeny-based taxonomical system purportedly parallels many 
aspects of the current International Committee on Taxonomy in Virology (ICTV) classification 
system. 
2. Antibiotics, antibiotic resistance and the future role of bacteriophages 
There is worldwide concern over the present state of antimicrobial resistance (AMR) issues 
with zoonotic bacteria potentially circulating among food-producing animals, including 
poultry (McDermott et al., 2002; Gyles, 2008). This has resulted in the general public’s 
perception that antibiotic use by humans and in food animals selects for the development of 
AMR among food-borne bacteria that could complicate public health therapies (DuPont, 
2007). A major issue is that antibiotic resistance may not only occur among disease-causing 
organisms but also become an issue for other resident organisms in the host which may 
accumulate in the environment (Yan & Gilbert, 2004).  Sub-therapeutic use of antibiotics as 
growth promoters has been discontinued in the European Union (Regulation EC No. 
1831/2003 of the European parliament and the council of 22 September 2003 on additives for 
use in animal nutrition; Castanon, 2007). This concern is justified due to the increase in 
antibiotic resistance among bacterial pathogens (NAS, 2006; Gyles, 2008), including bacteria 
from healthy broiler chickens (Persoons et al., 2010). Consequently, there is a need for 
developing novel intervention methods including narrow-spectrum antimicrobials and 
probiotics that selectively target pathogenic organisms while avoiding killing of beneficial 
organisms (NAS, 2006). 
There has been a resurgent interest in bacteriophage biology and their use or use of phage 
gene products as antibacterial agents (Merril et al., 1996; Wagner and Walder, 2002; Liu et al., 
2004; Fischetti, 2010). The potential use of lytic bacteriophage and/or their lytic enzymes is 
of considerable interest for medicine, veterinary and bioindustry worldwide due to 
antibiotic resistance issues. Recently, the U.S. Food and Drug Administration approved a 
mixture of anti-Listeria viruses as a food additive to be used in processing plants for 
spraying onto ready-to-eat meat and poultry products to protect consumers from Listeria 
monocytogenes (Bren, 2007). In veterinary practice, experimental alimentary E. coli infections 
in mice and cattle were controlled by bacteriophage therapy (Smith & Huggins, 1982; 1987). 
Similarly Barrow et al. (1998) reported the use of lytic bacteriophages to protect against E. 
coli septicemia and meningitis in chickens and young cattle. Huff et al. (2002a,b; 2003) 
reported the use of a lytic bacteriophage to reduce effects of E. coli respiratory illness in 
chickens and bacteriophages have been proposed as a strategy for control of food-borne 
pathogens (Hudson et al., 2005). Joerger (2002) reviewed the literature for application of lytic 
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bacteriophage to control specific bacteria in poultry and concluded that evidence from 
several trials indicated that phage therapy may be effective under certain circumstances. 
However, obstacles for the use of phage as antimicrobials remain due to reasons such as 
limited host-range for many bacteriophages (Labrie et al., 2010). 
In the European Union (EU) antimicrobial growth promoters have been banned from animal 
feeds because of concerns over the spread of antibiotic resistances among bacteria (Bedford, 
2000; Moore et al.,2006) and the EU-wide ban on the use of antibiotics as growth promoters 
in animal feed entered into effect on January 1, 2006 (Regulation 1831/2003/EC). Removal 
of these antimicrobials will induce changes within the chicken intestinal microbial flora, 
dictating the need to further understand the microbial ecology of this system (Knarreborg et 
al., 2002; Wise and Siragusa, 2007), so that appropriate antibiotic alternatives may be 
developed based on this knowledge (Cotter et al., 2005; Ricke et al., 2005). There has been a 
limited number of new antibiotic drugs marketed recently with only two, linezolid which 
targets bacterial protein synthesis and daptomycin wherein the mechanism of action is 
unknown, appearing since 2000. This is disconcerting considering that this is happening at a 
time when there is an increasing emergence of antibiotic resistant bacteria with a meager 
number of new drugs being developed active against such agents (Projan et al., 2004). The 
view that there is no compelling reason to pursue development of novel therapeutic agents 
is unwise (Projan & Youngman, 2002), especially considering emergence of “pan-resistant” 
or multiple-antibiotic resistant strains of Gram-positive bacteria (French, 2010). 
Consequently, bacteriophage or perhaps more importantly their gene products may provide 
us with new antimicrobials to combat antibiotic resistant bacteria or that could be used 
synergistically with traditional antibiotics. 
3. Biology of Clostridium perfringens, human and veterinary medical issues 
Clostridium perfringens is a Gram-positive, spore forming, anaerobic bacterium that is 
commonly present in the intestines of people and animals. C. perfringens is classified into 
one of five types (A, B, C, D, or E) based on toxin production (Smedley et al., 2004; Sawires & 
Songer, 2006). Spores of the pathogen can persist in soil, feces or the environment and the 
bacterium causes many severe infections of animals and humans. The bacterium can cause 
food poisoning, gas gangrene (clostridial myonecrosis), enteritis necroticans and non-
foodborne gastrointestinal infections in humans and is a veterinary pathogen causing 
enteric diseases in both domestic and wild animals (Smedley et al., 2004; Sawires & Songer, 
2006). Spores of the pathogen can persist in soil, feces, and in the environment causing many 
severe infections in humans and animals. Clinical symptoms and pathogenesis of the 
infection is determined by enterotoxins produced by C. perfringens strains of type A (CPE 
strains). If a sufficient number of pre-formed C. perfringens cells are ingested from 
contaminated food, these cells are capable of passage from the stomach to the intestinal tract 
where upon sporulation (spore formation) CPE is released causing the disease state of C. 
perfringens food poisoning (Smedley et al., 2004; Sawires & Songer, 2006). Many heat 
processes are incapable of inactivating the C. perfringens endospores. Survival of spores in 
these products allows the subsequent outgrowth where spores can germinate and 
commence growth at temperatures of 43 to 47C. In foods such as meats with gravy, heating 
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numbers of C. perfringens will rapidly divide. Importantly, C. perfringens has been 
documented to have very rapid doubling times, in some cases as low as 7 to 9 minutes in 
beef broth (Smedley et al., 2004; Sawires & Songer, 2006). 
Clostridium perfringens plays a significant role in food-borne human disease and is among the 
most common food-borne illnesses in industrialized countries (Brynestad & Granum, 2002; 
Lindström et al., 2011). It can be the second or third most frequent cause of bacterial foodborne 
illness in the United States and is responsible for approximately one million domestic cases 
annually (Mead et al., 1999; Scallan et al., 2011). Outbreaks are frequently associated with 
temperature-abused meat or poultry dishes and typically involve a large number of victims 
(Lindström et al., 2010). If a sufficient number of C. perfringens cells are ingested from 
contaminated food, these cells are capable of passage from the stomach to the intestinal tract 
where, upon sporulation, CPE is released causing the disease state of C. perfringens food 
poisoning (Wen & McClane, 2004). In addition to food poisonings, CPE-positive C. perfringens 
type A has been implicated in other diseases such as antibiotic-associated and sporadic 
diarrhea in humans that also may be food-related or non-food sources (Lindström et al., 2010). 
The Centers for Disease Control and Prevention (CDC) collects data on food-borne disease 
outbreaks (FBDOs) from all states and territories through the Food-borne Disease Outbreak 
Surveillance System (FBDSS). The 12 June 2009 issue of Morbidity and Mortality Weekly 
Report (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5822a1.htm) states that one 
of the pathogen-commodity pairs responsible for the most outbreak-related cases was C. 
perfringens in poultry (902 cases). Although C. perfringens is considered in the "medium" risk 
category, it can become a high risk pathogen/product combination with temperature 
abused poultry-meat products during extended shelf life or when cross-contaminated by 
Listeria monocytogenes (Mataragas et al., 2008). It was reported that improper retail and 
consumer refrigeration accounted for approximately 90% of the C. perfringens illnesses 
(Crouch et al., 2009) and poultry meat can be a frequently implicated food vehicle during 
outbreaks (Gormley et al., 2010; Nowell et al., 2010). 
Necrotic enteritis is a peracute disease syndrome and the subclinical form of C. perfringens 
infection in poultry are caused by C. perfringens type A producing the alpha toxin, and some 
strains of C. perfringens type A produce an enterotoxin at the moment of sporulation that are 
responsible for food-borne disease in humans. The mechanisms for colonization of the avian 
small intestinal tract and the factors involved in toxin production are largely unknown. 
Unfortunately, few tools and strategies are available for prevention and control of C. 
perfringens in poultry. Vaccination against the pathogen and the use of probiotic or prebiotic 
products has been suggested, but are not available for practical use in the field at the present 
time (Van Immerseel et al., 2004). Since most poultry harbor intestinal C. perfringens 
commensally as a component of the gut microflora, these issues lend credence to the 
hypothesis that as subtherapeutic usage of antibiotics is discontinued during poultry 
production, food-borne illness associated with C. perfringens will likely increase. This could 
potentially become a greater problem for the U.S. poultry industry as antibiotics are 
withdrawn from animal feeds as has been done in the European Union (Casewell et al., 2003; 
Van Immerseel et al., 2004). Control of clostridia in commercial poultry has traditionally 
been accomplished by feeding sub-therapeutic amounts of antibiotics in feed (Jones & Ricke, 
2003; Collier et al, 2003). Antibiotics have been utilized for over thirty years (Maxey and 
Page, 1977; George et al., 1982; Engberg et al., 2000; Brennan et al., 2003) and resistance of C. 
perfringens to growth-enhancing antibiotics has been detected among isolates from poultry 
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(Diarra et al., 2007). Consequently, there is a need for developing on-farm interventions to 
reduce populations of this bacterial pathogen that lead to peracute flock disease and 
possibly greater numbers of CPE+ isolates of C. perfringens entering the human food chain.  
4. Early literature reporting bacteriophages of Clostridium perfringens 
There is a paucity of genomics data for C. perfringens bacteriophages, but it has been known 
that both temperate and lytic phages are associated with the pathogen, while the Russian 
literature compiled by Spencer (1953) reported the use of clostridial bacteriophages to treat 
gas gangrene. Investigators at the Institute Pasteur reported bacteriophages that could be 
induced from lysogeny among isolates of C. perfringens that were long-tailed viruses of the 
Siphoviridae (Kreguer et al., 1947; Guelin & Kreguer, 1950; Guelin, 1953; Elford et al., 1953; 
Hirano & Yonekura, 1967). Subsequently, a member of the Podoviridae designated 
bacteriophage 80 was isolated with a distinct tail structure that was considered 
morphologically different from previously reported viruses of anaerobic bacteria (Vieu et al., 
1965). Intracellular replication of this virus was examined by Bradley & Hoeniger (1971) 
who reported that the bacteriophage had a head of approximately 40 nm in size with a 30 
nm tail. Intact viruses could be detected within the bacterial cell by 75 minutes post-
infection (p.i.) with cell lysis beginning at 105 to 115 min p.i. 
Gaspar & Tolnai (1959) published isolation of a virulent C. perfringens phage, while Ionesco 
et al. (1974) reported isolation of lysogenic bacteriophages. Lysogenic cultures could be 
induced by UV irradiation, nitrogen mustard [mechlorethamine; 2-chloro-N-(2-chloroethyl)-
N-ethyl-ethanamine, a nonspecific DNA alkylating agent] and to a lesser extent by 
mercaptoacetic acid. Twelve bacteriophages were induced from type A C. perfringens strains, 
ten from type B and 26 from type C strains of the bacterium, many of the phages were 
highly host specific with a high proportion of the C. perfringens strains resistant to infection 
by the viruses (Smith, 1959). Smith (1959) also reported that several viruses were apparently 
unable to enter into lysogeny and hence those were classified as ‘virulent’ bacteriophages. 
Following UV irradiation one lysogenic strain of C. perfringens resulted in isolation of a long-
tailed, DNA-containing bacteriophage with a non-contractile tail, designated CPT1 that 
produced turbid plaques. This phage had an eclipse phase of approximately 45 min with a 
maximum rise in titer 45 min following initial release of progeny virus (Mahony and Kalz, 
1968). A second bacteriophage designated CPT4 with similar characteristics, but with a 
shorter tail as compared with CPT1, was also isolated by these investigators (Mahony & 
Easterbrook, 1970). However, U.V. irradiation did not result in release of viruses from the 
indicator strain and it was reported that spontaneous release of the virus occurred with all 
resultant plaques that were clear. 
Lysogenic bacteriophages were isolated specifically from C. perfringens type C that were 
induced using mitomycin C treatment on specific isolates of the bacterium (Grant & 
Riemann, 1976). All the viruses had a similar morphology with polyhedral heads of 55 nm 
and long flexible tails of 130 to 190 nm.  Paquette & Fredette (1977) reported four lysogenic 
phages from C. perfringens type A that were induced with UV irradiation for 5 sec and had 
0.5 mm plaques with outer lysis rings. One phage was a podovirus, while the others were 
siphoviruses (Paquette & Fredette, 1977). Stewart & Johnson (1977) reported that lysogenic 
phages can have a positive effect on C. perfringens sporulation and Canard & Cole (1990) 
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(Diarra et al., 2007). Consequently, there is a need for developing on-farm interventions to 
reduce populations of this bacterial pathogen that lead to peracute flock disease and 
possibly greater numbers of CPE+ isolates of C. perfringens entering the human food chain.  
4. Early literature reporting bacteriophages of Clostridium perfringens 
There is a paucity of genomics data for C. perfringens bacteriophages, but it has been known 
that both temperate and lytic phages are associated with the pathogen, while the Russian 
literature compiled by Spencer (1953) reported the use of clostridial bacteriophages to treat 
gas gangrene. Investigators at the Institute Pasteur reported bacteriophages that could be 
induced from lysogeny among isolates of C. perfringens that were long-tailed viruses of the 
Siphoviridae (Kreguer et al., 1947; Guelin & Kreguer, 1950; Guelin, 1953; Elford et al., 1953; 
Hirano & Yonekura, 1967). Subsequently, a member of the Podoviridae designated 
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et al. (1974) reported isolation of lysogenic bacteriophages. Lysogenic cultures could be 
induced by UV irradiation, nitrogen mustard [mechlorethamine; 2-chloro-N-(2-chloroethyl)-
N-ethyl-ethanamine, a nonspecific DNA alkylating agent] and to a lesser extent by 
mercaptoacetic acid. Twelve bacteriophages were induced from type A C. perfringens strains, 
ten from type B and 26 from type C strains of the bacterium, many of the phages were 
highly host specific with a high proportion of the C. perfringens strains resistant to infection 
by the viruses (Smith, 1959). Smith (1959) also reported that several viruses were apparently 
unable to enter into lysogeny and hence those were classified as ‘virulent’ bacteriophages. 
Following UV irradiation one lysogenic strain of C. perfringens resulted in isolation of a long-
tailed, DNA-containing bacteriophage with a non-contractile tail, designated CPT1 that 
produced turbid plaques. This phage had an eclipse phase of approximately 45 min with a 
maximum rise in titer 45 min following initial release of progeny virus (Mahony and Kalz, 
1968). A second bacteriophage designated CPT4 with similar characteristics, but with a 
shorter tail as compared with CPT1, was also isolated by these investigators (Mahony & 
Easterbrook, 1970). However, U.V. irradiation did not result in release of viruses from the 
indicator strain and it was reported that spontaneous release of the virus occurred with all 
resultant plaques that were clear. 
Lysogenic bacteriophages were isolated specifically from C. perfringens type C that were 
induced using mitomycin C treatment on specific isolates of the bacterium (Grant & 
Riemann, 1976). All the viruses had a similar morphology with polyhedral heads of 55 nm 
and long flexible tails of 130 to 190 nm.  Paquette & Fredette (1977) reported four lysogenic 
phages from C. perfringens type A that were induced with UV irradiation for 5 sec and had 
0.5 mm plaques with outer lysis rings. One phage was a podovirus, while the others were 
siphoviruses (Paquette & Fredette, 1977). Stewart & Johnson (1977) reported that lysogenic 
phages can have a positive effect on C. perfringens sporulation and Canard & Cole (1990) 





share sequence similarity. Also, Shimizu et al. (2002) reported at least 20 phage-related 
sequence elements in the complete C. perfringens Strain 13, a gas gangrene isolate.  
A bacteriophage isolated from a C. perfringens fecal strain was adapted to a number of host 
strains from clinical swab and fecal isolates to develop a typing scheme using nine host 
modified phages (Yan, 1989). Of 109 strains, the phage types of 57 (52.3%) were identified, 
while nine (8.2%) other strains were sensitive to the phages at varying degrees. The 
remaining 43 (39.4%) strains were resistant and eleven of the 57 typable strains yielded cell-
surface mutants which belonged to different phage types from their parent strains (Yan, 
1989). Another phage-typing method for the bacterium was developed, but little or no 
information was available from the report (Satija & Narayan, 1980). 
 
Fig. 1. Plaques and bacteriophages of Clostridium perfringens isolated from a joint Russian 
Federation-USA collaborative research project. (A) Clear plaques produced by 
bacteriophages from a series of isolates reported in the text and references. (B) Long-tailed 
phages of the Siphoviridae. (C) Short-tailed phages of the Podoviridae. 
Initial screening for bacteriophages lytic for C. perfringens at the Poultry Microbiological 
Safety Research Unit, of the ARS, USDA and at the State Research Center for Applied 
Microbiology and Biotechnology in the Russian Federation was performed using filtered 
samples obtained from poultry (intestinal material), soil and processing drainage water 
(Figure 1). Bacterial viruses capable of lysing strains of C. perfringens type A and producing 
clear plaques were identified by spot-testing and titration of strains susceptible to the 
isolated phages (Fig. 1A). Lytic phage preparations were initially characterized 
morphologically utilizing plaque purified (3X) phage by electron microscopy using the 
modified method of Horne (1973) where both siphoviruses (Fig. 1B) and podoviruses (Fig. 
1C) have been discovered that are virulent for C. perfringens (Seal et al., 2011; Volozhantsev et 
al., 2011). 
5. Characteristics of Clostridium perfringens bacteriophage and prophage 
genomes 
Zimmer et al. (2002a) isolated two temperate bacteriophages by UV irradiation (phi3626 and 
phi8533) from lysogenic С. perfringens. The linear, double-stranded DNA genome of phi3626 
was reported to be 33.5 kb with nine nucleotide 3’ protruding cohesive ends and a G+C 
content of 28.4% (Zimmer et al., 2002a) which is essentially equivalent to its host DNA of 
28.6% (Shimizu et al., 2002; Myers et al., 2006). The phage phi3626 had a 55 nm diameter 
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isometric capsid with a 170 nm flexible, non-contractile tail (Zimmer et al., 2002a) that 
conformed to the Siphoviridae phage family in the order Caudovirales (Ackermann, 2006). 
Phage phi3626 was reportedly easier to propagate, so no genomics data were provided for 
phi8533 (Zimmer et al., 2002a). Physical characteristics of other C. perfringens bacteriophages 
are similar to phi3626 in that they were reported to have polyhedral heads of 55 nm in 
diameter with long flexible tails (Grant & Riemann, 1976; Paquette & Fredette, 1977) that 
also presumably had double-stranded DNA genomes. Only nineteen gene products could 
be assigned to the phage phi3626 genome based on bioinformatics analyses. Those were 
identified as encoding DNA-packaging proteins, structural components, a dual lysis system, 
a putative lysogeny switch, and proteins involved with replication, recombination, and 
modification of phage DNA. Several of the genes potentially influence cell spore-formation 
due to availability of the phage genes in the bacterial genome. Also, the phi3626 attachment 
site, attP, lies in a non-coding region immediately downstream of int encoding the integrase 
protein. Integration of the viral genome occurred into the bacterial attachment site attB, 
which is located within the 3' end of a C. perfringens guaA gene homologue. Subsequently, a 
phage-specific enzyme, a murein hydrolase, was expressed which had lytic activity against 
forty-eight test cultures of С. perfringens, but was not active against other clostridial species 
or bacteria belonging to other genera (Zimmer et al., 2002a). 
Bacteriophage genomes from viruses isolated from broiler chicken offal washes (O) and 
poultry feces (F), designated phiCP39O and phiCP26F, respectively, produced clear plaques 
on host strains (Seal et al., 2011). Both bacteriophages had isometric heads of 57 nm in 
diameter with 100-nm non-contractile tails characteristic of members of the family 
Siphoviridae in the order Caudovirales. The double-strand DNA genome of bacteriophage 
phiCP39O was 38,753 base pairs (bp), while the phiCP26F genome was 39,188 bp, with an 
average GC content of 30.3%. Both viral genomes contained 62 potential open reading 
frames (ORFs) predicted to be encoded on one strand of the DNA (Table 1). Among the 
ORFs, 29 predicted proteins had no known similarity to other reported proteins while others 
encoded putative bacteriophage capsid components such as a pre-neck/appendage, tail, 
tape measure and portal proteins. Other genes encoded a predicted DNA primase, single-
strand DNA-binding protein, terminase, thymidylate synthase and a potential transcription 
factor. Lytic proteins such as a fibronectin-binding autolysin, an amidase/hydrolase and a 
holin were encoded in the viral genomes. Several ORFs encoded proteins that gave BLASTP 
matches with proteins from Clostridium spp. and other Gram-positive bacterial or 
bacteriophage genomes as well as unknown putative Collinsella aerofaciens proteins that were 
detected in the virion. Proteomics analysis of the purified viruses resulted in the 
identification of the putative pre-neck/appendage protein and a minor structural protein 
encoded by large open reading frames. Variants due to potential phosphorylation of the 
portal protein were identified in the virion, and several mycobacteriophage gp6-like protein 
variants were detected in large amounts relative to other virion proteins. The predicted 
amino acid sequences of the pre-neck/appendage proteins had major differences in the 
central portion of the protein between the two phage gene products indicating that it may be 
the potential anti-receptor for the virus. Based on phylogenetic analysis of the large 
terminase protein, these phages were predicted to be pac-type phages, using a head-full 
DNA packaging strategy. Table 1 summarizes the gene products common to currently 
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protein. Integration of the viral genome occurred into the bacterial attachment site attB, 
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phage-specific enzyme, a murein hydrolase, was expressed which had lytic activity against 
forty-eight test cultures of С. perfringens, but was not active against other clostridial species 
or bacteria belonging to other genera (Zimmer et al., 2002a). 
Bacteriophage genomes from viruses isolated from broiler chicken offal washes (O) and 
poultry feces (F), designated phiCP39O and phiCP26F, respectively, produced clear plaques 
on host strains (Seal et al., 2011). Both bacteriophages had isometric heads of 57 nm in 
diameter with 100-nm non-contractile tails characteristic of members of the family 
Siphoviridae in the order Caudovirales. The double-strand DNA genome of bacteriophage 
phiCP39O was 38,753 base pairs (bp), while the phiCP26F genome was 39,188 bp, with an 
average GC content of 30.3%. Both viral genomes contained 62 potential open reading 
frames (ORFs) predicted to be encoded on one strand of the DNA (Table 1). Among the 
ORFs, 29 predicted proteins had no known similarity to other reported proteins while others 
encoded putative bacteriophage capsid components such as a pre-neck/appendage, tail, 
tape measure and portal proteins. Other genes encoded a predicted DNA primase, single-
strand DNA-binding protein, terminase, thymidylate synthase and a potential transcription 
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the potential anti-receptor for the virus. Based on phylogenetic analysis of the large 
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Function ID Function Name 
 
COG0629 Single-stranded DNA-binding protein 
COG0860 N-acetylmuramoyl-L-alanine amidase 
COG4722 Phage-related protein 
COG5412 Phage-related protein 
COG1351 Predicted alternative thymidylate synthase 
COG2333 Predicted hydrolase (metallo-beta-lactamase superfamily) 
COG3561 Phage anti-repressor protein 
COG3645 Uncharacterized phage-encoded protein 
COG5545 Predicted P-loop ATPase and inactivated derivatives 
COG5546 Small integral membrane protein 
COG3617 Prophage antirepressor 
COG3747 Phage terminase, small subunit 
COG4626 Phage terminase-like protein, large subunit 
COG4695 Phage-related protein 
COG0175 3'- PAPS reductase/FAD synthetase and related enzymes 
COG2369 Uncharacterized protein, homolog of phage Mu protein gp30 
COG2755 Lysophospholipase L1 and related esterases 
COG4926 Phage-related protein 
COG4974 Site-specific recombinase XerD 
COG0338 Site-specific DNA methylase 
COG0740 Protease subunit of ATP-dependent Clp proteases 
COG1476 Predicted transcriptional regulators 
COG3757 Lyzozyme M1 (1,4-beta-N-acetylmuramidase) 
COG5283 Phage-related tail protein 
COG5614 Bacteriophage head-tail adaptor 
COG0305 Replicative DNA helicase 
COG1191 DNA-directed RNA polymerase specialized sigma subunit 
COG1783 Phage terminase large subunit 
COG3064 Membrane protein involved in colicin uptake 
COG3740 Phage head maturation protease 
COG4824 Phage-related holin (Lysis protein) 
 
Note: Domains are observed in all Clostridium perfringens siphoviral genomes. 
Table 1. The Siphoviridae pan-genome encoded proteins representative of Clostridium 
perfringens bacteriophages. The table shows the union of all COGs present in the genomes of 
phages SM101, 3626, 9O, 13O, 26F, 34O, and 39O.  
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Function ID Function Name 
 
COG0417 DNA polymerase elongation subunit (family B) 
COG0739 Membrane proteins related to metalloendopeptidases 
COG0860  N-acetylmuramoyl-L-alanine amidase 
COG1196 Chromosome segregation ATPases 
COG2088 Uncharacterized protein, involved in the regulation of septum location 
COG3023 N-acetyl-anhydromuramyl-L-alanine amidase 




pfam05352 Phage Connector  
pfam05894 Podovirus_Gp16 (DNA encapsidation) 
pfam12841 YvrJ protein family 
PHA00144 major head protein 
PHA00148  lower collar protein 
PHA00380 tail protein 
 
Note: Domains are observed in all Clostridium perfringens podoviral genomes. 
Table 2. Podoviridae pan-genome protein products representative of Clostridium perfringens 
bacteriophages. The table shows the union of all conserved domains present in the genomes 
of phages CPV1, CPV4, ZP2, CP7R, and CP24R.  
Other bacteriophages lytic for C. perfringens were isolated from sewage, feces and broiler 
intestinal contents and phiCPV1, a virulent bacteriophage, was classified in the family 
Podoviridae (Volozhantsev et al., 2011). The purified virus had an icosahedral head and collar 
of approximately 42nm and 23nm in diameter, respectively, with a structurally complex tail 
of 37nm lengthwise and a basal plate of 30nm. The phiCPV1 double-stranded DNA genome 
was 16,747 base pairs with a GC composition of 30.5%, similar to its host. Twenty-two open 
reading frames (ORFs) coding for putative peptides containing 30 or more amino acid 
residues were identified in the genome. Amino acid sequences of the predicted proteins 
from the phiCPV1 genome ORFs were compared with those from the NCBI database and 
potential functions of 12 proteins were predicted by sequence homology. Three putative 
proteins were similar to hypothetical proteins with unknown functions, whereas seven 
proteins did not have similarity with any known bacteriophage or bacterial proteins. 
Identified ORFs formed at least four genomic clusters that accounted for predicted proteins 
involved with replication of the viral DNA, its folding, production of structural components 
and lytic properties. One bacteriophage genome encoded lysin was predicted to share 
homology with N-acetylmuramoyl-l-alanine amidases and a second structural lysin was 
predicted to be a lysozyme-endopeptidase. These enzymes probably digest peptidoglycan of 
the bacterial cell wall and could be considered potential therapeutics to control C. 
perfringens. Table 2 summarizes the gene products common to currently known C. 
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Fig. 2. Protein gel profiles for purified virions from bacteriophages virulent for Clostridium 
perfringens representing the Siphoviridae and Podoviridae from a joint Russian Federation-USA 
collaborative research project. 
Three structural proteins were identified in the lysogenic phi3626 by N-terminal sequencing 
of proteins following SDS-PAGE of the purified virions (Zimmer et al., 2002a). The major 
capsid component was estimated to be 43.3% of total phage protein and was determined to 
be post-translationally processed resulting in a decrease in size from 47.7 to 34.3 kDa. The 
major tail protein represented approximately 12.7% of the total protein, with an apparent 
size of 27 kDa while a minor structural protein composing 2.1% of the virion protein was 
reported with a predicted size of 55.1kD. More recently the proteins of virulent 
bacteriophages infecting C. perfringens have been described in detail (Seal et al., 2011; 
Volozhantsev et al., 2011). From the siphoviruses (Seal et al., 2011), four principle virion 
protein regions were identified (Fig. 2) that included a portal protein, mycobacteriophage 
gp6-like protein which was the major virion protein, a pre-neck appendage protein and 
several lower molecular weight minor structural proteins with no known function. The 
portal protein was identified as a protein that was also highly variable with respect to 
isoelectric point and size at approximately 50kDa. This was attributed to potential 
differences in phosporylation and myristilation of the portal protein due to the large 
number of post-translational modification sites on the molecule. The podoviruses identified 
to date have virion proteins essentially indicative of those types of bacteriophages 
(Volozhantsev et al., 2011). These viruses encode for a collar protein with a predicted size of 
approximately 27kDa and a connector protein with a predicted size of approximately 
35.9kDa. The major head or major capsid protein was predicted to have a size of 43.3kDa 
and was found in the greatest abundance in the purified virus. A large pre-neck protein of 
75 kDa and a tail protein of a size similar to the major capsid protein were also identified in 
C. perfringens phages of the Podoviridae (Fig. 2). 
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C. perfringens is an important agricultural as well as human pathogen and because 
biotechnological uses of bacteriophage gene products as alternatives to conventional 
antibiotics will require a thorough understanding of their genomic context, we sequenced 
and analyzed the genomes of four more closely related viruses isolated from the bacterium, 
then compared the known phage genomes (Oakley et al., 2011).  Phage whole-genome tetra-
nucleotide signatures and proteomic tree topologies correlated closely with host phylogeny. 
Comparisons of our phage genomes to 26 others revealed three shared COGs of which one 
of particular interest within this core genome was an endolysin (PF01520, an N-
acetylmuramoyl-L-alanine amidase) and a holin (PF04531). Comparative analyses of the 
evolutionary history and genomic context of these common phage proteins revealed two 
important results. One was a strongly significant, host-specific sequence variation within the 
endolysin and secondly is the protein domain architecture apparently unique to our phage 
genomes in which the endolysin is located upstream of its associated holin among certain 
members of the Siphoviridae (Oakley et al., 2011). Endolysin sequences from our viruses were 
one of two very distinct genotypes distinguished by variability within the putative 
enzymatically-active domain. The shared or core genome was comprised of genes with 
multiple sequence types belonging to five pfam families, and genes belonging to 12 pfam 
families, including the holin genes, which were nearly identical. 
6. Potential use of bacteriophages or their gene products to control 
Clostridium perfringens 
Bacteriophages have been utilized experimentally in an attempt to control a variety of 
pathogens and there has been increased interest to control disease among poultry (Joerger, 
2002). In vivo studies were conducted to determine if a cocktail of C. perfringens 
bacteriophages (INT-401) would be capable of controlling necrotic enteritis (NE) caused by 
C. perfringens (Miller et al., 2010). The first study investigated the efficacy of INT-401 and a 
toxoid-type vaccine in controlling NE among C. perfringens-challenged broiler chickens 
reared until 28 days old. Compared with the mortality observed with the bacterium-
challenged, but untreated chickens, oral administration of INT-401 significantly reduced 
mortality of the C. perfringens-challenged birds by 92%. Overall, INT-401 was more effective 
than the toxoid vaccine in controlling active C. perfringens infections of chickens. When the 
phage cocktail was administered via oral gavages, feed, or drinking water it significantly 
reduced mortality due to the bacterium and weight gain as well as feed conversion ratios 
were significantly better in the C. perfringens-challenged chickens treated with 
bacteriophages than in the C. perfringens-challenged, phage-untreated control birds (Miller et 
al., 2010). 
In order to repeat a similar study by Miller et al., (2010) and to determine optimal schemes 
for application of bacteriophage formulations to cure or prevent disease from C. perfringens 
infection in poultry, investigators at the State Research Center for Applied Microbiology and 
Biotechnology (Obolensk, Moscow Region, Russian Federation) completed a series of 
experiments to monitor the persistence of C. perfringens lytic bacteriophage phiCPV1 in 
broiler gastrointestinal tracts (GIT). The phage suspension was administered per os once to 
14-17 days old chicks (6×108 pfu/bird). To determine concentrations of the phage, materials 
from each section of the gastrointestinal tract (the crop, glandular stomach, the upper 






Fig. 2. Protein gel profiles for purified virions from bacteriophages virulent for Clostridium 
perfringens representing the Siphoviridae and Podoviridae from a joint Russian Federation-USA 
collaborative research project. 
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families, including the holin genes, which were nearly identical. 
6. Potential use of bacteriophages or their gene products to control 
Clostridium perfringens 
Bacteriophages have been utilized experimentally in an attempt to control a variety of 
pathogens and there has been increased interest to control disease among poultry (Joerger, 
2002). In vivo studies were conducted to determine if a cocktail of C. perfringens 
bacteriophages (INT-401) would be capable of controlling necrotic enteritis (NE) caused by 
C. perfringens (Miller et al., 2010). The first study investigated the efficacy of INT-401 and a 
toxoid-type vaccine in controlling NE among C. perfringens-challenged broiler chickens 
reared until 28 days old. Compared with the mortality observed with the bacterium-
challenged, but untreated chickens, oral administration of INT-401 significantly reduced 
mortality of the C. perfringens-challenged birds by 92%. Overall, INT-401 was more effective 
than the toxoid vaccine in controlling active C. perfringens infections of chickens. When the 
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Note: Fourteen-day old broilers were inoculated with a suspension of two phiCPV1-sensitive C. 
perfringens RifR-strains in the volume of 0.2ml (3×107 - 1×108 CFU for broilers) given per os to each broiler 
at day 19 (Groups 1 and 2) and at days 19, 20, 21 and 22 (Groups 4 and 5). The phiCPV1 in the volume 
of 0.2ml was administered per os twice a day to birds of Group 2 (108 pfu/bird) when they reached the 
age of 19 days, and to broilers of Groups 3 and 5 (109 PFU/bird) at days 19, 20, 21 and 22. 
Fig. 3. Titres of Clostridium perfringens and phiCPV1 in lower sections of the gastrointestinal 
tract (ileum/cecum) of broiler chickens experimentally infected with the bacterium. 
phage buffer followed by agar layer titration on a lawn produced by a C. perfringens 
phiCPV1- susceptible strain. Two independent experiments revealed that the highest 
concentration of the phage titer at 7×107 pfu/g was in the crop one hour after the 
administration. In the glandular stomach its concentration varied between 2×103 and 3×105 
pfu/g. In the interval between 3 and 12 hours after treatment, phage concentration reached 
107pfu/g both in cecum and ileum of all birds. Such high concentrations of the phage in the 
GIT are extremely important from the standpoint of the phage therapy for C. perfringens-
associated infection. Ileum and cecum are known to be main sites for the bacterium to 
colonize and proliferate. In the ileum and cecum, as well as in the large intestine, the 
maximal phage concentration (>106 pfu/g) was detected 6 hours after the administration of 
viruses and retained at a rather high level (>105 pfu/g) at least for the next 6 hours. The 
following day after administration of the phage in the GIT, the concentration decreased 
markedly. However, the phage was not fully eliminated even from the crop and was 
detected at the concentration of 500 pfu/g 48 hours later. The assessment of therapeutic and 
prophylactic effects of bacteriophage formulations in broilers during model experiments has 
demonstrated that phiCPV1 reduced intestinal colonization of the phage-sensitive C. 
perfringens in broiler chickens, with the phage titer being increased (Fig.3). At the same time 
experiments on phage therapy of broilers carrying natural C. perfringens infection by means 
of a phage cocktail were not successful and this was associated with the narrow lytic spectra 
of the phages. Consequently, natural C. perfringens isolated from the broiler chickens were 
 
Bacteriophages of Clostridium perfringens 
 
227 
resistant to the bacteriophages used during the experimentation, demonstrating the need for 
libraries of bacteriophage isolates to therapeutically eliminate the bacterium in animals. 
Zimmer et al. (2002b) investigated the cell wall lysis system of C. perfringens bacteriophage 
phi3626, whose dual lysis gene cassette consisted of a holin gene and an endolysin gene. The 
Hol3626 had two predicted membrane-spanning domains (MSDs) and was designated a 
group II holin. A positively charged beta turn between the two MSDs indicated that both the 
amino-terminus and the carboxy-terminus of Hol3626 protein might be located outside the 
cell membrane which is a very unusual holin topology (Young, 2002). The holin function 
was experimentally demonstrated by using the ability of the peptide to complement a 
deletion of the heterologous phage lambda S holin in lambda delta-Sthf. The endolysin gene 
ply3626 was cloned into an E. coli expression system. However, protein synthesis occurred 
only when the E. coli were supplemented with rare tRNA(Arg) and tRNA(Ile) genes 
required for proper codon usage of Gram+ genes in a Gram- system (Kane, 1995). Amino-
terminal modification by a six-histidine tag did not affect enzyme activity and enabled 
purification by Ni-chelate affinity chromatography. The Ply3626 had an N-terminal amidase 
domain and a unique C-terminal portion that was hypothesized to be responsible for the 
specific lytic range of the enzyme. A total of 48 C. perfringens strains were sensitive to the 
murein hydrolase, whereas other clostridia and bacteria belonging to other genera were 
generally not affected by the lysin (Zimmer et al., 2002b). 
Two putative phage lysin genes (ply) from the clostridial phages phiCP39O and phiCP26F 
were cloned, expressed in E. coli and the resultant proteins were purified to near 
homogeneity (Simmons et al., 2010). Gene and protein sequencing revealed that the 
predicted and chemically determined amino acid sequences of the two recombinant proteins 
were homologous to N-acetylmuramoyl-L-alanine amidases. The proteins were identical in 
the C-terminus cell-wall binding domain, but only 55 per cent identical to each other in the 
N-terminal catalytic domain. Both recombinant lytic enzymes were capable of lysing both 
parental phage host strains of C. perfringens as well as other type-strains of the bacterium in 
spot and turbidity reduction assays. The observed reduction in turbidity was correlated 
with up to a 3 log cfu/ml reduction in viable C. perfringens on brain heart infusion agar 
plates. However other member species of the clostridia were resistant to the enzymes by 
both assay methods. Interestingly, diversity exists even among closely-related 
bacteriophages, holins and endolysins represent conserved functions across divergent phage 
genomes and endolysins can have significant variability with host-specificity even among 
closely-related genomes. Endolysins of phage genomes in the presented study may be 
subject to different selective pressures than the rest of the genome and these findings may 
have important implications for potential biotechnological applications of phage gene 
products (Oakley et al., 2011). Interestingly, a variety of encoded potential gene products 
have been detected in the genomes of C. perfringens bacteriophages that could potentially be 
utilized as antimicrobials to control the bacterium (Fig. 4). 
The number of known genes encoding these peptidoglycan hydrolases has increased 
markedly in recent years, due in large part to advances in DNA sequencing technology. As the 
genomes of more bacterial species/strains are sequenced, lysin-encoding open reading frames 
(ORFs) can be readily identified in lysogenized prophage regions such as in the genomes of C. 
perfringens (Shimizu, et al., 2002; Myers et al., 2006). The genomes of nine C. perfringens strains 
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only when the E. coli were supplemented with rare tRNA(Arg) and tRNA(Ile) genes 
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generally not affected by the lysin (Zimmer et al., 2002b). 
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Fig. 4. Lytic proteins discovered in Clostridium perfringens bacteriophages from a joint 
Russian Federation-USA collaborative research project. 
proteins of various enzymatic classes (Schmitz et al., 2011). Of these lysins, a muramidase from 
strain ATCC 13124 (termed PlyCM) was chosen for recombinant analysis based on its 
dissimilarity to previously characterized C. perfringens lysins. Following expression and 
purification, various biochemical properties of PlyCM were determined in vitro, including 
pH/salt-dependence and temperature stability. The enzyme exhibited activity at low μg/ml 
concentrations, a typical value for phage lysins. It was active against 23 of 24 strains of C. 
perfringens assayed, with virtually no activity against other clostridial or non-clostridial species 
(Schmitz et al., 2011). Also, an endolysin predicted to encode an N-acetylmuramidase was 
identified as encoded by the episomal phage phiSM101 of C. perfringens (Nariya et al., 2011). 
Homologous genes were identified in the genomes of all five C. perfringens toxin types and the 
phiSM101 muramidase gene (psm) was cloned, then expressed in E. coli as a protein histidine-
tagged at the N-terminus (Psm-his). Similar to other C. perfringens phage lysins the purified 
protein lysed cells of all C. perfringens toxin types, but not other clostridial species tested as 
demonstrated by a turbidity reduction assay (Nariya et al., 2011). Consequently, more potential 
antimicrobials remain to be discovered utilizing genomics approaches. 
Immobilization and separation of bacterial cells by replacing antibodies with cell wall-
binding domains (CBDs) of bacteriophage-encoded peptidoglycan hydrolases (endolysins) 
has been accomplished for use as a potential diagnostic (Kretzer et al., 2007). Paramagnetic 
beads coated with recombinant phage endolysin-derived CBD molecules and bacterial cells 
could be immobilized and recovered from diluted suspensions within 20 to 40 min. The 
CBD-based magnetic separation (CBD-MS) procedure was evaluated for capture and 
detection of Listeria monocytogenes from contaminated food samples and this approach was 
demonstrated by using specific phage-encoded CBDs specifically recognizing both Bacillus 
cereus and C. perfringens cells (Kretzer et al., 2007). Consequently, the use of bacteriophage 
lysin cell-wall binding domains could be utilized for other applications as well as for 
improving diagnostic detection of Gram+ bacteria. 
7. Conclusions 
Bacteriophages have been utilized as potential interventions to treat bacterial infections. 
However, the development of bacterial resistances to their viruses occurs that include 
evolution of phage receptors, super-infection exclusion, restriction-modification systems 
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and abortive infection systems such as genomic CRISPR sequences (Labrie et al., 2010). 
These phenomena substantiate the inevitable need to constantly search for new 
bacteriophage isolates to use therapeutically. Also, it should be noted that although 
bacteriophage therapy has been utilized and examined as a treatment, it was pointed out 
early on by Smith (1959) that a large proportion of C. perfringens strains remained 
insusceptible to many of the bacteriophages isolated during those studies. This has routinely 
been observed during our investigations wherein most bacteriophages virulent for C. 
perfringens have a restricted host range (Fig. 5). Host specificity has routinely been observed 
relative to the bacteriophages isolated from various C. perfringens isolates that is most likely 
due to evolution of the receptor and anti-receptor molecules (Seal et al., 2011; Volozhantsev 
et al., 2011; Oakley et al., 2011). Therefore, selection of appropriate ‘bacteriophage cocktails’ 
may not necessarily be effective against many of the various bacterial isolates that exist in 
the environment and cause disease. 
 
Fig. 5. Spot-assay with Clostridium perfringens bacteriophages on their respective hosts. Note 
that most all phages are restricted in their respective host-ranges. 
Many enzymes are added to monogastric animal feeds to increase the digestibility of 
nutrients, leading to greater feed efficiency during the production of meat animals and eggs. 
Enzymes are added to monogastric animal feed for digesting carbohydrates and for 
metabolizing phytate to produce free phosphorus (Cowieson et al., 2006; Olukosi et al., 2010). 
There are a wide variety of enzymes marketed commercially for poultry feed additives, 
many of which are produced as a recombinant proteins in yeast and sold as a lysate which 
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cat.com/applicationDetails.php?application_id=8; Ultra BioLogics: 
http://www.ublcorp.com/; Danisco: http://www.danisco.com/; Novozymes: 
http://www.novozymes.com/en/solutions/agriculture/animal-nutrition/). Consequently, 
production of enzymes by Pichia pastoris can serve as a potential source for structural or 
animal feed studies (Johnson et al., 2010) and lysozyme can be encapsulated (Zhong & Jin, 
2009) which has been utilized as a feed additive in the diet of chickens to significantly 
reduce the concentration of C. perfringens in the ileum and reduce intestinal lesions due to 
the organism (Liu et al., 2010). Therefore, it is conceivable that bacteriophage proteins 
capable of lysing C. perfringens could be expressed in yeast and added as lysates to animal 
feed for reducing the bacterium to improve health and food safety for monogastric animals. 
Clostridium perfringens (formerly known as C. welchii) is a ubiquitous Gram+ anaerobic, 
spore-forming bacterium that causes debilitating diseases in both humans and a wide 
variety of animals resulting in both personal tragedy and economic losses. Although the 
bacterium can cause severe diseases in most animals including domestic chickens, non-
virulent forms of the bacillus are commonly found in the intestinal tracts of warm-blooded 
species as well as the environment. Several antibiotics can be utilized to treat clostridial 
diseases and sub-therapeutic amounts of antibiotics have been used in animal feeds as 
antibiotic growth promoters (AGP). Removal of AGP’s from animal feed has resulted in the 
need for increased use of antibiotics therapeutically to treat diseases among food-producing 
animals, in particular necrotic enteritis in poultry. Consequently, this situation along with a 
concern as how to treat antibiotic resistant bacteria has provided the impetus to develop 
alternative antimicrobials or new antimicrobials that can be used synergistically with 
antibiotics. Prior to the discovery and widespread use of antibiotics, bacterial infections 
were often treated with bacteriophages, which were marketed and sold commercially for 
human use up until the 1940’s. Following discovery of antibiotics, the use of phages to treat 
bacterial diseases was discontinued in Western Europe and the United States. 
Bacteriophages continue to be sold in the Russian Federation and Eastern Europe as 
treatments for bacterial infections and there is renewed interest in utilizing bacterial viruses 
to prevent or treat bacterial infections. Bacteriophages which infect C. perfringens that are 
both lysogenic and virulent have been discovered that have long tails, members of the 
Siphoviridae, and those with short tails, members of the Podoviridae. If these bacteriophages 
or their gene products are to be used as antimicrobials, it is essential to have a blueprint of 
the genomic machinery underlying phage-mediated bacterial lysis. As genome sequencing 
costs are reduced in price, genomics-enabled approaches to utilizing bacteriophages, or 
perhaps more importantly their gene products, as naturally occurring antimicrobials will 
become increasingly more common. 
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1. Introduction 
The discovery, development and exploitation of antibiotics was one of the most significant 
advances in medicine in 20th century and in a golden era lasting from 1940s to late 1960s, 
antibiotic research provided mankind with a wide range of structurally diverse and effective 
agents to treat microbial infections (Table 1) (McDevitt and Rosenberg, 2001; Hopwood, 
2007). However, antibiotic resistance has developed steadily as new agents have been 
introduced and there has been a dramatic increase in the occurrence of resistant organisms 
in both community and hospital settings for the past 10-15 years. In particular, pathogens 
such as Staphylococcus aureus and Streptococcus pneumoniae and Enterococcus faecalis capable of 
resulting in severe and fatal infections have become increasingly resistant to multiple 
antibiotics. In hospital and community environments, Methicillin-resistant S. aureus (MRSA) 
and Vancomycin resistant enterococci (VRE) have become persistent pathogens. Other 
multiple drug resistant organisms currently include Mycobacterium tuberculosis and 
Pseudomonas, and related species in the hospital environment. Last line of antibiotics such as 
vancomycin might also become ineffective against super-bugs such as vancomycin-
intermediate-resistant S. aureus isolates. New classes of antibiotics with a new mode of 
action (e.g. Linezolid™) are necessary to combat existing and emerging infectious diseases 
deriving from multiple drug resistant agents (McDevitt and Rosenberg, 2001; Hopwood, 
2007).  
An extreme example for yet to be faced outbreaks has been the recent occurrence of multi- 
drug resistant enterohaemorrhagic E. coli in Germany claiming the lives of many 
(Chattaway et al., 2011). Interestingly, this strain acquired virulence genes from another 
group of diarrhoeagenic E. coli, the enteroaggregative E. coli (EAEC), which is the most 
common bacterial cause of diarrhoea. This event once more stressed the importance of 
powerful diagnostic systems to detect all diarrheagenic E. coli as part of routine surveillance 
systems, which would thus contribute to the mapping of the global distribution of EAEC 
(Chattaway et al., 2011; Mellmann et al., 2011). 
For more than a century, infectious diseases have been controlled by vaccination and the 
administration of antibiotics (Muzzi et al., 2007). In spite of the technical progress of the past 
century, innovation in both fields came exclusively from traditional approaches, and 
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introduced and there has been a dramatic increase in the occurrence of resistant organisms 
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action (e.g. Linezolid™) are necessary to combat existing and emerging infectious diseases 
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group of diarrhoeagenic E. coli, the enteroaggregative E. coli (EAEC), which is the most 
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powerful diagnostic systems to detect all diarrheagenic E. coli as part of routine surveillance 
systems, which would thus contribute to the mapping of the global distribution of EAEC 
(Chattaway et al., 2011; Mellmann et al., 2011). 
For more than a century, infectious diseases have been controlled by vaccination and the 
administration of antibiotics (Muzzi et al., 2007). In spite of the technical progress of the past 
century, innovation in both fields came exclusively from traditional approaches, and 
antibiotics have been identified by screening natural compounds for their ability to kill  
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Table 1. Antibiotics since discovery of Streptomycin (adapted from Hopwood, 2007). 
bacteria grown in vitro. Furthermore, by improving existing drugs such as glycylcylines and 
fluoroquinolones deriving from tetracyclines and quinolones, pharmaceutical industries 
aimed to stay "one step ahead" of resistant microorganisms. Although such an approach has 
been effective, it is becoming increasingly difficult to meet the needs of the community and 
to provide sufficient coverage for all emerging infectious agents (McDevitt and Rosenberg, 
2001; Muzzi et al., 2007).  
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To keep pace with microbial resistance, objective and target-directed strategies are needed 
to discover and develop new classes of antibiotics. In the light of the global threat outlined 
above, this chapter will overview emerging novel strategies with particular emphasis on 
bacteriophages as tools in the search for new and potent therapeutic agents from 
actinomycetes. 
2. Genomics based approaches to drug discovery 
Since early 2000s, information from completed genome sequences and genomic based 
technologies has been a driving force in antibiotic discovery resulting in new target 
identification of pathogens as well as in the enhancement of action studies of antimicrobial 
compounds. Exploitation of high-throughput automated DNA sequencing capabilities and 
genome sequences of microbial pathogens advanced rapidly producing full genome 
sequence results (e.g. Enterococcus faecium genome) (Amber, 2000; McDevitt and Rosenberg, 
2001). In the past, antimicrobial studies were conducted on model microorganisms such as 
E. coli and Bacillus subtilis, however, with the new advances, research has become possible 
by directly using pathogens such as Staphylococcus aureus and Streptococcus pneumoniae 
(McDevitt and Rosenberg, 2001; Payne et al., 2007). These developments have led to a shift in 
the discovery of novel vaccines and antimicrobials from the traditional empirical approach 
to a novel knowledge-based approach.  
In conventional drug discovery, whole-cell screening approaches are adapted. This 
approach first identifies an antimicrobial compound and later seeks to establish the cellular 
target of that compound, and the vast majority of antibiotics that are currently used have 
this mode of action (e.g. targeting a limited number of proteins involved in critical cellular 
functions) (McDevitt and Rosenberg, 2001; Mills, 2003; Ricke et al., 2006). Whereas in the 
modern era of genome-driven and target-based approach a target gene is selected and its 
spectrum is identified. After it is validated for its role, cloned and sequenced, its 
corresponding protein product is expressed in an optimized expression system (e.g. Pichia 
pastoris, Baculovirus or E. coli). The target protein is then purified and screened against a 
large and diverse collection of low-molecular weight compounds in order to identify target 
inhibitors to investigate their potency, mechanism of inhibition and enzyme spectrum and 
selectivity (McDevitt and Rosenberg, 2001; Mills, 2003). 
Increasing knowledge of bacterial diversity based on genomics and pangenomics now 
suggests that the way forward should be to focus discovery strategies on the identification 
of targets that are essential for the formation and persistence of an in vivo infection or in the 
expression of virulence factors (Muzzi et al., 2007).  
Sequencing the entire genome of pathogens has revealed all of their open reading frames 
(ORFS), which can be utilized as selected targets in drug discovery. As summarized by 
McDevitt and Rosenberg (2001), there are several key criteria to be considered in target 
selection: “(1) the target should be present in a required spectrum of organisms; (2) it should 
be either absent in humans or, if present, it should be significantly different to allow 
confidence that selective inhibitors of the bacterial target over a human counterpart can be 
developed; (3) it should be essential for bacterial growth or viability under the conditions of 
the infection; (4) it should be expressed and relevant to the infection process; and (5) some 
aspects of its function should be understood to allow the relevant assays and high 
throughput screens to be developed”. 
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Table 1. Antibiotics since discovery of Streptomycin (adapted from Hopwood, 2007). 
bacteria grown in vitro. Furthermore, by improving existing drugs such as glycylcylines and 
fluoroquinolones deriving from tetracyclines and quinolones, pharmaceutical industries 
aimed to stay "one step ahead" of resistant microorganisms. Although such an approach has 
been effective, it is becoming increasingly difficult to meet the needs of the community and 
to provide sufficient coverage for all emerging infectious agents (McDevitt and Rosenberg, 
2001; Muzzi et al., 2007).  
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One example was the use of peptide deformylase (PDF) as a protein target to facilitate 
discovery of a broad spectrum antibacterial drug (Mills, 2003). The protein is encoded by the 
def gene which is present in all pathogenic bacteria, but does not share a functionally 
equivalent gene in mammalian cells, which is one of the most sought after characteristics 
related to a drug candidate (McDevitt and Rosenberg, 2001; Yuan et al., 2001; Mills, 2003). 
This example was a good proof-of-principle illustration of the genomics-driven, target-based 
approach; starting with a conserved gene and leading to an antimicrobial compound 
(Clements et al., 2001; Mills, 2003). 
Genome sequencing studies can also be utilized from the angle of drug producer 
microorganisms (Kurtböke, 2012). An example is the genome sequencing of Salinispora 
tropica, which has revealed its complex secondary metabolome as a rich source of drug-like 
molecules. Such a discovery has been a powerful interplay between genomic analysis and 
traditional natural product isolation studies (Udwary et al., 2007). Other examples that 
reveal the superior ability of actinobacteria to produce potent bioactive compounds 
facilitating discovery of novel bioactive compounds include genome sequences of 
Streptomyces coelicolor A3(2) (Bentley et al., 2002) and S. avermitilis (Ikeda et al., 2003). 
3. Bacteriophages in chemotherapy 
Therapeutic use of bacteriophages for the prevention and treatment of bacterial diseases, has 
been targeted since the discovery of phages in 1917 by Félix d’Hérelle. Following his 
discovery, he first attempted to use these against dysentery and since then, bacteriophages 
have been used to treat human infections as an alternative or a complement to antibiotic 
therapy (Hermoso et al., 2007). Particularly, from 1920s to 1950s, phage therapy has 
exploded and centres in the US, France and Georgia were established (Kütter and 
Sulakvelidze, 2005; Hermoso et al., 2007; Chanishvili, 2009), however, there have been 
limitations to antibacterial phage therapy that hamper its application as an antibiotic 
alternative. These have been summarized recently by Hermoso et al. (2007) as follows: (i) 
phages generally have narrow host range and only strongly lytic phage against bacterial 
strain infecting the patient, should be given to the patient; (ii) phages may not always 
remain lytic under the physiological conditions and bacteria can become resistant to phages 
after infection; (iii) phage preparations should be free of bacteria and their toxic components 
to meet clinical safety requirements, but sterilization of phage preparations could inactivate 
the phages; (iv) phages can be inactivated by a neutralizing antibody, and there is some risk 
of promoting allergic reactions to them; (v) the pharmacokinetics of phage treatments are 
more complicated than those of chemical drugs because of their self-replicating nature; (vi) 
phages might endow bacteria with toxic or antibacterial resistance genes. 
Due to the above-listed limitations of bacteriophage therapy, bacteriophages might have 
more value as tools in drug discovery such as for target discovery and validation, assay 
development and compound design (Brown, 2004; Projan, 2004), and some of these 
exploitations are discussed below. 
3.1 Bacterial virulence and injection mechanisms of bacteriophages 
Efficient host infection relies on bacterial virulence factors being localized outside the 
producing cell where they are identically placed to interact with host defences and subvert 
host cells for the pathogen's benefit. Pathogenic bacteria have thus developed powerful 
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molecular strategies to deliver their virulence factors across the bacterial cell envelope as 
well as powerful mechanisms to adverse host cell plasma membrane (Cambronne and Roy, 
2006; Filloux, 2009; 2011; Russell et al., 2011).  
In Gram-negative bacteria, the cell envelopes have two hydrophobic inner and outer 
membranes with a hydrophilic space in between. The secreted hydrophobic molecules of 
proteins, enzymes or toxins have to travel through the hydrophobic environment of the 
membranes in an aqueous channel, or another type of conduit, that spans the cell envelope. 
These paths to the external medium are built by assembling macromolecular complexes, 
called secretion machines (Filloux, 2009; 2011) and they are distinguishable by the number 
and characteristics of the components such as types I, II and V secretion systems and they 
play important roles in the virulence of pathogens (Filloux et al., 2008; Leiman et al., 2009; 
Pukatzki et al. 2009; Bönemann et al., 2010; Schwarz et al., 2010).  
In type VI secretion systems (T6SS) of Gram-negative bacteria the lack of an outer 
membrane channel for the T6SS might suggest an alternative delivery strategy such as local 
puncturing of the cell envelope to avoid cell lysis whilst allowing transient assembly of the 
secretion machine (Filloux, 2009; 2011). Filloux (2011) points out that the structural proteins 
of the T6SS are very similar to those that make up the injection machinery found in 
bacteriophages. Bacteriophages inject their DNA into bacterial cytosol and use the bacterium 
as a phage factory to replicate phage DNA. Bacterial cell envelope is perforated by 
bacteriophage puncturing device and its DNA is injected into bacterial cell via a tail tube. 
T6SS seems to use the same mechanism used by bacteriophages to inject their DNA into 
bacteria in which some components like the T6SS-specific exoproteins might have a similar 
tail-spike puncturing device of the T4 phage and might create a channel across the bacterial 
envelope which resembles the phage tail tube. T6SS translocation mechanism operate from 
the inside to the outside of the bacterial cell, and might be a mirror image of the phage 
translocation mechanism, which operates from outside to the inside of the bacterial cell 
Filloux (2011). Therefore, a sound understanding of bacteriophage injection and bacterial 
secretion systems might bring new insights to the development of effective therapeutic 
agents. 
3.2 Bacteriophage-guided route to biodiscovery 
Bacteriophages have evolved multiple strategies to interfere with bacterial growth. As a 
result, improved understanding of the bacteriophage-host interactions can also bring a new 
perspective to drug discovery (Young et al., 2000; Brown, 2004; Projan, 2004; Parisien et al., 
2008). Examples include successful use of phage encoded lytic enzymes to destroy bacterial 
targets (Fishetti et al., 2003) and use of lysostaphin to achieve sterilization in an endocarditis 
model (Climo et al., 1998). Furthermore, in a novel approach, Liu et al. (2004) applied 
information deriving from phage genome to target discovery of gene products that inhibit 
pathogenic bacterium such as Staphylococcus aureus. They uncovered strategies used by 
bacteriophage to disable bacteria for design of a method, which uses key phage proteins to 
identify and validate vulnerable targets and exploit them in the identification of new 
antimicrobials.  
Polysaccharide-specific phages were also suggested to treat encapsulated pathogenic bacteria 
since exolysaccharide production in bacteria involves biofilm formation and acts as a barrier 
to the penetration of therapeutic agents. Phages that can polymerize these substances 
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and/or kill the bacteria may potentially be useful for control of bacteria forming biofilms on 
medical devices (Hermoso et al., 2007). Protein antibiotics, which are the gene products of 
some small phages that do not produce endolysins, have also been shown to inhibit cell wall 
synthesis (Bernhardt et al., 2002). Genetic engineering of bacteriophages to carry toxic genes 
or proteins to produce cell death without lysis and hence avoiding the release of unwanted 
endotoxins has also been suggested (Westwater et al., 2003). Furthermore, Hagens et al. 
(2006) proposed a bacteriophage-based strategy to reduce effective doses of antibiotics 
during treatment for resensitization of antibiotic resistant pathogen via the presence of 
phage in vivo. In addition, it has been reported that phage host-cell lysis proteins, encoded 
by holins and amidases and elaborated late in the infection cycle, maintain their potent 
antibacterial activity when administered from outside cell (Loeffler et al., 2001; Schuch et al., 
2002). 
3.3 From bacteriophage genomics to drug discovery 
Over evolutionary time, bacteriophages have developed unique proteins that arrest critical 
cellular processes to commit bacterial host metabolism to phage reproduction (Liu et al., 
2004). Bacterial key metabolic processes can be shut off via inactivation of critical cellular 
proteins with these unique bacteriophage proteins, and host metabolism can be directed into 
the production of progeny phages. As an example; phages of E. coli, host physiology shuttoff 
is typically performed early during the phage lytic cycle by small phage-encoded proteins 
that target particularly vulnerable and accessible proteins involved in crucial host metabolic 
processes. Thus, Liu et al. (2004) using a high-throughput bacteriophage genomics strategy, 
exploited the concept of phage-mediated inhibition of bacterial growth to systematically 
identify antimicrobial phage-encoded polypeptides. They found that four proteins of the 
Staphylococcus aureus DNA replication machinery were targeted by a total of seven unrelated 
phage polypeptides leading to a superior approach to currently available antibiotics which 
only target topoisomerases. In some cases, sequence-unrelated polypeptides from different 
phages were found to target the same proteins in S. aureus, and such susceptibility might 
have uses in antimicrobial drug discovery.  
All these developments including increased understanding of the mechanism of injection, 
beginning with adsorption to the host and ending with complete delivery of genomic 
material (McPartland and Rothman-Denes, 2009) are now paving the way towards 
recruitment of phages in the search for new antibiotics with previously unknown 
antibacterial mechanisms. 
3.4 From endolysins to enzybiotics 
Phages have different methods of progeny release from bacterial cells: filamentous phages 
are ejected from bacterial cell walls without destroying the host cell, whereas non-
filamentous phages induce lysis through lytic enzymes. Phage lytic enzymes are highly 
evolved murein hydrolases to quickly destroy the cell wall of the host bacterium to release 
the progeny. Lysis is a result of abrupt damage to the bacterial cell wall by means of specific 
proteins and as stated by Hermoso et al. (2007) it can be completed in two different ways: (i) 
inhibition of peptidoglycan synthesis by a single protein or (ii) enzymatic cleavage of 
peptidoglycan by lysins or holin-lysin system.  
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Tailed phages achieve correctly-timed lysis by the consequtive use of endolysins and holins. 
Holins are small hydrophobic proteins that are encoded by the phage and inserted into 
cytoplasmic membrane to form membrane lesions or holes for endolysin passage. Whereas 
endolysins are phage-coded enzymes that break down bacterial peptidoglycan at the 
terminal stage of the phage reproduction cycle (Moak and Molineux, 2004; Loessner, 2005; 
Hermoso et al., 2007). Target specificity in endolysin studies reveal differences such as 
bifunctional enzyme of Streptococcus agalactiae phage with glycosidase and endopeptidase 
activities or muramidase activity of Lactobacillus helveticus phage (Loessner, 2005; Hermoso 
et al., 2007). However, most enzymes like amidases from phage that infect Gram-positive 
bacteria feature narrow lysis ranges, which can be genus-specific (Streptomyces aureofaciens) 
and even species-specific (Clostridium perfringens) (Loessner, 2005). Other examples include 
narrow specificity of endolysins only targeting Clavibacter michiganensis subspecies without 
affecting other bacteria in soil including closely related Clavibacter species (Wittmann et al., 
2010). 
Due to increasing antibiotic resistance, phage-derived lytic enzymes are now being 
exploited to control infections. In antibiotic resistant Gram-positive bacteria, it has been 
reported that even small quantities of purified recombinant lysin added externally lead to 
immediate lysis resulting in log-fold of death of the bacterial cells found on the mucosal 
surfaces and infected tissues. They have been suggested to make ideal antiinfectives due to 
lysin specificity for the pathogen that does not disturb the normal flora, the low chance of 
bacterial resistance towards lysins, and their ability to kill colonizing pathogens on mucosal 
surfaces illustrating a previously unavailable capacity (Hermoso et al., 2007, Fenton et al., 
2010; Fishetti, 2010). These enzymes are suggested to particularly be useful to control 
antibiotic resistant Gram-positive pathogens. In this group of bacteria, lysins can make 
direct contact with their cell wall carbohydrates and peptidoglycan externally making them 
suitable candidates in clinical applications (Loessner, 2005; Hermoso et al., 2007). 
Another example is Mycobacterium, phylogenetically related to Gram-positive bacteria but 
its cell envelope has a double-membrane structure similar to Gram-negative bacteria. Cell 
envelopes of mycobacteria contain peptidoglycan-arabinogalactan-mycolic acid complex 
(Sutcliffe, 2010). Mycobacteriophages must not only degrade the peptidoglycan layer but 
must also circumvent a mycolic acid-rich outer membrane covalently attached to the 
arabinogalactan-peptidoglycan complex. They utilize two lytic enzymes to produce lysis: (i) 
Lysin A that hydrolyzes peptidoglycan, and (ii) Lysin B, a novel mycolylarabinogalactan 
esterase, that cleaves the mycolylarabinogalactan bond to release free mycolic acids (Payne 
et al., 2009) and the study of phage ejection mechanisms in this group of bacteria might lead 
to the discovery of novel lytic systems and thus new antimicrobial agents.  
Effective antimicrobial activity against Gram-positive bacterial pathogens including 
Streptococcus pneumoniae and Bacillus anthracis by exogenously applied phage-encoded 
endolysins has already been demonstrated. This approach has however, proved ineffective 
against Gram-negative bacteria since the outer membrane blocks access to the peptidoglycan 
targets (Fishetti, 2008). Due to their mycolic acid, rich outer membrane mycobacteria are 
likely to be similarly intractable to exogenously added endolysins. In order to overcome this 
resistance, a novel approach has been proposed by Payne et al. (2009) to render 
mycobacterial pathogens such as M. tuberculosis susceptible to endolysin treatment through 
co-treatment with LysA and LysB proteins.  
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Another example is Mycobacterium, phylogenetically related to Gram-positive bacteria but 
its cell envelope has a double-membrane structure similar to Gram-negative bacteria. Cell 
envelopes of mycobacteria contain peptidoglycan-arabinogalactan-mycolic acid complex 
(Sutcliffe, 2010). Mycobacteriophages must not only degrade the peptidoglycan layer but 
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arabinogalactan-peptidoglycan complex. They utilize two lytic enzymes to produce lysis: (i) 
Lysin A that hydrolyzes peptidoglycan, and (ii) Lysin B, a novel mycolylarabinogalactan 
esterase, that cleaves the mycolylarabinogalactan bond to release free mycolic acids (Payne 
et al., 2009) and the study of phage ejection mechanisms in this group of bacteria might lead 
to the discovery of novel lytic systems and thus new antimicrobial agents.  
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Streptococcus pneumoniae and Bacillus anthracis by exogenously applied phage-encoded 
endolysins has already been demonstrated. This approach has however, proved ineffective 
against Gram-negative bacteria since the outer membrane blocks access to the peptidoglycan 
targets (Fishetti, 2008). Due to their mycolic acid, rich outer membrane mycobacteria are 
likely to be similarly intractable to exogenously added endolysins. In order to overcome this 
resistance, a novel approach has been proposed by Payne et al. (2009) to render 
mycobacterial pathogens such as M. tuberculosis susceptible to endolysin treatment through 
co-treatment with LysA and LysB proteins.  
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In-depth understanding of the host-phage interaction and the full lytic-system is required to 
design effective biocontrol strategies using bacteriophage lysins. In this search, another rich 
source for mycobacterial phages might be the activated sludge systems where fascinating 
suborder, family, genus and species-specific host-phage interactions occur (Thomas et al., 
2002). Recent genome sequencing of a Tsukamurella phage again isolated from an activated 
sludge system reveals a modular gene structure that shares some similarity with those of 
Mycobacterium phages (Petrovski et al., 2011). Accordingly, phylum level perspective and 
understanding of bacterial cell wall envelope architecture (Sutcliffe, 2010) with particular 
emphasis on monoderm and diderm bacteria, and translation of this understanding to 
phage lytic activity will advance current knowledge and contribute towards design and 
application of new phage-derived therapeutics. Actinobacteria-specific proteins, mainly 
specific for the Corynebacterium, Mycobacterium and Nocardia subgroups, have also been 
reported (Venture et al., 2007) and such specific proteins might have implications for the 
control of these pathogens. Mycetoma, a chronic granumatous infection persistent 
worldwide and endemic to tropical and subtropical regions, is another example (Linchon 
and Khachemoune, 2006) and among bacteria Actinomadura species reportedly cause the 
disease. However, in spite of trials in many different laboratories, phages specific to 
Actinomadura species were not reported until early 1990s (Long et al., 1993; Kurtböke et al., 
1993b). Phages isolated towards different species of Actinomadura from organic mulches 
used in avocado plantations revealed that they belonged to Siphoviridae group of phages 
(Kurtböke et al., 1993b). Further studies on the Actinodamura phage and host-cell-wall 
interactions might shed light on the development of effective treatment strategies deriving 
from phage lytic activity on the pathogenic host.  
Furthermore, metagenomics sequencing studies of uncultured viral populations have 
provided new insights into bacteriophage ecology. The cloning of phage lytic enzymes from 
uncultured viral DNA, and observations into colony lysis following exposure to inducing 
agent, revealed the value of viral metagenomes as potential sources of recombinant proteins 
with biotechnological value (Schmitz et al., 2010). Functional screens of viral metagenomes 
will inevitably provide a large source of recombinant proteins which might subsequently be 
used to treat infections resulting from difficult to control pathogens. 
3.5 Prophage genomics 
Prophage genomics has increased our understanding of the phage-bacterium interaction at 
the genetic level. Data deriving from these studies has also revealed genetic rules that 
underlie the arms race between the host bacterium and the infecting virus (Wagner and 
Waldor, 2002; Canchaya et al., 2003). Studies into non-pathogenic bacteria inhabiting varied 
but defined environments have also improved our understanding of the prophage 
contribution to the fitness increase of host bacterial cells. Even environmental and 
commensal bystander bacteria have been shown to be converted into toxin-producing ones 
via lysogenization (Chibani-Chennoufi et al., 2004).  
Prophage genomics studies will possibly lead to discovery of important genes for the 
ecological adaptation of bacterial commensals and symbionts (Canchaya et al., 2003; Venture 
et al., 2007). Moreover, prophage genomics studies will provide further information on the 
expression of many lysogenic conversion genes (Canchaya et al., 2003) and all this 
information will then provide significant clues to be further exploited in drug discovery.  
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4. Natural products 
Natural products have historically made significant contributions to the provision of new 
lead candidates in drug discovery programs (Newman and Cragg, 2004 a,b). Most 
characteristic features of the secondary metabolites are their incredible array of unique 
chemical structures and can be exploited as lead compounds, for chemical synthesis of new 
analogues or as templates, in the rational drug design studies. Their very frequent 
occurrence, versatile bioactivities and the rich structural and stereochemical attributes of 
natural products promote these compounds as valuable molecular scaffolds to explore their 
chemotherapeutic potential (Demain and Fang, 2000; Croteau et al., 2000; Firn and Jones, 
2002). However, to continue to be competitive with other drug discovery methods, natural 
product research needs to continually improve the speed of the screening, isolation, and 
structure elucidation processes, as well addressing the suitability of screens for natural 
product extracts and dealing with issues involved with large-scale compound supply 
(Butler, 2004). Current alternative strategies include exploitation opportunities for drug 
discovery arising from an understanding of the mode of action of existing antibiotics. In this 
way, biochemical pathways or processes (e.g. peptidoglycan synthesis, tRNA synthesis, 
transcription and DNA replication) inhibited by antibiotics already in clinical use may 
contain key functions that represent unexploited targets for further drug discovery. Since 
most of these antibiotics are of natural product origin they might provide further clues in 
the search for their alternatives (Chopra et al., 2002).  
4.1 Bioactive compounds from microbial resources 
In industrial applications, microbial secondary metabolites are often defined as “low 
molecular mass products of secondary metabolism,” which include antibiotics, pigments, 
toxins, effectors of ecological competition and symbiosis, pheromones, enzyme inhibitors, 
immunomodulating agents, receptor antagonists and agonists, pesticides, antitumor agents 
and growth promoters (Demain and Fang, 2000; Bérdy, 2005; Bull, 2004; 2007; 2010) (Table 2 
and 3).  
 
Amino sugars Glycopeptides Phenazines Pyrrolines 
Anthocyanins Glycosides Phenoxazinones Pyrrolizines 
Anthraquinones Hydroxylamines Phthaldehydes Quinolines 
Aziridines Indole derivatives Piperazines Quinones 
Benzoquinones Lactones Polyacetylenes Salicylates 
Coumarines Macrolides Polyenes Terpenoids 
Diazines Naphthalenes Polypeptides Tetracyclines 
Epoxides Naphthoquinones Pyrazines Tetronic acids 
Ergot alkoloids Nitriles Pyridines Triazines 
Flavonoids Nucleosides Pyrones Tropolones 
Furans Oligopeptides Pyrroles Vanillin 
Glutarimides Perylenes Pyrrolidones Zeaxanthin 
Table 2. Examples of classes of organic compounds deriving from microbial secondary 
metabolites (adapted from Demain, 1981 and reproduced from Kurtböke, 2010a) 
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ACTH-like Complement inhibition Hemolytic Leukemogenic 
Anabolic Convulsant Hemostatic Motility inhibition 
Analeptic Dermonecrotic Herbicidal Nephrotoxic 
Anesthetic Diabetogenic Hormone releasing Paralytic 
Anorectic Diuretic Hypersensitizing Parasympathomimetic 
Anticoagulant Edematous Hypochloresterolemic Photosensitizing 
Antidepressive Emetic Hypoglycemic Relaxant (smooth muscle) 
Antihelminthic Enzyme inhibitory Hypolipidemic Sedative 
Anti-infective Erythematous Hypotensive Serotonin antagonist 
Anti-inflammatory Estrogenic Immunostimulating Spasmolytic 
Anti-parasitic Coagulative (blood) Hallucinogenic Telecidal 
Anti-spasmodic Fertility enhancing Inflammatory Ulcerative 
Carcinogenesis inhibition Complement inhibition Hemolytic Vasodilatory 
Coagulative (blood) Hallucinogenic Insecticidal Anti-viral 
Table 3. Pharmacological activities of microbial secondary metabolites (adapted from 
Demain, 1983 and reproduced from Kurtböke, 2010a) 
However, existing antibiotics have mode of actions directed at a narrow spectrum of targets, 
principally cell wall, DNA and protein biosynthesis and so far multidrug resistance among 
bacterial pathogens has been largely due to a limited repertoire of antibacterial drugs that 
eradicate bacteria using a narrow range of mechanisms (Brown, 2004; Baltz, 2005; 2006a,b; 
2008). Novel structural attributes are also required and only one new class of antibiotics has 
reached the clinic since 2001 (Ford et al., 2001). Currently, many novel microorganisms are 
being isolated from extreme biological niches, revealing their own chemical defence 
mechanisms. These naturally occurring organisms, together with recombinant organisms 
generated using combinatorial genetics and the availability of new chimeric metabolic 
pathways, might deliver an abundance of new compounds (Payne et al., 2007; Goodfellow 
2010).  
As advocates of natural product screening to search for novel antibacterial leads, Payne et al. 
(2007) adapted an alternative innovative approach with the belief that leads were not going 
to come from screening, but from alternative approaches. They reconsidered known 
antibacterial molecules to see whether they could improve their antibacterial and 
developmental properties and along these lines, they modified the pleuromutilin core 
structure in ways to bring three derivatives into clinical development. They also found lead 
molecules by screening a small, discrete library of compounds for antibacterial activity, 
which resulted in the discovery of a novel compound class capable of inhibiting bacterial 
DNA replication, and reached the developmental stage.  
In the light of the above-mentioned advances, revisiting natural products with target-
directed strategies might again provide us with novel and potent therapeutic agents. 
4.2 Actinomycetes and drug discovery 
Among the bacteria, the members of the order Actinomycetales have proved to be a 
particularly rich source of secondary metabolites with extensive industrial applications 
(Table 4).  
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Source Bioactive secondary metabolites 
 Antibiotics Bioactive metabolites Total bioactive 
metabolites 








Bacteria 2900 780 900 1680 3800 
Actinomycetes 8700 2400 1400 3800 10100 
Fungi 4900 2300 3700 6000 8600 
Total 16500 5500 6000 11500 22500 
Table 4. Bioactive compounds of microbial origin (adapted from Bérdy, 2005 and 
reproduced from Kurtböke, 2010b). 
In particular, the capacity of the members of the genus Streptomyces to produce 
commercially significant compounds, especially antibiotics, remains unsurpassed, possibly 
because of the extra-large DNA complement of these bacteria (Goodfellow and Williams, 
1986; Kurtböke, 2010a; 2012). Members from this genus are even predicted to be the 
producers of many novel yet to be discovered bioactive compounds (Watve et al., 2001). As a 
result, selective isolation of previously undetected bioactive actinomycetes is one of the 
major targets of industrial microbiologists in the search for novel therapeutic agents (Bull et 
al., 2000; Bull and Stach, 2007; Goodfellow, 2010; Goodfellow and Fiedler, 2010; Kurtböke, 
2003; 2010a). 
The range of versatility of actinomycete metabolites is enormous and yields significant 
economic returns, yet, biodiscovery from these sources depends on the  
i. detection and recovery of bioactive actinomycete fraction from previously unexplored 
environmental sources,  
ii. effective assessment of their metabolites in defined targets (Goodfellow, 2010; 
Kurtböke, 2003; 2010a). 
4.3 Bacteriophage-guided route to detection of rare actinomycetes  
Chemical diversity of bioactive compounds, particularly from those rare and "yet to be 
discovered" actinomycetes is promising, however, detection of bioactive actinomycete taxa 
requires in-depth understanding of their true diversity and eco-physiology through which 
target-directed isolation strategies can be implemented (Bull et al., 2000; Bull, 2003; 
Kurtböke, 2012).  
Isolation of bioactive rare actinomycete taxa requires highly specialised isolation techniques 
(Lazzarini et al., 2000; Kurtböke, 2003; Goodfellow 2010), and those employed range from 
the use of antibiotics to chemotaxis chambers, and excessive heat treatments (Hayakawa, 
2003; Terekhova, 2003; Okazaki, 2003; Goodfellow 2010). In this context, bacteriophages 
have also proved to be useful tools in different applications, such as naturally-present 
indicators of under-represented or rare actinobacterial taxa in environmental samples; or as 
tools for deselecting unwanted taxa on the isolation plates in the process of target specific 
search for rare actinomycete taxa (Kurtböke, 2003; 2009; 2010b; 2011). 
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Bacteriophages 248 
4.3.1 Actinophages as naturally-present indicators of rare actinomycetes in 
environmental samples 
Presently, more than 50 rare actinomycete taxa are reported to be the producers of 2500 
bioactive compounds (Bérdy, 2005), including several clinically important antibiotics such as 
vancomycin, erythromycin, tobramycin, apramycin, and spinosyns. However, these 
actinomycetes are not commonly cultured from natural substrates. Vancomycin producer 
Amycolatopsis sp. or spinosyn producer Saccharopolyspora sp. were found to be 4% and 3% 
abundant (Baltz, 2005).  
Bacteriophages indicate presence of their host bacteria in an environmental sample and 
increased phage titre to detectable levels reflects the growth of indigenous host cells, and 
failure to do so reflects their absence from that source (Goyal, 1987). High densities of 
phages were reported in soils with conditions favourable for the host proliferation (Reanney 
and Marsh, 1973; Goyal et al., 1987). This ecological reality has been used to utilize 
bacteriophages as naturally-present indicators of under-represented or rare actinobacterial 
taxa in environmental samples (Williams et al., 1993; Kurtböke, 2003; Kurtböke, 2005; 2007; 
2010b; 2011). Examples include detection of indicator phages towards actinomycetes 
including members of the genera Saccharopolyspora and Salinispora species (Kurtböke, 2009). 
4.3.2 Exploitation of phages as deselection agents of unwanted taxa on isolation 
plates to recover rare actinomycetes from environmental samples 
Direct analysis of rRNA gene sequences and birth of metagenomic studies showed that the 
vast majority of microorganisms present in the environment had not been captured by 
culture-dependent methods (Handelsman, 2004). Current advances such as microarrays  
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Fig. 1. Use of polyvalent streptomycete phage to reduce their numbers on isolation plates of 
a soil sample (A: without phage, B: with phage)  
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targeting the 16S rRNA gene of bacteria and archaea and the use of PhyloChips to identify 
specific members within a complex microbial community as well as targeting known 
functional gene markers to study functional gene diversity and activities of microorganisms 
in specific environment reveal true microbial diversity (Andersen et al., 2010). Functional 
gene arrays (GeoChips) have also been used to analyse microbial communities, and provide 
linkages of microbial genes/populations to ecosystem processes and functions (Andersen et 
al., 2010). Culturing representatives of these microorganisms with particular reference to 
previously explored environments such as those extreme and marine, has thus importance 
for biotechnological applications (Kennedy et al., 2007; Joint et al., 2010). 
 
 
Fig. 2. Use of phage battery to reduce the numbers of (a) unwanted bacteria and (b) 
streptomycetes on ½ TSA plates to isolate rare actinomycetes. (1): Without phage, (2): With 
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Once information is generated on microbial diversity via above-listed molecular advances, 
phages can again be effective tools to remove unwanted taxa on the isolation plates in the 
process of target specific isolation of targeted taxa such as rare actinomycetes (Kurtböke et 
al., 1992; Kurtböke, 2003; Kurtböke, 2011). Examples include removal of smearing bacterial 
contaminants (e.g. as Bacillus species) rendering isolation of rare actinomycetes difficult 
from heated material on the isolation plates via phage battery (Kurtböke et al., 1993b; 
Kurtböke, 2003) (Figure 2 a,b).  
Furthermore, layer by layer removal of unwanted soil taxa can also reveal bioactive 
fractions of the test sample under study (Kurtböke et al., 2002; Kurtböke and French, 2007). 
This fact is illustrated in Figure 1 where removal of streptomycete fraction of the sample 
reveals the presence of other bacterial taxa which are obviously susceptible to the antibiotic 
activity of streptomycetes (Kurtböke et al., 1992). This approach can particularly be useful in 
the detection of antimicrobial compound producing actinomycetes, even including novel 
streptomycetes in the samples, proved to be carrying antibiotic-resistant bacteria. It is a 
known fact that most studied environments can still yield novel members of bioactive 
genera (Williams et al., 1984) and revisiting these environments via the aid of indicator 
phages might render new bioactive species. 
It is important to note that in-depth understanding of each sample‘s natural characteristics 
and its microfloral diversity is required for successful application of phage battery as a tool 
for selective isolation. In every different sample, a new set of bacteriophages suitable for the 
nature of the sample, has to be used to remove layers only to be present in that sample. 
Accordingly, new sets of phages obtained against contaminating background will be 
required for complete reduction in the numbers of background bacteria in each different 
sample (Kurtböke et al., 1992). 
5. Conclusion  
Bacteriophages can be powerful tools in the detection of bioactive actinomycetes and 
facilitate the discovery of novel bioactive compounds. They can offer more than we 
currently benefit from them if improved understanding of the host-phage ecology can be 
generated. Sound knowledge of microbial taxonomy is also a prerequisite for the effective 
use of bacteriophages in selective isolation procedures. Phage cross infectivity should also 
be interpreted carefully before they can be effectively exploited to select bioactive bacterial 
taxa (Kurtböke, 2011). In addition, current expansion of knowledge of phage and prophage 
genomics and phage infective mechanisms of host bacteria will provide a platform for the 
effective use of phages in biodiscovery.  
Targeting host bacterial functional diversity, in which, certain metabolic activities might be 
triggered in a defined ecosystem following phage-mediated gene transfer might also offer 
clues for bioactivity (e.g. abolishment of rapamycin production as a consequence of phage 
insertion and its restoration upon the loss of the inserted phage by a second recombination 
(König et al., 1997)). An evaluation of the role of host-phage interactions in antibiotic 
production as well as in rendering antibiotics ineffective via lysogenation or prophage 
exertion will also further complement therapeutic success, and all this provides enough 
reason for the value of phages to be reconsidered in the post-genomic era (Kurtböke, 2011). 
Current expertise of host receptor recognition by phages and the specificity of phage-
derived lytic enzymes also needs to be developed further as well as an in-depth 
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understanding of the ecological and evolutionary reasons for monovalency and polyvalency 
(Kurtböke, 2011). Through such cumulative information, bacteriophages will gain increasing 
value as tools in drug discovery with their further use ranging from assay development to 
compound design (Brown, 2004; Projan, 2004). 
6. In Memoriam  
This chapter is dedicated to the memory of Professor Romano Locci (1937-2010), University 
of Milan and University of Udine, Italy. 
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